data_1txe_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1txe _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.586 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 47.8 ttm . . . . . 0 CA--C 1.508 -0.649 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -139.46 151.81 46.51 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.7 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 2.2 pt20 -103.73 149.05 25.35 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 123.757 0.661 . . . . 0.0 111.243 176.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -138.25 103.68 4.99 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.323 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 48.9 m -91.34 120.16 31.98 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.493 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 73.6 m-85 -109.97 137.82 47.21 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 124.831 1.252 . . . . 0.0 111.726 -174.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.0 m -96.62 109.93 22.45 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 174.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.509 HG12 ' H ' ' A' ' 10' ' ' ASP . 10.8 tt -63.11 152.14 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.87 0 CA-C-O 121.1 0.476 . . . . 0.0 111.552 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.401 ' N ' HG12 ' A' ' 8' ' ' ILE . 23.6 pt -116.12 -14.9 10.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 O-C-N 122.033 -0.417 . . . . 0.0 110.879 176.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.509 ' H ' HG12 ' A' ' 8' ' ' ILE . 28.8 t70 -76.39 135.22 39.47 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.356 0.598 . . . . 0.0 111.589 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 . . . . . 0 C--N 1.299 -1.597 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.511 178.88 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.456 ' O ' ' HD2' ' A' ' 18' ' ' PRO 0.497 0.8 OUTLIER . . . . . 0 CA--C 1.521 -0.157 0 CA-C-O 122.282 1.039 . . . . 0.0 113.778 . . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.72 -31.84 69.99 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.209 -1.36 . . . . 0.0 113.98 -172.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.414 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 13.2 tpp180 -57.01 -56.07 37.32 Favored Pre-proline 0 CA--C 1.559 1.324 0 CA-C-O 118.669 -0.682 . . . . 0.0 112.193 -178.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.536 ' HA ' ' OE2' ' A' ' 84' ' ' GLU . 82.1 Cg_exo -48.83 -45.9 26.67 Favored 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 122.598 2.199 . . . . 0.0 112.347 172.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.429 ' O ' HG22 ' A' ' 23' ' ' VAL . . . -65.36 -27.08 68.32 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.478 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.496 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 18.2 m -72.6 -28.81 63.01 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 61.7 mtt -71.62 -35.23 70.37 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 174.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -60.22 -41.77 93.79 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.236 172.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.496 ' HB ' ' O ' ' A' ' 20' ' ' THR . 47.8 t -51.85 -56.15 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 O-C-N 124.458 1.099 . . . . 0.0 110.523 175.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -67.65 -26.99 66.49 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 120.812 0.339 . . . . 0.0 111.494 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.0 m -71.05 -52.7 17.98 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.02 -30.57 71.05 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.586 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.5 m -62.15 -31.02 71.46 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.74 8.09 45.08 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -173.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -101.73 150.73 22.83 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.56 176.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -63.37 -42.44 98.85 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 121.819 0.818 . . . . 0.0 108.966 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.587 ' OG ' ' HA3' ' A' ' 67' ' ' GLY . 13.3 m -71.88 149.24 45.35 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.722 -177.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -102.61 130.35 49.47 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.366 173.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.41 HG23 HG23 ' A' ' 63' ' ' ILE . 3.2 mp -108.21 126.04 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.085 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -98.82 136.3 39.04 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 174.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.67 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 40.4 tp -104.04 117.91 35.4 Favored 'General case' 0 C--N 1.277 -2.578 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -114.53 106.52 14.37 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-O 121.185 0.517 . . . . 0.0 110.226 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -131.23 94.58 3.6 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.077 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.6 t30 41.3 69.41 0.35 Allowed 'General case' 0 C--O 1.247 0.961 0 C-N-CA 125.902 1.681 . . . . 0.0 113.753 173.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.18 -26.69 23.57 Favored Glycine 0 CA--C 1.502 -0.749 0 C-N-CA 120.846 -0.693 . . . . 0.0 111.731 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.58 99.78 10.7 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 178.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.67 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -116.55 133.16 56.35 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-N 115.287 -0.869 . . . . 0.0 108.997 171.679 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 p -156.16 155.14 5.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.826 -172.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -62.56 118.17 7.22 Favored 'General case' 0 C--O 1.208 -1.12 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 169.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.7 tp -64.26 -20.13 65.85 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -90.39 3.27 54.24 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 119.332 -0.947 . . . . 0.0 111.024 175.111 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.3 m -115.55 136.19 53.33 Favored 'General case' 0 N--CA 1.415 -2.185 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.3 pp -81.79 9.35 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -173.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 49.7 ttp -88.82 60.13 5.38 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.681 1.229 . . . . 0.0 110.403 -170.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.51 -45.27 0.69 Allowed Glycine 0 N--CA 1.426 -1.97 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 -175.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.32 -34.71 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 114.649 -0.775 . . . . 0.0 111.713 -177.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -76.73 -16.62 59.44 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.778 -173.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.8 m -116.44 17.56 15.43 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.192 0.52 . . . . 0.0 109.643 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.1 tp -62.93 112.51 2.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.121 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.76 56.55 2.61 Favored Glycine 0 C--N 1.31 -0.863 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.081 -176.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.5 m -87.2 138.08 19.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-O 120.937 0.399 . . . . 0.0 112.013 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -158.02 134.92 4.08 Favored Glycine 0 C--O 1.207 -1.569 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . 0.317 14.7 ptmm? 20.12 -64.28 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.09 0 N-CA-C 118.604 2.816 . . . . 0.0 118.604 -176.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -77.14 -8.59 57.77 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.78 -0.575 . . . . 0.0 111.769 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.1 109.07 5.64 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.305 0.574 . . . . 0.0 112.27 -175.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 31.6 mt-10 -98.42 119.46 37.16 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.439 HD13 HG22 ' A' ' 61' ' ' ILE . 17.6 pt -106.16 142.94 17.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.717 -173.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.1 m -114.47 125.93 54.38 Favored 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.95 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.6 mp -99.97 135.33 36.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.7 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 40.5 m-85 -121.5 114.6 21.46 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 172.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.586 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -107.02 125.06 50.52 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -128.97 123.08 31.52 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 177.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.587 ' HA3' ' OG ' ' A' ' 31' ' ' SER . . . 178.36 -171.88 44.27 Favored Glycine 0 N--CA 1.429 -1.78 0 C-N-CA 120.226 -0.988 . . . . 0.0 111.421 -174.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.6 t -85.85 -13.43 48.01 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 174.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -128.82 37.85 4.03 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.646 -178.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.463 ' O ' HG12 ' A' ' 74' ' ' ILE 0.336 0.0 OUTLIER -67.34 -48.17 68.32 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 -173.774 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.17 -32.83 73.5 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.26 0.552 . . . . 0.0 111.026 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -74.83 -39.08 61.83 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.707 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.55 ' O ' ' HB ' ' A' ' 77' ' ' ILE . . . -61.71 -41.33 97.47 Favored 'General case' 0 C--O 1.201 -1.488 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 70' ' ' GLU . 28.1 mm -57.26 -49.53 79.58 Favored 'Isoleucine or valine' 0 C--O 1.248 0.974 0 C-N-CA 123.536 0.735 . . . . 0.0 111.271 176.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -67.22 -31.06 71.18 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 120.452 -0.499 . . . . 0.0 112.196 -176.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.17 -42.26 38.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.333 0.587 . . . . 0.0 109.744 175.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.55 ' HB ' ' O ' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -56.32 -43.31 76.69 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 C-N-CA 124.701 1.2 . . . . 0.0 111.758 179.783 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 56.2 m -63.51 -44.69 93.58 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -59.21 -53.54 57.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.763 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.6 m -67.1 -37.73 79.84 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.016 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.795 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 29.9 mt -65.47 -35.26 80.38 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.3 p -75.65 -34.64 60.53 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.398 177.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -62.52 -39.08 92.4 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.528 0.68 . . . . 0.0 109.894 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.536 ' OE2' ' HA ' ' A' ' 18' ' ' PRO . 5.6 mm-40 -87.22 -3.98 59.07 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.962 -177.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.4 15.25 80.31 Favored Glycine 0 C--N 1.317 -0.504 0 N-CA-C 115.746 1.058 . . . . 0.0 115.746 173.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.486 ' HA ' HG13 ' A' ' 8' ' ' ILE . 4.9 mp -88.81 5.59 42.92 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 118.607 1.203 . . . . 0.0 110.474 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.472 ' HB ' ' HB3' ' A' ' 6' ' ' TYR . 10.2 t -163.23 156.12 18.83 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.5 176.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 N--CA 1.419 -2.004 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 167.18 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.508 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 90.2 mtp . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -103.58 151.04 23.37 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 174.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.669 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 16.8 pt20 -111.22 150.08 30.06 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-O 121.724 0.774 . . . . 0.0 112.744 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.472 ' O ' ' HA ' ' A' ' 62' ' ' THR . 8.5 mm-40 -128.67 119.46 24.72 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 114.014 -1.448 . . . . 0.0 109.288 176.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.5 t -98.72 97.31 8.57 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 176.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.572 ' HH ' HG22 ' A' ' 77' ' ' ILE . 56.9 m-85 -88.1 127.59 35.41 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.575 -176.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.4 m -88.84 90.1 8.27 Favored 'General case' 0 N--CA 1.409 -2.475 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 172.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.678 ' O ' ' HA ' ' A' ' 57' ' ' LYS . 8.4 mt -71.91 131.13 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.063 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 33.9 pt -125.65 23.3 3.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.457 ' HB2' ' HA ' ' A' ' 86' ' ' LEU . 25.1 t70 -71.4 104.68 3.28 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.572 -177.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 C--N 1.305 -1.368 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -174.891 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 . . . . . 0 C--O 1.24 0.586 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.12 -43.93 73.44 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.498 ' O ' HG23 ' A' ' 20' ' ' THR 0.258 26.9 mmt180 -60.16 -47.66 96.24 Favored Pre-proline 0 N--CA 1.473 0.703 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 -178.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -53.76 -45.39 41.37 Favored 'Trans proline' 0 C--N 1.363 1.324 0 C-N-CA 121.582 1.521 . . . . 0.0 110.401 174.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.407 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -67.74 -34.34 76.65 Favored 'General case' 0 C--O 1.205 -1.264 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.593 -178.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 17' ' ' ARG . 1.3 t -71.16 -28.12 64.04 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.183 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.2 mtm -78.37 -28.47 47.1 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 175.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.12 -42.4 93.96 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 170.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 19' ' ' ALA . 55.7 t -56.45 -49.51 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.941 173.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.404 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 29.0 tt0 -59.37 -27.48 66.01 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.446 1.098 . . . . 0.0 111.715 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.425 ' O ' ' HD1' ' A' ' 29' ' ' PHE . 94.4 m -80.73 -56.55 4.07 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.62 86.13 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.242 -176.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.8 m -59.09 -29.14 67.12 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -119.05 14.1 13.09 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 -170.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.425 ' HD1' ' O ' ' A' ' 25' ' ' THR . 6.7 m-85 -99.33 9.94 42.38 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.248 -0.581 . . . . 0.0 112.207 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.5 t70 48.97 39.49 14.72 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 123.559 1.647 . . . . 0.0 110.486 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.459 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 21.7 m -143.35 141.22 30.86 Favored 'General case' 0 N--CA 1.393 -3.307 0 CA-C-N 112.897 -1.956 . . . . 0.0 107.18 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -95.64 98.73 10.71 Favored 'General case' 0 N--CA 1.391 -3.423 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.493 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 97.9 mt -93.1 125.42 45.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.888 177.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -119.9 147.08 45.16 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.3 tt -106.7 112.85 26.03 Favored 'General case' 0 N--CA 1.399 -2.986 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 41' ' ' LYS . 8.6 tp10 -98.76 116.11 30.27 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 175.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -141.08 108.01 5.42 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.354 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 42.02 77.91 0.05 Allowed 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 126.409 1.883 . . . . 0.0 113.476 173.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.33 -52.83 0.64 Allowed Glycine 0 N--CA 1.418 -2.542 0 C-N-CA 119.721 -1.228 . . . . 0.0 112.397 175.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.7 147.65 48.59 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 -173.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.471 ' H ' ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -103.9 131.48 51.07 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 113.696 -1.593 . . . . 0.0 108.766 177.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.9 p -125.98 137.84 56.46 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.753 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -54.44 125.06 18.04 Favored 'General case' 0 C--O 1.207 -1.144 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 172.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.23 -14.34 61.32 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 121.633 0.73 . . . . 0.0 111.167 -174.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.2 3.39 54.94 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 121.486 -0.759 . . . . 0.0 110.329 172.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 57.2 m -113.29 124.85 53.46 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.429 177.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.424 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -78.58 8.64 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 123.068 0.547 . . . . 0.0 112.413 -173.635 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 16.5 tpt -105.59 78.08 1.33 Allowed 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -168.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 135.75 -32.71 2.49 Favored Glycine 0 C--N 1.291 -1.958 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -173.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 88.0 t -80.97 -43.4 20.69 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 CA-C-N 114.965 -0.617 . . . . 0.0 110.529 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.5 mtt -65.65 -40.19 92.19 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 119.205 -0.998 . . . . 0.0 111.451 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.4 m -80.57 16.53 1.34 Allowed 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 176.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.7 tp -65.92 107.08 1.73 Allowed 'General case' 0 C--O 1.244 0.777 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.93 55.6 4.53 Favored Glycine 0 C--O 1.222 -0.635 0 N-CA-C 110.519 -1.033 . . . . 0.0 110.519 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.4 p -88.13 139.35 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -173.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -122.86 -83.03 0.62 Allowed Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 119.802 -1.189 . . . . 0.0 113.48 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.678 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -169.15 136.49 1.83 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -177.037 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.3 t70 74.83 4.81 4.36 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 123.033 1.397 . . . . 0.0 107.801 -171.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.18 108.61 7.08 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 113.345 -1.752 . . . . 0.0 109.818 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -83.36 110.81 18.45 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 123.627 0.579 . . . . 0.0 110.308 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.421 ' CG1' ' HB2' ' A' ' 6' ' ' TYR . 25.3 pt -106.09 143.44 17.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 174.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 4' ' ' GLN . 28.1 m -112.94 111.41 22.14 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 121.557 0.694 . . . . 0.0 111.405 -176.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.571 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.4 mp -89.56 135.4 26.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.416 177.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.669 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 34.2 m-85 -117.29 119.13 34.22 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 172.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -114.65 122.4 46.35 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.508 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 25.8 t70 -136.05 122.83 21.15 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.495 ' N ' ' HB3' ' A' ' 70' ' ' GLU . . . -178.29 -170.04 39.9 Favored Glycine 0 C--N 1.287 -2.155 0 C-N-CA 119.024 -1.56 . . . . 0.0 112.209 -173.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.0 m -76.83 -30.15 56.24 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.603 0.716 . . . . 0.0 109.31 175.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -124.06 30.17 6.2 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.097 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.544 ' O ' HG12 ' A' ' 74' ' ' ILE . 12.4 pt-20 -54.1 -42.96 69.98 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -175.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.85 -31.93 72.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.594 0.711 . . . . 0.0 110.906 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -83.32 -32.3 26.38 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.138 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.99 -28.74 68.5 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.941 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 70' ' ' GLU . 25.3 mm -54.04 -48.3 64.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 O-C-N 123.857 0.723 . . . . 0.0 110.85 175.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -68.44 -39.65 81.43 Favored 'General case' 0 N--CA 1.403 -2.781 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.86 -47.26 84.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.823 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.572 HG22 ' HH ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -66.74 -36.4 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.868 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.623 -179.615 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 41.0 m -68.03 -40.04 82.99 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 175.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.485 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 20.1 t70 -56.18 -56.15 24.41 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.904 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.1 m -61.76 -36.85 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 38.6 mt -63.47 -48.26 78.38 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.41 -0.218 . . . . 0.0 110.41 176.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.575 ' HA ' ' O ' ' A' ' 87' ' ' THR . 38.1 t -57.66 -47.37 82.47 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.224 0.61 . . . . 0.0 111.333 174.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 32.6 mmtp -57.58 -42.67 83.61 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.641 0.734 . . . . 0.0 110.489 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -77.66 -22.43 50.61 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.922 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.11 14.83 47.19 Favored Glycine 0 C--N 1.301 -1.389 0 C-N-CA 120.358 -0.925 . . . . 0.0 113.797 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.457 ' HA ' ' HB2' ' A' ' 10' ' ' ASP . 5.1 mp -87.05 -25.41 24.21 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.575 ' O ' ' HA ' ' A' ' 82' ' ' SER . 34.3 m -126.7 148.79 49.83 Favored 'General case' 0 N--CA 1.414 -2.233 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 176.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 . . . . . 0 C--N 1.301 -1.505 0 C-N-CA 123.604 0.762 . . . . 0.0 111.124 -176.926 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 mtm . . . . . 0 CA--C 1.504 -0.792 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 31.9 tt0 -100.78 141.45 33.65 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.623 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 3.8 pt20 -106.59 154.27 21.15 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -175.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -138.53 127.52 23.93 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.458 -1.701 . . . . 0.0 107.367 172.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.7 p -103.6 103.4 13.33 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-O 121.741 0.782 . . . . 0.0 110.109 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -104.69 164.64 11.62 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.716 -177.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.9 m -129.57 130.42 45.68 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 174.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.48 HG13 ' HA ' ' A' ' 86' ' ' LEU . 15.1 tt -90.93 153.71 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.638 0 C-N-CA 121.18 -0.208 . . . . 0.0 111.492 -175.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 36.4 pt -136.49 24.55 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 121.117 0.484 . . . . 0.0 110.667 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.403 ' H ' HG12 ' A' ' 8' ' ' ILE . 7.1 p-10 -65.75 -39.96 91.63 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.899 -177.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.408 ' HG2' ' HG2' ' A' ' 57' ' ' LYS . 36.8 mt-10 . . . . . 0 N--CA 1.477 0.912 0 C-N-CA 125.334 1.453 . . . . 0.0 112.191 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . 0.298 9.1 p80 . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.938 0.875 . . . . 0.0 112.945 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.94 80.09 4.39 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -173.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.445 ' H ' ' HD2' ' A' ' 18' ' ' PRO . 2.1 tmt_? -137.77 -51.21 0.02 OUTLIER Pre-proline 0 C--N 1.291 -1.963 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 172.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.445 ' HD2' ' H ' ' A' ' 17' ' ' ARG . 4.9 Cg_endo -53.27 -33.59 66.08 Favored 'Trans proline' 0 C--N 1.384 2.427 0 C-N-CA 121.343 1.362 . . . . 0.0 109.693 168.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.497 ' O ' HG21 ' A' ' 23' ' ' VAL . . . -60.25 -27.8 67.52 Favored 'General case' 0 C--O 1.201 -1.49 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.58 178.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.5 m -65.82 -26.77 67.82 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.229 0.538 . . . . 0.0 110.471 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 55.9 tpp -71.76 -32.0 67.24 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.12 -30.37 63.58 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.197 176.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.497 HG21 ' O ' ' A' ' 19' ' ' ALA . 77.0 t -69.96 -39.9 78.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -70.26 -37.74 74.97 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.321 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.1 m -91.26 -66.79 0.9 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -172.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.482 ' HB1' ' HB3' ' A' ' 45' ' ' LYS . . . -62.97 -32.64 74.01 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -171.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.4 m -61.49 -25.69 67.42 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.34 14.93 30.64 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -176.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.476 ' C ' ' H ' ' A' ' 31' ' ' SER . 28.8 m-85 -105.23 3.7 30.36 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.814 178.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.5 t70 68.78 -36.82 0.34 Allowed 'General case' 0 N--CA 1.507 2.406 0 C-N-CA 124.644 1.177 . . . . 0.0 113.187 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.504 ' OG ' ' HA3' ' A' ' 67' ' ' GLY . 19.9 m -58.95 148.95 28.61 Favored 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 125.261 1.424 . . . . 0.0 112.029 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -99.68 102.69 14.25 Favored 'General case' 0 N--CA 1.409 -2.513 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.927 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 2.6 mp -91.48 121.59 42.07 Favored 'Isoleucine or valine' 0 C--O 1.259 1.588 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.844 177.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -119.97 135.63 54.84 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 -174.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 5.8 tt -101.24 116.26 32.39 Favored 'General case' 0 N--CA 1.406 -2.656 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.42 ' HB3' ' HB ' ' A' ' 62' ' ' THR . 3.4 tm-20 -99.93 105.35 17.05 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . 0.285 1.2 t80 -110.3 79.83 1.25 Allowed 'General case' 0 C--N 1.287 -2.134 0 CA-C-O 122.149 0.976 . . . . 0.0 110.476 175.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 34.81 79.95 0.03 OUTLIER 'General case' 0 C--O 1.238 0.476 0 CA-C-N 111.949 -2.387 . . . . 0.0 113.711 172.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 135.48 -61.72 0.62 Allowed Glycine 0 CA--C 1.484 -1.848 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.427 ' H ' ' HD2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -127.12 159.21 34.89 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-N 113.871 -1.164 . . . . 0.0 110.285 -174.18 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -142.74 142.71 32.0 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.588 -173.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.416 HG21 ' HA3' ' A' ' 49' ' ' GLY . 10.4 p -151.33 160.16 3.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -61.57 132.72 54.25 Favored 'General case' 0 C--O 1.216 -0.679 0 C-N-CA 122.83 0.452 . . . . 0.0 111.329 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 35' ' ' LEU . 34.2 tp -91.33 -15.63 28.77 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.773 0.797 . . . . 0.0 111.423 -178.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.482 ' HB3' ' HB1' ' A' ' 26' ' ' ALA . 16.0 pttp -90.06 1.91 55.81 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 122.075 0.94 . . . . 0.0 109.672 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 61.3 m -121.51 139.33 53.63 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-N 113.958 -1.474 . . . . 0.0 108.167 175.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.15 -27.56 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-O 121.611 0.72 . . . . 0.0 110.247 -175.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 53.8 ttp -68.19 91.91 0.38 Allowed 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 113.694 -1.594 . . . . 0.0 108.658 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.416 ' HA3' HG21 ' A' ' 42' ' ' VAL . . . 139.79 -58.52 0.59 Allowed Glycine 0 C--N 1.264 -3.458 0 CA-C-N 113.379 -1.737 . . . . 0.0 110.138 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.2 t -66.28 -33.95 66.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 114.629 -0.785 . . . . 0.0 112.376 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 55.1 ttm -64.86 -52.17 58.06 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.011 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.2 m -69.25 -16.28 63.55 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 123.655 0.782 . . . . 0.0 112.897 177.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.2 tp -69.02 103.58 1.89 Allowed 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 123.899 0.88 . . . . 0.0 109.291 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.22 62.68 4.23 Favored Glycine 0 C--N 1.31 -0.873 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.893 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.445 ' HB ' HG21 ' A' ' 8' ' ' ILE . 1.2 m -56.94 -62.72 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 C-N-CA 122.187 0.195 . . . . 0.0 110.863 176.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 49.42 75.37 0.21 Allowed Glycine 0 CA--C 1.53 1.001 0 N-CA-C 116.004 1.162 . . . . 0.0 116.004 171.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.478 ' HA ' HG22 ' A' ' 8' ' ' ILE . 0.0 OUTLIER 43.16 -13.8 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.456 0 N-CA-C 119.589 3.181 . . . . 0.0 119.589 177.565 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -102.46 -8.7 20.87 Favored 'General case' 0 C--N 1.285 -2.225 0 O-C-N 121.242 -0.911 . . . . 0.0 109.802 -176.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.1 127.24 32.41 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -171.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -91.54 101.24 13.89 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 169.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 pt -104.87 126.56 59.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.731 -0.787 . . . . 0.0 109.918 -171.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.42 ' HB ' ' HB3' ' A' ' 36' ' ' GLU . 19.4 m -108.9 118.15 36.05 Favored 'General case' 0 C--N 1.287 -2.114 0 O-C-N 121.913 -0.492 . . . . 0.0 109.838 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.5 mp -88.71 132.78 32.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.623 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 38.9 m-85 -119.27 125.84 50.08 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.961 171.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.23 120.5 40.67 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.469 ' HA ' ' OE1' ' A' ' 70' ' ' GLU . 29.0 t70 -125.56 108.02 11.18 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.504 ' HA3' ' OG ' ' A' ' 31' ' ' SER . . . -165.73 -172.89 33.65 Favored Glycine 0 N--CA 1.416 -2.645 0 C-N-CA 119.148 -1.501 . . . . 0.0 113.482 -171.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.3 p -78.75 -26.91 44.64 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 114.582 -0.809 . . . . 0.0 110.027 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -129.2 35.91 4.22 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.286 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.469 ' OE1' ' HA ' ' A' ' 66' ' ' ASP . 11.0 pt-20 -58.53 -36.18 73.44 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -175.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.84 -43.52 95.94 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 121.218 0.532 . . . . 0.0 110.497 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -76.28 -31.13 58.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.786 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.445 ' O ' ' HB ' ' A' ' 77' ' ' ILE . . . -64.27 -36.67 84.84 Favored 'General case' 0 C--O 1.205 -1.265 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.915 176.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.543 ' O ' HG21 ' A' ' 77' ' ' ILE . 25.8 mm -61.22 -43.65 96.86 Favored 'Isoleucine or valine' 0 C--O 1.251 1.143 0 C-N-CA 122.691 0.396 . . . . 0.0 110.784 175.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -53.04 62.68 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.64 -39.17 93.23 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.566 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.543 HG21 ' O ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -64.65 -40.61 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 C-N-CA 123.127 0.571 . . . . 0.0 110.607 -178.024 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.8 m -72.85 -33.91 66.43 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 24.1 t70 -63.26 -46.74 85.42 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.549 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.3 m -77.68 -23.5 14.19 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.262 0 C-N-CA 120.517 -0.473 . . . . 0.0 112.188 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 77' ' ' ILE . 23.6 mt -73.19 -48.02 38.7 Favored 'General case' 0 C--O 1.206 -1.185 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.588 174.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.7 p -61.3 -29.5 69.91 Favored 'General case' 0 C--N 1.316 -0.85 0 O-C-N 121.626 -0.671 . . . . 0.0 111.438 173.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 79' ' ' ASP . 18.4 ttmm -70.94 -39.57 72.55 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.909 176.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -104.53 -82.8 0.51 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -177.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -173.22 -156.9 13.68 Favored Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -176.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.48 ' HA ' HG13 ' A' ' 8' ' ' ILE . 3.2 mp 64.87 19.67 11.91 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 125.276 1.43 . . . . 0.0 112.3 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 60.3 m -154.45 156.89 37.58 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 . . . . . 0 C--O 1.25 1.096 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.647 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.5 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 1.1 mpt? . . . . . 0 CA--C 1.502 -0.9 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -105.23 145.35 30.76 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 118.908 -1.117 . . . . 0.0 113.118 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.76 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 3.5 pt20 -111.82 151.88 28.54 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -172.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.441 ' O ' ' HA ' ' A' ' 62' ' ' THR . 13.8 mm100 -137.16 131.57 32.74 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.224 -1.353 . . . . 0.0 108.369 173.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.8 t -98.71 121.29 40.47 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 82.4 m-85 -113.34 159.51 19.34 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 122.662 0.385 . . . . 0.0 110.933 -177.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.2 m -131.68 106.36 8.1 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 174.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.451 HD12 ' O ' ' A' ' 86' ' ' LEU . 9.7 tp -66.83 144.96 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.603 0 C-N-CA 123.229 0.612 . . . . 0.0 110.353 -176.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.0 pt -109.52 -14.74 10.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-O 121.744 0.783 . . . . 0.0 109.154 174.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.465 ' O ' ' HA2' ' A' ' 56' ' ' GLY . 9.9 t70 -73.28 149.67 42.54 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.583 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 . . . . . 0 C--N 1.316 -0.877 0 CA-C-O 121.626 0.727 . . . . 0.0 109.516 178.158 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . 0.494 30.9 p-80 . . . . . 0 CA--C 1.542 0.652 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.47 -55.99 23.32 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 116.36 1.985 . . . . 0.0 116.36 -166.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -54.89 -53.41 61.27 Favored Pre-proline 0 N--CA 1.48 1.04 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -172.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.17 -37.44 83.56 Favored 'Trans proline' 0 C--N 1.36 1.175 0 C-N-CA 121.671 1.58 . . . . 0.0 110.978 177.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 23' ' ' VAL . . . -68.81 -27.54 65.95 Favored 'General case' 0 C--O 1.21 -1.023 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.03 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.509 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 14.8 m -74.87 -27.46 60.26 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 97.0 mmm -71.23 -37.82 71.99 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 173.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -61.96 -35.98 80.07 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.442 172.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.509 ' HB ' ' O ' ' A' ' 20' ' ' THR . 52.9 t -56.43 -53.98 33.88 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.698 0 O-C-N 123.669 0.606 . . . . 0.0 109.72 174.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -64.04 -26.28 68.49 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-O 121.264 0.554 . . . . 0.0 111.218 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.544 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 37.1 m -79.55 -62.66 1.62 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.577 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.522 ' CB ' ' HB3' ' A' ' 45' ' ' LYS . . . -67.52 -26.82 66.52 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -175.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 27.1 m -72.48 -10.83 60.27 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 177.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.544 ' HG3' ' O ' ' A' ' 25' ' ' THR . 0.0 OUTLIER -100.14 -2.7 33.43 Favored 'General case' 0 CA--C 1.504 -0.813 0 C-N-CA 119.514 -0.875 . . . . 0.0 112.369 179.213 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -99.09 144.65 28.0 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.488 ' C ' ' HG ' ' A' ' 31' ' ' SER . 10.0 m-20 -88.02 65.52 8.26 Favored 'General case' 0 CA--C 1.484 -1.576 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 173.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.591 ' OG ' ' HA3' ' A' ' 67' ' ' GLY . 23.2 m -161.56 135.97 7.02 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-N 113.397 -1.729 . . . . 0.0 107.455 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -102.35 112.77 25.61 Favored 'General case' 0 C--N 1.278 -2.504 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.62 175.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 59.3 mt -80.58 112.59 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.002 0 CA-C-N 114.142 -1.39 . . . . 0.0 107.636 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 35.2 mt-30 -97.08 127.51 43.12 Favored 'General case' 0 N--CA 1.403 -2.814 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 1.6 tt -91.63 115.09 27.75 Favored 'General case' 0 N--CA 1.4 -2.946 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 176.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -110.11 113.19 25.68 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 124.947 1.299 . . . . 0.0 108.732 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -133.88 94.35 3.25 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-O 121.52 0.676 . . . . 0.0 110.638 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 50.89 67.68 0.9 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.524 -1.671 . . . . 0.0 112.166 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.4 -23.57 31.42 Favored Glycine 0 N--CA 1.438 -1.186 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.699 175.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -99.04 109.95 22.62 Favored 'General case' 0 CA--C 1.476 -1.879 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 6.5 ptpp? -114.93 128.21 56.15 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.806 175.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 34' ' ' GLN . 6.0 m -135.95 -175.18 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.937 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 46' ' ' SER . 19.6 m120 -94.22 120.51 34.57 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.4 tt -74.12 -21.97 59.66 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-O 121.241 0.543 . . . . 0.0 111.381 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.522 ' HB3' ' CB ' ' A' ' 26' ' ' ALA . 14.5 pttp -87.93 6.86 33.68 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 122.255 1.026 . . . . 0.0 109.647 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.488 ' HB2' ' HB2' ' A' ' 43' ' ' ASN . 73.7 m -117.14 133.64 55.75 Favored 'General case' 0 N--CA 1.398 -3.029 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.137 175.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.576 HD12 ' H ' ' A' ' 47' ' ' ILE . 1.4 mp -75.17 -38.01 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.209 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -172.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 44.3 ttm -51.7 -37.39 50.58 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 112.688 -2.051 . . . . 0.0 110.571 175.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.5 -60.43 3.48 Favored Glycine 0 N--CA 1.426 -2.02 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.885 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 90.7 t -57.49 -40.96 77.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 96.4 mmm -75.33 2.86 10.16 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 51.9 m -92.82 -21.38 19.93 Favored 'General case' 0 C--N 1.31 -1.11 0 O-C-N 122.061 -0.399 . . . . 0.0 110.607 176.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.435 HD22 HD21 ' A' ' 35' ' ' LEU . 6.9 mp -79.93 155.89 27.51 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.045 0.45 . . . . 0.0 110.704 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.16 69.22 0.79 Allowed Glycine 0 N--CA 1.426 -1.969 0 N-CA-C 107.5 -2.24 . . . . 0.0 107.5 169.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.5 t -77.25 80.72 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -175.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 10' ' ' ASP . . . -134.92 135.22 7.79 Favored Glycine 0 N--CA 1.425 -2.052 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt 28.08 -57.89 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 129.817 3.247 . . . . 0.0 118.837 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -90.11 -0.84 57.81 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.743 0.782 . . . . 0.0 110.581 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.24 96.72 1.86 Allowed 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 121.927 0.87 . . . . 0.0 112.569 -178.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 36.0 mt-10 -92.58 105.6 17.74 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 175.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.414 HD13 HG23 ' A' ' 61' ' ' ILE . 29.3 pt -103.23 157.2 5.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.458 -172.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 4' ' ' GLN . 34.1 m -122.89 127.66 49.26 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-O 121.254 0.55 . . . . 0.0 109.762 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.76 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.4 mp -97.31 130.08 46.48 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 177.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.416 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 27.4 m-85 -116.8 107.04 14.14 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 123.733 0.646 . . . . 0.0 109.48 171.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -93.63 111.42 23.1 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -113.77 110.19 19.76 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.591 ' HA3' ' OG ' ' A' ' 31' ' ' SER . . . -174.05 -168.49 35.05 Favored Glycine 0 N--CA 1.41 -3.069 0 C-N-CA 118.93 -1.605 . . . . 0.0 113.819 -175.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.2 m -94.79 -17.18 22.36 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 175.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -119.05 18.55 13.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.401 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.443 ' O ' HG12 ' A' ' 74' ' ' ILE . 4.7 pt-20 -57.24 -37.66 72.62 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -174.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.91 -42.58 99.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.111 0.481 . . . . 0.0 111.052 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -78.99 -26.87 43.34 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.36 0.6 . . . . 0.0 109.508 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.401 ' O ' ' HB ' ' A' ' 77' ' ' ILE . . . -63.59 -41.38 98.35 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.357 175.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.443 HG12 ' O ' ' A' ' 70' ' ' GLU . 35.4 mm -60.09 -46.26 94.61 Favored 'Isoleucine or valine' 0 C--O 1.255 1.384 0 CA-C-O 121.542 0.686 . . . . 0.0 109.745 175.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -58.59 -40.1 82.26 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.43 -1.259 . . . . 0.0 112.657 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.06 -44.48 17.96 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.434 HG21 ' OH ' ' A' ' 6' ' ' TYR . 0.2 OUTLIER -59.25 -36.97 66.27 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.55 0 C-N-CA 123.59 0.756 . . . . 0.0 112.459 -173.742 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.7 p -73.74 -43.16 59.87 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.263 0.554 . . . . 0.0 110.248 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.555 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 24.5 t70 -60.8 -47.77 84.84 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.288 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.498 ' HA ' ' CG ' ' A' ' 83' ' ' LYS . 27.9 m -66.01 -39.21 83.91 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.516 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.928 177.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.5 mt -64.12 -35.62 81.36 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.4 p -70.29 -44.97 67.26 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 118.345 0.521 . . . . 0.0 112.075 174.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.555 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 12.9 ptmm? -67.29 -28.26 67.86 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.684 177.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 80' ' ' VAL . 24.2 mm-40 -81.14 -26.46 36.08 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.056 0.455 . . . . 0.0 110.687 175.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.24 41.31 8.03 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 116.136 -0.484 . . . . 0.0 113.663 175.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.451 ' O ' HD12 ' A' ' 8' ' ' ILE . 8.8 mp -91.71 -46.41 7.92 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.183 176.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.2 t -101.84 168.69 9.27 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -176.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 C--N 1.309 -1.16 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 176.883 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.585 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 91.0 mtp . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -105.18 148.16 27.21 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 169.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.693 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 3.9 pt20 -107.16 143.34 35.49 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -132.88 99.92 4.75 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.032 174.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 49.1 m -87.91 116.2 25.91 Favored 'General case' 0 C--N 1.286 -2.175 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.428 176.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.409 ' HB2' ' CG1' ' A' ' 61' ' ' ILE . 78.3 m-85 -102.03 139.02 38.22 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.031 -173.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.9 m -101.65 100.54 10.94 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 171.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.68 ' O ' ' HA ' ' A' ' 57' ' ' LYS 0.262 3.0 mt -74.75 135.41 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 119.97 -0.692 . . . . 0.0 112.028 -179.014 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.9 pt -107.09 -7.39 10.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.334 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -76.65 125.15 28.75 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.74 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.7 mp0 . . . . . 0 C--N 1.318 -0.777 0 C-N-CA 120.536 -0.465 . . . . 0.0 111.977 178.772 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 . . . . . 0 C--O 1.219 -0.54 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.95 -76.33 0.59 Allowed 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.401 ' HD3' ' HA ' ' A' ' 17' ' ' ARG 0.257 33.9 mmt180 -69.36 -52.73 14.44 Favored Pre-proline 0 C--N 1.315 -0.911 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -176.392 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -59.55 -29.52 90.14 Favored 'Trans proline' 0 C--N 1.36 1.174 0 CA-C-N 120.838 1.335 . . . . 0.0 110.782 174.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.68 -28.45 66.88 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.231 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 57.1 m -70.59 -26.29 63.45 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 83.8 mtp -70.03 -31.84 69.68 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.32 -44.31 83.74 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 172.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.4 t -54.01 -55.29 14.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 123.963 0.79 . . . . 0.0 109.497 174.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -53.41 -44.36 68.67 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 124.403 1.081 . . . . 0.0 112.317 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.1 m -81.31 -58.91 2.84 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -175.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.472 ' HB2' ' HB3' ' A' ' 45' ' ' LYS . . . -64.86 -27.82 69.13 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -173.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.6 m -69.64 -16.11 63.31 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.256 0.0 OUTLIER -108.25 6.34 26.52 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 -175.606 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -101.43 137.62 39.52 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 174.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.447 ' C ' ' HG ' ' A' ' 31' ' ' SER . 38.0 t70 -84.78 73.07 10.67 Favored 'General case' 0 CA--C 1.496 -1.112 0 CA-C-O 122.749 1.262 . . . . 0.0 109.349 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.563 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 33.8 m -161.5 152.88 18.73 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 112.871 -1.968 . . . . 0.0 105.908 177.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -113.36 109.4 18.65 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.0 mp -89.87 125.57 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.272 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 -98.09 136.07 38.86 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.7 tp -99.94 114.94 28.54 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.59 ' HA ' ' O ' ' A' ' 40' ' ' LYS . 9.2 tt0 -111.66 136.34 51.02 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.706 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.437 ' CD2' ' HG ' ' A' ' 53' ' ' LEU . 50.7 t80 -165.24 104.5 0.75 Allowed 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 123.386 0.674 . . . . 0.0 110.572 178.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.7 t30 48.07 74.84 0.15 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.804 1.242 . . . . 0.0 113.025 176.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.98 -13.12 33.0 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 121.001 -0.618 . . . . 0.0 113.114 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.59 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -94.6 123.56 38.11 Favored 'General case' 0 CA--C 1.48 -1.729 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -179.588 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -119.57 113.42 20.68 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 169.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.7 p -143.53 167.14 13.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -175.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.419 HD22 ' HE3' ' A' ' 45' ' ' LYS . 19.3 t-20 -78.92 133.38 36.92 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 117.864 0.302 . . . . 0.0 111.184 -177.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.6 tp -75.97 -35.01 59.81 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.472 ' HB3' ' HB2' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -87.39 9.36 20.89 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.691 -178.358 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 75.6 m -106.68 125.01 50.46 Favored 'General case' 0 N--CA 1.392 -3.37 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 173.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.46 -25.47 38.44 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 CA-C-O 121.39 0.614 . . . . 0.0 111.636 -175.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 49.7 ttp -55.47 -27.04 45.85 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 125.429 1.492 . . . . 0.0 110.468 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.22 -60.62 4.35 Favored Glycine 0 N--CA 1.42 -2.423 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.515 178.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.0 t -64.04 -36.1 75.75 Favored 'Isoleucine or valine' 0 C--O 1.249 1.045 0 O-C-N 122.688 -0.301 . . . . 0.0 110.876 -176.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.2 mmt -57.84 -34.79 70.08 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.267 0.627 . . . . 0.0 112.237 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.1 p -85.03 -31.43 23.45 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.84 -175.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.437 ' HG ' ' CD2' ' A' ' 37' ' ' TYR . 11.0 mp -59.09 -61.95 2.25 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.95 0.405 . . . . 0.0 111.833 176.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.38 46.53 55.98 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 -171.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.6 p -69.88 123.68 24.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 C-N-CA 123.666 0.786 . . . . 0.0 111.586 -176.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.41 -172.24 14.69 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.68 ' HA ' ' O ' ' A' ' 8' ' ' ILE 0.272 55.0 pttt -64.88 136.02 56.38 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 118.226 1.013 . . . . 0.0 113.689 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t70 84.31 -7.1 1.02 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 126.32 1.848 . . . . 0.0 111.087 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.45 113.0 6.35 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.609 177.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -81.69 115.85 21.14 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.773 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 5' ' ' SER . 17.3 pt -116.04 160.07 15.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 5' ' ' SER . 98.6 m -129.18 128.04 42.57 Favored 'General case' 0 C--N 1.275 -2.648 0 CA-C-O 120.878 0.37 . . . . 0.0 110.305 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.542 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.4 mp -101.8 131.59 49.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.693 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 34.8 m-85 -121.56 113.76 20.24 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 123.574 0.547 . . . . 0.0 109.684 173.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.585 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -104.0 119.86 39.82 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.475 ' OD1' ' HG3' ' A' ' 1' ' ' MET . 15.7 t70 -126.08 115.43 19.82 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.563 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -179.22 -171.67 42.6 Favored Glycine 0 N--CA 1.431 -1.675 0 C-N-CA 119.952 -1.118 . . . . 0.0 113.171 -175.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.4 m -89.13 -7.18 56.23 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.474 0.654 . . . . 0.0 109.642 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -130.37 29.37 4.86 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.587 ' O ' HG12 ' A' ' 74' ' ' ILE . 9.7 pt-20 -69.21 -44.01 72.95 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -168.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.2 -31.88 69.53 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.212 0.529 . . . . 0.0 110.357 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -75.01 -33.58 61.83 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-O 121.556 0.693 . . . . 0.0 109.779 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.19 -36.15 82.31 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.969 176.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.587 HG12 ' O ' ' A' ' 70' ' ' GLU . 38.0 mm -54.1 -39.29 41.28 Favored 'Isoleucine or valine' 0 C--O 1.25 1.119 0 C-N-CA 123.503 0.721 . . . . 0.0 111.431 178.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -67.32 -44.26 79.58 Favored 'General case' 0 N--CA 1.402 -2.855 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.231 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.33 -39.36 47.93 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.485 -175.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.43 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -64.11 -41.78 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -178.367 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 33.0 m -67.78 -43.45 79.75 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.409 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 32.3 t70 -55.34 -48.13 74.66 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.3 m -67.22 -29.96 47.68 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.593 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.736 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 77' ' ' ILE . 40.4 mt -79.56 -2.29 41.71 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.983 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 21.6 m -118.38 -16.36 9.6 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.437 0.637 . . . . 0.0 110.253 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 75.2 mmtt -78.46 -27.47 46.37 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 169.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -104.75 172.53 6.74 Favored 'General case' 0 N--CA 1.41 -2.431 0 CA-C-N 112.921 -1.945 . . . . 0.0 107.41 175.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -104.3 51.51 0.8 Allowed Glycine 0 C--N 1.291 -1.967 0 C-N-CA 119.893 -1.146 . . . . 0.0 113.364 -175.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.8 mp -92.74 -53.43 4.18 Favored 'General case' 0 C--O 1.213 -0.847 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.303 176.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.6 t -116.51 148.29 40.95 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.916 -178.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 . . . . . 0 N--CA 1.429 -1.523 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.709 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.633 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 52.9 ttm . . . . . 0 CA--C 1.514 -0.415 0 N-CA-C 110.581 -0.155 . . . . 0.0 110.581 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -114.83 157.35 23.4 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 176.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.634 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 4.1 pt20 -111.35 153.96 25.24 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -142.36 103.73 4.31 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.697 -1.592 . . . . 0.0 107.59 173.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 50.2 m -91.49 89.45 7.21 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 122.293 1.044 . . . . 0.0 110.451 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.442 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 73.8 m-85 -72.87 130.02 39.47 Favored 'General case' 0 CA--C 1.488 -1.433 0 CA-C-N 113.493 -1.685 . . . . 0.0 112.146 -175.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.2 m -88.88 101.01 13.63 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 170.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.5 mt -77.22 136.49 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.9 -178.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 35.4 pt -119.03 6.55 6.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -71.39 127.11 31.48 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.505 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 C--N 1.298 -1.648 0 CA-C-O 121.609 0.718 . . . . 0.0 110.368 -179.225 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 . . . . . 0 CA--C 1.535 0.367 0 CA-C-O 121.349 0.595 . . . . 0.0 111.827 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.81 -34.42 66.86 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -170.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.401 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 13.9 tpp180 -63.45 -52.95 56.39 Favored Pre-proline 0 C--N 1.317 -0.839 0 C-N-CA 119.594 -0.842 . . . . 0.0 112.448 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.515 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 31.8 Cg_exo -66.72 -10.86 29.65 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 121.573 1.516 . . . . 0.0 112.645 174.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.54 -15.47 60.86 Favored 'General case' 0 C--O 1.216 -0.682 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.7 m -66.73 -27.16 67.39 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 174.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.515 ' SD ' ' HA ' ' A' ' 18' ' ' PRO . 1.4 mpt? -67.69 -34.88 77.76 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 174.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.27 -38.1 78.21 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.938 175.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 81.9 t -55.69 -49.84 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 O-C-N 124.113 0.883 . . . . 0.0 109.351 175.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.12 -64.33 0.99 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.18 177.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.7 m -42.35 -63.16 0.8 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.734 1.214 . . . . 0.0 113.81 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.05 -43.05 88.61 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -174.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.7 t -60.75 -39.09 87.41 Favored 'General case' 0 C--N 1.322 -0.594 0 O-C-N 123.27 0.356 . . . . 0.0 111.37 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.269 0.6 OUTLIER -82.5 3.0 30.11 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -174.198 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -95.16 -3.25 48.21 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.764 177.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.4 t70 59.52 24.34 13.04 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 123.377 1.56 . . . . 0.0 109.403 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.523 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 19.3 m -118.8 146.29 44.95 Favored 'General case' 0 N--CA 1.408 -2.53 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.183 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -105.76 112.69 25.85 Favored 'General case' 0 N--CA 1.392 -3.366 0 C-N-CA 118.706 -1.197 . . . . 0.0 108.771 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 2.9 mp -100.77 130.25 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.807 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.678 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -106.12 132.13 52.56 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.8 tt -98.01 100.16 11.47 Favored 'General case' 0 N--CA 1.407 -2.576 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 173.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.38 112.53 23.67 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.449 ' HB3' HD13 ' A' ' 53' ' ' LEU . 55.4 t80 -139.77 85.17 2.02 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 176.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.9 t30 60.56 90.2 0.06 Allowed 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 125.365 1.466 . . . . 0.0 113.656 170.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.85 -48.13 3.99 Favored Glycine 0 C--N 1.311 -0.813 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.641 175.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.21 144.94 43.53 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 120.851 0.358 . . . . 0.0 111.909 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.11 147.35 50.95 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 176.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.8 p -120.8 143.59 32.46 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.76 -177.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.439 ' OD1' ' HE3' ' A' ' 45' ' ' LYS . 16.1 t30 -61.55 110.23 1.41 Allowed 'General case' 0 C--O 1.208 -1.124 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 171.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.407 HD13 ' O ' ' A' ' 44' ' ' LEU . 3.4 tm? -60.37 -23.5 64.35 Favored 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -171.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -90.56 21.99 3.7 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.179 -0.951 . . . . 0.0 110.757 174.359 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.0 m -134.43 146.44 49.84 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.645 176.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.578 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -94.83 -20.11 6.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.289 -178.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 50.3 ttm -64.21 81.53 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 125.622 1.569 . . . . 0.0 110.115 175.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 137.43 -32.08 2.44 Favored Glycine 0 C--N 1.291 -1.927 0 CA-C-N 113.616 -1.629 . . . . 0.0 110.431 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 85.5 t -73.51 -35.76 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 69.8 mtm -64.0 -54.2 38.04 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.09 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.1 m -81.06 2.63 26.38 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.449 HD13 ' HB3' ' A' ' 37' ' ' TYR . 22.5 tp -39.75 -47.32 2.05 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 124.589 1.156 . . . . 0.0 113.286 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.73 34.19 25.54 Favored Glycine 0 N--CA 1.439 -1.128 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -89.4 151.48 3.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -175.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -157.61 -170.72 22.76 Favored Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -64.03 138.71 58.59 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 117.97 0.885 . . . . 0.0 111.331 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.7 t70 79.88 -5.4 1.86 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.395 1.478 . . . . 0.0 111.328 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.57 123.08 21.68 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.584 176.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -98.55 116.86 31.69 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.6 -178.649 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 5' ' ' SER . 20.1 pt -110.73 137.42 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.18 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 5' ' ' SER . 85.1 m -108.49 112.98 25.66 Favored 'General case' 0 C--N 1.276 -2.588 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.37 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.62 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.3 mp -84.78 130.32 36.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.634 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 51.6 m-85 -117.06 106.83 13.8 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 173.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.633 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -101.4 117.04 34.15 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -128.62 115.75 18.55 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.523 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -172.67 -169.86 35.76 Favored Glycine 0 C--N 1.293 -1.84 0 C-N-CA 119.535 -1.317 . . . . 0.0 112.345 -175.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.4 t -81.9 -22.65 36.71 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -131.79 33.38 3.99 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.775 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.406 ' CD ' ' H1 ' ' A' ' 1' ' ' MET . 9.3 pt-20 -58.05 -35.91 72.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -175.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.55 -43.63 96.52 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.001 0.429 . . . . 0.0 110.78 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -82.62 -19.91 37.39 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.06 0.457 . . . . 0.0 109.945 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.62 -42.32 98.19 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 30.4 mm -57.45 -45.45 85.72 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.347 173.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -60.82 -42.81 98.43 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.573 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.1 -47.95 75.41 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.429 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 33.4 mt -60.82 -48.32 89.37 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.912 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.427 ' CG2' ' HH ' ' A' ' 6' ' ' TYR . 13.6 p -58.04 -35.24 71.03 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.449 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 26.8 t70 -70.71 -52.84 18.37 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 120.875 0.369 . . . . 0.0 110.103 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.43 -27.61 40.91 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.435 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 77' ' ' ILE . 14.0 mt -79.89 -6.2 56.97 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 122.412 0.285 . . . . 0.0 110.64 177.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.1 t -102.92 -41.0 6.28 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 31.7 mmmt -65.35 -29.23 69.94 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.372 0.606 . . . . 0.0 109.413 176.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -93.26 -17.31 23.79 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.874 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.22 49.7 60.36 Favored Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 115.524 -0.762 . . . . 0.0 114.548 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.0 mp -88.56 -27.52 21.33 Favored 'General case' 0 CA--C 1.491 -1.307 0 C-N-CA 118.462 -1.295 . . . . 0.0 108.498 174.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.0 t -133.74 -171.01 2.62 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 . . . . . 0 C--N 1.301 -1.522 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.01 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.487 ' HG3' ' HA ' ' A' ' 66' ' ' ASP . 1.1 mpt? . . . . . 0 CA--C 1.49 -1.362 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.502 ' HG2' ' N ' ' A' ' 3' ' ' GLN . 36.7 tt0 -125.76 158.95 33.62 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.719 -172.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.793 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 12.4 pt20 -115.15 140.22 49.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 124.068 0.855 . . . . 0.0 110.824 173.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -121.09 107.76 13.01 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.171 175.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.0 p -88.13 92.22 9.07 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-O 121.441 0.639 . . . . 0.0 109.544 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.45 ' OH ' HG23 ' A' ' 77' ' ' ILE . 80.8 m-85 -80.56 113.67 18.91 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.679 -176.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.8 m -91.09 102.12 14.86 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.483 HG22 ' O ' ' A' ' 55' ' ' VAL . 1.5 mp -71.93 122.9 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.862 0 CA-C-O 122.207 1.003 . . . . 0.0 112.031 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.39 9.05 7.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 114.109 -1.405 . . . . 0.0 107.852 -177.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -123.93 158.7 31.38 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.422 -170.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 . . . . . 0 C--O 1.235 0.326 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 178.888 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.58 ' O ' ' HD2' ' A' ' 18' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.432 -1.326 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.56 81.68 3.23 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -170.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -162.66 -47.47 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.206 1.002 . . . . 0.0 108.568 169.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.58 ' HD2' ' O ' ' A' ' 15' ' ' HIS . 84.0 Cg_exo -54.88 -24.56 39.42 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 121.849 1.7 . . . . 0.0 111.362 170.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.39 -21.24 66.65 Favored 'General case' 0 C--O 1.201 -1.474 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.048 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.3 m -70.11 -27.35 64.52 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-O 121.296 0.57 . . . . 0.0 110.032 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 48.5 ttm -69.46 -32.19 70.96 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 174.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -73.14 -36.95 66.77 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.172 -1.377 . . . . 0.0 110.306 175.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.0 t -55.96 -48.66 78.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -61.82 -58.36 8.28 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.585 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.581 ' O ' ' HB3' ' A' ' 28' ' ' LYS . 36.4 m -49.86 -43.57 49.22 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 176.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.73 -37.21 84.21 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.573 -0.705 . . . . 0.0 111.337 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.448 ' OG ' ' HB2' ' A' ' 45' ' ' LYS . 19.3 m -67.49 -32.36 73.13 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 122.022 0.915 . . . . 0.0 110.036 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.581 ' HB3' ' O ' ' A' ' 25' ' ' THR . 12.6 tmtt? -65.9 -33.57 76.12 Favored 'General case' 0 N--CA 1.424 -1.758 0 C-N-CA 126.196 1.798 . . . . 0.0 111.879 -176.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -96.37 150.12 20.94 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.885 -177.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.93 59.37 5.59 Favored 'General case' 0 CA--C 1.491 -1.314 0 CA-C-O 122.384 1.088 . . . . 0.0 108.96 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.546 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 40.9 m -150.83 141.31 22.49 Favored 'General case' 0 N--CA 1.41 -2.445 0 CA-C-N 114.021 -1.445 . . . . 0.0 108.439 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -98.15 99.43 10.68 Favored 'General case' 0 N--CA 1.394 -3.262 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 44.0 mt -84.91 124.76 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.875 0 CA-C-N 114.425 -1.262 . . . . 0.0 108.254 175.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -109.72 131.05 55.42 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 3.6 tt -97.77 124.82 42.28 Favored 'General case' 0 N--CA 1.402 -2.862 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.498 ' HB3' ' HB ' ' A' ' 62' ' ' THR . 0.8 OUTLIER -113.16 107.19 15.58 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -178.157 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.526 ' CD2' ' HG ' ' A' ' 53' ' ' LEU . 25.9 t80 -138.88 103.82 4.91 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.413 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 46.12 77.7 0.08 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.881 1.672 . . . . 0.0 113.155 173.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.21 -28.78 5.96 Favored Glycine 0 C--N 1.306 -1.122 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.233 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.413 ' HA ' ' HE3' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -105.32 113.5 27.12 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -179.272 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 18.7 ptpt -110.33 116.37 31.33 Favored 'General case' 0 N--CA 1.415 -2.187 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 168.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.9 p -130.03 146.07 34.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.697 -170.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -58.27 112.39 1.53 Allowed 'General case' 0 C--O 1.197 -1.703 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 171.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.526 HD21 ' O ' ' A' ' 44' ' ' LEU . 5.4 tt -60.45 -29.0 68.76 Favored 'General case' 0 C--O 1.218 -0.568 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -170.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.448 ' HB2' ' OG ' ' A' ' 27' ' ' SER . 0.5 OUTLIER -85.67 -0.63 55.67 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.001 179.359 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.8 m -108.19 124.11 49.77 Favored 'General case' 0 N--CA 1.396 -3.168 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 175.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 pp -73.19 7.99 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -172.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 15.6 tpt -94.39 61.08 2.74 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 122.286 1.041 . . . . 0.0 109.232 -167.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.8 -41.67 0.81 Allowed Glycine 0 C--N 1.292 -1.885 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 -174.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 89.7 t -65.01 -35.01 74.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 114.884 -0.658 . . . . 0.0 110.968 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 49.2 ttm -77.3 0.83 20.7 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 121.196 0.522 . . . . 0.0 110.962 -177.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.2 m -104.27 6.72 35.61 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.011 0.434 . . . . 0.0 111.327 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.526 ' HG ' ' CD2' ' A' ' 37' ' ' TYR . 8.8 mp -78.89 105.91 10.54 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.194 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.72 -49.38 24.05 Favored Glycine 0 CA--C 1.495 -1.175 0 N-CA-C 106.795 -2.522 . . . . 0.0 106.795 169.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.483 ' O ' HG22 ' A' ' 8' ' ' ILE . 9.9 p 51.07 25.95 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.323 0 C-N-CA 126.816 2.046 . . . . 0.0 114.801 169.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.78 112.72 3.74 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.353 -0.927 . . . . 0.0 110.92 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.401 ' C ' ' H ' ' A' ' 59' ' ' ALA . 7.5 ptpp? 49.14 154.29 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 C-N-CA 127.706 2.402 . . . . 0.0 115.664 -176.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.0 t70 68.82 -16.65 0.21 Allowed 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 126.054 1.742 . . . . 0.0 114.16 172.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.401 ' H ' ' C ' ' A' ' 57' ' ' LYS . . . -67.37 121.27 15.39 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 123.57 0.748 . . . . 0.0 112.326 -175.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -102.8 97.7 7.81 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 175.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.412 HG21 HD12 ' A' ' 61' ' ' ILE . 29.8 pt -96.81 124.8 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.817 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -177.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.498 ' HB ' ' HB3' ' A' ' 36' ' ' GLU . 4.7 m -100.35 120.21 39.6 Favored 'General case' 0 C--N 1.283 -2.31 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.849 -176.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.57 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.6 mp -95.68 121.17 45.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 176.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.793 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 30.7 m-85 -104.92 123.9 48.55 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 174.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -111.19 103.01 11.39 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.487 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 10.9 t70 -113.37 103.21 11.07 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.546 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -166.74 -163.81 21.19 Favored Glycine 0 N--CA 1.423 -2.227 0 C-N-CA 119.424 -1.369 . . . . 0.0 112.751 -173.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.3 m -105.51 -7.69 18.5 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.409 0.623 . . . . 0.0 109.508 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -127.33 18.92 6.94 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.495 ' O ' HG12 ' A' ' 74' ' ' ILE 0.27 0.0 OUTLIER -52.43 -44.62 65.56 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 -171.184 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.65 -41.45 98.23 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.859 0.361 . . . . 0.0 111.433 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -78.05 -28.15 48.86 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 121.584 0.707 . . . . 0.0 109.866 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.98 -38.8 92.16 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.65 174.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 70' ' ' GLU . 33.8 mm -60.91 -47.05 95.19 Favored 'Isoleucine or valine' 0 C--O 1.254 1.317 0 CA-C-O 121.38 0.609 . . . . 0.0 109.973 175.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -51.74 -54.34 29.48 Favored 'General case' 0 N--CA 1.412 -2.367 0 C-N-CA 125.032 1.333 . . . . 0.0 109.716 176.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.411 ' O ' HG23 ' A' ' 80' ' ' VAL . . . -69.21 -45.09 70.74 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.457 HG21 ' O ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -58.86 -40.14 79.3 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 C-N-CA 123.445 0.698 . . . . 0.0 111.054 -176.198 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.6 m -73.1 -37.6 66.66 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -61.38 -50.0 74.63 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.767 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.561 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 28.4 m -74.08 -32.25 32.26 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.35 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.996 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.428 HD21 ' CG ' ' A' ' 86' ' ' LEU . 15.3 mt -63.87 -45.05 91.14 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 121.388 -0.82 . . . . 0.0 111.353 175.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.9 p -63.19 -35.91 81.87 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 80' ' ' VAL . 12.3 ptmm? -70.39 -30.94 67.97 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 80' ' ' VAL . 21.8 mm-40 -76.71 -27.16 55.37 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.436 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.88 -1.37 22.99 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.472 -0.871 . . . . 0.0 114.713 173.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.428 ' CG ' HD21 ' A' ' 81' ' ' LEU . 1.2 pt? -99.62 26.87 5.76 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -177.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 35.8 m -148.41 109.68 4.36 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 121.652 -0.655 . . . . 0.0 110.016 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 C--O 1.255 1.386 0 C-N-CA 125.918 1.687 . . . . 0.0 112.173 -178.302 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.8 mtm . . . . . 0 CA--C 1.479 -1.75 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -113.17 147.9 36.49 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 176.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.721 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 15.6 pt20 -119.77 161.17 21.22 Favored 'General case' 0 N--CA 1.438 -1.031 0 O-C-N 123.802 0.689 . . . . 0.0 111.83 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.597 ' O ' ' HA ' ' A' ' 62' ' ' THR . 14.9 mm100 -141.16 138.0 33.09 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.167 -1.378 . . . . 0.0 108.279 174.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.8 t -100.58 131.27 46.58 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.517 ' HB2' ' CG1' ' A' ' 61' ' ' ILE . 57.8 m-85 -138.0 170.88 15.27 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -177.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.1 m -139.12 127.21 22.47 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 174.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.541 HG13 ' HA ' ' A' ' 86' ' ' LEU . 6.6 tt -82.8 147.22 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.542 -176.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.4 pt -133.69 26.87 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.511 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.3 OUTLIER -64.8 -38.59 91.5 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.436 -174.136 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.518 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 46.7 mt-10 . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 176.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.532 ' O ' ' HD2' ' A' ' 18' ' ' PRO 0.386 56.6 p-80 . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 122.452 1.12 . . . . 0.0 112.269 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.68 -30.6 22.59 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 -168.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 17' ' ' ARG 0.314 26.1 mmt180 -62.39 -55.64 37.84 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -177.076 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.532 ' HD2' ' O ' ' A' ' 15' ' ' HIS . 61.4 Cg_exo -53.96 -37.73 86.05 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 121.85 1.7 . . . . 0.0 111.454 170.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.423 ' O ' HG21 ' A' ' 23' ' ' VAL . . . -66.42 -19.61 65.84 Favored 'General case' 0 C--O 1.209 -1.063 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.154 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 29.7 m -77.12 -23.19 51.77 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.721 0.772 . . . . 0.0 108.954 176.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.4 ttt -71.63 -34.14 69.54 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 171.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.8 -37.21 81.7 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.655 173.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 19' ' ' ALA . 76.7 t -54.99 -55.26 16.98 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.084 0 O-C-N 123.92 0.763 . . . . 0.0 108.986 173.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -60.24 -25.85 65.98 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 123.387 0.675 . . . . 0.0 112.089 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.406 ' HA ' ' NZ ' ' A' ' 28' ' ' LYS . 88.1 m -78.95 -61.87 1.88 Allowed 'General case' 0 N--CA 1.423 -1.799 0 O-C-N 122.18 -0.325 . . . . 0.0 110.372 177.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.25 -43.68 94.13 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -177.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.4 t -59.09 -30.62 68.22 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.644 0.778 . . . . 0.0 112.916 -174.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.406 ' NZ ' ' HA ' ' A' ' 25' ' ' THR 0.27 0.9 OUTLIER -87.35 2.76 49.37 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -178.076 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -97.92 142.83 29.17 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -70.57 -35.3 72.98 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.38 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.543 ' OG ' ' HA3' ' A' ' 67' ' ' GLY . 50.7 m -71.12 142.19 50.77 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.581 175.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -93.37 109.92 21.47 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-O 121.211 0.529 . . . . 0.0 112.014 -176.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.435 HD11 ' HB3' ' A' ' 73' ' ' ALA . 15.9 mt -89.29 120.69 38.4 Favored 'Isoleucine or valine' 0 C--O 1.254 1.319 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.999 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -113.92 146.81 39.54 Favored 'General case' 0 N--CA 1.415 -2.224 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.735 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 0.9 OUTLIER -101.49 131.05 47.83 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 177.611 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 40' ' ' LYS . 8.3 tp10 -131.39 154.22 48.85 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 175.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -154.92 -25.96 0.12 Allowed 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 117.919 0.327 . . . . 0.0 110.724 178.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 172.85 77.75 0.0 OUTLIER 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.928 0.891 . . . . 0.0 109.011 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.31 -12.37 66.77 Favored Glycine 0 C--N 1.308 -0.992 0 CA-C-N 116.031 -0.531 . . . . 0.0 113.521 174.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 16.0 mmtp -113.14 114.64 27.08 Favored 'General case' 0 CA--C 1.471 -2.064 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 62.8 mttp -111.87 130.15 55.92 Favored 'General case' 0 N--CA 1.413 -2.292 0 CA-C-N 114.475 -1.238 . . . . 0.0 110.626 174.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.4 m -144.31 162.98 14.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.505 ' HB3' ' HE3' ' A' ' 45' ' ' LYS . 18.3 m120 -72.83 129.51 38.34 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 175.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 67.0 tp -70.76 -13.94 62.25 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-O 121.733 0.777 . . . . 0.0 111.832 -176.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.505 ' HE3' ' HB3' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -87.87 5.45 40.33 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.388 0.613 . . . . 0.0 110.377 176.17 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.1 t -106.09 109.85 21.92 Favored 'General case' 0 N--CA 1.416 -2.152 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.469 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -68.61 -30.57 47.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 27.9 ttt -57.43 -49.04 77.5 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 113.69 -1.596 . . . . 0.0 109.149 175.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.37 -47.0 89.03 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.968 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 91.5 t -57.99 -40.75 78.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 CA-C-O 120.737 0.303 . . . . 0.0 111.457 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -76.69 -9.61 58.79 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 120.161 -0.615 . . . . 0.0 111.669 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.3 m -80.33 -33.52 37.38 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 175.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 mp -73.18 -42.76 62.36 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.977 174.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.4 39.39 87.42 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.409 HG23 ' CG2' ' A' ' 61' ' ' ILE . 7.8 p -65.54 106.35 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.09 0 CA-C-O 121.162 0.506 . . . . 0.0 110.716 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.477 ' HA2' ' OD1' ' A' ' 10' ' ' ASP . . . -138.65 146.2 17.85 Favored Glycine 0 N--CA 1.429 -1.813 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.349 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.518 ' HB3' ' HA ' ' A' ' 11' ' ' GLU . 9.3 ptpp? 21.06 111.37 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.687 0 N-CA-C 117.233 2.308 . . . . 0.0 117.233 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.9 t70 74.8 -0.79 3.25 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.585 1.154 . . . . 0.0 111.97 176.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.4 116.84 10.29 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -81.88 135.68 35.4 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.718 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.517 ' CG1' ' HB2' ' A' ' 6' ' ' TYR . 19.4 pt -123.91 165.69 20.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 121.461 0.648 . . . . 0.0 111.155 -177.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 4' ' ' GLN . 84.1 m -136.74 118.31 14.88 Favored 'General case' 0 N--CA 1.408 -2.573 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 47.4 mm -96.83 127.76 48.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.721 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 29.7 m-85 -111.74 122.52 48.01 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 123.806 0.691 . . . . 0.0 110.745 177.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.08 112.7 25.8 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 173.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -104.65 106.16 16.54 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.543 ' HA3' ' OG ' ' A' ' 31' ' ' SER . . . -176.11 -166.77 33.97 Favored Glycine 0 C--N 1.296 -1.677 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.106 -174.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.0 m -105.19 -11.27 16.63 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.984 0.897 . . . . 0.0 108.667 172.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -112.45 20.6 16.51 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.219 178.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.65 -45.23 70.15 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -175.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.4 -36.89 81.57 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 122.566 0.346 . . . . 0.0 111.256 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -73.4 -43.61 60.15 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.35 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.435 ' HB3' HD11 ' A' ' 33' ' ' ILE . . . -60.4 -43.02 97.1 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.601 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.2 mm -57.71 -46.99 86.74 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 C-N-CA 123.626 0.771 . . . . 0.0 111.22 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -64.47 -38.63 91.68 Favored 'General case' 0 N--CA 1.411 -2.382 0 C-N-CA 124.031 0.932 . . . . 0.0 111.264 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.65 -35.4 77.21 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.37 0.605 . . . . 0.0 110.179 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.507 HG22 ' HH ' ' A' ' 6' ' ' TYR . 3.8 mm -62.01 -52.24 62.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 124.532 1.133 . . . . 0.0 113.046 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.3 m -56.99 -48.43 78.45 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 120.693 0.282 . . . . 0.0 110.289 -176.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -55.16 -50.26 69.74 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.194 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.9 m -75.08 -30.8 23.75 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 C-N-CA 120.422 -0.511 . . . . 0.0 112.267 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 25.2 mt -68.23 -37.0 80.37 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 87' ' ' THR . 23.2 t -85.54 -16.59 38.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.411 0.624 . . . . 0.0 109.99 178.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -71.17 -34.64 71.13 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 172.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -95.97 -172.65 2.63 Favored 'General case' 0 N--CA 1.418 -2.039 0 CA-C-N 113.273 -1.785 . . . . 0.0 109.905 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -101.61 19.17 51.43 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.243 -0.98 . . . . 0.0 112.748 -177.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.541 ' HA ' HG13 ' A' ' 8' ' ' ILE . 3.4 mp -93.81 -2.17 53.93 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 119.036 -1.065 . . . . 0.0 111.16 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 82' ' ' SER . 98.9 m -158.77 143.39 15.86 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 175.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.42 -1.936 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 172.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.583 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 55.1 ttp . . . . . 0 C--O 1.233 0.236 0 N-CA-C 111.263 0.097 . . . . 0.0 111.263 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -125.66 154.7 41.98 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 174.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.669 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 3.8 pt20 -106.4 143.7 34.15 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.553 0.692 . . . . 0.0 112.842 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 62' ' ' THR . 14.1 mm100 -127.48 120.54 28.56 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.706 173.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.8 t -93.6 103.29 15.47 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.486 ' HB2' ' CG1' ' A' ' 61' ' ' ILE . 85.0 m-85 -99.11 112.43 24.57 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.737 -178.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 m -86.37 118.3 25.72 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 175.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.5 mt -98.35 130.61 46.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-O 121.437 0.637 . . . . 0.0 112.59 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.619 HG23 ' O ' ' A' ' 87' ' ' THR . 4.9 tp -95.02 -26.37 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.808 176.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -26.91 97.28 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 -166.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 C--N 1.313 -0.98 0 CA-C-N 113.789 -1.55 . . . . 0.0 111.213 -176.473 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . 0.254 0.4 OUTLIER . . . . . 0 N--CA 1.437 -1.107 0 CA-C-O 121.987 0.899 . . . . 0.0 111.1 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.52 -23.13 61.73 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.149 -1.387 . . . . 0.0 113.273 -174.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -64.0 -50.61 68.59 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 119.575 -0.85 . . . . 0.0 112.168 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -55.15 -31.48 75.8 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 122.108 1.872 . . . . 0.0 111.253 171.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.59 ' O ' ' HB3' ' A' ' 22' ' ' LEU . . . -72.25 -22.17 61.27 Favored 'General case' 0 C--O 1.203 -1.346 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.806 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.6 m -75.49 -33.91 60.82 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 51.2 ttm -66.96 -38.59 86.37 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.59 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 59.1 tp -56.83 -47.69 79.74 Favored 'General case' 0 CA--C 1.477 -1.848 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.121 174.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 19' ' ' ALA . 13.2 t -53.55 -48.24 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.542 0 CA-C-N 113.503 -1.68 . . . . 0.0 110.607 -178.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.06 -29.79 70.19 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.488 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.7 m -74.3 -49.53 22.64 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -177.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.468 ' HA ' ' CD2' ' A' ' 29' ' ' PHE . . . -61.61 -31.27 71.34 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 174.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.6 m -56.24 -39.28 72.29 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 123.419 0.45 . . . . 0.0 111.766 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.48 7.62 40.37 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -177.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.468 ' CD2' ' HA ' ' A' ' 26' ' ' ALA . 12.7 m-85 -96.33 -16.99 21.0 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 54.29 17.12 1.41 Allowed 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 124.795 1.238 . . . . 0.0 113.955 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.464 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 53.2 m -102.8 160.82 14.26 Favored 'General case' 0 N--CA 1.412 -2.345 0 CA-C-O 121.081 0.467 . . . . 0.0 110.334 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -91.47 83.63 5.44 Favored 'General case' 0 N--CA 1.405 -2.702 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.404 HG22 HG21 ' A' ' 63' ' ' ILE . 84.6 mt -94.25 111.52 25.4 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 175.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -103.77 137.86 41.2 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.581 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 4.3 tt -101.72 111.48 23.75 Favored 'General case' 0 N--CA 1.392 -3.352 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -103.68 117.11 33.63 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 123.523 0.729 . . . . 0.0 109.278 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.484 ' HB3' HD11 ' A' ' 53' ' ' LEU . 15.5 t80 -135.26 90.58 2.64 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.182 177.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 43.7 64.93 1.11 Allowed 'General case' 0 C--O 1.244 0.769 0 C-N-CA 126.567 1.947 . . . . 0.0 113.13 176.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.76 -29.25 10.59 Favored Glycine 0 N--CA 1.432 -1.625 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.433 175.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -98.6 110.59 23.16 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 4.3 ptpp? -122.98 131.42 53.71 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 171.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.414 HG21 ' N ' ' A' ' 49' ' ' GLY . 11.6 p -146.63 158.63 10.58 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.544 ' OD1' ' HG2' ' A' ' 45' ' ' LYS . 23.0 t-20 -69.91 125.99 28.38 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 174.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.466 HD23 ' HG ' ' A' ' 22' ' ' LEU . 10.4 tt -62.81 -22.43 66.63 Favored 'General case' 0 N--CA 1.42 -1.936 0 C-N-CA 125.224 1.41 . . . . 0.0 114.209 -171.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.544 ' HG2' ' OD1' ' A' ' 43' ' ' ASN . 8.1 pttp -91.22 4.11 53.12 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 118.51 -1.276 . . . . 0.0 110.423 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.486 ' C ' ' H ' ' A' ' 48' ' ' MET . 39.9 t -105.55 129.62 53.78 Favored 'General case' 0 N--CA 1.409 -2.499 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.314 174.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 pp -75.65 2.62 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 123.545 0.738 . . . . 0.0 111.804 -178.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.486 ' H ' ' C ' ' A' ' 46' ' ' SER . 16.0 tpt -61.83 -48.35 80.97 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 113.35 -1.75 . . . . 0.0 110.186 -174.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.414 ' N ' HG21 ' A' ' 42' ' ' VAL . . . -108.45 -29.96 4.0 Favored Glycine 0 C--N 1.305 -1.171 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.428 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.1 t -61.52 -36.61 74.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -175.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 84.0 mtp -87.5 12.91 11.16 Favored 'General case' 0 C--O 1.22 -0.476 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.264 -178.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.9 m -124.86 5.48 8.06 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.484 HD11 ' HB3' ' A' ' 37' ' ' TYR . 8.2 tp -81.09 105.86 12.63 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.59 66.11 3.57 Favored Glycine 0 CA--C 1.508 -0.386 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 175.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.6 p -89.48 97.82 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 CA-C-O 122.49 1.138 . . . . 0.0 111.452 -173.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.28 -153.99 9.45 Favored Glycine 0 N--CA 1.432 -1.586 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.455 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -61.51 136.06 57.89 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.9 t70 77.99 3.96 2.86 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.972 1.309 . . . . 0.0 111.444 175.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.93 118.74 14.09 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.404 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -95.19 108.34 20.46 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.486 ' CG1' ' HB2' ' A' ' 6' ' ' TYR . 11.4 pt -110.49 157.4 11.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.31 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 4' ' ' GLN . 61.4 m -133.08 124.25 27.25 Favored 'General case' 0 C--N 1.273 -2.74 0 CA-C-O 121.185 0.517 . . . . 0.0 110.986 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.55 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.4 mp -91.85 125.84 44.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 175.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.669 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 45.3 m-85 -110.42 106.76 16.22 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 171.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -105.37 113.32 26.82 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.208 -176.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -128.29 120.06 26.35 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -174.66 -172.25 39.55 Favored Glycine 0 CA--C 1.475 -2.419 0 C-N-CA 117.787 -2.149 . . . . 0.0 113.351 -172.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.4 p -73.86 -26.97 60.84 Favored 'General case' 0 N--CA 1.421 -1.913 0 C-N-CA 124.197 0.999 . . . . 0.0 111.002 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -134.63 21.88 3.62 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.453 ' O ' HG12 ' A' ' 74' ' ' ILE . 9.5 pt-20 -42.52 -52.8 4.61 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -172.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.512 ' O ' ' HB ' ' A' ' 74' ' ' ILE . . . -65.24 -42.74 93.07 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -173.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -84.73 -21.97 29.87 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.18 -39.98 95.14 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 172.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.512 ' HB ' ' O ' ' A' ' 71' ' ' ALA . 24.6 mm -56.26 -48.06 80.08 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 CA-C-O 121.731 0.777 . . . . 0.0 109.572 173.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.454 ' HA ' ' OE1' ' A' ' 75' ' ' GLN . 12.2 mm-40 -57.54 -39.49 76.75 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.117 -1.401 . . . . 0.0 111.998 -178.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.36 -41.82 17.76 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.8 tt -62.52 -32.75 56.32 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.082 0 CA-C-O 120.847 0.356 . . . . 0.0 111.199 -174.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.7 m -68.1 -28.45 67.36 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 120.854 0.359 . . . . 0.0 110.762 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.544 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 16.3 t70 -78.44 -47.55 17.26 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -175.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 23.8 m -66.0 -32.13 56.77 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.47 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.8 mt -67.37 -45.94 74.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.141 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.592 ' HA ' ' OG1' ' A' ' 87' ' ' THR . 22.7 t -62.97 -43.53 98.54 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.04 178.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 33.1 mmtp -64.72 -40.53 95.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.956 0.408 . . . . 0.0 110.67 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -77.06 -17.46 58.74 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.06 53.87 2.43 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 120.644 -0.788 . . . . 0.0 111.867 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 79.9 mt -140.56 39.16 1.86 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 122.386 1.088 . . . . 0.0 108.124 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.619 ' O ' HG23 ' A' ' 9' ' ' ILE . 17.4 p -139.87 -155.03 0.55 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 175.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 . . . . . 0 C--N 1.307 -1.24 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 171.58 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.438 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 66.9 mtt . . . . . 0 CA--C 1.491 -1.303 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -98.84 149.63 22.7 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 172.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.747 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 4.0 pt20 -114.19 149.11 36.24 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -176.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 62' ' ' THR . 30.6 mm-40 -127.37 129.48 47.66 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 113.707 -1.588 . . . . 0.0 107.89 173.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.2 t -103.23 104.16 14.27 Favored 'General case' 0 N--CA 1.416 -2.147 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 175.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.541 ' HH ' HG22 ' A' ' 77' ' ' ILE . 31.3 m-85 -95.37 103.4 15.26 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.822 -176.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.2 m -79.61 89.35 5.12 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.448 HG23 ' CG1' ' A' ' 55' ' ' VAL . 4.3 mt -69.41 138.2 22.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 114.779 -1.1 . . . . 0.0 113.098 -175.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 pp -96.12 -4.31 10.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.834 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.48 ' O ' ' HA2' ' A' ' 56' ' ' GLY . 6.5 t70 -59.04 125.82 25.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.177 176.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 . . . . . 0 C--N 1.301 -1.521 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.087 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . 0.257 2.4 p-80 . . . . . 0 N--CA 1.446 -0.647 0 CA-C-O 122.532 1.158 . . . . 0.0 110.666 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.28 -29.63 64.07 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 113.36 -1.745 . . . . 0.0 114.407 -170.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.51 -51.26 52.4 Favored Pre-proline 0 CA--C 1.556 1.202 0 CA-C-O 119.147 -0.454 . . . . 0.0 110.241 -178.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -57.73 -37.2 97.46 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 121.758 1.639 . . . . 0.0 110.812 172.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.655 ' O ' ' HG ' ' A' ' 22' ' ' LEU . . . -66.01 -18.84 65.61 Favored 'General case' 0 C--O 1.197 -1.7 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.929 178.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.4 m -70.02 -24.57 63.31 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 49.7 ttm -78.26 -35.26 48.35 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 175.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -64.84 -37.58 88.11 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 176.308 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.404 HG11 ' O ' ' A' ' 45' ' ' LYS . 4.5 t -58.57 -47.43 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.107 176.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -66.18 -19.28 65.79 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.784 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 54.2 m -84.2 -50.38 7.95 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.99 -29.09 69.41 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.6 p -62.71 -19.02 63.49 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -114.09 -145.77 0.4 Allowed 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 69.63 13.23 8.21 Favored 'General case' 0 C--O 1.247 0.921 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 174.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 56.92 27.11 12.59 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.913 0.885 . . . . 0.0 112.648 170.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.525 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 19.3 m -142.69 156.29 45.01 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.806 -177.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -105.57 113.81 27.61 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 175.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 3.1 mp -97.74 126.16 50.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.144 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -104.78 143.84 32.57 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.535 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 3.9 tt -96.48 129.69 43.79 Favored 'General case' 0 N--CA 1.403 -2.776 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 173.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.662 ' HA ' ' O ' ' A' ' 40' ' ' LYS . 0.5 OUTLIER -130.2 119.83 23.56 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -150.31 103.12 3.13 Favored 'General case' 0 C--N 1.293 -1.879 0 O-C-N 122.304 -0.248 . . . . 0.0 111.246 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.0 t30 59.56 28.71 18.17 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.84 0.856 . . . . 0.0 111.329 171.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.48 -17.03 8.44 Favored Glycine 0 CA--C 1.495 -1.215 0 C-N-CA 119.821 -1.18 . . . . 0.0 111.608 -178.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.662 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 13.3 mmtp -77.63 140.19 39.6 Favored 'General case' 0 CA--C 1.481 -1.705 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 15.1 ptmm? -143.99 112.56 6.53 Favored 'General case' 0 N--CA 1.413 -2.292 0 CA-C-N 114.299 -1.319 . . . . 0.0 108.594 169.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.3 p -149.04 160.46 5.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.772 -174.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.54 ' O ' ' HB2' ' A' ' 46' ' ' SER . 15.6 t30 -66.47 109.0 2.58 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -62.73 -25.93 68.44 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.661 0.784 . . . . 0.0 112.713 -173.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.505 ' HG2' ' ND2' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -88.37 24.61 1.87 Allowed 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 122.249 1.024 . . . . 0.0 110.356 178.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.54 ' HB2' ' O ' ' A' ' 43' ' ' ASN . 52.0 m -122.29 125.94 47.07 Favored 'General case' 0 N--CA 1.4 -2.974 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.145 172.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.46 -23.24 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 47.0 ttp -58.75 -22.02 56.87 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.859 -1.519 . . . . 0.0 110.187 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -84.94 -67.33 1.42 Allowed Glycine 0 N--CA 1.423 -2.211 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 94.4 t -55.09 -40.7 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -175.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 34.5 ttm -77.19 -0.75 26.26 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-O 120.797 0.332 . . . . 0.0 111.537 -175.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 62.8 m -98.89 -19.07 17.56 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 121.692 -0.63 . . . . 0.0 111.748 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.463 ' HB2' ' CG2' ' A' ' 55' ' ' VAL . 4.7 mp -75.13 150.53 38.74 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.5 66.1 3.25 Favored Glycine 0 C--N 1.301 -1.364 0 N-CA-C 107.998 -2.041 . . . . 0.0 107.998 170.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.463 ' CG2' ' HB2' ' A' ' 53' ' ' LEU . 11.1 t -66.98 113.46 3.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 123.996 0.918 . . . . 0.0 110.194 -174.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 10' ' ' ASP . . . -162.22 111.57 0.48 Allowed Glycine 0 N--CA 1.432 -1.587 0 CA-C-O 119.44 -0.644 . . . . 0.0 111.94 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.3 pttp 39.31 -43.9 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.944 0 C-N-CA 129.766 3.226 . . . . 0.0 117.966 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -93.25 7.29 44.93 Favored 'General case' 0 C--N 1.285 -2.212 0 O-C-N 121.336 -0.852 . . . . 0.0 109.399 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.15 89.25 1.15 Allowed 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.173 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 35.5 mt-10 -94.58 93.03 7.35 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 174.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.5 pt -93.69 143.42 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.057 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.538 -174.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 4' ' ' GLN . 25.1 m -106.41 123.24 47.77 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-O 121.273 0.558 . . . . 0.0 109.983 -177.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.575 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.3 mp -100.5 129.54 51.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.182 176.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.747 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 38.0 m-85 -115.55 112.87 22.84 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 123.682 0.614 . . . . 0.0 109.925 174.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -106.29 119.88 40.4 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.438 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 26.1 t70 -131.44 117.06 18.31 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.525 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -173.91 -163.92 28.17 Favored Glycine 0 N--CA 1.425 -2.09 0 C-N-CA 119.524 -1.322 . . . . 0.0 112.736 -174.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.5 m -87.59 -22.32 24.84 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.844 0.831 . . . . 0.0 109.373 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -132.39 35.85 3.63 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.838 -177.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.401 ' OE1' ' HA ' ' A' ' 66' ' ' ASP . 11.3 pt-20 -64.28 -38.0 89.47 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -173.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.31 -30.37 68.42 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.136 0.493 . . . . 0.0 110.658 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -76.06 -39.39 55.56 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 177.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.47 -41.23 98.59 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.441 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.6 mm -51.71 -51.33 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.279 0.631 . . . . 0.0 111.235 177.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -65.32 -41.53 93.92 Favored 'General case' 0 N--CA 1.405 -2.716 0 C-N-CA 122.799 0.44 . . . . 0.0 110.46 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.457 ' O ' ' HB3' ' A' ' 79' ' ' ASP . . . -67.15 -38.67 85.91 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.578 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.541 HG22 ' HH ' ' A' ' 6' ' ' TYR . 5.1 tt -72.25 -35.03 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.025 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.856 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.5 m -66.6 -41.62 88.17 Favored 'General case' 0 C--O 1.253 1.285 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 174.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.457 ' HB3' ' O ' ' A' ' 76' ' ' ALA . 26.3 t70 -51.22 -55.0 20.31 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 114.199 -1.364 . . . . 0.0 110.975 176.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.0 m -70.42 -34.14 56.71 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.081 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.9 mp -61.89 -50.35 72.57 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 119.278 0.945 . . . . 0.0 110.949 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.6 p -63.46 -39.22 93.88 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.03 0.443 . . . . 0.0 111.58 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -59.25 -43.78 92.41 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 124.227 1.011 . . . . 0.0 109.665 176.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -86.22 5.99 31.65 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 124.473 1.109 . . . . 0.0 112.505 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.88 30.76 70.06 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 115.429 0.932 . . . . 0.0 115.429 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.4 mp -90.56 -34.68 15.42 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 118.436 1.118 . . . . 0.0 109.713 174.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 27.1 p -119.49 150.18 40.66 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 . . . . . 0 N--CA 1.424 -1.749 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.387 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.586 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 47.8 ttm . . . . . 0 CA--C 1.508 -0.649 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -139.46 151.81 46.51 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.7 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 2.2 pt20 -103.73 149.05 25.35 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 123.757 0.661 . . . . 0.0 111.243 176.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -138.25 103.68 4.99 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.323 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 48.9 m -91.34 120.16 31.98 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.493 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 73.6 m-85 -109.97 137.82 47.21 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 124.831 1.252 . . . . 0.0 111.726 -174.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.0 m -96.62 109.93 22.45 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 174.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.509 HG12 ' H ' ' A' ' 10' ' ' ASP . 10.8 tt -63.11 152.14 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.87 0 CA-C-O 121.1 0.476 . . . . 0.0 111.552 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.401 ' N ' HG12 ' A' ' 8' ' ' ILE . 23.6 pt -116.12 -14.9 10.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 O-C-N 122.033 -0.417 . . . . 0.0 110.879 176.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.509 ' H ' HG12 ' A' ' 8' ' ' ILE . 28.8 t70 -76.39 135.22 39.47 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.356 0.598 . . . . 0.0 111.589 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -116.7 -5.22 11.6 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.511 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.8 m -70.51 -29.9 66.53 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.402 -177.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.44 33.26 0.83 Allowed Glycine 0 N--CA 1.435 -1.388 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.993 174.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 87.89 -53.81 0.04 OUTLIER 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 124.802 1.241 . . . . 0.0 112.008 174.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.456 ' O ' ' HD2' ' A' ' 18' ' ' PRO 0.497 0.8 OUTLIER 59.57 111.9 0.02 OUTLIER 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.542 1.137 . . . . 0.0 113.778 -173.602 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.72 -31.84 69.99 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.209 -1.36 . . . . 0.0 113.98 -172.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.414 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 13.2 tpp180 -57.01 -56.07 37.32 Favored Pre-proline 0 CA--C 1.559 1.324 0 CA-C-O 118.669 -0.682 . . . . 0.0 112.193 -178.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.536 ' HA ' ' OE2' ' A' ' 84' ' ' GLU . 82.1 Cg_exo -48.83 -45.9 26.67 Favored 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 122.598 2.199 . . . . 0.0 112.347 172.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.429 ' O ' HG22 ' A' ' 23' ' ' VAL . . . -65.36 -27.08 68.32 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.478 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.496 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 18.2 m -72.6 -28.81 63.01 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 61.7 mtt -71.62 -35.23 70.37 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 174.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -60.22 -41.77 93.79 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.236 172.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.496 ' HB ' ' O ' ' A' ' 20' ' ' THR . 47.8 t -51.85 -56.15 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 O-C-N 124.458 1.099 . . . . 0.0 110.523 175.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -67.65 -26.99 66.49 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 120.812 0.339 . . . . 0.0 111.494 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.0 m -71.05 -52.7 17.98 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.02 -30.57 71.05 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.586 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.5 m -62.15 -31.02 71.46 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.74 8.09 45.08 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -173.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -101.73 150.73 22.83 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.56 176.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -63.37 -42.44 98.85 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 121.819 0.818 . . . . 0.0 108.966 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.587 ' OG ' ' HA3' ' A' ' 67' ' ' GLY . 13.3 m -71.88 149.24 45.35 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.722 -177.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -102.61 130.35 49.47 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.366 173.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.41 HG23 HG23 ' A' ' 63' ' ' ILE . 3.2 mp -108.21 126.04 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.085 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -98.82 136.3 39.04 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 174.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.67 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 40.4 tp -104.04 117.91 35.4 Favored 'General case' 0 C--N 1.277 -2.578 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -114.53 106.52 14.37 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-O 121.185 0.517 . . . . 0.0 110.226 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -131.23 94.58 3.6 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.077 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.6 t30 41.3 69.41 0.35 Allowed 'General case' 0 C--O 1.247 0.961 0 C-N-CA 125.902 1.681 . . . . 0.0 113.753 173.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.18 -26.69 23.57 Favored Glycine 0 CA--C 1.502 -0.749 0 C-N-CA 120.846 -0.693 . . . . 0.0 111.731 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.58 99.78 10.7 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 178.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.67 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -116.55 133.16 56.35 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-N 115.287 -0.869 . . . . 0.0 108.997 171.679 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 p -156.16 155.14 5.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.826 -172.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -62.56 118.17 7.22 Favored 'General case' 0 C--O 1.208 -1.12 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 169.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.7 tp -64.26 -20.13 65.85 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -90.39 3.27 54.24 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 119.332 -0.947 . . . . 0.0 111.024 175.111 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.3 m -115.55 136.19 53.33 Favored 'General case' 0 N--CA 1.415 -2.185 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.3 pp -81.79 9.35 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -173.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 49.7 ttp -88.82 60.13 5.38 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.681 1.229 . . . . 0.0 110.403 -170.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.51 -45.27 0.69 Allowed Glycine 0 N--CA 1.426 -1.97 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 -175.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.32 -34.71 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 114.649 -0.775 . . . . 0.0 111.713 -177.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -76.73 -16.62 59.44 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.778 -173.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.8 m -116.44 17.56 15.43 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.192 0.52 . . . . 0.0 109.643 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.1 tp -62.93 112.51 2.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.121 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.76 56.55 2.61 Favored Glycine 0 C--N 1.31 -0.863 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.081 -176.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.5 m -87.2 138.08 19.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-O 120.937 0.399 . . . . 0.0 112.013 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -158.02 134.92 4.08 Favored Glycine 0 C--O 1.207 -1.569 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . 0.317 14.7 ptmm? 20.12 -64.28 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.09 0 N-CA-C 118.604 2.816 . . . . 0.0 118.604 -176.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -77.14 -8.59 57.77 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.78 -0.575 . . . . 0.0 111.769 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.1 109.07 5.64 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.305 0.574 . . . . 0.0 112.27 -175.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 31.6 mt-10 -98.42 119.46 37.16 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.439 HD13 HG22 ' A' ' 61' ' ' ILE . 17.6 pt -106.16 142.94 17.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.717 -173.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.1 m -114.47 125.93 54.38 Favored 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.95 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.6 mp -99.97 135.33 36.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.7 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 40.5 m-85 -121.5 114.6 21.46 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 172.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.586 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -107.02 125.06 50.52 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -128.97 123.08 31.52 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 177.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.587 ' HA3' ' OG ' ' A' ' 31' ' ' SER . . . 178.36 -171.88 44.27 Favored Glycine 0 N--CA 1.429 -1.78 0 C-N-CA 120.226 -0.988 . . . . 0.0 111.421 -174.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.6 t -85.85 -13.43 48.01 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 174.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -128.82 37.85 4.03 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.646 -178.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.463 ' O ' HG12 ' A' ' 74' ' ' ILE 0.336 0.0 OUTLIER -67.34 -48.17 68.32 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 -173.774 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.17 -32.83 73.5 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.26 0.552 . . . . 0.0 111.026 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -74.83 -39.08 61.83 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.707 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.55 ' O ' ' HB ' ' A' ' 77' ' ' ILE . . . -61.71 -41.33 97.47 Favored 'General case' 0 C--O 1.201 -1.488 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 70' ' ' GLU . 28.1 mm -57.26 -49.53 79.58 Favored 'Isoleucine or valine' 0 C--O 1.248 0.974 0 C-N-CA 123.536 0.735 . . . . 0.0 111.271 176.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -67.22 -31.06 71.18 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 120.452 -0.499 . . . . 0.0 112.196 -176.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.17 -42.26 38.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.333 0.587 . . . . 0.0 109.744 175.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.55 ' HB ' ' O ' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -56.32 -43.31 76.69 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 C-N-CA 124.701 1.2 . . . . 0.0 111.758 179.783 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 56.2 m -63.51 -44.69 93.58 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -59.21 -53.54 57.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.763 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.6 m -67.1 -37.73 79.84 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.016 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.795 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 29.9 mt -65.47 -35.26 80.38 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.3 p -75.65 -34.64 60.53 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.398 177.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -62.52 -39.08 92.4 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.528 0.68 . . . . 0.0 109.894 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.536 ' OE2' ' HA ' ' A' ' 18' ' ' PRO . 5.6 mm-40 -87.22 -3.98 59.07 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.962 -177.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.4 15.25 80.31 Favored Glycine 0 C--N 1.317 -0.504 0 N-CA-C 115.746 1.058 . . . . 0.0 115.746 173.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.486 ' HA ' HG13 ' A' ' 8' ' ' ILE . 4.9 mp -88.81 5.59 42.92 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 118.607 1.203 . . . . 0.0 110.474 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.472 ' HB ' ' HB3' ' A' ' 6' ' ' TYR . 10.2 t -163.23 156.12 18.83 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.5 176.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 N--CA 1.419 -2.004 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 167.18 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.508 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 90.2 mtp . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -103.58 151.04 23.37 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 174.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.669 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 16.8 pt20 -111.22 150.08 30.06 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-O 121.724 0.774 . . . . 0.0 112.744 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.472 ' O ' ' HA ' ' A' ' 62' ' ' THR . 8.5 mm-40 -128.67 119.46 24.72 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 114.014 -1.448 . . . . 0.0 109.288 176.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.5 t -98.72 97.31 8.57 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 176.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.572 ' HH ' HG22 ' A' ' 77' ' ' ILE . 56.9 m-85 -88.1 127.59 35.41 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.575 -176.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.4 m -88.84 90.1 8.27 Favored 'General case' 0 N--CA 1.409 -2.475 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 172.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.678 ' O ' ' HA ' ' A' ' 57' ' ' LYS . 8.4 mt -71.91 131.13 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.063 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 33.9 pt -125.65 23.3 3.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.457 ' HB2' ' HA ' ' A' ' 86' ' ' LEU . 25.1 t70 -71.4 104.68 3.28 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.572 -177.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -79.7 -0.36 33.78 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -174.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 p -90.4 -7.03 54.22 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.336 0.589 . . . . 0.0 110.404 170.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.84 25.48 71.66 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.582 -0.736 . . . . 0.0 113.573 175.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 79.48 111.12 0.07 Allowed 'General case' 0 C--O 1.245 0.817 0 C-N-CA 124.442 1.097 . . . . 0.0 112.418 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -95.15 166.75 11.76 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.12 -43.93 73.44 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.498 ' O ' HG23 ' A' ' 20' ' ' THR 0.258 26.9 mmt180 -60.16 -47.66 96.24 Favored Pre-proline 0 N--CA 1.473 0.703 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 -178.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -53.76 -45.39 41.37 Favored 'Trans proline' 0 C--N 1.363 1.324 0 C-N-CA 121.582 1.521 . . . . 0.0 110.401 174.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.407 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -67.74 -34.34 76.65 Favored 'General case' 0 C--O 1.205 -1.264 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.593 -178.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 17' ' ' ARG . 1.3 t -71.16 -28.12 64.04 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.183 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.2 mtm -78.37 -28.47 47.1 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 175.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.12 -42.4 93.96 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 170.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 19' ' ' ALA . 55.7 t -56.45 -49.51 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.941 173.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.404 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 29.0 tt0 -59.37 -27.48 66.01 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.446 1.098 . . . . 0.0 111.715 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.425 ' O ' ' HD1' ' A' ' 29' ' ' PHE . 94.4 m -80.73 -56.55 4.07 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.62 86.13 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.242 -176.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.8 m -59.09 -29.14 67.12 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -119.05 14.1 13.09 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 -170.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.425 ' HD1' ' O ' ' A' ' 25' ' ' THR . 6.7 m-85 -99.33 9.94 42.38 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.248 -0.581 . . . . 0.0 112.207 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.5 t70 48.97 39.49 14.72 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 123.559 1.647 . . . . 0.0 110.486 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.459 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 21.7 m -143.35 141.22 30.86 Favored 'General case' 0 N--CA 1.393 -3.307 0 CA-C-N 112.897 -1.956 . . . . 0.0 107.18 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -95.64 98.73 10.71 Favored 'General case' 0 N--CA 1.391 -3.423 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.493 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 97.9 mt -93.1 125.42 45.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.888 177.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -119.9 147.08 45.16 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.3 tt -106.7 112.85 26.03 Favored 'General case' 0 N--CA 1.399 -2.986 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 41' ' ' LYS . 8.6 tp10 -98.76 116.11 30.27 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 175.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -141.08 108.01 5.42 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.354 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 42.02 77.91 0.05 Allowed 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 126.409 1.883 . . . . 0.0 113.476 173.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.33 -52.83 0.64 Allowed Glycine 0 N--CA 1.418 -2.542 0 C-N-CA 119.721 -1.228 . . . . 0.0 112.397 175.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.7 147.65 48.59 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 -173.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.471 ' H ' ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -103.9 131.48 51.07 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 113.696 -1.593 . . . . 0.0 108.766 177.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.9 p -125.98 137.84 56.46 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.753 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -54.44 125.06 18.04 Favored 'General case' 0 C--O 1.207 -1.144 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 172.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.23 -14.34 61.32 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 121.633 0.73 . . . . 0.0 111.167 -174.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.2 3.39 54.94 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 121.486 -0.759 . . . . 0.0 110.329 172.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 57.2 m -113.29 124.85 53.46 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.429 177.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.424 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -78.58 8.64 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 123.068 0.547 . . . . 0.0 112.413 -173.635 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 16.5 tpt -105.59 78.08 1.33 Allowed 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -168.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 135.75 -32.71 2.49 Favored Glycine 0 C--N 1.291 -1.958 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -173.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 88.0 t -80.97 -43.4 20.69 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 CA-C-N 114.965 -0.617 . . . . 0.0 110.529 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.5 mtt -65.65 -40.19 92.19 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 119.205 -0.998 . . . . 0.0 111.451 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.4 m -80.57 16.53 1.34 Allowed 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 176.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.7 tp -65.92 107.08 1.73 Allowed 'General case' 0 C--O 1.244 0.777 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.93 55.6 4.53 Favored Glycine 0 C--O 1.222 -0.635 0 N-CA-C 110.519 -1.033 . . . . 0.0 110.519 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.4 p -88.13 139.35 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -173.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -122.86 -83.03 0.62 Allowed Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 119.802 -1.189 . . . . 0.0 113.48 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.678 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -169.15 136.49 1.83 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -177.037 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.3 t70 74.83 4.81 4.36 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 123.033 1.397 . . . . 0.0 107.801 -171.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.18 108.61 7.08 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 113.345 -1.752 . . . . 0.0 109.818 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -83.36 110.81 18.45 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 123.627 0.579 . . . . 0.0 110.308 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.421 ' CG1' ' HB2' ' A' ' 6' ' ' TYR . 25.3 pt -106.09 143.44 17.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 174.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 4' ' ' GLN . 28.1 m -112.94 111.41 22.14 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 121.557 0.694 . . . . 0.0 111.405 -176.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.571 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.4 mp -89.56 135.4 26.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.416 177.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.669 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 34.2 m-85 -117.29 119.13 34.22 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 172.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -114.65 122.4 46.35 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.508 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 25.8 t70 -136.05 122.83 21.15 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.495 ' N ' ' HB3' ' A' ' 70' ' ' GLU . . . -178.29 -170.04 39.9 Favored Glycine 0 C--N 1.287 -2.155 0 C-N-CA 119.024 -1.56 . . . . 0.0 112.209 -173.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.0 m -76.83 -30.15 56.24 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.603 0.716 . . . . 0.0 109.31 175.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -124.06 30.17 6.2 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.097 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.544 ' O ' HG12 ' A' ' 74' ' ' ILE . 12.4 pt-20 -54.1 -42.96 69.98 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -175.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.85 -31.93 72.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.594 0.711 . . . . 0.0 110.906 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -83.32 -32.3 26.38 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.138 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.99 -28.74 68.5 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.941 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 70' ' ' GLU . 25.3 mm -54.04 -48.3 64.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 O-C-N 123.857 0.723 . . . . 0.0 110.85 175.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -68.44 -39.65 81.43 Favored 'General case' 0 N--CA 1.403 -2.781 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.86 -47.26 84.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.823 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.572 HG22 ' HH ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -66.74 -36.4 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.868 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.623 -179.615 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 41.0 m -68.03 -40.04 82.99 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 175.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.485 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 20.1 t70 -56.18 -56.15 24.41 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.904 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.1 m -61.76 -36.85 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 38.6 mt -63.47 -48.26 78.38 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.41 -0.218 . . . . 0.0 110.41 176.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.575 ' HA ' ' O ' ' A' ' 87' ' ' THR . 38.1 t -57.66 -47.37 82.47 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.224 0.61 . . . . 0.0 111.333 174.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 32.6 mmtp -57.58 -42.67 83.61 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.641 0.734 . . . . 0.0 110.489 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -77.66 -22.43 50.61 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.922 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.11 14.83 47.19 Favored Glycine 0 C--N 1.301 -1.389 0 C-N-CA 120.358 -0.925 . . . . 0.0 113.797 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.457 ' HA ' ' HB2' ' A' ' 10' ' ' ASP . 5.1 mp -87.05 -25.41 24.21 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.575 ' O ' ' HA ' ' A' ' 82' ' ' SER . 34.3 m -126.7 148.79 49.83 Favored 'General case' 0 N--CA 1.414 -2.233 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 176.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 . . . . . 0 C--N 1.301 -1.505 0 C-N-CA 123.604 0.762 . . . . 0.0 111.124 -176.926 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 mtm . . . . . 0 CA--C 1.504 -0.792 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 31.9 tt0 -100.78 141.45 33.65 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.623 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 3.8 pt20 -106.59 154.27 21.15 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -175.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -138.53 127.52 23.93 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.458 -1.701 . . . . 0.0 107.367 172.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.7 p -103.6 103.4 13.33 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-O 121.741 0.782 . . . . 0.0 110.109 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -104.69 164.64 11.62 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.716 -177.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.9 m -129.57 130.42 45.68 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 174.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.48 HG13 ' HA ' ' A' ' 86' ' ' LEU . 15.1 tt -90.93 153.71 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.638 0 C-N-CA 121.18 -0.208 . . . . 0.0 111.492 -175.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 36.4 pt -136.49 24.55 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 121.117 0.484 . . . . 0.0 110.667 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.403 ' H ' HG12 ' A' ' 8' ' ' ILE . 7.1 p-10 -65.75 -39.96 91.63 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.899 -177.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.408 ' HG2' ' HG2' ' A' ' 57' ' ' LYS . 36.8 mt-10 65.61 6.66 3.95 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.334 1.453 . . . . 0.0 112.191 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.4 m -108.75 -37.99 5.74 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.268 0.556 . . . . 0.0 111.55 -172.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 117.25 40.19 0.76 Allowed Glycine 0 N--CA 1.427 -1.909 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 93.37 -67.21 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.652 1.581 . . . . 0.0 114.14 175.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . 0.298 9.1 p80 49.02 107.11 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 125.4 1.48 . . . . 0.0 112.945 -172.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.94 80.09 4.39 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -173.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.445 ' H ' ' HD2' ' A' ' 18' ' ' PRO . 2.1 tmt_? -137.77 -51.21 0.02 OUTLIER Pre-proline 0 C--N 1.291 -1.963 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 172.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.445 ' HD2' ' H ' ' A' ' 17' ' ' ARG . 4.9 Cg_endo -53.27 -33.59 66.08 Favored 'Trans proline' 0 C--N 1.384 2.427 0 C-N-CA 121.343 1.362 . . . . 0.0 109.693 168.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.497 ' O ' HG21 ' A' ' 23' ' ' VAL . . . -60.25 -27.8 67.52 Favored 'General case' 0 C--O 1.201 -1.49 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.58 178.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.5 m -65.82 -26.77 67.82 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.229 0.538 . . . . 0.0 110.471 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 55.9 tpp -71.76 -32.0 67.24 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.12 -30.37 63.58 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.197 176.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.497 HG21 ' O ' ' A' ' 19' ' ' ALA . 77.0 t -69.96 -39.9 78.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -70.26 -37.74 74.97 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.321 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.1 m -91.26 -66.79 0.9 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -172.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.482 ' HB1' ' HB3' ' A' ' 45' ' ' LYS . . . -62.97 -32.64 74.01 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -171.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.4 m -61.49 -25.69 67.42 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.34 14.93 30.64 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -176.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.476 ' C ' ' H ' ' A' ' 31' ' ' SER . 28.8 m-85 -105.23 3.7 30.36 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.814 178.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.5 t70 68.78 -36.82 0.34 Allowed 'General case' 0 N--CA 1.507 2.406 0 C-N-CA 124.644 1.177 . . . . 0.0 113.187 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.504 ' OG ' ' HA3' ' A' ' 67' ' ' GLY . 19.9 m -58.95 148.95 28.61 Favored 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 125.261 1.424 . . . . 0.0 112.029 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -99.68 102.69 14.25 Favored 'General case' 0 N--CA 1.409 -2.513 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.927 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 2.6 mp -91.48 121.59 42.07 Favored 'Isoleucine or valine' 0 C--O 1.259 1.588 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.844 177.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -119.97 135.63 54.84 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 -174.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 5.8 tt -101.24 116.26 32.39 Favored 'General case' 0 N--CA 1.406 -2.656 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.42 ' HB3' ' HB ' ' A' ' 62' ' ' THR . 3.4 tm-20 -99.93 105.35 17.05 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . 0.285 1.2 t80 -110.3 79.83 1.25 Allowed 'General case' 0 C--N 1.287 -2.134 0 CA-C-O 122.149 0.976 . . . . 0.0 110.476 175.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 34.81 79.95 0.03 OUTLIER 'General case' 0 C--O 1.238 0.476 0 CA-C-N 111.949 -2.387 . . . . 0.0 113.711 172.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 135.48 -61.72 0.62 Allowed Glycine 0 CA--C 1.484 -1.848 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.427 ' H ' ' HD2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -127.12 159.21 34.89 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-N 113.871 -1.164 . . . . 0.0 110.285 -174.18 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -142.74 142.71 32.0 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.588 -173.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.416 HG21 ' HA3' ' A' ' 49' ' ' GLY . 10.4 p -151.33 160.16 3.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -61.57 132.72 54.25 Favored 'General case' 0 C--O 1.216 -0.679 0 C-N-CA 122.83 0.452 . . . . 0.0 111.329 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 35' ' ' LEU . 34.2 tp -91.33 -15.63 28.77 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.773 0.797 . . . . 0.0 111.423 -178.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.482 ' HB3' ' HB1' ' A' ' 26' ' ' ALA . 16.0 pttp -90.06 1.91 55.81 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 122.075 0.94 . . . . 0.0 109.672 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 61.3 m -121.51 139.33 53.63 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-N 113.958 -1.474 . . . . 0.0 108.167 175.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.15 -27.56 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-O 121.611 0.72 . . . . 0.0 110.247 -175.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 53.8 ttp -68.19 91.91 0.38 Allowed 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 113.694 -1.594 . . . . 0.0 108.658 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.416 ' HA3' HG21 ' A' ' 42' ' ' VAL . . . 139.79 -58.52 0.59 Allowed Glycine 0 C--N 1.264 -3.458 0 CA-C-N 113.379 -1.737 . . . . 0.0 110.138 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.2 t -66.28 -33.95 66.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 114.629 -0.785 . . . . 0.0 112.376 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 55.1 ttm -64.86 -52.17 58.06 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.011 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.2 m -69.25 -16.28 63.55 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 123.655 0.782 . . . . 0.0 112.897 177.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.2 tp -69.02 103.58 1.89 Allowed 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 123.899 0.88 . . . . 0.0 109.291 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.22 62.68 4.23 Favored Glycine 0 C--N 1.31 -0.873 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.893 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.445 ' HB ' HG21 ' A' ' 8' ' ' ILE . 1.2 m -56.94 -62.72 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 C-N-CA 122.187 0.195 . . . . 0.0 110.863 176.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 49.42 75.37 0.21 Allowed Glycine 0 CA--C 1.53 1.001 0 N-CA-C 116.004 1.162 . . . . 0.0 116.004 171.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.478 ' HA ' HG22 ' A' ' 8' ' ' ILE . 0.0 OUTLIER 43.16 -13.8 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.456 0 N-CA-C 119.589 3.181 . . . . 0.0 119.589 177.565 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -102.46 -8.7 20.87 Favored 'General case' 0 C--N 1.285 -2.225 0 O-C-N 121.242 -0.911 . . . . 0.0 109.802 -176.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.1 127.24 32.41 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -171.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -91.54 101.24 13.89 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 169.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 pt -104.87 126.56 59.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.731 -0.787 . . . . 0.0 109.918 -171.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.42 ' HB ' ' HB3' ' A' ' 36' ' ' GLU . 19.4 m -108.9 118.15 36.05 Favored 'General case' 0 C--N 1.287 -2.114 0 O-C-N 121.913 -0.492 . . . . 0.0 109.838 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.5 mp -88.71 132.78 32.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.623 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 38.9 m-85 -119.27 125.84 50.08 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.961 171.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.23 120.5 40.67 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.469 ' HA ' ' OE1' ' A' ' 70' ' ' GLU . 29.0 t70 -125.56 108.02 11.18 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.504 ' HA3' ' OG ' ' A' ' 31' ' ' SER . . . -165.73 -172.89 33.65 Favored Glycine 0 N--CA 1.416 -2.645 0 C-N-CA 119.148 -1.501 . . . . 0.0 113.482 -171.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.3 p -78.75 -26.91 44.64 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 114.582 -0.809 . . . . 0.0 110.027 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -129.2 35.91 4.22 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.286 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.469 ' OE1' ' HA ' ' A' ' 66' ' ' ASP . 11.0 pt-20 -58.53 -36.18 73.44 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -175.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.84 -43.52 95.94 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 121.218 0.532 . . . . 0.0 110.497 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -76.28 -31.13 58.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.786 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.445 ' O ' ' HB ' ' A' ' 77' ' ' ILE . . . -64.27 -36.67 84.84 Favored 'General case' 0 C--O 1.205 -1.265 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.915 176.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.543 ' O ' HG21 ' A' ' 77' ' ' ILE . 25.8 mm -61.22 -43.65 96.86 Favored 'Isoleucine or valine' 0 C--O 1.251 1.143 0 C-N-CA 122.691 0.396 . . . . 0.0 110.784 175.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -53.04 62.68 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.64 -39.17 93.23 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.566 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.543 HG21 ' O ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -64.65 -40.61 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 C-N-CA 123.127 0.571 . . . . 0.0 110.607 -178.024 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.8 m -72.85 -33.91 66.43 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 24.1 t70 -63.26 -46.74 85.42 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.549 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.3 m -77.68 -23.5 14.19 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.262 0 C-N-CA 120.517 -0.473 . . . . 0.0 112.188 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 77' ' ' ILE . 23.6 mt -73.19 -48.02 38.7 Favored 'General case' 0 C--O 1.206 -1.185 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.588 174.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.7 p -61.3 -29.5 69.91 Favored 'General case' 0 C--N 1.316 -0.85 0 O-C-N 121.626 -0.671 . . . . 0.0 111.438 173.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 79' ' ' ASP . 18.4 ttmm -70.94 -39.57 72.55 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.909 176.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -104.53 -82.8 0.51 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -177.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -173.22 -156.9 13.68 Favored Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -176.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.48 ' HA ' HG13 ' A' ' 8' ' ' ILE . 3.2 mp 64.87 19.67 11.91 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 125.276 1.43 . . . . 0.0 112.3 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 60.3 m -154.45 156.89 37.58 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 . . . . . 0 C--O 1.25 1.096 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.647 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.5 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 1.1 mpt? . . . . . 0 CA--C 1.502 -0.9 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -105.23 145.35 30.76 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 118.908 -1.117 . . . . 0.0 113.118 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.76 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 3.5 pt20 -111.82 151.88 28.54 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -172.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.441 ' O ' ' HA ' ' A' ' 62' ' ' THR . 13.8 mm100 -137.16 131.57 32.74 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.224 -1.353 . . . . 0.0 108.369 173.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.8 t -98.71 121.29 40.47 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 82.4 m-85 -113.34 159.51 19.34 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 122.662 0.385 . . . . 0.0 110.933 -177.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.2 m -131.68 106.36 8.1 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 174.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.451 HD12 ' O ' ' A' ' 86' ' ' LEU . 9.7 tp -66.83 144.96 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.603 0 C-N-CA 123.229 0.612 . . . . 0.0 110.353 -176.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.0 pt -109.52 -14.74 10.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-O 121.744 0.783 . . . . 0.0 109.154 174.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.465 ' O ' ' HA2' ' A' ' 56' ' ' GLY . 9.9 t70 -73.28 149.67 42.54 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.583 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -129.19 27.58 5.35 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.626 0.727 . . . . 0.0 109.516 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.4 m -106.92 -32.32 7.95 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.295 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.34 34.5 1.1 Allowed Glycine 0 N--CA 1.427 -1.921 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 -177.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 89.43 -34.26 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 127.201 2.2 . . . . 0.0 110.786 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . 0.494 30.9 p-80 67.42 135.95 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 126.632 1.973 . . . . 0.0 114.33 -178.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.47 -55.99 23.32 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 116.36 1.985 . . . . 0.0 116.36 -166.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -54.89 -53.41 61.27 Favored Pre-proline 0 N--CA 1.48 1.04 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -172.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.17 -37.44 83.56 Favored 'Trans proline' 0 C--N 1.36 1.175 0 C-N-CA 121.671 1.58 . . . . 0.0 110.978 177.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 23' ' ' VAL . . . -68.81 -27.54 65.95 Favored 'General case' 0 C--O 1.21 -1.023 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.03 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.509 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 14.8 m -74.87 -27.46 60.26 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 97.0 mmm -71.23 -37.82 71.99 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 173.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -61.96 -35.98 80.07 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.442 172.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.509 ' HB ' ' O ' ' A' ' 20' ' ' THR . 52.9 t -56.43 -53.98 33.88 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.698 0 O-C-N 123.669 0.606 . . . . 0.0 109.72 174.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -64.04 -26.28 68.49 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-O 121.264 0.554 . . . . 0.0 111.218 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.544 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 37.1 m -79.55 -62.66 1.62 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.577 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.522 ' CB ' ' HB3' ' A' ' 45' ' ' LYS . . . -67.52 -26.82 66.52 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -175.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 27.1 m -72.48 -10.83 60.27 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 177.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.544 ' HG3' ' O ' ' A' ' 25' ' ' THR . 0.0 OUTLIER -100.14 -2.7 33.43 Favored 'General case' 0 CA--C 1.504 -0.813 0 C-N-CA 119.514 -0.875 . . . . 0.0 112.369 179.213 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -99.09 144.65 28.0 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.488 ' C ' ' HG ' ' A' ' 31' ' ' SER . 10.0 m-20 -88.02 65.52 8.26 Favored 'General case' 0 CA--C 1.484 -1.576 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 173.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.591 ' OG ' ' HA3' ' A' ' 67' ' ' GLY . 23.2 m -161.56 135.97 7.02 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-N 113.397 -1.729 . . . . 0.0 107.455 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -102.35 112.77 25.61 Favored 'General case' 0 C--N 1.278 -2.504 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.62 175.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 59.3 mt -80.58 112.59 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.002 0 CA-C-N 114.142 -1.39 . . . . 0.0 107.636 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 35.2 mt-30 -97.08 127.51 43.12 Favored 'General case' 0 N--CA 1.403 -2.814 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 1.6 tt -91.63 115.09 27.75 Favored 'General case' 0 N--CA 1.4 -2.946 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 176.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -110.11 113.19 25.68 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 124.947 1.299 . . . . 0.0 108.732 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -133.88 94.35 3.25 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-O 121.52 0.676 . . . . 0.0 110.638 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 50.89 67.68 0.9 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.524 -1.671 . . . . 0.0 112.166 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.4 -23.57 31.42 Favored Glycine 0 N--CA 1.438 -1.186 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.699 175.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -99.04 109.95 22.62 Favored 'General case' 0 CA--C 1.476 -1.879 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 6.5 ptpp? -114.93 128.21 56.15 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.806 175.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 34' ' ' GLN . 6.0 m -135.95 -175.18 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.937 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 46' ' ' SER . 19.6 m120 -94.22 120.51 34.57 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.4 tt -74.12 -21.97 59.66 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-O 121.241 0.543 . . . . 0.0 111.381 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.522 ' HB3' ' CB ' ' A' ' 26' ' ' ALA . 14.5 pttp -87.93 6.86 33.68 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 122.255 1.026 . . . . 0.0 109.647 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.488 ' HB2' ' HB2' ' A' ' 43' ' ' ASN . 73.7 m -117.14 133.64 55.75 Favored 'General case' 0 N--CA 1.398 -3.029 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.137 175.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.576 HD12 ' H ' ' A' ' 47' ' ' ILE . 1.4 mp -75.17 -38.01 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.209 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -172.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 44.3 ttm -51.7 -37.39 50.58 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 112.688 -2.051 . . . . 0.0 110.571 175.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.5 -60.43 3.48 Favored Glycine 0 N--CA 1.426 -2.02 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.885 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 90.7 t -57.49 -40.96 77.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 96.4 mmm -75.33 2.86 10.16 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 51.9 m -92.82 -21.38 19.93 Favored 'General case' 0 C--N 1.31 -1.11 0 O-C-N 122.061 -0.399 . . . . 0.0 110.607 176.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.435 HD22 HD21 ' A' ' 35' ' ' LEU . 6.9 mp -79.93 155.89 27.51 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.045 0.45 . . . . 0.0 110.704 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.16 69.22 0.79 Allowed Glycine 0 N--CA 1.426 -1.969 0 N-CA-C 107.5 -2.24 . . . . 0.0 107.5 169.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.5 t -77.25 80.72 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -175.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 10' ' ' ASP . . . -134.92 135.22 7.79 Favored Glycine 0 N--CA 1.425 -2.052 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt 28.08 -57.89 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 129.817 3.247 . . . . 0.0 118.837 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -90.11 -0.84 57.81 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.743 0.782 . . . . 0.0 110.581 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.24 96.72 1.86 Allowed 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 121.927 0.87 . . . . 0.0 112.569 -178.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 36.0 mt-10 -92.58 105.6 17.74 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 175.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.414 HD13 HG23 ' A' ' 61' ' ' ILE . 29.3 pt -103.23 157.2 5.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.458 -172.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 4' ' ' GLN . 34.1 m -122.89 127.66 49.26 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-O 121.254 0.55 . . . . 0.0 109.762 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.76 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.4 mp -97.31 130.08 46.48 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 177.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.416 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 27.4 m-85 -116.8 107.04 14.14 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 123.733 0.646 . . . . 0.0 109.48 171.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -93.63 111.42 23.1 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -113.77 110.19 19.76 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.591 ' HA3' ' OG ' ' A' ' 31' ' ' SER . . . -174.05 -168.49 35.05 Favored Glycine 0 N--CA 1.41 -3.069 0 C-N-CA 118.93 -1.605 . . . . 0.0 113.819 -175.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.2 m -94.79 -17.18 22.36 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 175.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -119.05 18.55 13.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.401 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.443 ' O ' HG12 ' A' ' 74' ' ' ILE . 4.7 pt-20 -57.24 -37.66 72.62 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -174.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.91 -42.58 99.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.111 0.481 . . . . 0.0 111.052 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -78.99 -26.87 43.34 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.36 0.6 . . . . 0.0 109.508 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.401 ' O ' ' HB ' ' A' ' 77' ' ' ILE . . . -63.59 -41.38 98.35 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.357 175.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.443 HG12 ' O ' ' A' ' 70' ' ' GLU . 35.4 mm -60.09 -46.26 94.61 Favored 'Isoleucine or valine' 0 C--O 1.255 1.384 0 CA-C-O 121.542 0.686 . . . . 0.0 109.745 175.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -58.59 -40.1 82.26 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.43 -1.259 . . . . 0.0 112.657 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.06 -44.48 17.96 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.434 HG21 ' OH ' ' A' ' 6' ' ' TYR . 0.2 OUTLIER -59.25 -36.97 66.27 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.55 0 C-N-CA 123.59 0.756 . . . . 0.0 112.459 -173.742 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.7 p -73.74 -43.16 59.87 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.263 0.554 . . . . 0.0 110.248 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.555 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 24.5 t70 -60.8 -47.77 84.84 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.288 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.498 ' HA ' ' CG ' ' A' ' 83' ' ' LYS . 27.9 m -66.01 -39.21 83.91 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.516 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.928 177.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.5 mt -64.12 -35.62 81.36 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.4 p -70.29 -44.97 67.26 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 118.345 0.521 . . . . 0.0 112.075 174.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.555 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 12.9 ptmm? -67.29 -28.26 67.86 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.684 177.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 80' ' ' VAL . 24.2 mm-40 -81.14 -26.46 36.08 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.056 0.455 . . . . 0.0 110.687 175.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.24 41.31 8.03 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 116.136 -0.484 . . . . 0.0 113.663 175.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.451 ' O ' HD12 ' A' ' 8' ' ' ILE . 8.8 mp -91.71 -46.41 7.92 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.183 176.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.2 t -101.84 168.69 9.27 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -176.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 C--N 1.309 -1.16 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 176.883 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.585 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 91.0 mtp . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -105.18 148.16 27.21 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 169.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.693 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 3.9 pt20 -107.16 143.34 35.49 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -132.88 99.92 4.75 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.032 174.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 49.1 m -87.91 116.2 25.91 Favored 'General case' 0 C--N 1.286 -2.175 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.428 176.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.409 ' HB2' ' CG1' ' A' ' 61' ' ' ILE . 78.3 m-85 -102.03 139.02 38.22 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.031 -173.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.9 m -101.65 100.54 10.94 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 171.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.68 ' O ' ' HA ' ' A' ' 57' ' ' LYS 0.262 3.0 mt -74.75 135.41 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 119.97 -0.692 . . . . 0.0 112.028 -179.014 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.9 pt -107.09 -7.39 10.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.334 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -76.65 125.15 28.75 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.74 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.7 mp0 -77.05 74.72 3.62 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.536 -0.465 . . . . 0.0 111.977 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.0 p 57.41 11.05 1.06 Allowed 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 117.124 2.268 . . . . 0.0 117.124 172.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.86 -32.49 10.95 Favored Glycine 0 CA--C 1.484 -1.869 0 C-N-CA 119.549 -1.31 . . . . 0.0 111.191 -174.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.65 10.21 0.1 Allowed 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 115.483 1.661 . . . . 0.0 115.483 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -80.89 -4.1 53.67 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -173.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.95 -76.33 0.59 Allowed 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.401 ' HD3' ' HA ' ' A' ' 17' ' ' ARG 0.257 33.9 mmt180 -69.36 -52.73 14.44 Favored Pre-proline 0 C--N 1.315 -0.911 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -176.392 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -59.55 -29.52 90.14 Favored 'Trans proline' 0 C--N 1.36 1.174 0 CA-C-N 120.838 1.335 . . . . 0.0 110.782 174.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.68 -28.45 66.88 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.231 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 57.1 m -70.59 -26.29 63.45 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 83.8 mtp -70.03 -31.84 69.68 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.32 -44.31 83.74 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 172.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.4 t -54.01 -55.29 14.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 123.963 0.79 . . . . 0.0 109.497 174.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -53.41 -44.36 68.67 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 124.403 1.081 . . . . 0.0 112.317 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.1 m -81.31 -58.91 2.84 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -175.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.472 ' HB2' ' HB3' ' A' ' 45' ' ' LYS . . . -64.86 -27.82 69.13 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -173.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.6 m -69.64 -16.11 63.31 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.256 0.0 OUTLIER -108.25 6.34 26.52 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 -175.606 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -101.43 137.62 39.52 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 174.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.447 ' C ' ' HG ' ' A' ' 31' ' ' SER . 38.0 t70 -84.78 73.07 10.67 Favored 'General case' 0 CA--C 1.496 -1.112 0 CA-C-O 122.749 1.262 . . . . 0.0 109.349 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.563 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 33.8 m -161.5 152.88 18.73 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 112.871 -1.968 . . . . 0.0 105.908 177.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -113.36 109.4 18.65 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.0 mp -89.87 125.57 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.272 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 -98.09 136.07 38.86 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.7 tp -99.94 114.94 28.54 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.59 ' HA ' ' O ' ' A' ' 40' ' ' LYS . 9.2 tt0 -111.66 136.34 51.02 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.706 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.437 ' CD2' ' HG ' ' A' ' 53' ' ' LEU . 50.7 t80 -165.24 104.5 0.75 Allowed 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 123.386 0.674 . . . . 0.0 110.572 178.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.7 t30 48.07 74.84 0.15 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.804 1.242 . . . . 0.0 113.025 176.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.98 -13.12 33.0 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 121.001 -0.618 . . . . 0.0 113.114 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.59 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -94.6 123.56 38.11 Favored 'General case' 0 CA--C 1.48 -1.729 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -179.588 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -119.57 113.42 20.68 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 169.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.7 p -143.53 167.14 13.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -175.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.419 HD22 ' HE3' ' A' ' 45' ' ' LYS . 19.3 t-20 -78.92 133.38 36.92 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 117.864 0.302 . . . . 0.0 111.184 -177.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.6 tp -75.97 -35.01 59.81 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.472 ' HB3' ' HB2' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -87.39 9.36 20.89 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.691 -178.358 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 75.6 m -106.68 125.01 50.46 Favored 'General case' 0 N--CA 1.392 -3.37 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 173.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.46 -25.47 38.44 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 CA-C-O 121.39 0.614 . . . . 0.0 111.636 -175.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 49.7 ttp -55.47 -27.04 45.85 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 125.429 1.492 . . . . 0.0 110.468 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.22 -60.62 4.35 Favored Glycine 0 N--CA 1.42 -2.423 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.515 178.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.0 t -64.04 -36.1 75.75 Favored 'Isoleucine or valine' 0 C--O 1.249 1.045 0 O-C-N 122.688 -0.301 . . . . 0.0 110.876 -176.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.2 mmt -57.84 -34.79 70.08 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.267 0.627 . . . . 0.0 112.237 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.1 p -85.03 -31.43 23.45 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.84 -175.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.437 ' HG ' ' CD2' ' A' ' 37' ' ' TYR . 11.0 mp -59.09 -61.95 2.25 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.95 0.405 . . . . 0.0 111.833 176.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.38 46.53 55.98 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 -171.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.6 p -69.88 123.68 24.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 C-N-CA 123.666 0.786 . . . . 0.0 111.586 -176.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.41 -172.24 14.69 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.68 ' HA ' ' O ' ' A' ' 8' ' ' ILE 0.272 55.0 pttt -64.88 136.02 56.38 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 118.226 1.013 . . . . 0.0 113.689 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t70 84.31 -7.1 1.02 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 126.32 1.848 . . . . 0.0 111.087 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.45 113.0 6.35 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.609 177.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -81.69 115.85 21.14 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.773 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 5' ' ' SER . 17.3 pt -116.04 160.07 15.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 5' ' ' SER . 98.6 m -129.18 128.04 42.57 Favored 'General case' 0 C--N 1.275 -2.648 0 CA-C-O 120.878 0.37 . . . . 0.0 110.305 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.542 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.4 mp -101.8 131.59 49.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.693 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 34.8 m-85 -121.56 113.76 20.24 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 123.574 0.547 . . . . 0.0 109.684 173.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.585 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -104.0 119.86 39.82 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.475 ' OD1' ' HG3' ' A' ' 1' ' ' MET . 15.7 t70 -126.08 115.43 19.82 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.563 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -179.22 -171.67 42.6 Favored Glycine 0 N--CA 1.431 -1.675 0 C-N-CA 119.952 -1.118 . . . . 0.0 113.171 -175.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.4 m -89.13 -7.18 56.23 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.474 0.654 . . . . 0.0 109.642 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -130.37 29.37 4.86 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.587 ' O ' HG12 ' A' ' 74' ' ' ILE . 9.7 pt-20 -69.21 -44.01 72.95 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -168.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.2 -31.88 69.53 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.212 0.529 . . . . 0.0 110.357 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -75.01 -33.58 61.83 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-O 121.556 0.693 . . . . 0.0 109.779 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.19 -36.15 82.31 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.969 176.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.587 HG12 ' O ' ' A' ' 70' ' ' GLU . 38.0 mm -54.1 -39.29 41.28 Favored 'Isoleucine or valine' 0 C--O 1.25 1.119 0 C-N-CA 123.503 0.721 . . . . 0.0 111.431 178.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -67.32 -44.26 79.58 Favored 'General case' 0 N--CA 1.402 -2.855 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.231 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.33 -39.36 47.93 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.485 -175.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.43 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -64.11 -41.78 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -178.367 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 33.0 m -67.78 -43.45 79.75 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.409 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 32.3 t70 -55.34 -48.13 74.66 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.3 m -67.22 -29.96 47.68 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.593 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.736 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 77' ' ' ILE . 40.4 mt -79.56 -2.29 41.71 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.983 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 21.6 m -118.38 -16.36 9.6 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.437 0.637 . . . . 0.0 110.253 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 75.2 mmtt -78.46 -27.47 46.37 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 169.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -104.75 172.53 6.74 Favored 'General case' 0 N--CA 1.41 -2.431 0 CA-C-N 112.921 -1.945 . . . . 0.0 107.41 175.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -104.3 51.51 0.8 Allowed Glycine 0 C--N 1.291 -1.967 0 C-N-CA 119.893 -1.146 . . . . 0.0 113.364 -175.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.8 mp -92.74 -53.43 4.18 Favored 'General case' 0 C--O 1.213 -0.847 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.303 176.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.6 t -116.51 148.29 40.95 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.916 -178.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 . . . . . 0 N--CA 1.429 -1.523 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.709 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.633 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 52.9 ttm . . . . . 0 CA--C 1.514 -0.415 0 N-CA-C 110.581 -0.155 . . . . 0.0 110.581 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -114.83 157.35 23.4 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 176.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.634 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 4.1 pt20 -111.35 153.96 25.24 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -142.36 103.73 4.31 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.697 -1.592 . . . . 0.0 107.59 173.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 50.2 m -91.49 89.45 7.21 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 122.293 1.044 . . . . 0.0 110.451 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.442 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 73.8 m-85 -72.87 130.02 39.47 Favored 'General case' 0 CA--C 1.488 -1.433 0 CA-C-N 113.493 -1.685 . . . . 0.0 112.146 -175.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.2 m -88.88 101.01 13.63 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 170.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.5 mt -77.22 136.49 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.9 -178.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 35.4 pt -119.03 6.55 6.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -71.39 127.11 31.48 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.505 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -112.11 13.23 20.61 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.609 0.718 . . . . 0.0 110.368 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -84.63 -33.7 23.23 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.04 37.48 3.86 Favored Glycine 0 N--CA 1.425 -2.033 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 72.28 79.03 0.15 Allowed 'General case' 0 CA--C 1.508 -0.643 0 C-N-CA 124.203 1.001 . . . . 0.0 110.743 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -55.6 113.88 1.63 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.827 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.81 -34.42 66.86 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -170.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.401 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 13.9 tpp180 -63.45 -52.95 56.39 Favored Pre-proline 0 C--N 1.317 -0.839 0 C-N-CA 119.594 -0.842 . . . . 0.0 112.448 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.515 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 31.8 Cg_exo -66.72 -10.86 29.65 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 121.573 1.516 . . . . 0.0 112.645 174.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.54 -15.47 60.86 Favored 'General case' 0 C--O 1.216 -0.682 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.7 m -66.73 -27.16 67.39 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 174.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.515 ' SD ' ' HA ' ' A' ' 18' ' ' PRO . 1.4 mpt? -67.69 -34.88 77.76 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 174.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.27 -38.1 78.21 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.938 175.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 81.9 t -55.69 -49.84 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 O-C-N 124.113 0.883 . . . . 0.0 109.351 175.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.12 -64.33 0.99 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.18 177.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.7 m -42.35 -63.16 0.8 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.734 1.214 . . . . 0.0 113.81 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.05 -43.05 88.61 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -174.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.7 t -60.75 -39.09 87.41 Favored 'General case' 0 C--N 1.322 -0.594 0 O-C-N 123.27 0.356 . . . . 0.0 111.37 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.269 0.6 OUTLIER -82.5 3.0 30.11 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -174.198 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -95.16 -3.25 48.21 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.764 177.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.4 t70 59.52 24.34 13.04 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 123.377 1.56 . . . . 0.0 109.403 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.523 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 19.3 m -118.8 146.29 44.95 Favored 'General case' 0 N--CA 1.408 -2.53 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.183 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -105.76 112.69 25.85 Favored 'General case' 0 N--CA 1.392 -3.366 0 C-N-CA 118.706 -1.197 . . . . 0.0 108.771 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 2.9 mp -100.77 130.25 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.807 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.678 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -106.12 132.13 52.56 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.8 tt -98.01 100.16 11.47 Favored 'General case' 0 N--CA 1.407 -2.576 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 173.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.38 112.53 23.67 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.449 ' HB3' HD13 ' A' ' 53' ' ' LEU . 55.4 t80 -139.77 85.17 2.02 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 176.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.9 t30 60.56 90.2 0.06 Allowed 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 125.365 1.466 . . . . 0.0 113.656 170.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.85 -48.13 3.99 Favored Glycine 0 C--N 1.311 -0.813 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.641 175.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.21 144.94 43.53 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 120.851 0.358 . . . . 0.0 111.909 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.11 147.35 50.95 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 176.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.8 p -120.8 143.59 32.46 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.76 -177.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.439 ' OD1' ' HE3' ' A' ' 45' ' ' LYS . 16.1 t30 -61.55 110.23 1.41 Allowed 'General case' 0 C--O 1.208 -1.124 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 171.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.407 HD13 ' O ' ' A' ' 44' ' ' LEU . 3.4 tm? -60.37 -23.5 64.35 Favored 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -171.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -90.56 21.99 3.7 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.179 -0.951 . . . . 0.0 110.757 174.359 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.0 m -134.43 146.44 49.84 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.645 176.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.578 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -94.83 -20.11 6.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.289 -178.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 50.3 ttm -64.21 81.53 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 125.622 1.569 . . . . 0.0 110.115 175.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 137.43 -32.08 2.44 Favored Glycine 0 C--N 1.291 -1.927 0 CA-C-N 113.616 -1.629 . . . . 0.0 110.431 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 85.5 t -73.51 -35.76 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 69.8 mtm -64.0 -54.2 38.04 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.09 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.1 m -81.06 2.63 26.38 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.449 HD13 ' HB3' ' A' ' 37' ' ' TYR . 22.5 tp -39.75 -47.32 2.05 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 124.589 1.156 . . . . 0.0 113.286 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.73 34.19 25.54 Favored Glycine 0 N--CA 1.439 -1.128 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -89.4 151.48 3.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -175.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -157.61 -170.72 22.76 Favored Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -64.03 138.71 58.59 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 117.97 0.885 . . . . 0.0 111.331 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.7 t70 79.88 -5.4 1.86 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.395 1.478 . . . . 0.0 111.328 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.57 123.08 21.68 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.584 176.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -98.55 116.86 31.69 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.6 -178.649 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 5' ' ' SER . 20.1 pt -110.73 137.42 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.18 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 5' ' ' SER . 85.1 m -108.49 112.98 25.66 Favored 'General case' 0 C--N 1.276 -2.588 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.37 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.62 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.3 mp -84.78 130.32 36.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.634 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 51.6 m-85 -117.06 106.83 13.8 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 173.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.633 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -101.4 117.04 34.15 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -128.62 115.75 18.55 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.523 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -172.67 -169.86 35.76 Favored Glycine 0 C--N 1.293 -1.84 0 C-N-CA 119.535 -1.317 . . . . 0.0 112.345 -175.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.4 t -81.9 -22.65 36.71 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -131.79 33.38 3.99 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.775 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.406 ' CD ' ' H1 ' ' A' ' 1' ' ' MET . 9.3 pt-20 -58.05 -35.91 72.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -175.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.55 -43.63 96.52 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.001 0.429 . . . . 0.0 110.78 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -82.62 -19.91 37.39 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.06 0.457 . . . . 0.0 109.945 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.62 -42.32 98.19 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 30.4 mm -57.45 -45.45 85.72 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.347 173.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -60.82 -42.81 98.43 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.573 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.1 -47.95 75.41 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.429 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 33.4 mt -60.82 -48.32 89.37 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.912 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.427 ' CG2' ' HH ' ' A' ' 6' ' ' TYR . 13.6 p -58.04 -35.24 71.03 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.449 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 26.8 t70 -70.71 -52.84 18.37 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 120.875 0.369 . . . . 0.0 110.103 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.43 -27.61 40.91 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.435 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 77' ' ' ILE . 14.0 mt -79.89 -6.2 56.97 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 122.412 0.285 . . . . 0.0 110.64 177.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.1 t -102.92 -41.0 6.28 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 31.7 mmmt -65.35 -29.23 69.94 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.372 0.606 . . . . 0.0 109.413 176.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -93.26 -17.31 23.79 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.874 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.22 49.7 60.36 Favored Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 115.524 -0.762 . . . . 0.0 114.548 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.0 mp -88.56 -27.52 21.33 Favored 'General case' 0 CA--C 1.491 -1.307 0 C-N-CA 118.462 -1.295 . . . . 0.0 108.498 174.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.0 t -133.74 -171.01 2.62 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 . . . . . 0 C--N 1.301 -1.522 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.01 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.487 ' HG3' ' HA ' ' A' ' 66' ' ' ASP . 1.1 mpt? . . . . . 0 CA--C 1.49 -1.362 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.502 ' HG2' ' N ' ' A' ' 3' ' ' GLN . 36.7 tt0 -125.76 158.95 33.62 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.719 -172.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.793 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 12.4 pt20 -115.15 140.22 49.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 124.068 0.855 . . . . 0.0 110.824 173.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -121.09 107.76 13.01 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.171 175.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.0 p -88.13 92.22 9.07 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-O 121.441 0.639 . . . . 0.0 109.544 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.45 ' OH ' HG23 ' A' ' 77' ' ' ILE . 80.8 m-85 -80.56 113.67 18.91 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.679 -176.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.8 m -91.09 102.12 14.86 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.483 HG22 ' O ' ' A' ' 55' ' ' VAL . 1.5 mp -71.93 122.9 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.862 0 CA-C-O 122.207 1.003 . . . . 0.0 112.031 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.39 9.05 7.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 114.109 -1.405 . . . . 0.0 107.852 -177.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -123.93 158.7 31.38 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.422 -170.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -131.56 1.04 4.05 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.0 p -117.22 -36.0 3.89 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -175.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.57 -39.68 8.14 Favored Glycine 0 N--CA 1.425 -2.076 0 N-CA-C 106.215 -2.754 . . . . 0.0 106.215 174.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.81 78.19 0.3 Allowed 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.845 -1.177 . . . . 0.0 110.532 171.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.58 ' O ' ' HD2' ' A' ' 18' ' ' PRO . 0.7 OUTLIER -154.31 151.23 28.84 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 176.786 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.56 81.68 3.23 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -170.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -162.66 -47.47 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.206 1.002 . . . . 0.0 108.568 169.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.58 ' HD2' ' O ' ' A' ' 15' ' ' HIS . 84.0 Cg_exo -54.88 -24.56 39.42 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 121.849 1.7 . . . . 0.0 111.362 170.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.39 -21.24 66.65 Favored 'General case' 0 C--O 1.201 -1.474 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.048 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.3 m -70.11 -27.35 64.52 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-O 121.296 0.57 . . . . 0.0 110.032 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 48.5 ttm -69.46 -32.19 70.96 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 174.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -73.14 -36.95 66.77 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.172 -1.377 . . . . 0.0 110.306 175.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.0 t -55.96 -48.66 78.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -61.82 -58.36 8.28 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.585 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.581 ' O ' ' HB3' ' A' ' 28' ' ' LYS . 36.4 m -49.86 -43.57 49.22 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 176.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.73 -37.21 84.21 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.573 -0.705 . . . . 0.0 111.337 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.448 ' OG ' ' HB2' ' A' ' 45' ' ' LYS . 19.3 m -67.49 -32.36 73.13 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 122.022 0.915 . . . . 0.0 110.036 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.581 ' HB3' ' O ' ' A' ' 25' ' ' THR . 12.6 tmtt? -65.9 -33.57 76.12 Favored 'General case' 0 N--CA 1.424 -1.758 0 C-N-CA 126.196 1.798 . . . . 0.0 111.879 -176.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -96.37 150.12 20.94 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.885 -177.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.93 59.37 5.59 Favored 'General case' 0 CA--C 1.491 -1.314 0 CA-C-O 122.384 1.088 . . . . 0.0 108.96 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.546 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 40.9 m -150.83 141.31 22.49 Favored 'General case' 0 N--CA 1.41 -2.445 0 CA-C-N 114.021 -1.445 . . . . 0.0 108.439 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -98.15 99.43 10.68 Favored 'General case' 0 N--CA 1.394 -3.262 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 44.0 mt -84.91 124.76 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.875 0 CA-C-N 114.425 -1.262 . . . . 0.0 108.254 175.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -109.72 131.05 55.42 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 3.6 tt -97.77 124.82 42.28 Favored 'General case' 0 N--CA 1.402 -2.862 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.498 ' HB3' ' HB ' ' A' ' 62' ' ' THR . 0.8 OUTLIER -113.16 107.19 15.58 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -178.157 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.526 ' CD2' ' HG ' ' A' ' 53' ' ' LEU . 25.9 t80 -138.88 103.82 4.91 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.413 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 46.12 77.7 0.08 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.881 1.672 . . . . 0.0 113.155 173.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.21 -28.78 5.96 Favored Glycine 0 C--N 1.306 -1.122 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.233 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.413 ' HA ' ' HE3' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -105.32 113.5 27.12 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -179.272 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 18.7 ptpt -110.33 116.37 31.33 Favored 'General case' 0 N--CA 1.415 -2.187 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 168.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.9 p -130.03 146.07 34.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.697 -170.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -58.27 112.39 1.53 Allowed 'General case' 0 C--O 1.197 -1.703 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 171.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.526 HD21 ' O ' ' A' ' 44' ' ' LEU . 5.4 tt -60.45 -29.0 68.76 Favored 'General case' 0 C--O 1.218 -0.568 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -170.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.448 ' HB2' ' OG ' ' A' ' 27' ' ' SER . 0.5 OUTLIER -85.67 -0.63 55.67 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.001 179.359 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.8 m -108.19 124.11 49.77 Favored 'General case' 0 N--CA 1.396 -3.168 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 175.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 pp -73.19 7.99 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -172.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 15.6 tpt -94.39 61.08 2.74 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 122.286 1.041 . . . . 0.0 109.232 -167.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.8 -41.67 0.81 Allowed Glycine 0 C--N 1.292 -1.885 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 -174.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 89.7 t -65.01 -35.01 74.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 114.884 -0.658 . . . . 0.0 110.968 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 49.2 ttm -77.3 0.83 20.7 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 121.196 0.522 . . . . 0.0 110.962 -177.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.2 m -104.27 6.72 35.61 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.011 0.434 . . . . 0.0 111.327 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.526 ' HG ' ' CD2' ' A' ' 37' ' ' TYR . 8.8 mp -78.89 105.91 10.54 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.194 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.72 -49.38 24.05 Favored Glycine 0 CA--C 1.495 -1.175 0 N-CA-C 106.795 -2.522 . . . . 0.0 106.795 169.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.483 ' O ' HG22 ' A' ' 8' ' ' ILE . 9.9 p 51.07 25.95 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.323 0 C-N-CA 126.816 2.046 . . . . 0.0 114.801 169.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.78 112.72 3.74 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.353 -0.927 . . . . 0.0 110.92 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.401 ' C ' ' H ' ' A' ' 59' ' ' ALA . 7.5 ptpp? 49.14 154.29 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 C-N-CA 127.706 2.402 . . . . 0.0 115.664 -176.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.0 t70 68.82 -16.65 0.21 Allowed 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 126.054 1.742 . . . . 0.0 114.16 172.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.401 ' H ' ' C ' ' A' ' 57' ' ' LYS . . . -67.37 121.27 15.39 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 123.57 0.748 . . . . 0.0 112.326 -175.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -102.8 97.7 7.81 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 175.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.412 HG21 HD12 ' A' ' 61' ' ' ILE . 29.8 pt -96.81 124.8 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.817 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -177.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.498 ' HB ' ' HB3' ' A' ' 36' ' ' GLU . 4.7 m -100.35 120.21 39.6 Favored 'General case' 0 C--N 1.283 -2.31 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.849 -176.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.57 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.6 mp -95.68 121.17 45.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 176.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.793 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 30.7 m-85 -104.92 123.9 48.55 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 174.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -111.19 103.01 11.39 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.487 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 10.9 t70 -113.37 103.21 11.07 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.546 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -166.74 -163.81 21.19 Favored Glycine 0 N--CA 1.423 -2.227 0 C-N-CA 119.424 -1.369 . . . . 0.0 112.751 -173.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.3 m -105.51 -7.69 18.5 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.409 0.623 . . . . 0.0 109.508 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -127.33 18.92 6.94 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.495 ' O ' HG12 ' A' ' 74' ' ' ILE 0.27 0.0 OUTLIER -52.43 -44.62 65.56 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 -171.184 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.65 -41.45 98.23 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.859 0.361 . . . . 0.0 111.433 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -78.05 -28.15 48.86 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 121.584 0.707 . . . . 0.0 109.866 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.98 -38.8 92.16 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.65 174.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 70' ' ' GLU . 33.8 mm -60.91 -47.05 95.19 Favored 'Isoleucine or valine' 0 C--O 1.254 1.317 0 CA-C-O 121.38 0.609 . . . . 0.0 109.973 175.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -51.74 -54.34 29.48 Favored 'General case' 0 N--CA 1.412 -2.367 0 C-N-CA 125.032 1.333 . . . . 0.0 109.716 176.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.411 ' O ' HG23 ' A' ' 80' ' ' VAL . . . -69.21 -45.09 70.74 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.457 HG21 ' O ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -58.86 -40.14 79.3 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 C-N-CA 123.445 0.698 . . . . 0.0 111.054 -176.198 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.6 m -73.1 -37.6 66.66 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -61.38 -50.0 74.63 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.767 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.561 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 28.4 m -74.08 -32.25 32.26 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.35 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.996 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.428 HD21 ' CG ' ' A' ' 86' ' ' LEU . 15.3 mt -63.87 -45.05 91.14 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 121.388 -0.82 . . . . 0.0 111.353 175.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.9 p -63.19 -35.91 81.87 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 80' ' ' VAL . 12.3 ptmm? -70.39 -30.94 67.97 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 80' ' ' VAL . 21.8 mm-40 -76.71 -27.16 55.37 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.436 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.88 -1.37 22.99 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.472 -0.871 . . . . 0.0 114.713 173.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.428 ' CG ' HD21 ' A' ' 81' ' ' LEU . 1.2 pt? -99.62 26.87 5.76 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -177.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 35.8 m -148.41 109.68 4.36 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 121.652 -0.655 . . . . 0.0 110.016 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 C--O 1.255 1.386 0 C-N-CA 125.918 1.687 . . . . 0.0 112.173 -178.302 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.8 mtm . . . . . 0 CA--C 1.479 -1.75 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -113.17 147.9 36.49 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 176.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.721 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 15.6 pt20 -119.77 161.17 21.22 Favored 'General case' 0 N--CA 1.438 -1.031 0 O-C-N 123.802 0.689 . . . . 0.0 111.83 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.597 ' O ' ' HA ' ' A' ' 62' ' ' THR . 14.9 mm100 -141.16 138.0 33.09 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.167 -1.378 . . . . 0.0 108.279 174.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.8 t -100.58 131.27 46.58 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.517 ' HB2' ' CG1' ' A' ' 61' ' ' ILE . 57.8 m-85 -138.0 170.88 15.27 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -177.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.1 m -139.12 127.21 22.47 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 174.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.541 HG13 ' HA ' ' A' ' 86' ' ' LEU . 6.6 tt -82.8 147.22 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.542 -176.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.4 pt -133.69 26.87 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.511 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.3 OUTLIER -64.8 -38.59 91.5 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.436 -174.136 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.518 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 46.7 mt-10 68.82 4.08 4.27 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 176.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.5 m -109.29 -42.05 4.48 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.797 -0.564 . . . . 0.0 110.319 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 128.89 49.23 0.14 Allowed Glycine 0 C--N 1.303 -1.258 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 89.67 -53.55 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.21 0 C-N-CA 126.89 2.076 . . . . 0.0 109.923 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.532 ' O ' ' HD2' ' A' ' 18' ' ' PRO 0.386 56.6 p-80 53.02 99.26 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.137 -1.392 . . . . 0.0 112.269 -175.337 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.68 -30.6 22.59 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 -168.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 17' ' ' ARG 0.314 26.1 mmt180 -62.39 -55.64 37.84 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -177.076 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.532 ' HD2' ' O ' ' A' ' 15' ' ' HIS . 61.4 Cg_exo -53.96 -37.73 86.05 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 121.85 1.7 . . . . 0.0 111.454 170.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.423 ' O ' HG21 ' A' ' 23' ' ' VAL . . . -66.42 -19.61 65.84 Favored 'General case' 0 C--O 1.209 -1.063 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.154 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 29.7 m -77.12 -23.19 51.77 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.721 0.772 . . . . 0.0 108.954 176.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.4 ttt -71.63 -34.14 69.54 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 171.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.8 -37.21 81.7 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.655 173.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 19' ' ' ALA . 76.7 t -54.99 -55.26 16.98 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.084 0 O-C-N 123.92 0.763 . . . . 0.0 108.986 173.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -60.24 -25.85 65.98 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 123.387 0.675 . . . . 0.0 112.089 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.406 ' HA ' ' NZ ' ' A' ' 28' ' ' LYS . 88.1 m -78.95 -61.87 1.88 Allowed 'General case' 0 N--CA 1.423 -1.799 0 O-C-N 122.18 -0.325 . . . . 0.0 110.372 177.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.25 -43.68 94.13 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -177.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.4 t -59.09 -30.62 68.22 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.644 0.778 . . . . 0.0 112.916 -174.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.406 ' NZ ' ' HA ' ' A' ' 25' ' ' THR 0.27 0.9 OUTLIER -87.35 2.76 49.37 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -178.076 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -97.92 142.83 29.17 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -70.57 -35.3 72.98 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.38 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.543 ' OG ' ' HA3' ' A' ' 67' ' ' GLY . 50.7 m -71.12 142.19 50.77 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.581 175.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -93.37 109.92 21.47 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-O 121.211 0.529 . . . . 0.0 112.014 -176.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.435 HD11 ' HB3' ' A' ' 73' ' ' ALA . 15.9 mt -89.29 120.69 38.4 Favored 'Isoleucine or valine' 0 C--O 1.254 1.319 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.999 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -113.92 146.81 39.54 Favored 'General case' 0 N--CA 1.415 -2.224 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.735 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 0.9 OUTLIER -101.49 131.05 47.83 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 177.611 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 40' ' ' LYS . 8.3 tp10 -131.39 154.22 48.85 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 175.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -154.92 -25.96 0.12 Allowed 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 117.919 0.327 . . . . 0.0 110.724 178.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 172.85 77.75 0.0 OUTLIER 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.928 0.891 . . . . 0.0 109.011 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.31 -12.37 66.77 Favored Glycine 0 C--N 1.308 -0.992 0 CA-C-N 116.031 -0.531 . . . . 0.0 113.521 174.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 16.0 mmtp -113.14 114.64 27.08 Favored 'General case' 0 CA--C 1.471 -2.064 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 62.8 mttp -111.87 130.15 55.92 Favored 'General case' 0 N--CA 1.413 -2.292 0 CA-C-N 114.475 -1.238 . . . . 0.0 110.626 174.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.4 m -144.31 162.98 14.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.505 ' HB3' ' HE3' ' A' ' 45' ' ' LYS . 18.3 m120 -72.83 129.51 38.34 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 175.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 67.0 tp -70.76 -13.94 62.25 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-O 121.733 0.777 . . . . 0.0 111.832 -176.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.505 ' HE3' ' HB3' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -87.87 5.45 40.33 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.388 0.613 . . . . 0.0 110.377 176.17 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.1 t -106.09 109.85 21.92 Favored 'General case' 0 N--CA 1.416 -2.152 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.469 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -68.61 -30.57 47.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 27.9 ttt -57.43 -49.04 77.5 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 113.69 -1.596 . . . . 0.0 109.149 175.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.37 -47.0 89.03 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.968 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 91.5 t -57.99 -40.75 78.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 CA-C-O 120.737 0.303 . . . . 0.0 111.457 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -76.69 -9.61 58.79 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 120.161 -0.615 . . . . 0.0 111.669 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.3 m -80.33 -33.52 37.38 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 175.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 mp -73.18 -42.76 62.36 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.977 174.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.4 39.39 87.42 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.409 HG23 ' CG2' ' A' ' 61' ' ' ILE . 7.8 p -65.54 106.35 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.09 0 CA-C-O 121.162 0.506 . . . . 0.0 110.716 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.477 ' HA2' ' OD1' ' A' ' 10' ' ' ASP . . . -138.65 146.2 17.85 Favored Glycine 0 N--CA 1.429 -1.813 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.349 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.518 ' HB3' ' HA ' ' A' ' 11' ' ' GLU . 9.3 ptpp? 21.06 111.37 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.687 0 N-CA-C 117.233 2.308 . . . . 0.0 117.233 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.9 t70 74.8 -0.79 3.25 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.585 1.154 . . . . 0.0 111.97 176.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.4 116.84 10.29 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -81.88 135.68 35.4 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.718 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.517 ' CG1' ' HB2' ' A' ' 6' ' ' TYR . 19.4 pt -123.91 165.69 20.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 121.461 0.648 . . . . 0.0 111.155 -177.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 4' ' ' GLN . 84.1 m -136.74 118.31 14.88 Favored 'General case' 0 N--CA 1.408 -2.573 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 47.4 mm -96.83 127.76 48.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.721 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 29.7 m-85 -111.74 122.52 48.01 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 123.806 0.691 . . . . 0.0 110.745 177.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.08 112.7 25.8 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 173.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -104.65 106.16 16.54 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.543 ' HA3' ' OG ' ' A' ' 31' ' ' SER . . . -176.11 -166.77 33.97 Favored Glycine 0 C--N 1.296 -1.677 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.106 -174.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.0 m -105.19 -11.27 16.63 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.984 0.897 . . . . 0.0 108.667 172.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -112.45 20.6 16.51 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.219 178.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.65 -45.23 70.15 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -175.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.4 -36.89 81.57 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 122.566 0.346 . . . . 0.0 111.256 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -73.4 -43.61 60.15 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.35 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.435 ' HB3' HD11 ' A' ' 33' ' ' ILE . . . -60.4 -43.02 97.1 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.601 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.2 mm -57.71 -46.99 86.74 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 C-N-CA 123.626 0.771 . . . . 0.0 111.22 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -64.47 -38.63 91.68 Favored 'General case' 0 N--CA 1.411 -2.382 0 C-N-CA 124.031 0.932 . . . . 0.0 111.264 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.65 -35.4 77.21 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.37 0.605 . . . . 0.0 110.179 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.507 HG22 ' HH ' ' A' ' 6' ' ' TYR . 3.8 mm -62.01 -52.24 62.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 124.532 1.133 . . . . 0.0 113.046 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.3 m -56.99 -48.43 78.45 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 120.693 0.282 . . . . 0.0 110.289 -176.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -55.16 -50.26 69.74 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.194 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.9 m -75.08 -30.8 23.75 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 C-N-CA 120.422 -0.511 . . . . 0.0 112.267 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 25.2 mt -68.23 -37.0 80.37 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 87' ' ' THR . 23.2 t -85.54 -16.59 38.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.411 0.624 . . . . 0.0 109.99 178.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -71.17 -34.64 71.13 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 172.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -95.97 -172.65 2.63 Favored 'General case' 0 N--CA 1.418 -2.039 0 CA-C-N 113.273 -1.785 . . . . 0.0 109.905 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -101.61 19.17 51.43 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.243 -0.98 . . . . 0.0 112.748 -177.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.541 ' HA ' HG13 ' A' ' 8' ' ' ILE . 3.4 mp -93.81 -2.17 53.93 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 119.036 -1.065 . . . . 0.0 111.16 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 82' ' ' SER . 98.9 m -158.77 143.39 15.86 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 175.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.42 -1.936 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 172.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.583 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 55.1 ttp . . . . . 0 C--O 1.233 0.236 0 N-CA-C 111.263 0.097 . . . . 0.0 111.263 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -125.66 154.7 41.98 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 174.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.669 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 3.8 pt20 -106.4 143.7 34.15 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.553 0.692 . . . . 0.0 112.842 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 62' ' ' THR . 14.1 mm100 -127.48 120.54 28.56 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.706 173.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.8 t -93.6 103.29 15.47 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.486 ' HB2' ' CG1' ' A' ' 61' ' ' ILE . 85.0 m-85 -99.11 112.43 24.57 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.737 -178.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 m -86.37 118.3 25.72 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 175.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.5 mt -98.35 130.61 46.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-O 121.437 0.637 . . . . 0.0 112.59 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.619 HG23 ' O ' ' A' ' 87' ' ' THR . 4.9 tp -95.02 -26.37 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.808 176.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -26.91 97.28 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 -166.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -70.01 -13.46 62.23 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 113.789 -1.55 . . . . 0.0 111.213 -176.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.1 m -66.24 -25.14 66.75 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.28 40.65 6.85 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.409 ' HB2' ' N ' ' A' ' 55' ' ' VAL . . . 90.75 72.05 0.0 OUTLIER 'General case' 0 CA--C 1.482 -1.648 0 C-N-CA 125.568 1.547 . . . . 0.0 112.28 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . 0.254 0.4 OUTLIER -73.97 98.2 2.99 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.568 -1.253 . . . . 0.0 111.1 173.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.52 -23.13 61.73 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.149 -1.387 . . . . 0.0 113.273 -174.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -64.0 -50.61 68.59 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 119.575 -0.85 . . . . 0.0 112.168 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -55.15 -31.48 75.8 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 122.108 1.872 . . . . 0.0 111.253 171.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.59 ' O ' ' HB3' ' A' ' 22' ' ' LEU . . . -72.25 -22.17 61.27 Favored 'General case' 0 C--O 1.203 -1.346 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.806 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.6 m -75.49 -33.91 60.82 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 51.2 ttm -66.96 -38.59 86.37 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.59 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 59.1 tp -56.83 -47.69 79.74 Favored 'General case' 0 CA--C 1.477 -1.848 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.121 174.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 19' ' ' ALA . 13.2 t -53.55 -48.24 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.542 0 CA-C-N 113.503 -1.68 . . . . 0.0 110.607 -178.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.06 -29.79 70.19 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.488 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.7 m -74.3 -49.53 22.64 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -177.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.468 ' HA ' ' CD2' ' A' ' 29' ' ' PHE . . . -61.61 -31.27 71.34 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 174.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.6 m -56.24 -39.28 72.29 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 123.419 0.45 . . . . 0.0 111.766 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.48 7.62 40.37 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -177.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.468 ' CD2' ' HA ' ' A' ' 26' ' ' ALA . 12.7 m-85 -96.33 -16.99 21.0 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 54.29 17.12 1.41 Allowed 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 124.795 1.238 . . . . 0.0 113.955 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.464 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 53.2 m -102.8 160.82 14.26 Favored 'General case' 0 N--CA 1.412 -2.345 0 CA-C-O 121.081 0.467 . . . . 0.0 110.334 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -91.47 83.63 5.44 Favored 'General case' 0 N--CA 1.405 -2.702 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.404 HG22 HG21 ' A' ' 63' ' ' ILE . 84.6 mt -94.25 111.52 25.4 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 175.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -103.77 137.86 41.2 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.581 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 4.3 tt -101.72 111.48 23.75 Favored 'General case' 0 N--CA 1.392 -3.352 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -103.68 117.11 33.63 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 123.523 0.729 . . . . 0.0 109.278 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.484 ' HB3' HD11 ' A' ' 53' ' ' LEU . 15.5 t80 -135.26 90.58 2.64 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.182 177.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 43.7 64.93 1.11 Allowed 'General case' 0 C--O 1.244 0.769 0 C-N-CA 126.567 1.947 . . . . 0.0 113.13 176.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.76 -29.25 10.59 Favored Glycine 0 N--CA 1.432 -1.625 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.433 175.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -98.6 110.59 23.16 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 4.3 ptpp? -122.98 131.42 53.71 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 171.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.414 HG21 ' N ' ' A' ' 49' ' ' GLY . 11.6 p -146.63 158.63 10.58 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.544 ' OD1' ' HG2' ' A' ' 45' ' ' LYS . 23.0 t-20 -69.91 125.99 28.38 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 174.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.466 HD23 ' HG ' ' A' ' 22' ' ' LEU . 10.4 tt -62.81 -22.43 66.63 Favored 'General case' 0 N--CA 1.42 -1.936 0 C-N-CA 125.224 1.41 . . . . 0.0 114.209 -171.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.544 ' HG2' ' OD1' ' A' ' 43' ' ' ASN . 8.1 pttp -91.22 4.11 53.12 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 118.51 -1.276 . . . . 0.0 110.423 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.486 ' C ' ' H ' ' A' ' 48' ' ' MET . 39.9 t -105.55 129.62 53.78 Favored 'General case' 0 N--CA 1.409 -2.499 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.314 174.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 pp -75.65 2.62 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 123.545 0.738 . . . . 0.0 111.804 -178.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.486 ' H ' ' C ' ' A' ' 46' ' ' SER . 16.0 tpt -61.83 -48.35 80.97 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 113.35 -1.75 . . . . 0.0 110.186 -174.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.414 ' N ' HG21 ' A' ' 42' ' ' VAL . . . -108.45 -29.96 4.0 Favored Glycine 0 C--N 1.305 -1.171 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.428 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.1 t -61.52 -36.61 74.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -175.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 84.0 mtp -87.5 12.91 11.16 Favored 'General case' 0 C--O 1.22 -0.476 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.264 -178.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.9 m -124.86 5.48 8.06 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.484 HD11 ' HB3' ' A' ' 37' ' ' TYR . 8.2 tp -81.09 105.86 12.63 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.59 66.11 3.57 Favored Glycine 0 CA--C 1.508 -0.386 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 175.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.409 ' N ' ' HB2' ' A' ' 14' ' ' ALA . 4.6 p -89.48 97.82 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 CA-C-O 122.49 1.138 . . . . 0.0 111.452 -173.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.28 -153.99 9.45 Favored Glycine 0 N--CA 1.432 -1.586 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.455 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -61.51 136.06 57.89 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.9 t70 77.99 3.96 2.86 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.972 1.309 . . . . 0.0 111.444 175.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.93 118.74 14.09 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.404 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -95.19 108.34 20.46 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.486 ' CG1' ' HB2' ' A' ' 6' ' ' TYR . 11.4 pt -110.49 157.4 11.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.31 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 4' ' ' GLN . 61.4 m -133.08 124.25 27.25 Favored 'General case' 0 C--N 1.273 -2.74 0 CA-C-O 121.185 0.517 . . . . 0.0 110.986 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.55 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.4 mp -91.85 125.84 44.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 175.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.669 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 45.3 m-85 -110.42 106.76 16.22 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 171.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -105.37 113.32 26.82 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.208 -176.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -128.29 120.06 26.35 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -174.66 -172.25 39.55 Favored Glycine 0 CA--C 1.475 -2.419 0 C-N-CA 117.787 -2.149 . . . . 0.0 113.351 -172.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.4 p -73.86 -26.97 60.84 Favored 'General case' 0 N--CA 1.421 -1.913 0 C-N-CA 124.197 0.999 . . . . 0.0 111.002 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -134.63 21.88 3.62 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.453 ' O ' HG12 ' A' ' 74' ' ' ILE . 9.5 pt-20 -42.52 -52.8 4.61 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -172.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.512 ' O ' ' HB ' ' A' ' 74' ' ' ILE . . . -65.24 -42.74 93.07 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -173.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -84.73 -21.97 29.87 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.18 -39.98 95.14 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 172.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.512 ' HB ' ' O ' ' A' ' 71' ' ' ALA . 24.6 mm -56.26 -48.06 80.08 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 CA-C-O 121.731 0.777 . . . . 0.0 109.572 173.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.454 ' HA ' ' OE1' ' A' ' 75' ' ' GLN . 12.2 mm-40 -57.54 -39.49 76.75 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.117 -1.401 . . . . 0.0 111.998 -178.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.36 -41.82 17.76 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.8 tt -62.52 -32.75 56.32 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.082 0 CA-C-O 120.847 0.356 . . . . 0.0 111.199 -174.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.7 m -68.1 -28.45 67.36 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 120.854 0.359 . . . . 0.0 110.762 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.544 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 16.3 t70 -78.44 -47.55 17.26 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -175.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 23.8 m -66.0 -32.13 56.77 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.47 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.8 mt -67.37 -45.94 74.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.141 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.592 ' HA ' ' OG1' ' A' ' 87' ' ' THR . 22.7 t -62.97 -43.53 98.54 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.04 178.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 33.1 mmtp -64.72 -40.53 95.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.956 0.408 . . . . 0.0 110.67 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -77.06 -17.46 58.74 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.06 53.87 2.43 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 120.644 -0.788 . . . . 0.0 111.867 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 79.9 mt -140.56 39.16 1.86 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 122.386 1.088 . . . . 0.0 108.124 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.619 ' O ' HG23 ' A' ' 9' ' ' ILE . 17.4 p -139.87 -155.03 0.55 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 175.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 . . . . . 0 C--N 1.307 -1.24 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 171.58 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.438 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 66.9 mtt . . . . . 0 CA--C 1.491 -1.303 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -98.84 149.63 22.7 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 172.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.747 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 4.0 pt20 -114.19 149.11 36.24 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -176.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 62' ' ' THR . 30.6 mm-40 -127.37 129.48 47.66 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 113.707 -1.588 . . . . 0.0 107.89 173.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.2 t -103.23 104.16 14.27 Favored 'General case' 0 N--CA 1.416 -2.147 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 175.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.541 ' HH ' HG22 ' A' ' 77' ' ' ILE . 31.3 m-85 -95.37 103.4 15.26 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.822 -176.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.2 m -79.61 89.35 5.12 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.448 HG23 ' CG1' ' A' ' 55' ' ' VAL . 4.3 mt -69.41 138.2 22.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 114.779 -1.1 . . . . 0.0 113.098 -175.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 pp -96.12 -4.31 10.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.834 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.48 ' O ' ' HA2' ' A' ' 56' ' ' GLY . 6.5 t70 -59.04 125.82 25.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.177 176.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -124.11 19.33 9.13 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.7 m -87.1 -24.54 24.51 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 113.966 -1.47 . . . . 0.0 108.825 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.67 21.88 10.04 Favored Glycine 0 N--CA 1.434 -1.479 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -178.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.444 ' HB1' ' CG2' ' A' ' 55' ' ' VAL . . . 91.8 92.73 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.14 0 C-N-CA 127.069 2.148 . . . . 0.0 111.34 -178.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . 0.257 2.4 p-80 -69.99 95.81 0.98 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 122.532 1.158 . . . . 0.0 110.666 172.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.28 -29.63 64.07 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 113.36 -1.745 . . . . 0.0 114.407 -170.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.51 -51.26 52.4 Favored Pre-proline 0 CA--C 1.556 1.202 0 CA-C-O 119.147 -0.454 . . . . 0.0 110.241 -178.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -57.73 -37.2 97.46 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 121.758 1.639 . . . . 0.0 110.812 172.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.655 ' O ' ' HG ' ' A' ' 22' ' ' LEU . . . -66.01 -18.84 65.61 Favored 'General case' 0 C--O 1.197 -1.7 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.929 178.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.4 m -70.02 -24.57 63.31 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 49.7 ttm -78.26 -35.26 48.35 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 175.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -64.84 -37.58 88.11 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 176.308 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.404 HG11 ' O ' ' A' ' 45' ' ' LYS . 4.5 t -58.57 -47.43 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.107 176.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -66.18 -19.28 65.79 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.784 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 54.2 m -84.2 -50.38 7.95 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.99 -29.09 69.41 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.6 p -62.71 -19.02 63.49 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -114.09 -145.77 0.4 Allowed 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 69.63 13.23 8.21 Favored 'General case' 0 C--O 1.247 0.921 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 174.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 56.92 27.11 12.59 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.913 0.885 . . . . 0.0 112.648 170.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.525 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 19.3 m -142.69 156.29 45.01 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.806 -177.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -105.57 113.81 27.61 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 175.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 3.1 mp -97.74 126.16 50.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.144 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -104.78 143.84 32.57 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.535 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 3.9 tt -96.48 129.69 43.79 Favored 'General case' 0 N--CA 1.403 -2.776 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 173.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.662 ' HA ' ' O ' ' A' ' 40' ' ' LYS . 0.5 OUTLIER -130.2 119.83 23.56 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -150.31 103.12 3.13 Favored 'General case' 0 C--N 1.293 -1.879 0 O-C-N 122.304 -0.248 . . . . 0.0 111.246 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.0 t30 59.56 28.71 18.17 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.84 0.856 . . . . 0.0 111.329 171.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.48 -17.03 8.44 Favored Glycine 0 CA--C 1.495 -1.215 0 C-N-CA 119.821 -1.18 . . . . 0.0 111.608 -178.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.662 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 13.3 mmtp -77.63 140.19 39.6 Favored 'General case' 0 CA--C 1.481 -1.705 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 15.1 ptmm? -143.99 112.56 6.53 Favored 'General case' 0 N--CA 1.413 -2.292 0 CA-C-N 114.299 -1.319 . . . . 0.0 108.594 169.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.3 p -149.04 160.46 5.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.772 -174.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.54 ' O ' ' HB2' ' A' ' 46' ' ' SER . 15.6 t30 -66.47 109.0 2.58 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -62.73 -25.93 68.44 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.661 0.784 . . . . 0.0 112.713 -173.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.505 ' HG2' ' ND2' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -88.37 24.61 1.87 Allowed 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 122.249 1.024 . . . . 0.0 110.356 178.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.54 ' HB2' ' O ' ' A' ' 43' ' ' ASN . 52.0 m -122.29 125.94 47.07 Favored 'General case' 0 N--CA 1.4 -2.974 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.145 172.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.46 -23.24 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 47.0 ttp -58.75 -22.02 56.87 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.859 -1.519 . . . . 0.0 110.187 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -84.94 -67.33 1.42 Allowed Glycine 0 N--CA 1.423 -2.211 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 94.4 t -55.09 -40.7 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -175.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 34.5 ttm -77.19 -0.75 26.26 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-O 120.797 0.332 . . . . 0.0 111.537 -175.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 62.8 m -98.89 -19.07 17.56 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 121.692 -0.63 . . . . 0.0 111.748 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.463 ' HB2' ' CG2' ' A' ' 55' ' ' VAL . 4.7 mp -75.13 150.53 38.74 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.5 66.1 3.25 Favored Glycine 0 C--N 1.301 -1.364 0 N-CA-C 107.998 -2.041 . . . . 0.0 107.998 170.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.463 ' CG2' ' HB2' ' A' ' 53' ' ' LEU . 11.1 t -66.98 113.46 3.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 123.996 0.918 . . . . 0.0 110.194 -174.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 10' ' ' ASP . . . -162.22 111.57 0.48 Allowed Glycine 0 N--CA 1.432 -1.587 0 CA-C-O 119.44 -0.644 . . . . 0.0 111.94 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.3 pttp 39.31 -43.9 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.944 0 C-N-CA 129.766 3.226 . . . . 0.0 117.966 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -93.25 7.29 44.93 Favored 'General case' 0 C--N 1.285 -2.212 0 O-C-N 121.336 -0.852 . . . . 0.0 109.399 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.15 89.25 1.15 Allowed 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.173 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 35.5 mt-10 -94.58 93.03 7.35 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 174.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.5 pt -93.69 143.42 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.057 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.538 -174.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 4' ' ' GLN . 25.1 m -106.41 123.24 47.77 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-O 121.273 0.558 . . . . 0.0 109.983 -177.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.575 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.3 mp -100.5 129.54 51.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.182 176.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.747 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 38.0 m-85 -115.55 112.87 22.84 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 123.682 0.614 . . . . 0.0 109.925 174.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -106.29 119.88 40.4 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.438 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 26.1 t70 -131.44 117.06 18.31 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.525 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -173.91 -163.92 28.17 Favored Glycine 0 N--CA 1.425 -2.09 0 C-N-CA 119.524 -1.322 . . . . 0.0 112.736 -174.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.5 m -87.59 -22.32 24.84 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.844 0.831 . . . . 0.0 109.373 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -132.39 35.85 3.63 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.838 -177.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.401 ' OE1' ' HA ' ' A' ' 66' ' ' ASP . 11.3 pt-20 -64.28 -38.0 89.47 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -173.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.31 -30.37 68.42 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.136 0.493 . . . . 0.0 110.658 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -76.06 -39.39 55.56 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 177.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.47 -41.23 98.59 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.441 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.6 mm -51.71 -51.33 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.279 0.631 . . . . 0.0 111.235 177.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -65.32 -41.53 93.92 Favored 'General case' 0 N--CA 1.405 -2.716 0 C-N-CA 122.799 0.44 . . . . 0.0 110.46 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.457 ' O ' ' HB3' ' A' ' 79' ' ' ASP . . . -67.15 -38.67 85.91 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.578 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.541 HG22 ' HH ' ' A' ' 6' ' ' TYR . 5.1 tt -72.25 -35.03 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.025 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.856 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.5 m -66.6 -41.62 88.17 Favored 'General case' 0 C--O 1.253 1.285 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 174.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.457 ' HB3' ' O ' ' A' ' 76' ' ' ALA . 26.3 t70 -51.22 -55.0 20.31 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 114.199 -1.364 . . . . 0.0 110.975 176.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.0 m -70.42 -34.14 56.71 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.081 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.9 mp -61.89 -50.35 72.57 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 119.278 0.945 . . . . 0.0 110.949 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.6 p -63.46 -39.22 93.88 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.03 0.443 . . . . 0.0 111.58 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -59.25 -43.78 92.41 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 124.227 1.011 . . . . 0.0 109.665 176.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -86.22 5.99 31.65 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 124.473 1.109 . . . . 0.0 112.505 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.88 30.76 70.06 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 115.429 0.932 . . . . 0.0 115.429 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.4 mp -90.56 -34.68 15.42 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 118.436 1.118 . . . . 0.0 109.713 174.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 27.1 p -119.49 150.18 40.66 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 . . . . . 0 N--CA 1.424 -1.749 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.387 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.596 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 47.8 ttm . . . . . 0 CA--C 1.508 -0.649 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -139.46 151.81 46.51 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.706 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 15.9 pt20 -103.73 149.05 25.35 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 123.757 0.661 . . . . 0.0 111.243 176.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -138.25 103.68 4.99 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.323 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 48.9 m -91.34 120.16 31.98 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.528 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 73.6 m-85 -109.97 137.82 47.21 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 124.831 1.252 . . . . 0.0 111.726 -174.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.0 m -96.62 109.93 22.45 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 174.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.561 HG12 ' H ' ' A' ' 10' ' ' ASP . 10.8 tt -63.11 152.14 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.87 0 CA-C-O 121.1 0.476 . . . . 0.0 111.552 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.6 pt -116.12 -14.9 10.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 O-C-N 122.033 -0.417 . . . . 0.0 110.879 176.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.561 ' H ' HG12 ' A' ' 8' ' ' ILE . 28.8 t70 -76.39 135.22 39.47 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.356 0.598 . . . . 0.0 111.589 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.414 ' HG2' ' HB3' ' A' ' 57' ' ' LYS . 34.1 mt-10 . . . . . 0 C--N 1.299 -1.597 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.511 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.449 ' O ' ' HD2' ' A' ' 18' ' ' PRO 0.497 0.8 OUTLIER . . . . . 0 CA--C 1.521 -0.157 0 CA-C-O 122.282 1.039 . . . . 0.0 113.778 . . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.72 -31.84 69.99 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.209 -1.36 . . . . 0.0 113.98 -172.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.481 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 13.2 tpp180 -57.01 -56.07 37.32 Favored Pre-proline 0 CA--C 1.559 1.324 0 CA-C-O 118.669 -0.682 . . . . 0.0 112.193 -178.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.504 ' HA ' ' OE2' ' A' ' 84' ' ' GLU . 82.1 Cg_exo -48.83 -45.9 26.67 Favored 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 122.598 2.199 . . . . 0.0 112.347 172.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.44 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -65.36 -27.08 68.32 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.478 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.512 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 18.2 m -72.6 -28.81 63.01 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 61.7 mtt -71.62 -35.23 70.37 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 174.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 22' ' ' LEU . 4.0 mm? -60.22 -41.77 93.79 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.236 172.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.512 ' HB ' ' O ' ' A' ' 20' ' ' THR . 47.8 t -51.85 -56.15 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 O-C-N 124.458 1.099 . . . . 0.0 110.523 175.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -67.65 -26.99 66.49 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 120.812 0.339 . . . . 0.0 111.494 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.0 m -71.05 -52.7 17.98 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.02 -30.57 71.05 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.586 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.5 m -62.15 -31.02 71.46 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.74 8.09 45.08 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -173.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -101.73 150.73 22.83 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.56 176.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -63.37 -42.44 98.85 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 121.819 0.818 . . . . 0.0 108.966 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.521 ' OG ' ' HA3' ' A' ' 67' ' ' GLY . 13.3 m -71.88 149.24 45.35 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.722 -177.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -102.61 130.35 49.47 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.366 173.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.577 HG23 HG23 ' A' ' 63' ' ' ILE . 3.2 mp -108.21 126.04 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.085 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -98.82 136.3 39.04 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 174.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.703 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 40.4 tp -104.04 117.91 35.4 Favored 'General case' 0 C--N 1.277 -2.578 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -114.53 106.52 14.37 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-O 121.185 0.517 . . . . 0.0 110.226 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -131.23 94.58 3.6 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.077 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.6 t30 41.3 69.41 0.35 Allowed 'General case' 0 C--O 1.247 0.961 0 C-N-CA 125.902 1.681 . . . . 0.0 113.753 173.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.18 -26.69 23.57 Favored Glycine 0 CA--C 1.502 -0.749 0 C-N-CA 120.846 -0.693 . . . . 0.0 111.731 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.58 99.78 10.7 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 178.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.703 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -116.55 133.16 56.35 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-N 115.287 -0.869 . . . . 0.0 108.997 171.679 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 p -156.16 155.14 5.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.826 -172.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -62.56 118.17 7.22 Favored 'General case' 0 C--O 1.208 -1.12 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 169.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.7 tp -64.26 -20.13 65.85 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -90.39 3.27 54.24 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 119.332 -0.947 . . . . 0.0 111.024 175.111 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.3 m -115.55 136.19 53.33 Favored 'General case' 0 N--CA 1.415 -2.185 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.3 pp -81.79 9.35 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -173.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 49.7 ttp -88.82 60.13 5.38 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.681 1.229 . . . . 0.0 110.403 -170.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.51 -45.27 0.69 Allowed Glycine 0 N--CA 1.426 -1.97 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 -175.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.32 -34.71 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 114.649 -0.775 . . . . 0.0 111.713 -177.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -76.73 -16.62 59.44 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.778 -173.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.8 m -116.44 17.56 15.43 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.192 0.52 . . . . 0.0 109.643 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.1 tp -62.93 112.51 2.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.121 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.76 56.55 2.61 Favored Glycine 0 C--N 1.31 -0.863 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.081 -176.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.425 HG11 HG21 ' A' ' 61' ' ' ILE . 6.5 m -87.2 138.08 19.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-O 120.937 0.399 . . . . 0.0 112.013 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -158.02 134.92 4.08 Favored Glycine 0 C--O 1.207 -1.569 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.414 ' HB3' ' HG2' ' A' ' 11' ' ' GLU 0.317 14.7 ptmm? 20.12 -64.28 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.09 0 N-CA-C 118.604 2.816 . . . . 0.0 118.604 -176.391 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -77.14 -8.59 57.77 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.78 -0.575 . . . . 0.0 111.769 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.1 109.07 5.64 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.305 0.574 . . . . 0.0 112.27 -175.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.528 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 31.6 mt-10 -98.42 119.46 37.16 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 5' ' ' SER . 17.6 pt -106.16 142.94 17.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.717 -173.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.1 m -114.47 125.93 54.38 Favored 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.95 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.577 HG23 HG23 ' A' ' 33' ' ' ILE . 1.6 mp -99.97 135.33 36.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.706 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 40.5 m-85 -121.5 114.6 21.46 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 172.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.596 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -107.02 125.06 50.52 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -128.97 123.08 31.52 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 177.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.521 ' HA3' ' OG ' ' A' ' 31' ' ' SER . . . 178.36 -171.88 44.27 Favored Glycine 0 N--CA 1.429 -1.78 0 C-N-CA 120.226 -0.988 . . . . 0.0 111.421 -174.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.6 t -85.85 -13.43 48.01 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 174.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -128.82 37.85 4.03 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.646 -178.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.481 ' O ' HG12 ' A' ' 74' ' ' ILE 0.336 0.0 OUTLIER -67.34 -48.17 68.32 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 -173.774 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.17 -32.83 73.5 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.26 0.552 . . . . 0.0 111.026 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 17.2 t70 -74.83 -39.08 61.83 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.707 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.557 ' O ' ' HB ' ' A' ' 77' ' ' ILE . . . -61.71 -41.33 97.47 Favored 'General case' 0 C--O 1.201 -1.488 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 70' ' ' GLU . 28.1 mm -57.26 -49.53 79.58 Favored 'Isoleucine or valine' 0 C--O 1.248 0.974 0 C-N-CA 123.536 0.735 . . . . 0.0 111.271 176.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 18.9 pt20 -67.22 -31.06 71.18 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 120.452 -0.499 . . . . 0.0 112.196 -176.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.17 -42.26 38.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.333 0.587 . . . . 0.0 109.744 175.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.557 ' HB ' ' O ' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -56.32 -43.31 76.69 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 C-N-CA 124.701 1.2 . . . . 0.0 111.758 179.783 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 56.2 m -63.51 -44.69 93.58 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -59.21 -53.54 57.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.763 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.6 m -67.1 -37.73 79.84 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.016 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.795 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.428 HD22 ' HB2' ' A' ' 86' ' ' LEU . 29.9 mt -65.47 -35.26 80.38 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.3 p -75.65 -34.64 60.53 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.398 177.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -62.52 -39.08 92.4 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.528 0.68 . . . . 0.0 109.894 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.504 ' OE2' ' HA ' ' A' ' 18' ' ' PRO . 5.6 mm-40 -87.22 -3.98 59.07 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.962 -177.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.4 15.25 80.31 Favored Glycine 0 C--N 1.317 -0.504 0 N-CA-C 115.746 1.058 . . . . 0.0 115.746 173.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.533 ' HA ' HG13 ' A' ' 8' ' ' ILE . 4.9 mp -88.81 5.59 42.92 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 118.607 1.203 . . . . 0.0 110.474 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' A' ' 6' ' ' TYR . 10.2 t -163.23 156.12 18.83 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.5 176.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 N--CA 1.419 -2.004 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 167.18 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.603 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 90.2 mtp . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -103.58 151.04 23.37 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 174.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.678 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 16.8 pt20 -111.22 150.08 30.06 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-O 121.724 0.774 . . . . 0.0 112.744 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.497 ' O ' ' HA ' ' A' ' 62' ' ' THR . 8.5 mm-40 -128.67 119.46 24.72 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 114.014 -1.448 . . . . 0.0 109.288 176.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.5 t -98.72 97.31 8.57 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 176.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.484 ' OH ' HG23 ' A' ' 77' ' ' ILE . 56.9 m-85 -88.1 127.59 35.41 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.575 -176.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.4 m -88.84 90.1 8.27 Favored 'General case' 0 N--CA 1.409 -2.475 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 172.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.668 ' O ' ' HA ' ' A' ' 57' ' ' LYS . 8.4 mt -71.91 131.13 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.063 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 33.9 pt -125.65 23.3 3.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.576 ' HB2' ' HA ' ' A' ' 86' ' ' LEU . 25.1 t70 -71.4 104.68 3.28 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.572 -177.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 C--N 1.305 -1.368 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -174.891 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 . . . . . 0 C--O 1.24 0.586 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.12 -43.93 73.44 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.5 ' O ' HG22 ' A' ' 20' ' ' THR 0.258 26.9 mmt180 -60.16 -47.66 96.24 Favored Pre-proline 0 N--CA 1.473 0.703 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 -178.909 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -53.76 -45.39 41.37 Favored 'Trans proline' 0 C--N 1.363 1.324 0 C-N-CA 121.582 1.521 . . . . 0.0 110.401 174.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -67.74 -34.34 76.65 Favored 'General case' 0 C--O 1.205 -1.264 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.593 -178.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.5 HG22 ' O ' ' A' ' 17' ' ' ARG . 1.3 t -71.16 -28.12 64.04 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.183 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.2 mtm -78.37 -28.47 47.1 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 175.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.423 ' HB3' HD22 ' A' ' 44' ' ' LEU . 3.0 mm? -65.12 -42.4 93.96 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 170.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 55.7 t -56.45 -49.51 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.941 173.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.41 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 29.0 tt0 -59.37 -27.48 66.01 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.446 1.098 . . . . 0.0 111.715 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.425 ' O ' ' HD1' ' A' ' 29' ' ' PHE . 94.4 m -80.73 -56.55 4.07 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.62 86.13 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.242 -176.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.8 m -59.09 -29.14 67.12 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -119.05 14.1 13.09 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 -170.904 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.425 ' HD1' ' O ' ' A' ' 25' ' ' THR . 6.7 m-85 -99.33 9.94 42.38 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.248 -0.581 . . . . 0.0 112.207 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.5 t70 48.97 39.49 14.72 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 123.559 1.647 . . . . 0.0 110.486 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.475 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 21.7 m -143.35 141.22 30.86 Favored 'General case' 0 N--CA 1.393 -3.307 0 CA-C-N 112.897 -1.956 . . . . 0.0 107.18 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -95.64 98.73 10.71 Favored 'General case' 0 N--CA 1.391 -3.423 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 97.9 mt -93.1 125.42 45.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.888 177.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -119.9 147.08 45.16 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.448 ' HG ' HD11 ' A' ' 63' ' ' ILE . 4.3 tt -106.7 112.85 26.03 Favored 'General case' 0 N--CA 1.399 -2.986 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 41' ' ' LYS . 8.6 tp10 -98.76 116.11 30.27 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 175.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -141.08 108.01 5.42 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.354 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 42.02 77.91 0.05 Allowed 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 126.409 1.883 . . . . 0.0 113.476 173.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.33 -52.83 0.64 Allowed Glycine 0 N--CA 1.418 -2.542 0 C-N-CA 119.721 -1.228 . . . . 0.0 112.397 175.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.7 147.65 48.59 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 -173.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.586 ' H ' ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -103.9 131.48 51.07 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 113.696 -1.593 . . . . 0.0 108.766 177.85 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.9 p -125.98 137.84 56.46 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.753 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -54.44 125.06 18.04 Favored 'General case' 0 C--O 1.207 -1.144 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 172.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.423 HD22 ' HB3' ' A' ' 22' ' ' LEU . 0.7 OUTLIER -73.23 -14.34 61.32 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 121.633 0.73 . . . . 0.0 111.167 -174.368 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 0.1 OUTLIER -91.2 3.39 54.94 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 121.486 -0.759 . . . . 0.0 110.329 172.817 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 57.2 m -113.29 124.85 53.46 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.429 177.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.519 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -78.58 8.64 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 123.068 0.547 . . . . 0.0 112.413 -173.635 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 16.5 tpt -105.59 78.08 1.33 Allowed 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -168.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 135.75 -32.71 2.49 Favored Glycine 0 C--N 1.291 -1.958 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -173.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' A' ' 53' ' ' LEU . 88.0 t -80.97 -43.4 20.69 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 CA-C-N 114.965 -0.617 . . . . 0.0 110.529 178.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.5 mtt -65.65 -40.19 92.19 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 119.205 -0.998 . . . . 0.0 111.451 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.4 m -80.57 16.53 1.34 Allowed 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 176.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 7.7 tp -65.92 107.08 1.73 Allowed 'General case' 0 C--O 1.244 0.777 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.93 55.6 4.53 Favored Glycine 0 C--O 1.222 -0.635 0 N-CA-C 110.519 -1.033 . . . . 0.0 110.519 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.4 p -88.13 139.35 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -173.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -122.86 -83.03 0.62 Allowed Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 119.802 -1.189 . . . . 0.0 113.48 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.668 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -169.15 136.49 1.83 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -177.037 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.3 t70 74.83 4.81 4.36 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 123.033 1.397 . . . . 0.0 107.801 -171.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.18 108.61 7.08 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 113.345 -1.752 . . . . 0.0 109.818 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -83.36 110.81 18.45 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 123.627 0.579 . . . . 0.0 110.308 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.467 HG12 ' HB2' ' A' ' 6' ' ' TYR . 25.3 pt -106.09 143.44 17.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 174.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 4' ' ' GLN . 28.1 m -112.94 111.41 22.14 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 121.557 0.694 . . . . 0.0 111.405 -176.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.4 mp -89.56 135.4 26.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.416 177.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.678 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 34.2 m-85 -117.29 119.13 34.22 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 172.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -114.65 122.4 46.35 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.603 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 25.8 t70 -136.05 122.83 21.15 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.5 ' N ' ' HB3' ' A' ' 70' ' ' GLU . . . -178.29 -170.04 39.9 Favored Glycine 0 C--N 1.287 -2.155 0 C-N-CA 119.024 -1.56 . . . . 0.0 112.209 -173.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.0 m -76.83 -30.15 56.24 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.603 0.716 . . . . 0.0 109.31 175.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -124.06 30.17 6.2 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.097 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.556 ' O ' HG12 ' A' ' 74' ' ' ILE . 12.4 pt-20 -54.1 -42.96 69.98 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -175.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.85 -31.93 72.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.594 0.711 . . . . 0.0 110.906 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -83.32 -32.3 26.38 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.138 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.99 -28.74 68.5 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.941 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.556 HG12 ' O ' ' A' ' 70' ' ' GLU . 25.3 mm -54.04 -48.3 64.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 O-C-N 123.857 0.723 . . . . 0.0 110.85 175.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -68.44 -39.65 81.43 Favored 'General case' 0 N--CA 1.403 -2.781 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.86 -47.26 84.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.823 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.484 HG23 ' OH ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -66.74 -36.4 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.868 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.623 -179.615 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 41.0 m -68.03 -40.04 82.99 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 175.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.498 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 20.1 t70 -56.18 -56.15 24.41 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.904 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.1 m -61.76 -36.85 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 38.6 mt -63.47 -48.26 78.38 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.41 -0.218 . . . . 0.0 110.41 176.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.581 ' HA ' ' O ' ' A' ' 87' ' ' THR . 38.1 t -57.66 -47.37 82.47 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.224 0.61 . . . . 0.0 111.333 174.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 32.6 mmtp -57.58 -42.67 83.61 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.641 0.734 . . . . 0.0 110.489 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -77.66 -22.43 50.61 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.922 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.11 14.83 47.19 Favored Glycine 0 C--N 1.301 -1.389 0 C-N-CA 120.358 -0.925 . . . . 0.0 113.797 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.576 ' HA ' ' HB2' ' A' ' 10' ' ' ASP . 5.1 mp -87.05 -25.41 24.21 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.581 ' O ' ' HA ' ' A' ' 82' ' ' SER . 34.3 m -126.7 148.79 49.83 Favored 'General case' 0 N--CA 1.414 -2.233 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 176.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 . . . . . 0 C--N 1.301 -1.505 0 C-N-CA 123.604 0.762 . . . . 0.0 111.124 -176.926 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 mtm . . . . . 0 CA--C 1.504 -0.792 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 31.9 tt0 -100.78 141.45 33.65 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.631 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 28.6 pt20 -106.59 154.27 21.15 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -175.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' A' ' 62' ' ' THR . 28.4 mm-40 -138.53 127.52 23.93 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.458 -1.701 . . . . 0.0 107.367 172.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.7 p -103.6 103.4 13.33 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-O 121.741 0.782 . . . . 0.0 110.109 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.486 ' HB2' HG12 ' A' ' 61' ' ' ILE . 78.3 m-85 -104.69 164.64 11.62 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.716 -177.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.9 m -129.57 130.42 45.68 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 174.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.637 HG23 ' HA ' ' A' ' 57' ' ' LYS . 15.1 tt -90.93 153.71 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.638 0 C-N-CA 121.18 -0.208 . . . . 0.0 111.492 -175.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.438 HG23 ' HG2' ' A' ' 88' ' ' GLU . 36.4 pt -136.49 24.55 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 121.117 0.484 . . . . 0.0 110.667 177.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.469 ' H ' HG12 ' A' ' 8' ' ' ILE . 7.1 p-10 -65.75 -39.96 91.63 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.899 -177.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.438 ' HG2' ' HG2' ' A' ' 57' ' ' LYS . 36.8 mt-10 . . . . . 0 N--CA 1.477 0.912 0 C-N-CA 125.334 1.453 . . . . 0.0 112.191 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . 0.298 9.1 p80 . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.938 0.875 . . . . 0.0 112.945 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.94 80.09 4.39 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -173.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.516 ' H ' ' HD2' ' A' ' 18' ' ' PRO . 2.1 tmt_? -137.77 -51.21 0.02 OUTLIER Pre-proline 0 C--N 1.291 -1.963 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 172.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.516 ' HD2' ' H ' ' A' ' 17' ' ' ARG . 4.9 Cg_endo -53.27 -33.59 66.08 Favored 'Trans proline' 0 C--N 1.384 2.427 0 C-N-CA 121.343 1.362 . . . . 0.0 109.693 168.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.507 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -60.25 -27.8 67.52 Favored 'General case' 0 C--O 1.201 -1.49 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.58 178.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.5 m -65.82 -26.77 67.82 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.229 0.538 . . . . 0.0 110.471 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 55.9 tpp -71.76 -32.0 67.24 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.12 -30.37 63.58 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.197 176.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 19' ' ' ALA . 77.0 t -69.96 -39.9 78.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -70.26 -37.74 74.97 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.321 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.1 m -91.26 -66.79 0.9 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -172.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.657 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . . . -62.97 -32.64 74.01 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -171.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.4 m -61.49 -25.69 67.42 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.34 14.93 30.64 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -176.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.44 ' C ' ' H ' ' A' ' 31' ' ' SER . 28.8 m-85 -105.23 3.7 30.36 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.814 178.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.5 t70 68.78 -36.82 0.34 Allowed 'General case' 0 N--CA 1.507 2.406 0 C-N-CA 124.644 1.177 . . . . 0.0 113.187 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.508 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 19.9 m -58.95 148.95 28.61 Favored 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 125.261 1.424 . . . . 0.0 112.029 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -99.68 102.69 14.25 Favored 'General case' 0 N--CA 1.409 -2.513 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.927 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 2.6 mp -91.48 121.59 42.07 Favored 'Isoleucine or valine' 0 C--O 1.259 1.588 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.844 177.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -119.97 135.63 54.84 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 -174.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.528 HD12 HD13 ' A' ' 44' ' ' LEU . 5.8 tt -101.24 116.26 32.39 Favored 'General case' 0 N--CA 1.406 -2.656 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.451 ' HB3' ' HB ' ' A' ' 62' ' ' THR . 3.4 tm-20 -99.93 105.35 17.05 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.412 ' HB3' HD11 ' A' ' 53' ' ' LEU 0.285 1.2 t80 -110.3 79.83 1.25 Allowed 'General case' 0 C--N 1.287 -2.134 0 CA-C-O 122.149 0.976 . . . . 0.0 110.476 175.611 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 34.81 79.95 0.03 OUTLIER 'General case' 0 C--O 1.238 0.476 0 CA-C-N 111.949 -2.387 . . . . 0.0 113.711 172.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 135.48 -61.72 0.62 Allowed Glycine 0 CA--C 1.484 -1.848 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.48 ' H ' ' HD2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -127.12 159.21 34.89 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-N 113.871 -1.164 . . . . 0.0 110.285 -174.18 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 38.3 ttpt -142.74 142.71 32.0 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.588 -173.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.68 HG21 ' HA3' ' A' ' 49' ' ' GLY . 10.4 p -151.33 160.16 3.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -61.57 132.72 54.25 Favored 'General case' 0 C--O 1.216 -0.679 0 C-N-CA 122.83 0.452 . . . . 0.0 111.329 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.528 HD13 HD12 ' A' ' 35' ' ' LEU . 34.2 tp -91.33 -15.63 28.77 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.773 0.797 . . . . 0.0 111.423 -178.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.657 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 16.0 pttp -90.06 1.91 55.81 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 122.075 0.94 . . . . 0.0 109.672 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 61.3 m -121.51 139.33 53.63 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-N 113.958 -1.474 . . . . 0.0 108.167 175.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.43 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -78.15 -27.56 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-O 121.611 0.72 . . . . 0.0 110.247 -175.373 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 53.8 ttp -68.19 91.91 0.38 Allowed 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 113.694 -1.594 . . . . 0.0 108.658 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.68 ' HA3' HG21 ' A' ' 42' ' ' VAL . . . 139.79 -58.52 0.59 Allowed Glycine 0 C--N 1.264 -3.458 0 CA-C-N 113.379 -1.737 . . . . 0.0 110.138 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.414 HG21 ' HA ' ' A' ' 44' ' ' LEU . 59.2 t -66.28 -33.95 66.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 114.629 -0.785 . . . . 0.0 112.376 -175.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 55.1 ttm -64.86 -52.17 58.06 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.011 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.2 m -69.25 -16.28 63.55 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 123.655 0.782 . . . . 0.0 112.897 177.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.51 HD21 HD22 ' A' ' 35' ' ' LEU . 11.2 tp -69.02 103.58 1.89 Allowed 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 123.899 0.88 . . . . 0.0 109.291 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.22 62.68 4.23 Favored Glycine 0 C--N 1.31 -0.873 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.893 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.467 ' HB ' HG21 ' A' ' 8' ' ' ILE . 1.2 m -56.94 -62.72 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 C-N-CA 122.187 0.195 . . . . 0.0 110.863 176.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 49.42 75.37 0.21 Allowed Glycine 0 CA--C 1.53 1.001 0 N-CA-C 116.004 1.162 . . . . 0.0 116.004 171.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.637 ' HA ' HG23 ' A' ' 8' ' ' ILE . 0.0 OUTLIER 43.16 -13.8 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.456 0 N-CA-C 119.589 3.181 . . . . 0.0 119.589 177.565 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -102.46 -8.7 20.87 Favored 'General case' 0 C--N 1.285 -2.225 0 O-C-N 121.242 -0.911 . . . . 0.0 109.802 -176.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.1 127.24 32.41 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -171.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -91.54 101.24 13.89 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 169.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.523 ' HB ' HD21 ' A' ' 35' ' ' LEU . 1.4 pt -104.87 126.56 59.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.731 -0.787 . . . . 0.0 109.918 -171.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.451 ' HB ' ' HB3' ' A' ' 36' ' ' GLU . 19.4 m -108.9 118.15 36.05 Favored 'General case' 0 C--N 1.287 -2.114 0 O-C-N 121.913 -0.492 . . . . 0.0 109.838 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.57 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.5 mp -88.71 132.78 32.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.631 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 38.9 m-85 -119.27 125.84 50.08 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.961 171.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.23 120.5 40.67 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.46 ' HA ' ' OE1' ' A' ' 70' ' ' GLU . 29.0 t70 -125.56 108.02 11.18 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.508 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -165.73 -172.89 33.65 Favored Glycine 0 N--CA 1.416 -2.645 0 C-N-CA 119.148 -1.501 . . . . 0.0 113.482 -171.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.3 p -78.75 -26.91 44.64 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 114.582 -0.809 . . . . 0.0 110.027 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -129.2 35.91 4.22 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.286 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.46 ' OE1' ' HA ' ' A' ' 66' ' ' ASP . 11.0 pt-20 -58.53 -36.18 73.44 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -175.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.84 -43.52 95.94 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 121.218 0.532 . . . . 0.0 110.497 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -76.28 -31.13 58.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.786 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.471 ' O ' ' HB ' ' A' ' 77' ' ' ILE . . . -64.27 -36.67 84.84 Favored 'General case' 0 C--O 1.205 -1.265 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.915 176.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.539 ' O ' HG22 ' A' ' 77' ' ' ILE . 25.8 mm -61.22 -43.65 96.86 Favored 'Isoleucine or valine' 0 C--O 1.251 1.143 0 C-N-CA 122.691 0.396 . . . . 0.0 110.784 175.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -53.04 62.68 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.64 -39.17 93.23 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.566 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.539 HG22 ' O ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -64.65 -40.61 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 C-N-CA 123.127 0.571 . . . . 0.0 110.607 -178.024 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.8 m -72.85 -33.91 66.43 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 24.1 t70 -63.26 -46.74 85.42 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.549 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.435 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 35.3 m -77.68 -23.5 14.19 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.262 0 C-N-CA 120.517 -0.473 . . . . 0.0 112.188 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 77' ' ' ILE . 23.6 mt -73.19 -48.02 38.7 Favored 'General case' 0 C--O 1.206 -1.185 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.588 174.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.7 p -61.3 -29.5 69.91 Favored 'General case' 0 C--N 1.316 -0.85 0 O-C-N 121.626 -0.671 . . . . 0.0 111.438 173.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 79' ' ' ASP . 18.4 ttmm -70.94 -39.57 72.55 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.909 176.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -104.53 -82.8 0.51 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -177.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -173.22 -156.9 13.68 Favored Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -176.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.447 ' HA ' HG13 ' A' ' 8' ' ' ILE . 3.2 mp 64.87 19.67 11.91 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 125.276 1.43 . . . . 0.0 112.3 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 60.3 m -154.45 156.89 37.58 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.438 ' HG2' HG23 ' A' ' 9' ' ' ILE . 41.7 mt-10 . . . . . 0 C--O 1.25 1.096 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.462 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 1.1 mpt? . . . . . 0 CA--C 1.502 -0.9 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -105.23 145.35 30.76 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 118.908 -1.117 . . . . 0.0 113.118 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.758 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 24.1 pt20 -111.82 151.88 28.54 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -172.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' A' ' 62' ' ' THR . 83.8 mm-40 -137.16 131.57 32.74 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.224 -1.353 . . . . 0.0 108.369 173.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.8 t -98.71 121.29 40.47 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 82.4 m-85 -113.34 159.51 19.34 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 122.662 0.385 . . . . 0.0 110.933 -177.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.2 m -131.68 106.36 8.1 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 174.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.59 HG21 ' HB3' ' A' ' 59' ' ' ALA . 9.7 tp -66.83 144.96 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.603 0 C-N-CA 123.229 0.612 . . . . 0.0 110.353 -176.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.0 pt -109.52 -14.74 10.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-O 121.744 0.783 . . . . 0.0 109.154 174.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.471 ' O ' ' HA2' ' A' ' 56' ' ' GLY . 9.9 t70 -73.28 149.67 42.54 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.583 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 . . . . . 0 C--N 1.316 -0.877 0 CA-C-O 121.626 0.727 . . . . 0.0 109.516 178.158 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . 0.494 30.9 p-80 . . . . . 0 CA--C 1.542 0.652 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.47 -55.99 23.32 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 116.36 1.985 . . . . 0.0 116.36 -166.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.402 ' HD3' ' HA ' ' A' ' 17' ' ' ARG . 28.5 mmt180 -54.89 -53.41 61.27 Favored Pre-proline 0 N--CA 1.48 1.04 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -172.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.17 -37.44 83.56 Favored 'Trans proline' 0 C--N 1.36 1.175 0 C-N-CA 121.671 1.58 . . . . 0.0 110.978 177.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.511 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -68.81 -27.54 65.95 Favored 'General case' 0 C--O 1.21 -1.023 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.03 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.522 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 14.8 m -74.87 -27.46 60.26 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 97.0 mmm -71.23 -37.82 71.99 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 173.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.429 HD12 HD21 ' A' ' 44' ' ' LEU . 4.5 mm? -61.96 -35.98 80.07 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.442 172.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.522 ' HB ' ' O ' ' A' ' 20' ' ' THR . 52.9 t -56.43 -53.98 33.88 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.698 0 O-C-N 123.669 0.606 . . . . 0.0 109.72 174.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -64.04 -26.28 68.49 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-O 121.264 0.554 . . . . 0.0 111.218 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.567 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 37.1 m -79.55 -62.66 1.62 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.577 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.712 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . . . -67.52 -26.82 66.52 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -175.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 27.1 m -72.48 -10.83 60.27 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 177.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.567 ' HG3' ' O ' ' A' ' 25' ' ' THR . 0.0 OUTLIER -100.14 -2.7 33.43 Favored 'General case' 0 CA--C 1.504 -0.813 0 C-N-CA 119.514 -0.875 . . . . 0.0 112.369 179.213 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -99.09 144.65 28.0 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -88.02 65.52 8.26 Favored 'General case' 0 CA--C 1.484 -1.576 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 173.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.551 ' OG ' ' HA3' ' A' ' 67' ' ' GLY . 23.2 m -161.56 135.97 7.02 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-N 113.397 -1.729 . . . . 0.0 107.455 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -102.35 112.77 25.61 Favored 'General case' 0 C--N 1.278 -2.504 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.62 175.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.515 HG23 HG23 ' A' ' 63' ' ' ILE . 59.3 mt -80.58 112.59 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.002 0 CA-C-N 114.142 -1.39 . . . . 0.0 107.636 175.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 35.2 mt-30 -97.08 127.51 43.12 Favored 'General case' 0 N--CA 1.403 -2.814 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.662 HD22 HD21 ' A' ' 53' ' ' LEU . 1.6 tt -91.63 115.09 27.75 Favored 'General case' 0 N--CA 1.4 -2.946 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 176.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -110.11 113.19 25.68 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 124.947 1.299 . . . . 0.0 108.732 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -133.88 94.35 3.25 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-O 121.52 0.676 . . . . 0.0 110.638 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 50.89 67.68 0.9 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.524 -1.671 . . . . 0.0 112.166 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.4 -23.57 31.42 Favored Glycine 0 N--CA 1.438 -1.186 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.699 175.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 40' ' ' LYS . 10.1 mmtp -99.04 109.95 22.62 Favored 'General case' 0 CA--C 1.476 -1.879 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 6.5 ptpp? -114.93 128.21 56.15 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.806 175.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 34' ' ' GLN . 6.0 m -135.95 -175.18 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.937 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.536 ' HB2' ' HB2' ' A' ' 46' ' ' SER . 19.6 m120 -94.22 120.51 34.57 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.429 HD21 HD12 ' A' ' 22' ' ' LEU . 7.4 tt -74.12 -21.97 59.66 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-O 121.241 0.543 . . . . 0.0 111.381 -178.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.712 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 14.5 pttp -87.93 6.86 33.68 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 122.255 1.026 . . . . 0.0 109.647 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.536 ' HB2' ' HB2' ' A' ' 43' ' ' ASN . 73.7 m -117.14 133.64 55.75 Favored 'General case' 0 N--CA 1.398 -3.029 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.137 175.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.759 HD12 ' H ' ' A' ' 47' ' ' ILE . 1.4 mp -75.17 -38.01 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.209 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -172.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 44.3 ttm -51.7 -37.39 50.58 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 112.688 -2.051 . . . . 0.0 110.571 175.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.5 -60.43 3.48 Favored Glycine 0 N--CA 1.426 -2.02 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.885 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.438 HG22 HD12 ' A' ' 35' ' ' LEU . 90.7 t -57.49 -40.96 77.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 96.4 mmm -75.33 2.86 10.16 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 51.9 m -92.82 -21.38 19.93 Favored 'General case' 0 C--N 1.31 -1.11 0 O-C-N 122.061 -0.399 . . . . 0.0 110.607 176.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.662 HD21 HD22 ' A' ' 35' ' ' LEU . 6.9 mp -79.93 155.89 27.51 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.045 0.45 . . . . 0.0 110.704 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.16 69.22 0.79 Allowed Glycine 0 N--CA 1.426 -1.969 0 N-CA-C 107.5 -2.24 . . . . 0.0 107.5 169.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.5 t -77.25 80.72 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -175.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 10' ' ' ASP . . . -134.92 135.22 7.79 Favored Glycine 0 N--CA 1.425 -2.052 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt 28.08 -57.89 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 129.817 3.247 . . . . 0.0 118.837 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -90.11 -0.84 57.81 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.743 0.782 . . . . 0.0 110.581 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.59 ' HB3' HG21 ' A' ' 8' ' ' ILE . . . -72.24 96.72 1.86 Allowed 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 121.927 0.87 . . . . 0.0 112.569 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 36.0 mt-10 -92.58 105.6 17.74 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 175.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.5 HD12 HD21 ' A' ' 35' ' ' LEU . 29.3 pt -103.23 157.2 5.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.458 -172.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 4' ' ' GLN . 34.1 m -122.89 127.66 49.26 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-O 121.254 0.55 . . . . 0.0 109.762 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.758 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.4 mp -97.31 130.08 46.48 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 177.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.423 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 27.4 m-85 -116.8 107.04 14.14 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 123.733 0.646 . . . . 0.0 109.48 171.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -93.63 111.42 23.1 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -113.77 110.19 19.76 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.551 ' HA3' ' OG ' ' A' ' 31' ' ' SER . . . -174.05 -168.49 35.05 Favored Glycine 0 N--CA 1.41 -3.069 0 C-N-CA 118.93 -1.605 . . . . 0.0 113.819 -175.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.2 m -94.79 -17.18 22.36 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 175.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -119.05 18.55 13.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.401 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.46 ' O ' HG12 ' A' ' 74' ' ' ILE . 4.7 pt-20 -57.24 -37.66 72.62 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -174.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.91 -42.58 99.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.111 0.481 . . . . 0.0 111.052 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -78.99 -26.87 43.34 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.36 0.6 . . . . 0.0 109.508 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.59 -41.38 98.35 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.357 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 70' ' ' GLU . 35.4 mm -60.09 -46.26 94.61 Favored 'Isoleucine or valine' 0 C--O 1.255 1.384 0 CA-C-O 121.542 0.686 . . . . 0.0 109.745 175.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -58.59 -40.1 82.26 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.43 -1.259 . . . . 0.0 112.657 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.06 -44.48 17.96 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.5 HG13 HD13 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -59.25 -36.97 66.27 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.55 0 C-N-CA 123.59 0.756 . . . . 0.0 112.459 -173.742 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.7 p -73.74 -43.16 59.87 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.263 0.554 . . . . 0.0 110.248 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.547 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 24.5 t70 -60.8 -47.77 84.84 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.288 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.528 ' HA ' ' HG2' ' A' ' 83' ' ' LYS . 27.9 m -66.01 -39.21 83.91 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.516 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.928 177.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 81' ' ' LEU . 15.5 mt -64.12 -35.62 81.36 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 177.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.4 p -70.29 -44.97 67.26 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 118.345 0.521 . . . . 0.0 112.075 174.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.547 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 12.9 ptmm? -67.29 -28.26 67.86 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.684 177.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 80' ' ' VAL . 24.2 mm-40 -81.14 -26.46 36.08 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.056 0.455 . . . . 0.0 110.687 175.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.24 41.31 8.03 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 116.136 -0.484 . . . . 0.0 113.663 175.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.449 ' O ' HD12 ' A' ' 8' ' ' ILE . 8.8 mp -91.71 -46.41 7.92 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.183 176.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.2 t -101.84 168.69 9.27 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -176.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 C--N 1.309 -1.16 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 176.883 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.599 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 91.0 mtp . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -105.18 148.16 27.21 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 169.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.701 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 27.7 pt20 -107.16 143.34 35.49 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -132.88 99.92 4.75 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.032 174.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 49.1 m -87.91 116.2 25.91 Favored 'General case' 0 C--N 1.286 -2.175 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.428 176.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.497 ' HB2' HG12 ' A' ' 61' ' ' ILE . 78.3 m-85 -102.03 139.02 38.22 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.031 -173.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.9 m -101.65 100.54 10.94 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 171.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.692 ' O ' ' HA ' ' A' ' 57' ' ' LYS 0.262 3.0 mt -74.75 135.41 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 119.97 -0.692 . . . . 0.0 112.028 -179.014 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.9 pt -107.09 -7.39 10.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.334 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.514 ' H ' HG23 ' A' ' 8' ' ' ILE . 12.0 t70 -76.65 125.15 28.75 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.74 -178.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.7 mp0 . . . . . 0 C--N 1.318 -0.777 0 C-N-CA 120.536 -0.465 . . . . 0.0 111.977 178.772 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 26.3 p80 . . . . . 0 C--O 1.219 -0.54 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.95 -76.33 0.59 Allowed 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.426 ' HD3' ' HA ' ' A' ' 17' ' ' ARG 0.257 33.9 mmt180 -69.36 -52.73 14.44 Favored Pre-proline 0 C--N 1.315 -0.911 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -176.392 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -59.55 -29.52 90.14 Favored 'Trans proline' 0 C--N 1.36 1.174 0 CA-C-N 120.838 1.335 . . . . 0.0 110.782 174.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.417 ' HA ' HD23 ' A' ' 22' ' ' LEU . . . -68.68 -28.45 66.88 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.231 176.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.401 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 57.1 m -70.59 -26.29 63.45 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 175.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 83.8 mtp -70.03 -31.84 69.68 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.457 HD21 HD21 ' A' ' 81' ' ' LEU . 4.1 mm? -66.32 -44.31 83.74 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 172.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' A' ' 20' ' ' THR . 84.4 t -54.01 -55.29 14.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 123.963 0.79 . . . . 0.0 109.497 174.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -53.41 -44.36 68.67 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 124.403 1.081 . . . . 0.0 112.317 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.1 m -81.31 -58.91 2.84 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -175.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.632 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . . . -64.86 -27.82 69.13 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -173.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.6 m -69.64 -16.11 63.31 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.256 0.0 OUTLIER -108.25 6.34 26.52 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 -175.606 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -101.43 137.62 39.52 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 174.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -84.78 73.07 10.67 Favored 'General case' 0 CA--C 1.496 -1.112 0 CA-C-O 122.749 1.262 . . . . 0.0 109.349 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.557 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 33.8 m -161.5 152.88 18.73 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 112.871 -1.968 . . . . 0.0 105.908 177.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -113.36 109.4 18.65 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.0 mp -89.87 125.57 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.272 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 -98.09 136.07 38.86 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.7 tp -99.94 114.94 28.54 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.62 ' HA ' ' O ' ' A' ' 40' ' ' LYS . 9.2 tt0 -111.66 136.34 51.02 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.706 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.448 ' CD2' ' HG ' ' A' ' 53' ' ' LEU . 50.7 t80 -165.24 104.5 0.75 Allowed 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 123.386 0.674 . . . . 0.0 110.572 178.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.7 t30 48.07 74.84 0.15 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.804 1.242 . . . . 0.0 113.025 176.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.98 -13.12 33.0 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 121.001 -0.618 . . . . 0.0 113.114 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -94.6 123.56 38.11 Favored 'General case' 0 CA--C 1.48 -1.729 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -179.588 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -119.57 113.42 20.68 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 169.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.7 p -143.53 167.14 13.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -175.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.552 HD21 ' HE3' ' A' ' 45' ' ' LYS . 19.3 t-20 -78.92 133.38 36.92 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 117.864 0.302 . . . . 0.0 111.184 -177.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.6 tp -75.97 -35.01 59.81 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.632 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -87.39 9.36 20.89 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.691 -178.358 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 75.6 m -106.68 125.01 50.46 Favored 'General case' 0 N--CA 1.392 -3.37 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 173.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.46 -25.47 38.44 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 CA-C-O 121.39 0.614 . . . . 0.0 111.636 -175.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 49.7 ttp -55.47 -27.04 45.85 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 125.429 1.492 . . . . 0.0 110.468 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.22 -60.62 4.35 Favored Glycine 0 N--CA 1.42 -2.423 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.515 178.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.0 t -64.04 -36.1 75.75 Favored 'Isoleucine or valine' 0 C--O 1.249 1.045 0 O-C-N 122.688 -0.301 . . . . 0.0 110.876 -176.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.2 mmt -57.84 -34.79 70.08 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.267 0.627 . . . . 0.0 112.237 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.1 p -85.03 -31.43 23.45 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.84 -175.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.448 ' HG ' ' CD2' ' A' ' 37' ' ' TYR . 11.0 mp -59.09 -61.95 2.25 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.95 0.405 . . . . 0.0 111.833 176.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.38 46.53 55.98 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 -171.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.6 p -69.88 123.68 24.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 C-N-CA 123.666 0.786 . . . . 0.0 111.586 -176.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.41 -172.24 14.69 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.692 ' HA ' ' O ' ' A' ' 8' ' ' ILE 0.272 55.0 pttt -64.88 136.02 56.38 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 118.226 1.013 . . . . 0.0 113.689 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t70 84.31 -7.1 1.02 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 126.32 1.848 . . . . 0.0 111.087 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.45 113.0 6.35 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.609 177.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -81.69 115.85 21.14 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.773 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.497 HG12 ' HB2' ' A' ' 6' ' ' TYR . 17.3 pt -116.04 160.07 15.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 5' ' ' SER . 98.6 m -129.18 128.04 42.57 Favored 'General case' 0 C--N 1.275 -2.648 0 CA-C-O 120.878 0.37 . . . . 0.0 110.305 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.4 mp -101.8 131.59 49.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.701 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 34.8 m-85 -121.56 113.76 20.24 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 123.574 0.547 . . . . 0.0 109.684 173.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.599 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -104.0 119.86 39.82 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.485 ' OD1' ' HG3' ' A' ' 1' ' ' MET . 15.7 t70 -126.08 115.43 19.82 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.557 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -179.22 -171.67 42.6 Favored Glycine 0 N--CA 1.431 -1.675 0 C-N-CA 119.952 -1.118 . . . . 0.0 113.171 -175.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.4 m -89.13 -7.18 56.23 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.474 0.654 . . . . 0.0 109.642 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -130.37 29.37 4.86 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.596 ' O ' HG12 ' A' ' 74' ' ' ILE . 9.7 pt-20 -69.21 -44.01 72.95 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -168.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.2 -31.88 69.53 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.212 0.529 . . . . 0.0 110.357 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -75.01 -33.58 61.83 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-O 121.556 0.693 . . . . 0.0 109.779 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.19 -36.15 82.31 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.969 176.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.596 HG12 ' O ' ' A' ' 70' ' ' GLU . 38.0 mm -54.1 -39.29 41.28 Favored 'Isoleucine or valine' 0 C--O 1.25 1.119 0 C-N-CA 123.503 0.721 . . . . 0.0 111.431 178.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -67.32 -44.26 79.58 Favored 'General case' 0 N--CA 1.402 -2.855 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.231 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.33 -39.36 47.93 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.485 -175.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.435 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -64.11 -41.78 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -178.367 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 33.0 m -67.78 -43.45 79.75 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.419 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 32.3 t70 -55.34 -48.13 74.66 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.3 m -67.22 -29.96 47.68 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.593 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.736 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.457 HD21 HD21 ' A' ' 22' ' ' LEU . 40.4 mt -79.56 -2.29 41.71 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.983 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 21.6 m -118.38 -16.36 9.6 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.437 0.637 . . . . 0.0 110.253 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 75.2 mmtt -78.46 -27.47 46.37 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 169.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -104.75 172.53 6.74 Favored 'General case' 0 N--CA 1.41 -2.431 0 CA-C-N 112.921 -1.945 . . . . 0.0 107.41 175.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -104.3 51.51 0.8 Allowed Glycine 0 C--N 1.291 -1.967 0 C-N-CA 119.893 -1.146 . . . . 0.0 113.364 -175.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.433 HD22 HD22 ' A' ' 81' ' ' LEU . 4.8 mp -92.74 -53.43 4.18 Favored 'General case' 0 C--O 1.213 -0.847 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.303 176.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.412 HG22 ' HB3' ' A' ' 81' ' ' LEU . 14.6 t -116.51 148.29 40.95 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.916 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 . . . . . 0 N--CA 1.429 -1.523 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.709 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.639 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 52.9 ttm . . . . . 0 CA--C 1.514 -0.415 0 N-CA-C 110.581 -0.155 . . . . 0.0 110.581 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -114.83 157.35 23.4 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 176.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.645 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 23.5 pt20 -111.35 153.96 25.24 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -142.36 103.73 4.31 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.697 -1.592 . . . . 0.0 107.59 173.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 50.2 m -91.49 89.45 7.21 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 122.293 1.044 . . . . 0.0 110.451 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 73.8 m-85 -72.87 130.02 39.47 Favored 'General case' 0 CA--C 1.488 -1.433 0 CA-C-N 113.493 -1.685 . . . . 0.0 112.146 -175.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.2 m -88.88 101.01 13.63 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 170.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.577 HG23 ' H ' ' A' ' 10' ' ' ASP . 4.5 mt -77.22 136.49 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.9 -178.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 35.4 pt -119.03 6.55 6.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.577 ' H ' HG23 ' A' ' 8' ' ' ILE . 31.2 t70 -71.39 127.11 31.48 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.505 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 C--N 1.298 -1.648 0 CA-C-O 121.609 0.718 . . . . 0.0 110.368 -179.225 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 . . . . . 0 CA--C 1.535 0.367 0 CA-C-O 121.349 0.595 . . . . 0.0 111.827 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.81 -34.42 66.86 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -170.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.432 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 13.9 tpp180 -63.45 -52.95 56.39 Favored Pre-proline 0 C--N 1.317 -0.839 0 C-N-CA 119.594 -0.842 . . . . 0.0 112.448 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.563 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 31.8 Cg_exo -66.72 -10.86 29.65 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 121.573 1.516 . . . . 0.0 112.645 174.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.429 ' HA ' HD23 ' A' ' 22' ' ' LEU . . . -74.54 -15.47 60.86 Favored 'General case' 0 C--O 1.216 -0.682 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.411 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 7.7 m -66.73 -27.16 67.39 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 174.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.563 ' SD ' ' HA ' ' A' ' 18' ' ' PRO . 1.4 mpt? -67.69 -34.88 77.76 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 174.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 19' ' ' ALA . 4.4 mm? -69.27 -38.1 78.21 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.938 175.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 81.9 t -55.69 -49.84 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 O-C-N 124.113 0.883 . . . . 0.0 109.351 175.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.12 -64.33 0.99 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.18 177.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.7 m -42.35 -63.16 0.8 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.734 1.214 . . . . 0.0 113.81 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . . . -66.05 -43.05 88.61 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -174.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.7 t -60.75 -39.09 87.41 Favored 'General case' 0 C--N 1.322 -0.594 0 O-C-N 123.27 0.356 . . . . 0.0 111.37 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.269 0.6 OUTLIER -82.5 3.0 30.11 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -174.198 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -95.16 -3.25 48.21 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.764 177.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.4 t70 59.52 24.34 13.04 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 123.377 1.56 . . . . 0.0 109.403 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.521 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 19.3 m -118.8 146.29 44.95 Favored 'General case' 0 N--CA 1.408 -2.53 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.183 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.415 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . 7.6 t70 -105.76 112.69 25.85 Favored 'General case' 0 N--CA 1.392 -3.366 0 C-N-CA 118.706 -1.197 . . . . 0.0 108.771 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 2.9 mp -100.77 130.25 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.807 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.678 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -106.12 132.13 52.56 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.8 tt -98.01 100.16 11.47 Favored 'General case' 0 N--CA 1.407 -2.576 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 173.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.38 112.53 23.67 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.621 ' HB3' HD11 ' A' ' 53' ' ' LEU . 55.4 t80 -139.77 85.17 2.02 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 176.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.9 t30 60.56 90.2 0.06 Allowed 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 125.365 1.466 . . . . 0.0 113.656 170.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.85 -48.13 3.99 Favored Glycine 0 C--N 1.311 -0.813 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.641 175.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.21 144.94 43.53 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 120.851 0.358 . . . . 0.0 111.909 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.11 147.35 50.95 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 176.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.8 p -120.8 143.59 32.46 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.76 -177.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.623 ' ND2' ' HE3' ' A' ' 45' ' ' LYS . 26.8 t-20 -61.55 110.23 1.41 Allowed 'General case' 0 C--O 1.208 -1.124 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 171.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.423 ' O ' HD13 ' A' ' 44' ' ' LEU . 3.4 tm? -60.37 -23.5 64.35 Favored 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -171.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.623 ' HE3' ' ND2' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -90.56 21.99 3.7 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.179 -0.951 . . . . 0.0 110.757 174.359 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.0 m -134.43 146.44 49.84 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.645 176.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.734 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -94.83 -20.11 6.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.289 -178.817 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 50.3 ttm -64.21 81.53 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 125.622 1.569 . . . . 0.0 110.115 175.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 137.43 -32.08 2.44 Favored Glycine 0 C--N 1.291 -1.927 0 CA-C-N 113.616 -1.629 . . . . 0.0 110.431 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 85.5 t -73.51 -35.76 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 69.8 mtm -64.0 -54.2 38.04 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.09 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.1 m -81.06 2.63 26.38 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.621 HD11 ' HB3' ' A' ' 37' ' ' TYR . 22.5 tp -39.75 -47.32 2.05 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 124.589 1.156 . . . . 0.0 113.286 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.73 34.19 25.54 Favored Glycine 0 N--CA 1.439 -1.128 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.416 ' HB ' HD23 ' A' ' 53' ' ' LEU . 0.8 OUTLIER -89.4 151.48 3.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -175.783 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -157.61 -170.72 22.76 Favored Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -64.03 138.71 58.59 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 117.97 0.885 . . . . 0.0 111.331 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.7 t70 79.88 -5.4 1.86 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.395 1.478 . . . . 0.0 111.328 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.57 123.08 21.68 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.584 176.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -98.55 116.86 31.69 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.6 -178.649 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.45 HG12 ' HB2' ' A' ' 6' ' ' TYR . 20.1 pt -110.73 137.42 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.18 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 5' ' ' SER . 85.1 m -108.49 112.98 25.66 Favored 'General case' 0 C--N 1.276 -2.588 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.37 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.612 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.3 mp -84.78 130.32 36.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.645 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 51.6 m-85 -117.06 106.83 13.8 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 173.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.639 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -101.4 117.04 34.15 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -128.62 115.75 18.55 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.521 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -172.67 -169.86 35.76 Favored Glycine 0 C--N 1.293 -1.84 0 C-N-CA 119.535 -1.317 . . . . 0.0 112.345 -175.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.4 t -81.9 -22.65 36.71 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -131.79 33.38 3.99 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.775 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -58.05 -35.91 72.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -175.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.55 -43.63 96.52 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.001 0.429 . . . . 0.0 110.78 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -82.62 -19.91 37.39 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.06 0.457 . . . . 0.0 109.945 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.62 -42.32 98.19 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 30.4 mm -57.45 -45.45 85.72 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.347 173.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -60.82 -42.81 98.43 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.573 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.1 -47.95 75.41 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.439 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 33.4 mt -60.82 -48.32 89.37 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.912 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 13.6 p -58.04 -35.24 71.03 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.457 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 26.8 t70 -70.71 -52.84 18.37 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 120.875 0.369 . . . . 0.0 110.103 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.43 -27.61 40.91 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.435 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 77' ' ' ILE . 14.0 mt -79.89 -6.2 56.97 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 122.412 0.285 . . . . 0.0 110.64 177.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.1 t -102.92 -41.0 6.28 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 31.7 mmmt -65.35 -29.23 69.94 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.372 0.606 . . . . 0.0 109.413 176.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -93.26 -17.31 23.79 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.874 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.22 49.7 60.36 Favored Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 115.524 -0.762 . . . . 0.0 114.548 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.419 ' HA ' ' HB2' ' A' ' 10' ' ' ASP . 6.0 mp -88.56 -27.52 21.33 Favored 'General case' 0 CA--C 1.491 -1.307 0 C-N-CA 118.462 -1.295 . . . . 0.0 108.498 174.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.0 t -133.74 -171.01 2.62 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 . . . . . 0 C--N 1.301 -1.522 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.01 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.552 ' HG3' ' HA ' ' A' ' 66' ' ' ASP . 1.1 mpt? . . . . . 0 CA--C 1.49 -1.362 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.44 ' HG2' ' N ' ' A' ' 3' ' ' GLN . 36.7 tt0 -125.76 158.95 33.62 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.719 -172.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.794 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 12.4 pt20 -115.15 140.22 49.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 124.068 0.855 . . . . 0.0 110.824 173.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.401 ' O ' ' HA ' ' A' ' 62' ' ' THR . 73.5 mm-40 -121.09 107.76 13.01 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.171 175.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.0 p -88.13 92.22 9.07 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-O 121.441 0.639 . . . . 0.0 109.544 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.458 ' HB2' ' CG1' ' A' ' 61' ' ' ILE . 80.8 m-85 -80.56 113.67 18.91 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.679 -176.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.8 m -91.09 102.12 14.86 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.491 HG21 ' O ' ' A' ' 55' ' ' VAL . 1.5 mp -71.93 122.9 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.862 0 CA-C-O 122.207 1.003 . . . . 0.0 112.031 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.608 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -116.39 9.05 7.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 114.109 -1.405 . . . . 0.0 107.852 -177.596 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -123.93 158.7 31.38 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.422 -170.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 . . . . . 0 C--O 1.235 0.326 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 178.888 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.592 ' O ' ' HD2' ' A' ' 18' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.432 -1.326 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.56 81.68 3.23 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -170.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -162.66 -47.47 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.206 1.002 . . . . 0.0 108.568 169.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.592 ' HD2' ' O ' ' A' ' 15' ' ' HIS . 84.0 Cg_exo -54.88 -24.56 39.42 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 121.849 1.7 . . . . 0.0 111.362 170.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.409 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -65.39 -21.24 66.65 Favored 'General case' 0 C--O 1.201 -1.474 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.048 177.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.41 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 8.3 m -70.11 -27.35 64.52 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-O 121.296 0.57 . . . . 0.0 110.032 177.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 48.5 ttm -69.46 -32.19 70.96 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 174.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.411 ' HB3' HD21 ' A' ' 44' ' ' LEU . 4.5 mm? -73.14 -36.95 66.77 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.172 -1.377 . . . . 0.0 110.306 175.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 45.0 t -55.96 -48.66 78.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -61.82 -58.36 8.28 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.585 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.581 ' O ' ' HB3' ' A' ' 28' ' ' LYS . 36.4 m -49.86 -43.57 49.22 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 176.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.73 -37.21 84.21 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.573 -0.705 . . . . 0.0 111.337 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.471 ' OG ' ' HB2' ' A' ' 45' ' ' LYS . 19.3 m -67.49 -32.36 73.13 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 122.022 0.915 . . . . 0.0 110.036 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.581 ' HB3' ' O ' ' A' ' 25' ' ' THR . 12.6 tmtt? -65.9 -33.57 76.12 Favored 'General case' 0 N--CA 1.424 -1.758 0 C-N-CA 126.196 1.798 . . . . 0.0 111.879 -176.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -96.37 150.12 20.94 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.885 -177.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.93 59.37 5.59 Favored 'General case' 0 CA--C 1.491 -1.314 0 CA-C-O 122.384 1.088 . . . . 0.0 108.96 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.561 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 40.9 m -150.83 141.31 22.49 Favored 'General case' 0 N--CA 1.41 -2.445 0 CA-C-N 114.021 -1.445 . . . . 0.0 108.439 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -98.15 99.43 10.68 Favored 'General case' 0 N--CA 1.394 -3.262 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.545 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 44.0 mt -84.91 124.76 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.875 0 CA-C-N 114.425 -1.262 . . . . 0.0 108.254 175.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -109.72 131.05 55.42 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 3.6 tt -97.77 124.82 42.28 Favored 'General case' 0 N--CA 1.402 -2.862 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.556 ' HB3' ' HB ' ' A' ' 62' ' ' THR . 0.8 OUTLIER -113.16 107.19 15.58 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -178.157 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.554 ' CD2' ' HG ' ' A' ' 53' ' ' LEU . 25.9 t80 -138.88 103.82 4.91 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.413 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 46.12 77.7 0.08 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.881 1.672 . . . . 0.0 113.155 173.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.21 -28.78 5.96 Favored Glycine 0 C--N 1.306 -1.122 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.233 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.453 ' HA ' ' HE3' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -105.32 113.5 27.12 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -179.272 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 18.7 ptpt -110.33 116.37 31.33 Favored 'General case' 0 N--CA 1.415 -2.187 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 168.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.9 p -130.03 146.07 34.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.697 -170.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.444 ' HB2' ' HB2' ' A' ' 46' ' ' SER . 19.7 m120 -58.27 112.39 1.53 Allowed 'General case' 0 C--O 1.197 -1.703 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 171.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.522 ' O ' HD23 ' A' ' 44' ' ' LEU . 5.4 tt -60.45 -29.0 68.76 Favored 'General case' 0 C--O 1.218 -0.568 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -170.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.471 ' HB2' ' OG ' ' A' ' 27' ' ' SER . 0.5 OUTLIER -85.67 -0.63 55.67 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.001 179.359 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.444 ' HB2' ' HB2' ' A' ' 43' ' ' ASN . 43.8 m -108.19 124.11 49.77 Favored 'General case' 0 N--CA 1.396 -3.168 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 175.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 pp -73.19 7.99 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -172.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 15.6 tpt -94.39 61.08 2.74 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 122.286 1.041 . . . . 0.0 109.232 -167.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.8 -41.67 0.81 Allowed Glycine 0 C--N 1.292 -1.885 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 -174.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 89.7 t -65.01 -35.01 74.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 114.884 -0.658 . . . . 0.0 110.968 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 49.2 ttm -77.3 0.83 20.7 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 121.196 0.522 . . . . 0.0 110.962 -177.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.2 m -104.27 6.72 35.61 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.011 0.434 . . . . 0.0 111.327 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.554 ' HG ' ' CD2' ' A' ' 37' ' ' TYR . 8.8 mp -78.89 105.91 10.54 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.194 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.72 -49.38 24.05 Favored Glycine 0 CA--C 1.495 -1.175 0 N-CA-C 106.795 -2.522 . . . . 0.0 106.795 169.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.491 ' O ' HG21 ' A' ' 8' ' ' ILE . 9.9 p 51.07 25.95 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.323 0 C-N-CA 126.816 2.046 . . . . 0.0 114.801 169.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.78 112.72 3.74 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.353 -0.927 . . . . 0.0 110.92 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? 49.14 154.29 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 C-N-CA 127.706 2.402 . . . . 0.0 115.664 -176.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.0 t70 68.82 -16.65 0.21 Allowed 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 126.054 1.742 . . . . 0.0 114.16 172.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.37 121.27 15.39 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 123.57 0.748 . . . . 0.0 112.326 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -102.8 97.7 7.81 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 175.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.458 ' CG1' ' HB2' ' A' ' 6' ' ' TYR . 29.8 pt -96.81 124.8 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.817 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -177.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' A' ' 36' ' ' GLU . 4.7 m -100.35 120.21 39.6 Favored 'General case' 0 C--N 1.283 -2.31 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.849 -176.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.6 mp -95.68 121.17 45.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 176.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.794 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 30.7 m-85 -104.92 123.9 48.55 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 174.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -111.19 103.01 11.39 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.552 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 10.9 t70 -113.37 103.21 11.07 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.561 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -166.74 -163.81 21.19 Favored Glycine 0 N--CA 1.423 -2.227 0 C-N-CA 119.424 -1.369 . . . . 0.0 112.751 -173.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.3 m -105.51 -7.69 18.5 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.409 0.623 . . . . 0.0 109.508 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -127.33 18.92 6.94 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.506 ' O ' HG12 ' A' ' 74' ' ' ILE 0.27 0.0 OUTLIER -52.43 -44.62 65.56 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 -171.184 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.65 -41.45 98.23 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.859 0.361 . . . . 0.0 111.433 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -78.05 -28.15 48.86 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 121.584 0.707 . . . . 0.0 109.866 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.469 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -64.98 -38.8 92.16 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.65 174.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 70' ' ' GLU . 33.8 mm -60.91 -47.05 95.19 Favored 'Isoleucine or valine' 0 C--O 1.254 1.317 0 CA-C-O 121.38 0.609 . . . . 0.0 109.973 175.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -51.74 -54.34 29.48 Favored 'General case' 0 N--CA 1.412 -2.367 0 C-N-CA 125.032 1.333 . . . . 0.0 109.716 176.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.42 ' O ' HG22 ' A' ' 80' ' ' VAL . . . -69.21 -45.09 70.74 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.467 HG22 ' HA ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -58.86 -40.14 79.3 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 C-N-CA 123.445 0.698 . . . . 0.0 111.054 -176.198 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.6 m -73.1 -37.6 66.66 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -61.38 -50.0 74.63 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.767 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.551 ' HA ' ' HG2' ' A' ' 83' ' ' LYS . 28.4 m -74.08 -32.25 32.26 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.35 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.996 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.42 HD22 ' CG ' ' A' ' 86' ' ' LEU . 15.3 mt -63.87 -45.05 91.14 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 121.388 -0.82 . . . . 0.0 111.353 175.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.9 p -63.19 -35.91 81.87 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.551 ' HG2' ' HA ' ' A' ' 80' ' ' VAL . 12.3 ptmm? -70.39 -30.94 67.97 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 80' ' ' VAL . 21.8 mm-40 -76.71 -27.16 55.37 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.436 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.88 -1.37 22.99 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.472 -0.871 . . . . 0.0 114.713 173.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.476 ' H ' HD23 ' A' ' 86' ' ' LEU . 1.2 pt? -99.62 26.87 5.76 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -177.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 35.8 m -148.41 109.68 4.36 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 121.652 -0.655 . . . . 0.0 110.016 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 C--O 1.255 1.386 0 C-N-CA 125.918 1.687 . . . . 0.0 112.173 -178.302 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.8 mtm . . . . . 0 CA--C 1.479 -1.75 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -113.17 147.9 36.49 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 176.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.731 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 15.6 pt20 -119.77 161.17 21.22 Favored 'General case' 0 N--CA 1.438 -1.031 0 O-C-N 123.802 0.689 . . . . 0.0 111.83 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.616 ' O ' ' HA ' ' A' ' 62' ' ' THR . 14.9 mm100 -141.16 138.0 33.09 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.167 -1.378 . . . . 0.0 108.279 174.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.8 t -100.58 131.27 46.58 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.56 ' HB2' HG12 ' A' ' 61' ' ' ILE . 57.8 m-85 -138.0 170.88 15.27 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -177.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.1 m -139.12 127.21 22.47 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 174.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.731 HG13 ' HA ' ' A' ' 86' ' ' LEU . 6.6 tt -82.8 147.22 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.542 -176.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.4 pt -133.69 26.87 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.531 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.3 OUTLIER -64.8 -38.59 91.5 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.436 -174.136 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.582 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 46.7 mt-10 . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 176.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.532 ' O ' ' HD2' ' A' ' 18' ' ' PRO 0.386 56.6 p-80 . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 122.452 1.12 . . . . 0.0 112.269 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.68 -30.6 22.59 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 -168.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.442 ' HD3' ' HA ' ' A' ' 17' ' ' ARG 0.314 26.1 mmt180 -62.39 -55.64 37.84 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -177.076 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.532 ' HD2' ' O ' ' A' ' 15' ' ' HIS . 61.4 Cg_exo -53.96 -37.73 86.05 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 121.85 1.7 . . . . 0.0 111.454 170.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.434 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -66.42 -19.61 65.84 Favored 'General case' 0 C--O 1.209 -1.063 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.154 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 29.7 m -77.12 -23.19 51.77 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.721 0.772 . . . . 0.0 108.954 176.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.4 ttt -71.63 -34.14 69.54 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 171.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.446 ' HA ' HD13 ' A' ' 22' ' ' LEU . 4.2 mm? -67.8 -37.21 81.7 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.655 173.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 76.7 t -54.99 -55.26 16.98 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.084 0 O-C-N 123.92 0.763 . . . . 0.0 108.986 173.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -60.24 -25.85 65.98 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 123.387 0.675 . . . . 0.0 112.089 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.409 ' HA ' ' NZ ' ' A' ' 28' ' ' LYS . 88.1 m -78.95 -61.87 1.88 Allowed 'General case' 0 N--CA 1.423 -1.799 0 O-C-N 122.18 -0.325 . . . . 0.0 110.372 177.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.25 -43.68 94.13 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -177.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.4 t -59.09 -30.62 68.22 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.644 0.778 . . . . 0.0 112.916 -174.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.409 ' NZ ' ' HA ' ' A' ' 25' ' ' THR 0.27 0.9 OUTLIER -87.35 2.76 49.37 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -178.076 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -97.92 142.83 29.17 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -70.57 -35.3 72.98 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.38 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.54 ' OG ' ' HA3' ' A' ' 67' ' ' GLY . 50.7 m -71.12 142.19 50.77 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.581 175.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -93.37 109.92 21.47 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-O 121.211 0.529 . . . . 0.0 112.014 -176.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.69 HD11 ' HB1' ' A' ' 73' ' ' ALA . 15.9 mt -89.29 120.69 38.4 Favored 'Isoleucine or valine' 0 C--O 1.254 1.319 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.999 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -113.92 146.81 39.54 Favored 'General case' 0 N--CA 1.415 -2.224 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.735 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 0.9 OUTLIER -101.49 131.05 47.83 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 177.611 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' A' ' 40' ' ' LYS . 8.3 tp10 -131.39 154.22 48.85 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 175.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -154.92 -25.96 0.12 Allowed 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 117.919 0.327 . . . . 0.0 110.724 178.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 172.85 77.75 0.0 OUTLIER 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.928 0.891 . . . . 0.0 109.011 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.31 -12.37 66.77 Favored Glycine 0 C--N 1.308 -0.992 0 CA-C-N 116.031 -0.531 . . . . 0.0 113.521 174.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 16.0 mmtp -113.14 114.64 27.08 Favored 'General case' 0 CA--C 1.471 -2.064 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 62.8 mttp -111.87 130.15 55.92 Favored 'General case' 0 N--CA 1.413 -2.292 0 CA-C-N 114.475 -1.238 . . . . 0.0 110.626 174.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.4 m -144.31 162.98 14.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.566 ' HB3' ' HE3' ' A' ' 45' ' ' LYS . 18.3 m120 -72.83 129.51 38.34 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 175.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 67.0 tp -70.76 -13.94 62.25 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-O 121.733 0.777 . . . . 0.0 111.832 -176.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.566 ' HE3' ' HB3' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -87.87 5.45 40.33 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.388 0.613 . . . . 0.0 110.377 176.17 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.1 t -106.09 109.85 21.92 Favored 'General case' 0 N--CA 1.416 -2.152 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.581 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -68.61 -30.57 47.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.933 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 27.9 ttt -57.43 -49.04 77.5 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 113.69 -1.596 . . . . 0.0 109.149 175.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.37 -47.0 89.03 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.968 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 91.5 t -57.99 -40.75 78.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 CA-C-O 120.737 0.303 . . . . 0.0 111.457 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -76.69 -9.61 58.79 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 120.161 -0.615 . . . . 0.0 111.669 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.3 m -80.33 -33.52 37.38 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 175.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 mp -73.18 -42.76 62.36 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.977 174.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.4 39.39 87.42 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.443 HG21 ' CG2' ' A' ' 61' ' ' ILE . 7.8 p -65.54 106.35 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.09 0 CA-C-O 121.162 0.506 . . . . 0.0 110.716 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.487 ' HA2' ' OD1' ' A' ' 10' ' ' ASP . . . -138.65 146.2 17.85 Favored Glycine 0 N--CA 1.429 -1.813 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.349 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.582 ' HB3' ' HA ' ' A' ' 11' ' ' GLU . 9.3 ptpp? 21.06 111.37 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.687 0 N-CA-C 117.233 2.308 . . . . 0.0 117.233 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.9 t70 74.8 -0.79 3.25 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.585 1.154 . . . . 0.0 111.97 176.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.4 116.84 10.29 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -81.88 135.68 35.4 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.718 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.56 HG12 ' HB2' ' A' ' 6' ' ' TYR . 19.4 pt -123.91 165.69 20.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 121.461 0.648 . . . . 0.0 111.155 -177.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 4' ' ' GLN . 84.1 m -136.74 118.31 14.88 Favored 'General case' 0 N--CA 1.408 -2.573 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 47.4 mm -96.83 127.76 48.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.731 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 29.7 m-85 -111.74 122.52 48.01 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 123.806 0.691 . . . . 0.0 110.745 177.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.08 112.7 25.8 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 173.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -104.65 106.16 16.54 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.54 ' HA3' ' OG ' ' A' ' 31' ' ' SER . . . -176.11 -166.77 33.97 Favored Glycine 0 C--N 1.296 -1.677 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.106 -174.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.0 m -105.19 -11.27 16.63 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.984 0.897 . . . . 0.0 108.667 172.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -112.45 20.6 16.51 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.219 178.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.65 -45.23 70.15 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -175.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.4 -36.89 81.57 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 122.566 0.346 . . . . 0.0 111.256 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -73.4 -43.61 60.15 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.35 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.69 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -60.4 -43.02 97.1 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.601 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.2 mm -57.71 -46.99 86.74 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 C-N-CA 123.626 0.771 . . . . 0.0 111.22 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -64.47 -38.63 91.68 Favored 'General case' 0 N--CA 1.411 -2.382 0 C-N-CA 124.031 0.932 . . . . 0.0 111.264 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.65 -35.4 77.21 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.37 0.605 . . . . 0.0 110.179 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.8 mm -62.01 -52.24 62.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 124.532 1.133 . . . . 0.0 113.046 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.3 m -56.99 -48.43 78.45 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 120.693 0.282 . . . . 0.0 110.289 -176.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -55.16 -50.26 69.74 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.194 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.9 m -75.08 -30.8 23.75 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 C-N-CA 120.422 -0.511 . . . . 0.0 112.267 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.412 HD22 ' HB2' ' A' ' 86' ' ' LEU . 25.2 mt -68.23 -37.0 80.37 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 87' ' ' THR . 23.2 t -85.54 -16.59 38.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.411 0.624 . . . . 0.0 109.99 178.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -71.17 -34.64 71.13 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 172.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -95.97 -172.65 2.63 Favored 'General case' 0 N--CA 1.418 -2.039 0 CA-C-N 113.273 -1.785 . . . . 0.0 109.905 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -101.61 19.17 51.43 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.243 -0.98 . . . . 0.0 112.748 -177.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.731 ' HA ' HG13 ' A' ' 8' ' ' ILE . 3.4 mp -93.81 -2.17 53.93 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 119.036 -1.065 . . . . 0.0 111.16 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 82' ' ' SER . 98.9 m -158.77 143.39 15.86 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 175.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.42 -1.936 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 172.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.589 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 55.1 ttp . . . . . 0 C--O 1.233 0.236 0 N-CA-C 111.263 0.097 . . . . 0.0 111.263 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -125.66 154.7 41.98 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 174.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.683 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 27.8 pt20 -106.4 143.7 34.15 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.553 0.692 . . . . 0.0 112.842 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' A' ' 62' ' ' THR . 14.1 mm100 -127.48 120.54 28.56 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.706 173.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.8 t -93.6 103.29 15.47 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.529 ' HB2' ' CG1' ' A' ' 61' ' ' ILE . 85.0 m-85 -99.11 112.43 24.57 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.737 -178.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 m -86.37 118.3 25.72 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 175.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.5 mt -98.35 130.61 46.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-O 121.437 0.637 . . . . 0.0 112.59 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.628 HG22 ' O ' ' A' ' 87' ' ' THR . 4.9 tp -95.02 -26.37 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.808 176.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -26.91 97.28 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 -166.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 C--N 1.313 -0.98 0 CA-C-N 113.789 -1.55 . . . . 0.0 111.213 -176.473 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . 0.254 0.4 OUTLIER . . . . . 0 N--CA 1.437 -1.107 0 CA-C-O 121.987 0.899 . . . . 0.0 111.1 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.52 -23.13 61.73 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.149 -1.387 . . . . 0.0 113.273 -174.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -64.0 -50.61 68.59 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 119.575 -0.85 . . . . 0.0 112.168 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.501 ' HB3' ' HB3' ' A' ' 84' ' ' GLU . 82.7 Cg_exo -55.15 -31.48 75.8 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 122.108 1.872 . . . . 0.0 111.253 171.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.594 ' O ' ' HB3' ' A' ' 22' ' ' LEU . . . -72.25 -22.17 61.27 Favored 'General case' 0 C--O 1.203 -1.346 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.806 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.411 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 3.6 m -75.49 -33.91 60.82 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 51.2 ttm -66.96 -38.59 86.37 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.654 ' HG ' HD21 ' A' ' 44' ' ' LEU . 59.1 tp -56.83 -47.69 79.74 Favored 'General case' 0 CA--C 1.477 -1.848 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.121 174.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 19' ' ' ALA . 13.2 t -53.55 -48.24 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.542 0 CA-C-N 113.503 -1.68 . . . . 0.0 110.607 -178.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.06 -29.79 70.19 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.488 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.7 m -74.3 -49.53 22.64 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -177.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.505 ' HA ' ' CD2' ' A' ' 29' ' ' PHE . . . -61.61 -31.27 71.34 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 174.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.6 m -56.24 -39.28 72.29 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 123.419 0.45 . . . . 0.0 111.766 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.48 7.62 40.37 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -177.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.505 ' CD2' ' HA ' ' A' ' 26' ' ' ALA . 12.7 m-85 -96.33 -16.99 21.0 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 54.29 17.12 1.41 Allowed 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 124.795 1.238 . . . . 0.0 113.955 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.497 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 53.2 m -102.8 160.82 14.26 Favored 'General case' 0 N--CA 1.412 -2.345 0 CA-C-O 121.081 0.467 . . . . 0.0 110.334 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.429 ' HA ' HD21 ' A' ' 43' ' ' ASN . 33.2 t70 -91.47 83.63 5.44 Favored 'General case' 0 N--CA 1.405 -2.702 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.5 HG23 HG23 ' A' ' 63' ' ' ILE . 84.6 mt -94.25 111.52 25.4 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 175.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -103.77 137.86 41.2 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 4.3 tt -101.72 111.48 23.75 Favored 'General case' 0 N--CA 1.392 -3.352 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -103.68 117.11 33.63 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 123.523 0.729 . . . . 0.0 109.278 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.555 ' HB3' HD11 ' A' ' 53' ' ' LEU . 15.5 t80 -135.26 90.58 2.64 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.182 177.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 43.7 64.93 1.11 Allowed 'General case' 0 C--O 1.244 0.769 0 C-N-CA 126.567 1.947 . . . . 0.0 113.13 176.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.76 -29.25 10.59 Favored Glycine 0 N--CA 1.432 -1.625 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.433 175.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -98.6 110.59 23.16 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.597 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 4.3 ptpp? -122.98 131.42 53.71 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 171.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.425 HG21 ' N ' ' A' ' 49' ' ' GLY . 11.6 p -146.63 158.63 10.58 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.54 ' OD1' ' HG2' ' A' ' 45' ' ' LYS . 23.0 t-20 -69.91 125.99 28.38 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 174.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.654 HD21 ' HG ' ' A' ' 22' ' ' LEU . 10.4 tt -62.81 -22.43 66.63 Favored 'General case' 0 N--CA 1.42 -1.936 0 C-N-CA 125.224 1.41 . . . . 0.0 114.209 -171.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.54 ' HG2' ' OD1' ' A' ' 43' ' ' ASN . 8.1 pttp -91.22 4.11 53.12 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 118.51 -1.276 . . . . 0.0 110.423 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.9 t -105.55 129.62 53.78 Favored 'General case' 0 N--CA 1.409 -2.499 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.314 174.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 pp -75.65 2.62 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 123.545 0.738 . . . . 0.0 111.804 -178.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 16.0 tpt -61.83 -48.35 80.97 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 113.35 -1.75 . . . . 0.0 110.186 -174.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.425 ' N ' HG21 ' A' ' 42' ' ' VAL . . . -108.45 -29.96 4.0 Favored Glycine 0 C--N 1.305 -1.171 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.428 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.1 t -61.52 -36.61 74.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -175.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 84.0 mtp -87.5 12.91 11.16 Favored 'General case' 0 C--O 1.22 -0.476 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.264 -178.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.9 m -124.86 5.48 8.06 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.555 HD11 ' HB3' ' A' ' 37' ' ' TYR . 8.2 tp -81.09 105.86 12.63 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.59 66.11 3.57 Favored Glycine 0 CA--C 1.508 -0.386 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 175.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.6 p -89.48 97.82 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 CA-C-O 122.49 1.138 . . . . 0.0 111.452 -173.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.28 -153.99 9.45 Favored Glycine 0 N--CA 1.432 -1.586 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.455 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -61.51 136.06 57.89 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.9 t70 77.99 3.96 2.86 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.972 1.309 . . . . 0.0 111.444 175.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.93 118.74 14.09 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.404 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -95.19 108.34 20.46 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.529 ' CG1' ' HB2' ' A' ' 6' ' ' TYR . 11.4 pt -110.49 157.4 11.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.31 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 4' ' ' GLN . 61.4 m -133.08 124.25 27.25 Favored 'General case' 0 C--N 1.273 -2.74 0 CA-C-O 121.185 0.517 . . . . 0.0 110.986 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.533 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.4 mp -91.85 125.84 44.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 175.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.683 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 45.3 m-85 -110.42 106.76 16.22 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 171.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.589 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -105.37 113.32 26.82 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.208 -176.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -128.29 120.06 26.35 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.497 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -174.66 -172.25 39.55 Favored Glycine 0 CA--C 1.475 -2.419 0 C-N-CA 117.787 -2.149 . . . . 0.0 113.351 -172.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.4 p -73.86 -26.97 60.84 Favored 'General case' 0 N--CA 1.421 -1.913 0 C-N-CA 124.197 0.999 . . . . 0.0 111.002 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -134.63 21.88 3.62 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.465 ' O ' HG12 ' A' ' 74' ' ' ILE . 9.5 pt-20 -42.52 -52.8 4.61 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -172.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.523 ' O ' ' HB ' ' A' ' 74' ' ' ILE . . . -65.24 -42.74 93.07 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -173.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -84.73 -21.97 29.87 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.18 -39.98 95.14 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 172.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.523 ' HB ' ' O ' ' A' ' 71' ' ' ALA . 24.6 mm -56.26 -48.06 80.08 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 CA-C-O 121.731 0.777 . . . . 0.0 109.572 173.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.441 ' HA ' ' OE1' ' A' ' 75' ' ' GLN . 12.2 mm-40 -57.54 -39.49 76.75 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.117 -1.401 . . . . 0.0 111.998 -178.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.36 -41.82 17.76 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.422 HD12 HD13 ' A' ' 33' ' ' ILE . 4.8 tt -62.52 -32.75 56.32 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.082 0 CA-C-O 120.847 0.356 . . . . 0.0 111.199 -174.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.7 m -68.1 -28.45 67.36 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 120.854 0.359 . . . . 0.0 110.762 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.56 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 16.3 t70 -78.44 -47.55 17.26 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -175.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 23.8 m -66.0 -32.13 56.77 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.47 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.8 mt -67.37 -45.94 74.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.141 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.603 ' HA ' ' OG1' ' A' ' 87' ' ' THR . 22.7 t -62.97 -43.53 98.54 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.04 178.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 33.1 mmtp -64.72 -40.53 95.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.956 0.408 . . . . 0.0 110.67 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.501 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . 19.1 mm-40 -77.06 -17.46 58.74 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.06 53.87 2.43 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 120.644 -0.788 . . . . 0.0 111.867 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 79.9 mt -140.56 39.16 1.86 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 122.386 1.088 . . . . 0.0 108.124 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.628 ' O ' HG22 ' A' ' 9' ' ' ILE . 17.4 p -139.87 -155.03 0.55 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 175.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 . . . . . 0 C--N 1.307 -1.24 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 171.58 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.516 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 66.9 mtt . . . . . 0 CA--C 1.491 -1.303 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -98.84 149.63 22.7 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 172.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.757 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 23.7 pt20 -114.19 149.11 36.24 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -176.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.485 ' O ' ' HA ' ' A' ' 62' ' ' THR . 30.6 mm-40 -127.37 129.48 47.66 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 113.707 -1.588 . . . . 0.0 107.89 173.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.2 t -103.23 104.16 14.27 Favored 'General case' 0 N--CA 1.416 -2.147 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 175.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.49 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 31.3 m-85 -95.37 103.4 15.26 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.822 -176.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.2 m -79.61 89.35 5.12 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.52 HG23 ' H ' ' A' ' 10' ' ' ASP . 4.3 mt -69.41 138.2 22.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 114.779 -1.1 . . . . 0.0 113.098 -175.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 pp -96.12 -4.31 10.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.834 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.52 ' H ' HG23 ' A' ' 8' ' ' ILE . 6.5 t70 -59.04 125.82 25.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.177 176.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 . . . . . 0 C--N 1.301 -1.521 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.087 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . 0.257 2.4 p-80 . . . . . 0 N--CA 1.446 -0.647 0 CA-C-O 122.532 1.158 . . . . 0.0 110.666 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.28 -29.63 64.07 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 113.36 -1.745 . . . . 0.0 114.407 -170.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.51 -51.26 52.4 Favored Pre-proline 0 CA--C 1.556 1.202 0 CA-C-O 119.147 -0.454 . . . . 0.0 110.241 -178.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -57.73 -37.2 97.46 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 121.758 1.639 . . . . 0.0 110.812 172.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.68 ' O ' ' HG ' ' A' ' 22' ' ' LEU . . . -66.01 -18.84 65.61 Favored 'General case' 0 C--O 1.197 -1.7 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.929 178.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.4 m -70.02 -24.57 63.31 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 49.7 ttm -78.26 -35.26 48.35 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 175.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -64.84 -37.58 88.11 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 176.308 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 45' ' ' LYS . 4.5 t -58.57 -47.43 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.107 176.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -66.18 -19.28 65.79 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.784 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 54.2 m -84.2 -50.38 7.95 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.99 -29.09 69.41 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.6 p -62.71 -19.02 63.49 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -114.09 -145.77 0.4 Allowed 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 69.63 13.23 8.21 Favored 'General case' 0 C--O 1.247 0.921 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 174.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 56.92 27.11 12.59 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.913 0.885 . . . . 0.0 112.648 170.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.528 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 19.3 m -142.69 156.29 45.01 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.806 -177.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -105.57 113.81 27.61 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 175.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 3.1 mp -97.74 126.16 50.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.144 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -104.78 143.84 32.57 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 3.9 tt -96.48 129.69 43.79 Favored 'General case' 0 N--CA 1.403 -2.776 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 173.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.691 ' HA ' ' O ' ' A' ' 40' ' ' LYS . 0.5 OUTLIER -130.2 119.83 23.56 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -150.31 103.12 3.13 Favored 'General case' 0 C--N 1.293 -1.879 0 O-C-N 122.304 -0.248 . . . . 0.0 111.246 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.0 t30 59.56 28.71 18.17 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.84 0.856 . . . . 0.0 111.329 171.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.48 -17.03 8.44 Favored Glycine 0 CA--C 1.495 -1.215 0 C-N-CA 119.821 -1.18 . . . . 0.0 111.608 -178.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.691 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 13.3 mmtp -77.63 140.19 39.6 Favored 'General case' 0 CA--C 1.481 -1.705 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 15.1 ptmm? -143.99 112.56 6.53 Favored 'General case' 0 N--CA 1.413 -2.292 0 CA-C-N 114.299 -1.319 . . . . 0.0 108.594 169.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.3 p -149.04 160.46 5.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.772 -174.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.519 ' ND2' ' HG2' ' A' ' 45' ' ' LYS . 15.6 t30 -66.47 109.0 2.58 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.534 HD11 HD11 ' A' ' 77' ' ' ILE . 3.4 tm? -62.73 -25.93 68.44 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.661 0.784 . . . . 0.0 112.713 -173.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.519 ' HG2' ' ND2' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -88.37 24.61 1.87 Allowed 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 122.249 1.024 . . . . 0.0 110.356 178.945 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 43' ' ' ASN . 52.0 m -122.29 125.94 47.07 Favored 'General case' 0 N--CA 1.4 -2.974 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.145 172.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.46 -23.24 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 47.0 ttp -58.75 -22.02 56.87 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.859 -1.519 . . . . 0.0 110.187 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -84.94 -67.33 1.42 Allowed Glycine 0 N--CA 1.423 -2.211 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 94.4 t -55.09 -40.7 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -175.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 34.5 ttm -77.19 -0.75 26.26 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-O 120.797 0.332 . . . . 0.0 111.537 -175.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 62.8 m -98.89 -19.07 17.56 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 121.692 -0.63 . . . . 0.0 111.748 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.53 ' HB2' ' CG2' ' A' ' 55' ' ' VAL . 4.7 mp -75.13 150.53 38.74 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.5 66.1 3.25 Favored Glycine 0 C--N 1.301 -1.364 0 N-CA-C 107.998 -2.041 . . . . 0.0 107.998 170.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.53 ' CG2' ' HB2' ' A' ' 53' ' ' LEU . 11.1 t -66.98 113.46 3.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 123.996 0.918 . . . . 0.0 110.194 -174.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 10' ' ' ASP . . . -162.22 111.57 0.48 Allowed Glycine 0 N--CA 1.432 -1.587 0 CA-C-O 119.44 -0.644 . . . . 0.0 111.94 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.3 pttp 39.31 -43.9 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.944 0 C-N-CA 129.766 3.226 . . . . 0.0 117.966 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -93.25 7.29 44.93 Favored 'General case' 0 C--N 1.285 -2.212 0 O-C-N 121.336 -0.852 . . . . 0.0 109.399 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.15 89.25 1.15 Allowed 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.173 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 35.5 mt-10 -94.58 93.03 7.35 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 174.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.5 pt -93.69 143.42 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.057 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.538 -174.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 4' ' ' GLN . 25.1 m -106.41 123.24 47.77 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-O 121.273 0.558 . . . . 0.0 109.983 -177.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.3 mp -100.5 129.54 51.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.182 176.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.757 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 38.0 m-85 -115.55 112.87 22.84 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 123.682 0.614 . . . . 0.0 109.925 174.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -106.29 119.88 40.4 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.516 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 26.1 t70 -131.44 117.06 18.31 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.528 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -173.91 -163.92 28.17 Favored Glycine 0 N--CA 1.425 -2.09 0 C-N-CA 119.524 -1.322 . . . . 0.0 112.736 -174.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.5 m -87.59 -22.32 24.84 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.844 0.831 . . . . 0.0 109.373 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -132.39 35.85 3.63 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.838 -177.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.414 ' OE1' ' HA ' ' A' ' 66' ' ' ASP . 11.3 pt-20 -64.28 -38.0 89.47 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -173.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.31 -30.37 68.42 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.136 0.493 . . . . 0.0 110.658 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -76.06 -39.39 55.56 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 177.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.47 -41.23 98.59 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.441 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.466 HD12 ' HG2' ' A' ' 4' ' ' GLN . 16.6 mm -51.71 -51.33 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.279 0.631 . . . . 0.0 111.235 177.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -65.32 -41.53 93.92 Favored 'General case' 0 N--CA 1.405 -2.716 0 C-N-CA 122.799 0.44 . . . . 0.0 110.46 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.464 ' O ' ' HB3' ' A' ' 79' ' ' ASP . . . -67.15 -38.67 85.91 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.578 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.534 HD11 HD11 ' A' ' 44' ' ' LEU . 5.1 tt -72.25 -35.03 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.025 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.856 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.5 m -66.6 -41.62 88.17 Favored 'General case' 0 C--O 1.253 1.285 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 174.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 76' ' ' ALA . 26.3 t70 -51.22 -55.0 20.31 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 114.199 -1.364 . . . . 0.0 110.975 176.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.409 ' HA ' ' HB3' ' A' ' 83' ' ' LYS . 35.0 m -70.42 -34.14 56.71 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.081 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.9 mp -61.89 -50.35 72.57 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 119.278 0.945 . . . . 0.0 110.949 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.6 p -63.46 -39.22 93.88 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.03 0.443 . . . . 0.0 111.58 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 80' ' ' VAL . 36.8 ttmt -59.25 -43.78 92.41 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 124.227 1.011 . . . . 0.0 109.665 176.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -86.22 5.99 31.65 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 124.473 1.109 . . . . 0.0 112.505 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.88 30.76 70.06 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 115.429 0.932 . . . . 0.0 115.429 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.4 mp -90.56 -34.68 15.42 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 118.436 1.118 . . . . 0.0 109.713 174.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 27.1 p -119.49 150.18 40.66 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 . . . . . 0 N--CA 1.424 -1.749 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.387 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.596 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 47.8 ttm . . . . . 0 CA--C 1.508 -0.649 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -139.46 151.81 46.51 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.706 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 15.9 pt20 -103.73 149.05 25.35 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 123.757 0.661 . . . . 0.0 111.243 176.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -138.25 103.68 4.99 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.323 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 48.9 m -91.34 120.16 31.98 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.528 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 73.6 m-85 -109.97 137.82 47.21 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 124.831 1.252 . . . . 0.0 111.726 -174.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.0 m -96.62 109.93 22.45 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 174.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.561 HG12 ' H ' ' A' ' 10' ' ' ASP . 10.8 tt -63.11 152.14 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.87 0 CA-C-O 121.1 0.476 . . . . 0.0 111.552 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.6 pt -116.12 -14.9 10.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 O-C-N 122.033 -0.417 . . . . 0.0 110.879 176.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.561 ' H ' HG12 ' A' ' 8' ' ' ILE . 28.8 t70 -76.39 135.22 39.47 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.356 0.598 . . . . 0.0 111.589 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.414 ' HG2' ' HB3' ' A' ' 57' ' ' LYS . 34.1 mt-10 -116.7 -5.22 11.6 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.511 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.8 m -70.51 -29.9 66.53 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.402 -177.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.44 33.26 0.83 Allowed Glycine 0 N--CA 1.435 -1.388 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.993 174.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 87.89 -53.81 0.04 OUTLIER 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 124.802 1.241 . . . . 0.0 112.008 174.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.449 ' O ' ' HD2' ' A' ' 18' ' ' PRO 0.497 0.8 OUTLIER 59.57 111.9 0.02 OUTLIER 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.542 1.137 . . . . 0.0 113.778 -173.602 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.72 -31.84 69.99 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.209 -1.36 . . . . 0.0 113.98 -172.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.481 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 13.2 tpp180 -57.01 -56.07 37.32 Favored Pre-proline 0 CA--C 1.559 1.324 0 CA-C-O 118.669 -0.682 . . . . 0.0 112.193 -178.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.504 ' HA ' ' OE2' ' A' ' 84' ' ' GLU . 82.1 Cg_exo -48.83 -45.9 26.67 Favored 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 122.598 2.199 . . . . 0.0 112.347 172.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.44 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -65.36 -27.08 68.32 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.478 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.512 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 18.2 m -72.6 -28.81 63.01 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 61.7 mtt -71.62 -35.23 70.37 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 174.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 22' ' ' LEU . 4.0 mm? -60.22 -41.77 93.79 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.236 172.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.512 ' HB ' ' O ' ' A' ' 20' ' ' THR . 47.8 t -51.85 -56.15 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 O-C-N 124.458 1.099 . . . . 0.0 110.523 175.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -67.65 -26.99 66.49 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 120.812 0.339 . . . . 0.0 111.494 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.0 m -71.05 -52.7 17.98 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.02 -30.57 71.05 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.586 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.5 m -62.15 -31.02 71.46 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.74 8.09 45.08 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -173.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -101.73 150.73 22.83 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.56 176.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -63.37 -42.44 98.85 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 121.819 0.818 . . . . 0.0 108.966 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.521 ' OG ' ' HA3' ' A' ' 67' ' ' GLY . 13.3 m -71.88 149.24 45.35 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.722 -177.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -102.61 130.35 49.47 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.366 173.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.577 HG23 HG23 ' A' ' 63' ' ' ILE . 3.2 mp -108.21 126.04 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.085 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -98.82 136.3 39.04 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 174.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.703 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 40.4 tp -104.04 117.91 35.4 Favored 'General case' 0 C--N 1.277 -2.578 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -114.53 106.52 14.37 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-O 121.185 0.517 . . . . 0.0 110.226 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -131.23 94.58 3.6 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.077 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.6 t30 41.3 69.41 0.35 Allowed 'General case' 0 C--O 1.247 0.961 0 C-N-CA 125.902 1.681 . . . . 0.0 113.753 173.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.18 -26.69 23.57 Favored Glycine 0 CA--C 1.502 -0.749 0 C-N-CA 120.846 -0.693 . . . . 0.0 111.731 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.58 99.78 10.7 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 178.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.703 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -116.55 133.16 56.35 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-N 115.287 -0.869 . . . . 0.0 108.997 171.679 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 p -156.16 155.14 5.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.826 -172.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -62.56 118.17 7.22 Favored 'General case' 0 C--O 1.208 -1.12 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 169.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.7 tp -64.26 -20.13 65.85 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -90.39 3.27 54.24 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 119.332 -0.947 . . . . 0.0 111.024 175.111 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.3 m -115.55 136.19 53.33 Favored 'General case' 0 N--CA 1.415 -2.185 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.3 pp -81.79 9.35 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -173.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 49.7 ttp -88.82 60.13 5.38 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.681 1.229 . . . . 0.0 110.403 -170.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.51 -45.27 0.69 Allowed Glycine 0 N--CA 1.426 -1.97 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 -175.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.32 -34.71 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 114.649 -0.775 . . . . 0.0 111.713 -177.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -76.73 -16.62 59.44 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.778 -173.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.8 m -116.44 17.56 15.43 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.192 0.52 . . . . 0.0 109.643 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.1 tp -62.93 112.51 2.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.121 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.76 56.55 2.61 Favored Glycine 0 C--N 1.31 -0.863 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.081 -176.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.425 HG11 HG21 ' A' ' 61' ' ' ILE . 6.5 m -87.2 138.08 19.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-O 120.937 0.399 . . . . 0.0 112.013 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -158.02 134.92 4.08 Favored Glycine 0 C--O 1.207 -1.569 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.414 ' HB3' ' HG2' ' A' ' 11' ' ' GLU 0.317 14.7 ptmm? 20.12 -64.28 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.09 0 N-CA-C 118.604 2.816 . . . . 0.0 118.604 -176.391 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -77.14 -8.59 57.77 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.78 -0.575 . . . . 0.0 111.769 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.1 109.07 5.64 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.305 0.574 . . . . 0.0 112.27 -175.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.528 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 31.6 mt-10 -98.42 119.46 37.16 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 5' ' ' SER . 17.6 pt -106.16 142.94 17.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.717 -173.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.1 m -114.47 125.93 54.38 Favored 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.95 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.577 HG23 HG23 ' A' ' 33' ' ' ILE . 1.6 mp -99.97 135.33 36.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.706 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 40.5 m-85 -121.5 114.6 21.46 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 172.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.596 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -107.02 125.06 50.52 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -128.97 123.08 31.52 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 177.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.521 ' HA3' ' OG ' ' A' ' 31' ' ' SER . . . 178.36 -171.88 44.27 Favored Glycine 0 N--CA 1.429 -1.78 0 C-N-CA 120.226 -0.988 . . . . 0.0 111.421 -174.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.6 t -85.85 -13.43 48.01 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 174.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -128.82 37.85 4.03 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.646 -178.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.481 ' O ' HG12 ' A' ' 74' ' ' ILE 0.336 0.0 OUTLIER -67.34 -48.17 68.32 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 -173.774 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.17 -32.83 73.5 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.26 0.552 . . . . 0.0 111.026 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 17.2 t70 -74.83 -39.08 61.83 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.707 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.557 ' O ' ' HB ' ' A' ' 77' ' ' ILE . . . -61.71 -41.33 97.47 Favored 'General case' 0 C--O 1.201 -1.488 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 70' ' ' GLU . 28.1 mm -57.26 -49.53 79.58 Favored 'Isoleucine or valine' 0 C--O 1.248 0.974 0 C-N-CA 123.536 0.735 . . . . 0.0 111.271 176.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 18.9 pt20 -67.22 -31.06 71.18 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 120.452 -0.499 . . . . 0.0 112.196 -176.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.17 -42.26 38.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.333 0.587 . . . . 0.0 109.744 175.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.557 ' HB ' ' O ' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -56.32 -43.31 76.69 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 C-N-CA 124.701 1.2 . . . . 0.0 111.758 179.783 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 56.2 m -63.51 -44.69 93.58 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -59.21 -53.54 57.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.763 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.6 m -67.1 -37.73 79.84 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.016 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.795 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.428 HD22 ' HB2' ' A' ' 86' ' ' LEU . 29.9 mt -65.47 -35.26 80.38 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.3 p -75.65 -34.64 60.53 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.398 177.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -62.52 -39.08 92.4 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.528 0.68 . . . . 0.0 109.894 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.504 ' OE2' ' HA ' ' A' ' 18' ' ' PRO . 5.6 mm-40 -87.22 -3.98 59.07 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.962 -177.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.4 15.25 80.31 Favored Glycine 0 C--N 1.317 -0.504 0 N-CA-C 115.746 1.058 . . . . 0.0 115.746 173.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.533 ' HA ' HG13 ' A' ' 8' ' ' ILE . 4.9 mp -88.81 5.59 42.92 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 118.607 1.203 . . . . 0.0 110.474 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' A' ' 6' ' ' TYR . 10.2 t -163.23 156.12 18.83 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.5 176.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 N--CA 1.419 -2.004 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 167.18 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.603 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 90.2 mtp . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -103.58 151.04 23.37 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 174.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.678 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 16.8 pt20 -111.22 150.08 30.06 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-O 121.724 0.774 . . . . 0.0 112.744 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.497 ' O ' ' HA ' ' A' ' 62' ' ' THR . 8.5 mm-40 -128.67 119.46 24.72 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 114.014 -1.448 . . . . 0.0 109.288 176.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.5 t -98.72 97.31 8.57 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 176.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.484 ' OH ' HG23 ' A' ' 77' ' ' ILE . 56.9 m-85 -88.1 127.59 35.41 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.575 -176.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.4 m -88.84 90.1 8.27 Favored 'General case' 0 N--CA 1.409 -2.475 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 172.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.668 ' O ' ' HA ' ' A' ' 57' ' ' LYS . 8.4 mt -71.91 131.13 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.063 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 33.9 pt -125.65 23.3 3.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.576 ' HB2' ' HA ' ' A' ' 86' ' ' LEU . 25.1 t70 -71.4 104.68 3.28 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.572 -177.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -79.7 -0.36 33.78 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -174.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 p -90.4 -7.03 54.22 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.336 0.589 . . . . 0.0 110.404 170.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.84 25.48 71.66 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.582 -0.736 . . . . 0.0 113.573 175.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 79.48 111.12 0.07 Allowed 'General case' 0 C--O 1.245 0.817 0 C-N-CA 124.442 1.097 . . . . 0.0 112.418 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -95.15 166.75 11.76 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.12 -43.93 73.44 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.5 ' O ' HG22 ' A' ' 20' ' ' THR 0.258 26.9 mmt180 -60.16 -47.66 96.24 Favored Pre-proline 0 N--CA 1.473 0.703 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 -178.909 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -53.76 -45.39 41.37 Favored 'Trans proline' 0 C--N 1.363 1.324 0 C-N-CA 121.582 1.521 . . . . 0.0 110.401 174.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -67.74 -34.34 76.65 Favored 'General case' 0 C--O 1.205 -1.264 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.593 -178.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.5 HG22 ' O ' ' A' ' 17' ' ' ARG . 1.3 t -71.16 -28.12 64.04 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.183 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.2 mtm -78.37 -28.47 47.1 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 175.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.423 ' HB3' HD22 ' A' ' 44' ' ' LEU . 3.0 mm? -65.12 -42.4 93.96 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 170.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 55.7 t -56.45 -49.51 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.941 173.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.41 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 29.0 tt0 -59.37 -27.48 66.01 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.446 1.098 . . . . 0.0 111.715 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.425 ' O ' ' HD1' ' A' ' 29' ' ' PHE . 94.4 m -80.73 -56.55 4.07 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.62 86.13 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.242 -176.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.8 m -59.09 -29.14 67.12 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -119.05 14.1 13.09 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 -170.904 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.425 ' HD1' ' O ' ' A' ' 25' ' ' THR . 6.7 m-85 -99.33 9.94 42.38 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.248 -0.581 . . . . 0.0 112.207 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.5 t70 48.97 39.49 14.72 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 123.559 1.647 . . . . 0.0 110.486 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.475 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 21.7 m -143.35 141.22 30.86 Favored 'General case' 0 N--CA 1.393 -3.307 0 CA-C-N 112.897 -1.956 . . . . 0.0 107.18 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -95.64 98.73 10.71 Favored 'General case' 0 N--CA 1.391 -3.423 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 97.9 mt -93.1 125.42 45.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.888 177.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -119.9 147.08 45.16 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.448 ' HG ' HD11 ' A' ' 63' ' ' ILE . 4.3 tt -106.7 112.85 26.03 Favored 'General case' 0 N--CA 1.399 -2.986 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 41' ' ' LYS . 8.6 tp10 -98.76 116.11 30.27 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 175.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -141.08 108.01 5.42 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.354 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 42.02 77.91 0.05 Allowed 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 126.409 1.883 . . . . 0.0 113.476 173.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.33 -52.83 0.64 Allowed Glycine 0 N--CA 1.418 -2.542 0 C-N-CA 119.721 -1.228 . . . . 0.0 112.397 175.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.7 147.65 48.59 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 -173.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.586 ' H ' ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -103.9 131.48 51.07 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 113.696 -1.593 . . . . 0.0 108.766 177.85 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.9 p -125.98 137.84 56.46 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.753 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -54.44 125.06 18.04 Favored 'General case' 0 C--O 1.207 -1.144 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 172.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.423 HD22 ' HB3' ' A' ' 22' ' ' LEU . 0.7 OUTLIER -73.23 -14.34 61.32 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 121.633 0.73 . . . . 0.0 111.167 -174.368 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 0.1 OUTLIER -91.2 3.39 54.94 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 121.486 -0.759 . . . . 0.0 110.329 172.817 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 57.2 m -113.29 124.85 53.46 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.429 177.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.519 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -78.58 8.64 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 123.068 0.547 . . . . 0.0 112.413 -173.635 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 16.5 tpt -105.59 78.08 1.33 Allowed 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -168.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 135.75 -32.71 2.49 Favored Glycine 0 C--N 1.291 -1.958 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -173.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' A' ' 53' ' ' LEU . 88.0 t -80.97 -43.4 20.69 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 CA-C-N 114.965 -0.617 . . . . 0.0 110.529 178.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.5 mtt -65.65 -40.19 92.19 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 119.205 -0.998 . . . . 0.0 111.451 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.4 m -80.57 16.53 1.34 Allowed 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 176.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 7.7 tp -65.92 107.08 1.73 Allowed 'General case' 0 C--O 1.244 0.777 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.93 55.6 4.53 Favored Glycine 0 C--O 1.222 -0.635 0 N-CA-C 110.519 -1.033 . . . . 0.0 110.519 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.4 p -88.13 139.35 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -173.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -122.86 -83.03 0.62 Allowed Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 119.802 -1.189 . . . . 0.0 113.48 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.668 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -169.15 136.49 1.83 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -177.037 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.3 t70 74.83 4.81 4.36 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 123.033 1.397 . . . . 0.0 107.801 -171.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.18 108.61 7.08 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 113.345 -1.752 . . . . 0.0 109.818 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -83.36 110.81 18.45 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 123.627 0.579 . . . . 0.0 110.308 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.467 HG12 ' HB2' ' A' ' 6' ' ' TYR . 25.3 pt -106.09 143.44 17.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 174.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 4' ' ' GLN . 28.1 m -112.94 111.41 22.14 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 121.557 0.694 . . . . 0.0 111.405 -176.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.4 mp -89.56 135.4 26.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.416 177.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.678 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 34.2 m-85 -117.29 119.13 34.22 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 172.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -114.65 122.4 46.35 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.603 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 25.8 t70 -136.05 122.83 21.15 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.5 ' N ' ' HB3' ' A' ' 70' ' ' GLU . . . -178.29 -170.04 39.9 Favored Glycine 0 C--N 1.287 -2.155 0 C-N-CA 119.024 -1.56 . . . . 0.0 112.209 -173.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.0 m -76.83 -30.15 56.24 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.603 0.716 . . . . 0.0 109.31 175.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -124.06 30.17 6.2 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.097 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.556 ' O ' HG12 ' A' ' 74' ' ' ILE . 12.4 pt-20 -54.1 -42.96 69.98 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -175.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.85 -31.93 72.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.594 0.711 . . . . 0.0 110.906 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -83.32 -32.3 26.38 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.138 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.99 -28.74 68.5 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.941 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.556 HG12 ' O ' ' A' ' 70' ' ' GLU . 25.3 mm -54.04 -48.3 64.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 O-C-N 123.857 0.723 . . . . 0.0 110.85 175.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -68.44 -39.65 81.43 Favored 'General case' 0 N--CA 1.403 -2.781 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.86 -47.26 84.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.823 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.484 HG23 ' OH ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -66.74 -36.4 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.868 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.623 -179.615 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 41.0 m -68.03 -40.04 82.99 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 175.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.498 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 20.1 t70 -56.18 -56.15 24.41 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.904 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.1 m -61.76 -36.85 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 38.6 mt -63.47 -48.26 78.38 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.41 -0.218 . . . . 0.0 110.41 176.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.581 ' HA ' ' O ' ' A' ' 87' ' ' THR . 38.1 t -57.66 -47.37 82.47 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.224 0.61 . . . . 0.0 111.333 174.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 32.6 mmtp -57.58 -42.67 83.61 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.641 0.734 . . . . 0.0 110.489 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -77.66 -22.43 50.61 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.922 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.11 14.83 47.19 Favored Glycine 0 C--N 1.301 -1.389 0 C-N-CA 120.358 -0.925 . . . . 0.0 113.797 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.576 ' HA ' ' HB2' ' A' ' 10' ' ' ASP . 5.1 mp -87.05 -25.41 24.21 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.581 ' O ' ' HA ' ' A' ' 82' ' ' SER . 34.3 m -126.7 148.79 49.83 Favored 'General case' 0 N--CA 1.414 -2.233 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 176.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 . . . . . 0 C--N 1.301 -1.505 0 C-N-CA 123.604 0.762 . . . . 0.0 111.124 -176.926 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 mtm . . . . . 0 CA--C 1.504 -0.792 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 31.9 tt0 -100.78 141.45 33.65 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.631 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 28.6 pt20 -106.59 154.27 21.15 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -175.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' A' ' 62' ' ' THR . 28.4 mm-40 -138.53 127.52 23.93 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.458 -1.701 . . . . 0.0 107.367 172.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.7 p -103.6 103.4 13.33 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-O 121.741 0.782 . . . . 0.0 110.109 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.486 ' HB2' HG12 ' A' ' 61' ' ' ILE . 78.3 m-85 -104.69 164.64 11.62 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.716 -177.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.9 m -129.57 130.42 45.68 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 174.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.637 HG23 ' HA ' ' A' ' 57' ' ' LYS . 15.1 tt -90.93 153.71 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.638 0 C-N-CA 121.18 -0.208 . . . . 0.0 111.492 -175.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.438 HG23 ' HG2' ' A' ' 88' ' ' GLU . 36.4 pt -136.49 24.55 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 121.117 0.484 . . . . 0.0 110.667 177.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.469 ' H ' HG12 ' A' ' 8' ' ' ILE . 7.1 p-10 -65.75 -39.96 91.63 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.899 -177.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.438 ' HG2' ' HG2' ' A' ' 57' ' ' LYS . 36.8 mt-10 65.61 6.66 3.95 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.334 1.453 . . . . 0.0 112.191 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.4 m -108.75 -37.99 5.74 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.268 0.556 . . . . 0.0 111.55 -172.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 117.25 40.19 0.76 Allowed Glycine 0 N--CA 1.427 -1.909 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.418 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . 93.37 -67.21 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.652 1.581 . . . . 0.0 114.14 175.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . 0.298 9.1 p80 49.02 107.11 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 125.4 1.48 . . . . 0.0 112.945 -172.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.94 80.09 4.39 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -173.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.516 ' H ' ' HD2' ' A' ' 18' ' ' PRO . 2.1 tmt_? -137.77 -51.21 0.02 OUTLIER Pre-proline 0 C--N 1.291 -1.963 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 172.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.516 ' HD2' ' H ' ' A' ' 17' ' ' ARG . 4.9 Cg_endo -53.27 -33.59 66.08 Favored 'Trans proline' 0 C--N 1.384 2.427 0 C-N-CA 121.343 1.362 . . . . 0.0 109.693 168.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.507 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -60.25 -27.8 67.52 Favored 'General case' 0 C--O 1.201 -1.49 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.58 178.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.5 m -65.82 -26.77 67.82 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.229 0.538 . . . . 0.0 110.471 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 55.9 tpp -71.76 -32.0 67.24 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.12 -30.37 63.58 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.197 176.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 19' ' ' ALA . 77.0 t -69.96 -39.9 78.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -70.26 -37.74 74.97 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.321 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.1 m -91.26 -66.79 0.9 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -172.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.657 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . . . -62.97 -32.64 74.01 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -171.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.4 m -61.49 -25.69 67.42 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.34 14.93 30.64 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -176.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.44 ' C ' ' H ' ' A' ' 31' ' ' SER . 28.8 m-85 -105.23 3.7 30.36 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.814 178.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.5 t70 68.78 -36.82 0.34 Allowed 'General case' 0 N--CA 1.507 2.406 0 C-N-CA 124.644 1.177 . . . . 0.0 113.187 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.508 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 19.9 m -58.95 148.95 28.61 Favored 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 125.261 1.424 . . . . 0.0 112.029 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -99.68 102.69 14.25 Favored 'General case' 0 N--CA 1.409 -2.513 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.927 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 2.6 mp -91.48 121.59 42.07 Favored 'Isoleucine or valine' 0 C--O 1.259 1.588 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.844 177.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -119.97 135.63 54.84 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 -174.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.528 HD12 HD13 ' A' ' 44' ' ' LEU . 5.8 tt -101.24 116.26 32.39 Favored 'General case' 0 N--CA 1.406 -2.656 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.451 ' HB3' ' HB ' ' A' ' 62' ' ' THR . 3.4 tm-20 -99.93 105.35 17.05 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.412 ' HB3' HD11 ' A' ' 53' ' ' LEU 0.285 1.2 t80 -110.3 79.83 1.25 Allowed 'General case' 0 C--N 1.287 -2.134 0 CA-C-O 122.149 0.976 . . . . 0.0 110.476 175.611 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 34.81 79.95 0.03 OUTLIER 'General case' 0 C--O 1.238 0.476 0 CA-C-N 111.949 -2.387 . . . . 0.0 113.711 172.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 135.48 -61.72 0.62 Allowed Glycine 0 CA--C 1.484 -1.848 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.48 ' H ' ' HD2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -127.12 159.21 34.89 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-N 113.871 -1.164 . . . . 0.0 110.285 -174.18 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 38.3 ttpt -142.74 142.71 32.0 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.588 -173.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.68 HG21 ' HA3' ' A' ' 49' ' ' GLY . 10.4 p -151.33 160.16 3.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -61.57 132.72 54.25 Favored 'General case' 0 C--O 1.216 -0.679 0 C-N-CA 122.83 0.452 . . . . 0.0 111.329 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.528 HD13 HD12 ' A' ' 35' ' ' LEU . 34.2 tp -91.33 -15.63 28.77 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.773 0.797 . . . . 0.0 111.423 -178.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.657 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 16.0 pttp -90.06 1.91 55.81 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 122.075 0.94 . . . . 0.0 109.672 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 61.3 m -121.51 139.33 53.63 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-N 113.958 -1.474 . . . . 0.0 108.167 175.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.43 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -78.15 -27.56 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-O 121.611 0.72 . . . . 0.0 110.247 -175.373 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 53.8 ttp -68.19 91.91 0.38 Allowed 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 113.694 -1.594 . . . . 0.0 108.658 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.68 ' HA3' HG21 ' A' ' 42' ' ' VAL . . . 139.79 -58.52 0.59 Allowed Glycine 0 C--N 1.264 -3.458 0 CA-C-N 113.379 -1.737 . . . . 0.0 110.138 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.414 HG21 ' HA ' ' A' ' 44' ' ' LEU . 59.2 t -66.28 -33.95 66.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 114.629 -0.785 . . . . 0.0 112.376 -175.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 55.1 ttm -64.86 -52.17 58.06 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.011 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.2 m -69.25 -16.28 63.55 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 123.655 0.782 . . . . 0.0 112.897 177.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.51 HD21 HD22 ' A' ' 35' ' ' LEU . 11.2 tp -69.02 103.58 1.89 Allowed 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 123.899 0.88 . . . . 0.0 109.291 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.22 62.68 4.23 Favored Glycine 0 C--N 1.31 -0.873 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.893 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.467 ' HB ' HG21 ' A' ' 8' ' ' ILE . 1.2 m -56.94 -62.72 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 C-N-CA 122.187 0.195 . . . . 0.0 110.863 176.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 49.42 75.37 0.21 Allowed Glycine 0 CA--C 1.53 1.001 0 N-CA-C 116.004 1.162 . . . . 0.0 116.004 171.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.637 ' HA ' HG23 ' A' ' 8' ' ' ILE . 0.0 OUTLIER 43.16 -13.8 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.456 0 N-CA-C 119.589 3.181 . . . . 0.0 119.589 177.565 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -102.46 -8.7 20.87 Favored 'General case' 0 C--N 1.285 -2.225 0 O-C-N 121.242 -0.911 . . . . 0.0 109.802 -176.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.1 127.24 32.41 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -171.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -91.54 101.24 13.89 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 169.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.523 ' HB ' HD21 ' A' ' 35' ' ' LEU . 1.4 pt -104.87 126.56 59.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.731 -0.787 . . . . 0.0 109.918 -171.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.451 ' HB ' ' HB3' ' A' ' 36' ' ' GLU . 19.4 m -108.9 118.15 36.05 Favored 'General case' 0 C--N 1.287 -2.114 0 O-C-N 121.913 -0.492 . . . . 0.0 109.838 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.57 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.5 mp -88.71 132.78 32.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.631 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 38.9 m-85 -119.27 125.84 50.08 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.961 171.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.23 120.5 40.67 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.46 ' HA ' ' OE1' ' A' ' 70' ' ' GLU . 29.0 t70 -125.56 108.02 11.18 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.508 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -165.73 -172.89 33.65 Favored Glycine 0 N--CA 1.416 -2.645 0 C-N-CA 119.148 -1.501 . . . . 0.0 113.482 -171.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.3 p -78.75 -26.91 44.64 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 114.582 -0.809 . . . . 0.0 110.027 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -129.2 35.91 4.22 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.286 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.46 ' OE1' ' HA ' ' A' ' 66' ' ' ASP . 11.0 pt-20 -58.53 -36.18 73.44 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -175.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.84 -43.52 95.94 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 121.218 0.532 . . . . 0.0 110.497 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -76.28 -31.13 58.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.786 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.471 ' O ' ' HB ' ' A' ' 77' ' ' ILE . . . -64.27 -36.67 84.84 Favored 'General case' 0 C--O 1.205 -1.265 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.915 176.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.539 ' O ' HG22 ' A' ' 77' ' ' ILE . 25.8 mm -61.22 -43.65 96.86 Favored 'Isoleucine or valine' 0 C--O 1.251 1.143 0 C-N-CA 122.691 0.396 . . . . 0.0 110.784 175.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -53.04 62.68 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.64 -39.17 93.23 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.566 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.539 HG22 ' O ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -64.65 -40.61 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 C-N-CA 123.127 0.571 . . . . 0.0 110.607 -178.024 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.8 m -72.85 -33.91 66.43 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 24.1 t70 -63.26 -46.74 85.42 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.549 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.435 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 35.3 m -77.68 -23.5 14.19 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.262 0 C-N-CA 120.517 -0.473 . . . . 0.0 112.188 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 77' ' ' ILE . 23.6 mt -73.19 -48.02 38.7 Favored 'General case' 0 C--O 1.206 -1.185 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.588 174.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.7 p -61.3 -29.5 69.91 Favored 'General case' 0 C--N 1.316 -0.85 0 O-C-N 121.626 -0.671 . . . . 0.0 111.438 173.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 79' ' ' ASP . 18.4 ttmm -70.94 -39.57 72.55 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.909 176.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -104.53 -82.8 0.51 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -177.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -173.22 -156.9 13.68 Favored Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -176.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.447 ' HA ' HG13 ' A' ' 8' ' ' ILE . 3.2 mp 64.87 19.67 11.91 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 125.276 1.43 . . . . 0.0 112.3 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 60.3 m -154.45 156.89 37.58 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.438 ' HG2' HG23 ' A' ' 9' ' ' ILE . 41.7 mt-10 . . . . . 0 C--O 1.25 1.096 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.462 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 1.1 mpt? . . . . . 0 CA--C 1.502 -0.9 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -105.23 145.35 30.76 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 118.908 -1.117 . . . . 0.0 113.118 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.758 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 24.1 pt20 -111.82 151.88 28.54 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -172.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' A' ' 62' ' ' THR . 83.8 mm-40 -137.16 131.57 32.74 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.224 -1.353 . . . . 0.0 108.369 173.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.8 t -98.71 121.29 40.47 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 82.4 m-85 -113.34 159.51 19.34 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 122.662 0.385 . . . . 0.0 110.933 -177.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.2 m -131.68 106.36 8.1 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 174.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.59 HG21 ' HB3' ' A' ' 59' ' ' ALA . 9.7 tp -66.83 144.96 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.603 0 C-N-CA 123.229 0.612 . . . . 0.0 110.353 -176.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.0 pt -109.52 -14.74 10.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-O 121.744 0.783 . . . . 0.0 109.154 174.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.471 ' O ' ' HA2' ' A' ' 56' ' ' GLY . 9.9 t70 -73.28 149.67 42.54 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.583 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -129.19 27.58 5.35 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.626 0.727 . . . . 0.0 109.516 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.4 m -106.92 -32.32 7.95 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.295 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.34 34.5 1.1 Allowed Glycine 0 N--CA 1.427 -1.921 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 -177.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 89.43 -34.26 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 127.201 2.2 . . . . 0.0 110.786 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . 0.494 30.9 p-80 67.42 135.95 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 126.632 1.973 . . . . 0.0 114.33 -178.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.47 -55.99 23.32 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 116.36 1.985 . . . . 0.0 116.36 -166.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.402 ' HD3' ' HA ' ' A' ' 17' ' ' ARG . 28.5 mmt180 -54.89 -53.41 61.27 Favored Pre-proline 0 N--CA 1.48 1.04 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -172.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.17 -37.44 83.56 Favored 'Trans proline' 0 C--N 1.36 1.175 0 C-N-CA 121.671 1.58 . . . . 0.0 110.978 177.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.511 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -68.81 -27.54 65.95 Favored 'General case' 0 C--O 1.21 -1.023 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.03 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.522 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 14.8 m -74.87 -27.46 60.26 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 97.0 mmm -71.23 -37.82 71.99 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 173.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.429 HD12 HD21 ' A' ' 44' ' ' LEU . 4.5 mm? -61.96 -35.98 80.07 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.442 172.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.522 ' HB ' ' O ' ' A' ' 20' ' ' THR . 52.9 t -56.43 -53.98 33.88 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.698 0 O-C-N 123.669 0.606 . . . . 0.0 109.72 174.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -64.04 -26.28 68.49 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-O 121.264 0.554 . . . . 0.0 111.218 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.567 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 37.1 m -79.55 -62.66 1.62 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.577 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.712 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . . . -67.52 -26.82 66.52 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -175.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 27.1 m -72.48 -10.83 60.27 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 177.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.567 ' HG3' ' O ' ' A' ' 25' ' ' THR . 0.0 OUTLIER -100.14 -2.7 33.43 Favored 'General case' 0 CA--C 1.504 -0.813 0 C-N-CA 119.514 -0.875 . . . . 0.0 112.369 179.213 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -99.09 144.65 28.0 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -88.02 65.52 8.26 Favored 'General case' 0 CA--C 1.484 -1.576 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 173.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.551 ' OG ' ' HA3' ' A' ' 67' ' ' GLY . 23.2 m -161.56 135.97 7.02 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-N 113.397 -1.729 . . . . 0.0 107.455 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -102.35 112.77 25.61 Favored 'General case' 0 C--N 1.278 -2.504 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.62 175.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.515 HG23 HG23 ' A' ' 63' ' ' ILE . 59.3 mt -80.58 112.59 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.002 0 CA-C-N 114.142 -1.39 . . . . 0.0 107.636 175.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 35.2 mt-30 -97.08 127.51 43.12 Favored 'General case' 0 N--CA 1.403 -2.814 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.662 HD22 HD21 ' A' ' 53' ' ' LEU . 1.6 tt -91.63 115.09 27.75 Favored 'General case' 0 N--CA 1.4 -2.946 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 176.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -110.11 113.19 25.68 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 124.947 1.299 . . . . 0.0 108.732 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -133.88 94.35 3.25 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-O 121.52 0.676 . . . . 0.0 110.638 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 50.89 67.68 0.9 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.524 -1.671 . . . . 0.0 112.166 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.4 -23.57 31.42 Favored Glycine 0 N--CA 1.438 -1.186 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.699 175.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 40' ' ' LYS . 10.1 mmtp -99.04 109.95 22.62 Favored 'General case' 0 CA--C 1.476 -1.879 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 6.5 ptpp? -114.93 128.21 56.15 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.806 175.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 34' ' ' GLN . 6.0 m -135.95 -175.18 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.937 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.536 ' HB2' ' HB2' ' A' ' 46' ' ' SER . 19.6 m120 -94.22 120.51 34.57 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.429 HD21 HD12 ' A' ' 22' ' ' LEU . 7.4 tt -74.12 -21.97 59.66 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-O 121.241 0.543 . . . . 0.0 111.381 -178.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.712 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 14.5 pttp -87.93 6.86 33.68 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 122.255 1.026 . . . . 0.0 109.647 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.536 ' HB2' ' HB2' ' A' ' 43' ' ' ASN . 73.7 m -117.14 133.64 55.75 Favored 'General case' 0 N--CA 1.398 -3.029 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.137 175.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.759 HD12 ' H ' ' A' ' 47' ' ' ILE . 1.4 mp -75.17 -38.01 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.209 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -172.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 44.3 ttm -51.7 -37.39 50.58 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 112.688 -2.051 . . . . 0.0 110.571 175.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.5 -60.43 3.48 Favored Glycine 0 N--CA 1.426 -2.02 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.885 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.438 HG22 HD12 ' A' ' 35' ' ' LEU . 90.7 t -57.49 -40.96 77.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 96.4 mmm -75.33 2.86 10.16 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 51.9 m -92.82 -21.38 19.93 Favored 'General case' 0 C--N 1.31 -1.11 0 O-C-N 122.061 -0.399 . . . . 0.0 110.607 176.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.662 HD21 HD22 ' A' ' 35' ' ' LEU . 6.9 mp -79.93 155.89 27.51 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.045 0.45 . . . . 0.0 110.704 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.16 69.22 0.79 Allowed Glycine 0 N--CA 1.426 -1.969 0 N-CA-C 107.5 -2.24 . . . . 0.0 107.5 169.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.5 t -77.25 80.72 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -175.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 10' ' ' ASP . . . -134.92 135.22 7.79 Favored Glycine 0 N--CA 1.425 -2.052 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt 28.08 -57.89 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 129.817 3.247 . . . . 0.0 118.837 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -90.11 -0.84 57.81 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.743 0.782 . . . . 0.0 110.581 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.59 ' HB3' HG21 ' A' ' 8' ' ' ILE . . . -72.24 96.72 1.86 Allowed 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 121.927 0.87 . . . . 0.0 112.569 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 36.0 mt-10 -92.58 105.6 17.74 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 175.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.5 HD12 HD21 ' A' ' 35' ' ' LEU . 29.3 pt -103.23 157.2 5.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.458 -172.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 4' ' ' GLN . 34.1 m -122.89 127.66 49.26 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-O 121.254 0.55 . . . . 0.0 109.762 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.758 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.4 mp -97.31 130.08 46.48 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 177.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.423 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 27.4 m-85 -116.8 107.04 14.14 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 123.733 0.646 . . . . 0.0 109.48 171.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -93.63 111.42 23.1 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -113.77 110.19 19.76 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.551 ' HA3' ' OG ' ' A' ' 31' ' ' SER . . . -174.05 -168.49 35.05 Favored Glycine 0 N--CA 1.41 -3.069 0 C-N-CA 118.93 -1.605 . . . . 0.0 113.819 -175.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.2 m -94.79 -17.18 22.36 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 175.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -119.05 18.55 13.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.401 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.46 ' O ' HG12 ' A' ' 74' ' ' ILE . 4.7 pt-20 -57.24 -37.66 72.62 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -174.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.91 -42.58 99.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.111 0.481 . . . . 0.0 111.052 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -78.99 -26.87 43.34 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.36 0.6 . . . . 0.0 109.508 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.59 -41.38 98.35 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.357 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 70' ' ' GLU . 35.4 mm -60.09 -46.26 94.61 Favored 'Isoleucine or valine' 0 C--O 1.255 1.384 0 CA-C-O 121.542 0.686 . . . . 0.0 109.745 175.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -58.59 -40.1 82.26 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.43 -1.259 . . . . 0.0 112.657 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.06 -44.48 17.96 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.5 HG13 HD13 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -59.25 -36.97 66.27 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.55 0 C-N-CA 123.59 0.756 . . . . 0.0 112.459 -173.742 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.7 p -73.74 -43.16 59.87 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.263 0.554 . . . . 0.0 110.248 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.547 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 24.5 t70 -60.8 -47.77 84.84 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.288 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.528 ' HA ' ' HG2' ' A' ' 83' ' ' LYS . 27.9 m -66.01 -39.21 83.91 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.516 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.928 177.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 81' ' ' LEU . 15.5 mt -64.12 -35.62 81.36 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 177.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.4 p -70.29 -44.97 67.26 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 118.345 0.521 . . . . 0.0 112.075 174.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.547 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 12.9 ptmm? -67.29 -28.26 67.86 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.684 177.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 80' ' ' VAL . 24.2 mm-40 -81.14 -26.46 36.08 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.056 0.455 . . . . 0.0 110.687 175.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.24 41.31 8.03 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 116.136 -0.484 . . . . 0.0 113.663 175.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.449 ' O ' HD12 ' A' ' 8' ' ' ILE . 8.8 mp -91.71 -46.41 7.92 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.183 176.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.2 t -101.84 168.69 9.27 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -176.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 C--N 1.309 -1.16 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 176.883 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.599 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 91.0 mtp . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -105.18 148.16 27.21 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 169.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.701 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 27.7 pt20 -107.16 143.34 35.49 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -132.88 99.92 4.75 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.032 174.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 49.1 m -87.91 116.2 25.91 Favored 'General case' 0 C--N 1.286 -2.175 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.428 176.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.497 ' HB2' HG12 ' A' ' 61' ' ' ILE . 78.3 m-85 -102.03 139.02 38.22 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.031 -173.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.9 m -101.65 100.54 10.94 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 171.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.692 ' O ' ' HA ' ' A' ' 57' ' ' LYS 0.262 3.0 mt -74.75 135.41 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 119.97 -0.692 . . . . 0.0 112.028 -179.014 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.9 pt -107.09 -7.39 10.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.334 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.514 ' H ' HG23 ' A' ' 8' ' ' ILE . 12.0 t70 -76.65 125.15 28.75 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.74 -178.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.7 mp0 -77.05 74.72 3.62 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.536 -0.465 . . . . 0.0 111.977 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.0 p 57.41 11.05 1.06 Allowed 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 117.124 2.268 . . . . 0.0 117.124 172.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.86 -32.49 10.95 Favored Glycine 0 CA--C 1.484 -1.869 0 C-N-CA 119.549 -1.31 . . . . 0.0 111.191 -174.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.65 10.21 0.1 Allowed 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 115.483 1.661 . . . . 0.0 115.483 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -80.89 -4.1 53.67 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -173.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.95 -76.33 0.59 Allowed 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.426 ' HD3' ' HA ' ' A' ' 17' ' ' ARG 0.257 33.9 mmt180 -69.36 -52.73 14.44 Favored Pre-proline 0 C--N 1.315 -0.911 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -176.392 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -59.55 -29.52 90.14 Favored 'Trans proline' 0 C--N 1.36 1.174 0 CA-C-N 120.838 1.335 . . . . 0.0 110.782 174.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.417 ' HA ' HD23 ' A' ' 22' ' ' LEU . . . -68.68 -28.45 66.88 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.231 176.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.401 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 57.1 m -70.59 -26.29 63.45 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 175.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 83.8 mtp -70.03 -31.84 69.68 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.457 HD21 HD21 ' A' ' 81' ' ' LEU . 4.1 mm? -66.32 -44.31 83.74 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 172.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' A' ' 20' ' ' THR . 84.4 t -54.01 -55.29 14.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 123.963 0.79 . . . . 0.0 109.497 174.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -53.41 -44.36 68.67 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 124.403 1.081 . . . . 0.0 112.317 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.1 m -81.31 -58.91 2.84 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -175.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.632 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . . . -64.86 -27.82 69.13 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -173.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.6 m -69.64 -16.11 63.31 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.256 0.0 OUTLIER -108.25 6.34 26.52 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 -175.606 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -101.43 137.62 39.52 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 174.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -84.78 73.07 10.67 Favored 'General case' 0 CA--C 1.496 -1.112 0 CA-C-O 122.749 1.262 . . . . 0.0 109.349 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.557 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 33.8 m -161.5 152.88 18.73 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 112.871 -1.968 . . . . 0.0 105.908 177.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -113.36 109.4 18.65 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.0 mp -89.87 125.57 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.272 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 -98.09 136.07 38.86 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.7 tp -99.94 114.94 28.54 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.62 ' HA ' ' O ' ' A' ' 40' ' ' LYS . 9.2 tt0 -111.66 136.34 51.02 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.706 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.448 ' CD2' ' HG ' ' A' ' 53' ' ' LEU . 50.7 t80 -165.24 104.5 0.75 Allowed 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 123.386 0.674 . . . . 0.0 110.572 178.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.7 t30 48.07 74.84 0.15 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.804 1.242 . . . . 0.0 113.025 176.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.98 -13.12 33.0 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 121.001 -0.618 . . . . 0.0 113.114 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -94.6 123.56 38.11 Favored 'General case' 0 CA--C 1.48 -1.729 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -179.588 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -119.57 113.42 20.68 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 169.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.7 p -143.53 167.14 13.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -175.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.552 HD21 ' HE3' ' A' ' 45' ' ' LYS . 19.3 t-20 -78.92 133.38 36.92 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 117.864 0.302 . . . . 0.0 111.184 -177.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.6 tp -75.97 -35.01 59.81 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.632 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -87.39 9.36 20.89 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.691 -178.358 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 75.6 m -106.68 125.01 50.46 Favored 'General case' 0 N--CA 1.392 -3.37 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 173.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.46 -25.47 38.44 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 CA-C-O 121.39 0.614 . . . . 0.0 111.636 -175.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 49.7 ttp -55.47 -27.04 45.85 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 125.429 1.492 . . . . 0.0 110.468 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.22 -60.62 4.35 Favored Glycine 0 N--CA 1.42 -2.423 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.515 178.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.0 t -64.04 -36.1 75.75 Favored 'Isoleucine or valine' 0 C--O 1.249 1.045 0 O-C-N 122.688 -0.301 . . . . 0.0 110.876 -176.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.2 mmt -57.84 -34.79 70.08 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.267 0.627 . . . . 0.0 112.237 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.1 p -85.03 -31.43 23.45 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.84 -175.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.448 ' HG ' ' CD2' ' A' ' 37' ' ' TYR . 11.0 mp -59.09 -61.95 2.25 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.95 0.405 . . . . 0.0 111.833 176.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.38 46.53 55.98 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 -171.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.6 p -69.88 123.68 24.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 C-N-CA 123.666 0.786 . . . . 0.0 111.586 -176.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.41 -172.24 14.69 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.692 ' HA ' ' O ' ' A' ' 8' ' ' ILE 0.272 55.0 pttt -64.88 136.02 56.38 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 118.226 1.013 . . . . 0.0 113.689 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t70 84.31 -7.1 1.02 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 126.32 1.848 . . . . 0.0 111.087 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.45 113.0 6.35 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.609 177.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -81.69 115.85 21.14 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.773 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.497 HG12 ' HB2' ' A' ' 6' ' ' TYR . 17.3 pt -116.04 160.07 15.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 5' ' ' SER . 98.6 m -129.18 128.04 42.57 Favored 'General case' 0 C--N 1.275 -2.648 0 CA-C-O 120.878 0.37 . . . . 0.0 110.305 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.4 mp -101.8 131.59 49.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.701 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 34.8 m-85 -121.56 113.76 20.24 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 123.574 0.547 . . . . 0.0 109.684 173.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.599 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -104.0 119.86 39.82 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.485 ' OD1' ' HG3' ' A' ' 1' ' ' MET . 15.7 t70 -126.08 115.43 19.82 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.557 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -179.22 -171.67 42.6 Favored Glycine 0 N--CA 1.431 -1.675 0 C-N-CA 119.952 -1.118 . . . . 0.0 113.171 -175.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.4 m -89.13 -7.18 56.23 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.474 0.654 . . . . 0.0 109.642 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -130.37 29.37 4.86 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.596 ' O ' HG12 ' A' ' 74' ' ' ILE . 9.7 pt-20 -69.21 -44.01 72.95 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -168.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.2 -31.88 69.53 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.212 0.529 . . . . 0.0 110.357 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -75.01 -33.58 61.83 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-O 121.556 0.693 . . . . 0.0 109.779 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.19 -36.15 82.31 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.969 176.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.596 HG12 ' O ' ' A' ' 70' ' ' GLU . 38.0 mm -54.1 -39.29 41.28 Favored 'Isoleucine or valine' 0 C--O 1.25 1.119 0 C-N-CA 123.503 0.721 . . . . 0.0 111.431 178.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -67.32 -44.26 79.58 Favored 'General case' 0 N--CA 1.402 -2.855 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.231 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.33 -39.36 47.93 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.485 -175.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.435 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -64.11 -41.78 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -178.367 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 33.0 m -67.78 -43.45 79.75 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.419 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 32.3 t70 -55.34 -48.13 74.66 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.3 m -67.22 -29.96 47.68 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.593 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.736 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.457 HD21 HD21 ' A' ' 22' ' ' LEU . 40.4 mt -79.56 -2.29 41.71 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.983 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 21.6 m -118.38 -16.36 9.6 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.437 0.637 . . . . 0.0 110.253 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 75.2 mmtt -78.46 -27.47 46.37 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 169.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -104.75 172.53 6.74 Favored 'General case' 0 N--CA 1.41 -2.431 0 CA-C-N 112.921 -1.945 . . . . 0.0 107.41 175.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -104.3 51.51 0.8 Allowed Glycine 0 C--N 1.291 -1.967 0 C-N-CA 119.893 -1.146 . . . . 0.0 113.364 -175.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.433 HD22 HD22 ' A' ' 81' ' ' LEU . 4.8 mp -92.74 -53.43 4.18 Favored 'General case' 0 C--O 1.213 -0.847 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.303 176.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.412 HG22 ' HB3' ' A' ' 81' ' ' LEU . 14.6 t -116.51 148.29 40.95 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.916 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 . . . . . 0 N--CA 1.429 -1.523 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.709 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.639 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 52.9 ttm . . . . . 0 CA--C 1.514 -0.415 0 N-CA-C 110.581 -0.155 . . . . 0.0 110.581 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -114.83 157.35 23.4 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 176.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.645 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 23.5 pt20 -111.35 153.96 25.24 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -142.36 103.73 4.31 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.697 -1.592 . . . . 0.0 107.59 173.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 50.2 m -91.49 89.45 7.21 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 122.293 1.044 . . . . 0.0 110.451 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 73.8 m-85 -72.87 130.02 39.47 Favored 'General case' 0 CA--C 1.488 -1.433 0 CA-C-N 113.493 -1.685 . . . . 0.0 112.146 -175.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.2 m -88.88 101.01 13.63 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 170.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.577 HG23 ' H ' ' A' ' 10' ' ' ASP . 4.5 mt -77.22 136.49 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.9 -178.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 35.4 pt -119.03 6.55 6.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.577 ' H ' HG23 ' A' ' 8' ' ' ILE . 31.2 t70 -71.39 127.11 31.48 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.505 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -112.11 13.23 20.61 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.609 0.718 . . . . 0.0 110.368 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -84.63 -33.7 23.23 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.04 37.48 3.86 Favored Glycine 0 N--CA 1.425 -2.033 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 72.28 79.03 0.15 Allowed 'General case' 0 CA--C 1.508 -0.643 0 C-N-CA 124.203 1.001 . . . . 0.0 110.743 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -55.6 113.88 1.63 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.827 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.81 -34.42 66.86 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -170.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.432 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 13.9 tpp180 -63.45 -52.95 56.39 Favored Pre-proline 0 C--N 1.317 -0.839 0 C-N-CA 119.594 -0.842 . . . . 0.0 112.448 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.563 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 31.8 Cg_exo -66.72 -10.86 29.65 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 121.573 1.516 . . . . 0.0 112.645 174.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.429 ' HA ' HD23 ' A' ' 22' ' ' LEU . . . -74.54 -15.47 60.86 Favored 'General case' 0 C--O 1.216 -0.682 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.411 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 7.7 m -66.73 -27.16 67.39 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 174.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.563 ' SD ' ' HA ' ' A' ' 18' ' ' PRO . 1.4 mpt? -67.69 -34.88 77.76 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 174.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 19' ' ' ALA . 4.4 mm? -69.27 -38.1 78.21 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.938 175.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 81.9 t -55.69 -49.84 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 O-C-N 124.113 0.883 . . . . 0.0 109.351 175.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.12 -64.33 0.99 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.18 177.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.7 m -42.35 -63.16 0.8 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.734 1.214 . . . . 0.0 113.81 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . . . -66.05 -43.05 88.61 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -174.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.7 t -60.75 -39.09 87.41 Favored 'General case' 0 C--N 1.322 -0.594 0 O-C-N 123.27 0.356 . . . . 0.0 111.37 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.269 0.6 OUTLIER -82.5 3.0 30.11 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -174.198 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -95.16 -3.25 48.21 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.764 177.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.4 t70 59.52 24.34 13.04 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 123.377 1.56 . . . . 0.0 109.403 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.521 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 19.3 m -118.8 146.29 44.95 Favored 'General case' 0 N--CA 1.408 -2.53 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.183 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.415 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . 7.6 t70 -105.76 112.69 25.85 Favored 'General case' 0 N--CA 1.392 -3.366 0 C-N-CA 118.706 -1.197 . . . . 0.0 108.771 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 2.9 mp -100.77 130.25 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.807 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.678 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -106.12 132.13 52.56 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.8 tt -98.01 100.16 11.47 Favored 'General case' 0 N--CA 1.407 -2.576 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 173.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.38 112.53 23.67 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.621 ' HB3' HD11 ' A' ' 53' ' ' LEU . 55.4 t80 -139.77 85.17 2.02 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 176.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.9 t30 60.56 90.2 0.06 Allowed 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 125.365 1.466 . . . . 0.0 113.656 170.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.85 -48.13 3.99 Favored Glycine 0 C--N 1.311 -0.813 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.641 175.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.21 144.94 43.53 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 120.851 0.358 . . . . 0.0 111.909 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.11 147.35 50.95 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 176.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.8 p -120.8 143.59 32.46 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.76 -177.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.623 ' ND2' ' HE3' ' A' ' 45' ' ' LYS . 26.8 t-20 -61.55 110.23 1.41 Allowed 'General case' 0 C--O 1.208 -1.124 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 171.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.423 ' O ' HD13 ' A' ' 44' ' ' LEU . 3.4 tm? -60.37 -23.5 64.35 Favored 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -171.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.623 ' HE3' ' ND2' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -90.56 21.99 3.7 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.179 -0.951 . . . . 0.0 110.757 174.359 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.0 m -134.43 146.44 49.84 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.645 176.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.734 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -94.83 -20.11 6.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.289 -178.817 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 50.3 ttm -64.21 81.53 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 125.622 1.569 . . . . 0.0 110.115 175.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 137.43 -32.08 2.44 Favored Glycine 0 C--N 1.291 -1.927 0 CA-C-N 113.616 -1.629 . . . . 0.0 110.431 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 85.5 t -73.51 -35.76 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 69.8 mtm -64.0 -54.2 38.04 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.09 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.1 m -81.06 2.63 26.38 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.621 HD11 ' HB3' ' A' ' 37' ' ' TYR . 22.5 tp -39.75 -47.32 2.05 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 124.589 1.156 . . . . 0.0 113.286 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.73 34.19 25.54 Favored Glycine 0 N--CA 1.439 -1.128 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.416 ' HB ' HD23 ' A' ' 53' ' ' LEU . 0.8 OUTLIER -89.4 151.48 3.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -175.783 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -157.61 -170.72 22.76 Favored Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -64.03 138.71 58.59 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 117.97 0.885 . . . . 0.0 111.331 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.7 t70 79.88 -5.4 1.86 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.395 1.478 . . . . 0.0 111.328 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.57 123.08 21.68 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.584 176.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -98.55 116.86 31.69 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.6 -178.649 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.45 HG12 ' HB2' ' A' ' 6' ' ' TYR . 20.1 pt -110.73 137.42 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.18 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 5' ' ' SER . 85.1 m -108.49 112.98 25.66 Favored 'General case' 0 C--N 1.276 -2.588 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.37 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.612 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.3 mp -84.78 130.32 36.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.645 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 51.6 m-85 -117.06 106.83 13.8 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 173.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.639 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -101.4 117.04 34.15 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -128.62 115.75 18.55 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.521 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -172.67 -169.86 35.76 Favored Glycine 0 C--N 1.293 -1.84 0 C-N-CA 119.535 -1.317 . . . . 0.0 112.345 -175.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.4 t -81.9 -22.65 36.71 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -131.79 33.38 3.99 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.775 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -58.05 -35.91 72.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -175.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.55 -43.63 96.52 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.001 0.429 . . . . 0.0 110.78 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -82.62 -19.91 37.39 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.06 0.457 . . . . 0.0 109.945 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.62 -42.32 98.19 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 30.4 mm -57.45 -45.45 85.72 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.347 173.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -60.82 -42.81 98.43 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.573 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.1 -47.95 75.41 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.439 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 33.4 mt -60.82 -48.32 89.37 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.912 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 13.6 p -58.04 -35.24 71.03 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.457 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 26.8 t70 -70.71 -52.84 18.37 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 120.875 0.369 . . . . 0.0 110.103 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.43 -27.61 40.91 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.435 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 77' ' ' ILE . 14.0 mt -79.89 -6.2 56.97 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 122.412 0.285 . . . . 0.0 110.64 177.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.1 t -102.92 -41.0 6.28 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 31.7 mmmt -65.35 -29.23 69.94 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.372 0.606 . . . . 0.0 109.413 176.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -93.26 -17.31 23.79 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.874 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.22 49.7 60.36 Favored Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 115.524 -0.762 . . . . 0.0 114.548 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.419 ' HA ' ' HB2' ' A' ' 10' ' ' ASP . 6.0 mp -88.56 -27.52 21.33 Favored 'General case' 0 CA--C 1.491 -1.307 0 C-N-CA 118.462 -1.295 . . . . 0.0 108.498 174.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.0 t -133.74 -171.01 2.62 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 . . . . . 0 C--N 1.301 -1.522 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.01 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.552 ' HG3' ' HA ' ' A' ' 66' ' ' ASP . 1.1 mpt? . . . . . 0 CA--C 1.49 -1.362 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.44 ' HG2' ' N ' ' A' ' 3' ' ' GLN . 36.7 tt0 -125.76 158.95 33.62 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.719 -172.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.794 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 12.4 pt20 -115.15 140.22 49.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 124.068 0.855 . . . . 0.0 110.824 173.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.401 ' O ' ' HA ' ' A' ' 62' ' ' THR . 73.5 mm-40 -121.09 107.76 13.01 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.171 175.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.0 p -88.13 92.22 9.07 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-O 121.441 0.639 . . . . 0.0 109.544 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.458 ' HB2' ' CG1' ' A' ' 61' ' ' ILE . 80.8 m-85 -80.56 113.67 18.91 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.679 -176.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.8 m -91.09 102.12 14.86 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.491 HG21 ' O ' ' A' ' 55' ' ' VAL . 1.5 mp -71.93 122.9 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.862 0 CA-C-O 122.207 1.003 . . . . 0.0 112.031 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.608 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -116.39 9.05 7.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 114.109 -1.405 . . . . 0.0 107.852 -177.596 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -123.93 158.7 31.38 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.422 -170.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -131.56 1.04 4.05 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.0 p -117.22 -36.0 3.89 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -175.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.57 -39.68 8.14 Favored Glycine 0 N--CA 1.425 -2.076 0 N-CA-C 106.215 -2.754 . . . . 0.0 106.215 174.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.81 78.19 0.3 Allowed 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.845 -1.177 . . . . 0.0 110.532 171.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.592 ' O ' ' HD2' ' A' ' 18' ' ' PRO . 0.7 OUTLIER -154.31 151.23 28.84 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 176.786 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.56 81.68 3.23 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -170.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -162.66 -47.47 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.206 1.002 . . . . 0.0 108.568 169.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.592 ' HD2' ' O ' ' A' ' 15' ' ' HIS . 84.0 Cg_exo -54.88 -24.56 39.42 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 121.849 1.7 . . . . 0.0 111.362 170.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.409 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -65.39 -21.24 66.65 Favored 'General case' 0 C--O 1.201 -1.474 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.048 177.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.41 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 8.3 m -70.11 -27.35 64.52 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-O 121.296 0.57 . . . . 0.0 110.032 177.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 48.5 ttm -69.46 -32.19 70.96 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 174.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.411 ' HB3' HD21 ' A' ' 44' ' ' LEU . 4.5 mm? -73.14 -36.95 66.77 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.172 -1.377 . . . . 0.0 110.306 175.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 45.0 t -55.96 -48.66 78.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -61.82 -58.36 8.28 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.585 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.581 ' O ' ' HB3' ' A' ' 28' ' ' LYS . 36.4 m -49.86 -43.57 49.22 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 176.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.73 -37.21 84.21 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.573 -0.705 . . . . 0.0 111.337 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.471 ' OG ' ' HB2' ' A' ' 45' ' ' LYS . 19.3 m -67.49 -32.36 73.13 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 122.022 0.915 . . . . 0.0 110.036 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.581 ' HB3' ' O ' ' A' ' 25' ' ' THR . 12.6 tmtt? -65.9 -33.57 76.12 Favored 'General case' 0 N--CA 1.424 -1.758 0 C-N-CA 126.196 1.798 . . . . 0.0 111.879 -176.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -96.37 150.12 20.94 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.885 -177.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.93 59.37 5.59 Favored 'General case' 0 CA--C 1.491 -1.314 0 CA-C-O 122.384 1.088 . . . . 0.0 108.96 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.561 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 40.9 m -150.83 141.31 22.49 Favored 'General case' 0 N--CA 1.41 -2.445 0 CA-C-N 114.021 -1.445 . . . . 0.0 108.439 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -98.15 99.43 10.68 Favored 'General case' 0 N--CA 1.394 -3.262 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.545 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 44.0 mt -84.91 124.76 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.875 0 CA-C-N 114.425 -1.262 . . . . 0.0 108.254 175.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -109.72 131.05 55.42 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 3.6 tt -97.77 124.82 42.28 Favored 'General case' 0 N--CA 1.402 -2.862 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.556 ' HB3' ' HB ' ' A' ' 62' ' ' THR . 0.8 OUTLIER -113.16 107.19 15.58 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -178.157 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.554 ' CD2' ' HG ' ' A' ' 53' ' ' LEU . 25.9 t80 -138.88 103.82 4.91 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.413 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 46.12 77.7 0.08 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.881 1.672 . . . . 0.0 113.155 173.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.21 -28.78 5.96 Favored Glycine 0 C--N 1.306 -1.122 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.233 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.453 ' HA ' ' HE3' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -105.32 113.5 27.12 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -179.272 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 18.7 ptpt -110.33 116.37 31.33 Favored 'General case' 0 N--CA 1.415 -2.187 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 168.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.9 p -130.03 146.07 34.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.697 -170.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.444 ' HB2' ' HB2' ' A' ' 46' ' ' SER . 19.7 m120 -58.27 112.39 1.53 Allowed 'General case' 0 C--O 1.197 -1.703 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 171.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.522 ' O ' HD23 ' A' ' 44' ' ' LEU . 5.4 tt -60.45 -29.0 68.76 Favored 'General case' 0 C--O 1.218 -0.568 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -170.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.471 ' HB2' ' OG ' ' A' ' 27' ' ' SER . 0.5 OUTLIER -85.67 -0.63 55.67 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.001 179.359 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.444 ' HB2' ' HB2' ' A' ' 43' ' ' ASN . 43.8 m -108.19 124.11 49.77 Favored 'General case' 0 N--CA 1.396 -3.168 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 175.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 pp -73.19 7.99 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -172.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 15.6 tpt -94.39 61.08 2.74 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 122.286 1.041 . . . . 0.0 109.232 -167.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.8 -41.67 0.81 Allowed Glycine 0 C--N 1.292 -1.885 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 -174.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 89.7 t -65.01 -35.01 74.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 114.884 -0.658 . . . . 0.0 110.968 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 49.2 ttm -77.3 0.83 20.7 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 121.196 0.522 . . . . 0.0 110.962 -177.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.2 m -104.27 6.72 35.61 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.011 0.434 . . . . 0.0 111.327 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.554 ' HG ' ' CD2' ' A' ' 37' ' ' TYR . 8.8 mp -78.89 105.91 10.54 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.194 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.72 -49.38 24.05 Favored Glycine 0 CA--C 1.495 -1.175 0 N-CA-C 106.795 -2.522 . . . . 0.0 106.795 169.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.491 ' O ' HG21 ' A' ' 8' ' ' ILE . 9.9 p 51.07 25.95 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.323 0 C-N-CA 126.816 2.046 . . . . 0.0 114.801 169.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.78 112.72 3.74 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.353 -0.927 . . . . 0.0 110.92 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? 49.14 154.29 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 C-N-CA 127.706 2.402 . . . . 0.0 115.664 -176.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.0 t70 68.82 -16.65 0.21 Allowed 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 126.054 1.742 . . . . 0.0 114.16 172.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.37 121.27 15.39 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 123.57 0.748 . . . . 0.0 112.326 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -102.8 97.7 7.81 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 175.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.458 ' CG1' ' HB2' ' A' ' 6' ' ' TYR . 29.8 pt -96.81 124.8 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.817 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -177.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' A' ' 36' ' ' GLU . 4.7 m -100.35 120.21 39.6 Favored 'General case' 0 C--N 1.283 -2.31 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.849 -176.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.6 mp -95.68 121.17 45.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 176.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.794 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 30.7 m-85 -104.92 123.9 48.55 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 174.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -111.19 103.01 11.39 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.552 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 10.9 t70 -113.37 103.21 11.07 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.561 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -166.74 -163.81 21.19 Favored Glycine 0 N--CA 1.423 -2.227 0 C-N-CA 119.424 -1.369 . . . . 0.0 112.751 -173.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.3 m -105.51 -7.69 18.5 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.409 0.623 . . . . 0.0 109.508 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -127.33 18.92 6.94 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.506 ' O ' HG12 ' A' ' 74' ' ' ILE 0.27 0.0 OUTLIER -52.43 -44.62 65.56 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 -171.184 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.65 -41.45 98.23 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.859 0.361 . . . . 0.0 111.433 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -78.05 -28.15 48.86 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 121.584 0.707 . . . . 0.0 109.866 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.469 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -64.98 -38.8 92.16 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.65 174.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 70' ' ' GLU . 33.8 mm -60.91 -47.05 95.19 Favored 'Isoleucine or valine' 0 C--O 1.254 1.317 0 CA-C-O 121.38 0.609 . . . . 0.0 109.973 175.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -51.74 -54.34 29.48 Favored 'General case' 0 N--CA 1.412 -2.367 0 C-N-CA 125.032 1.333 . . . . 0.0 109.716 176.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.42 ' O ' HG22 ' A' ' 80' ' ' VAL . . . -69.21 -45.09 70.74 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.467 HG22 ' HA ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -58.86 -40.14 79.3 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 C-N-CA 123.445 0.698 . . . . 0.0 111.054 -176.198 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.6 m -73.1 -37.6 66.66 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -61.38 -50.0 74.63 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.767 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.551 ' HA ' ' HG2' ' A' ' 83' ' ' LYS . 28.4 m -74.08 -32.25 32.26 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.35 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.996 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.42 HD22 ' CG ' ' A' ' 86' ' ' LEU . 15.3 mt -63.87 -45.05 91.14 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 121.388 -0.82 . . . . 0.0 111.353 175.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.9 p -63.19 -35.91 81.87 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.551 ' HG2' ' HA ' ' A' ' 80' ' ' VAL . 12.3 ptmm? -70.39 -30.94 67.97 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 80' ' ' VAL . 21.8 mm-40 -76.71 -27.16 55.37 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.436 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.88 -1.37 22.99 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.472 -0.871 . . . . 0.0 114.713 173.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.476 ' H ' HD23 ' A' ' 86' ' ' LEU . 1.2 pt? -99.62 26.87 5.76 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -177.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 35.8 m -148.41 109.68 4.36 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 121.652 -0.655 . . . . 0.0 110.016 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 C--O 1.255 1.386 0 C-N-CA 125.918 1.687 . . . . 0.0 112.173 -178.302 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.8 mtm . . . . . 0 CA--C 1.479 -1.75 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -113.17 147.9 36.49 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 176.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.731 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 15.6 pt20 -119.77 161.17 21.22 Favored 'General case' 0 N--CA 1.438 -1.031 0 O-C-N 123.802 0.689 . . . . 0.0 111.83 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.616 ' O ' ' HA ' ' A' ' 62' ' ' THR . 14.9 mm100 -141.16 138.0 33.09 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.167 -1.378 . . . . 0.0 108.279 174.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.8 t -100.58 131.27 46.58 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.56 ' HB2' HG12 ' A' ' 61' ' ' ILE . 57.8 m-85 -138.0 170.88 15.27 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -177.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.1 m -139.12 127.21 22.47 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 174.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.731 HG13 ' HA ' ' A' ' 86' ' ' LEU . 6.6 tt -82.8 147.22 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.542 -176.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.4 pt -133.69 26.87 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.531 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.3 OUTLIER -64.8 -38.59 91.5 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.436 -174.136 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.582 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 46.7 mt-10 68.82 4.08 4.27 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 176.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.5 m -109.29 -42.05 4.48 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.797 -0.564 . . . . 0.0 110.319 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 128.89 49.23 0.14 Allowed Glycine 0 C--N 1.303 -1.258 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 89.67 -53.55 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.21 0 C-N-CA 126.89 2.076 . . . . 0.0 109.923 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.532 ' O ' ' HD2' ' A' ' 18' ' ' PRO 0.386 56.6 p-80 53.02 99.26 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.137 -1.392 . . . . 0.0 112.269 -175.337 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.68 -30.6 22.59 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 -168.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.442 ' HD3' ' HA ' ' A' ' 17' ' ' ARG 0.314 26.1 mmt180 -62.39 -55.64 37.84 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -177.076 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.532 ' HD2' ' O ' ' A' ' 15' ' ' HIS . 61.4 Cg_exo -53.96 -37.73 86.05 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 121.85 1.7 . . . . 0.0 111.454 170.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.434 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -66.42 -19.61 65.84 Favored 'General case' 0 C--O 1.209 -1.063 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.154 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 29.7 m -77.12 -23.19 51.77 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.721 0.772 . . . . 0.0 108.954 176.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.4 ttt -71.63 -34.14 69.54 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 171.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.446 ' HA ' HD13 ' A' ' 22' ' ' LEU . 4.2 mm? -67.8 -37.21 81.7 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.655 173.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 76.7 t -54.99 -55.26 16.98 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.084 0 O-C-N 123.92 0.763 . . . . 0.0 108.986 173.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -60.24 -25.85 65.98 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 123.387 0.675 . . . . 0.0 112.089 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.409 ' HA ' ' NZ ' ' A' ' 28' ' ' LYS . 88.1 m -78.95 -61.87 1.88 Allowed 'General case' 0 N--CA 1.423 -1.799 0 O-C-N 122.18 -0.325 . . . . 0.0 110.372 177.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.25 -43.68 94.13 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -177.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.4 t -59.09 -30.62 68.22 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.644 0.778 . . . . 0.0 112.916 -174.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.409 ' NZ ' ' HA ' ' A' ' 25' ' ' THR 0.27 0.9 OUTLIER -87.35 2.76 49.37 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -178.076 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -97.92 142.83 29.17 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -70.57 -35.3 72.98 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.38 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.54 ' OG ' ' HA3' ' A' ' 67' ' ' GLY . 50.7 m -71.12 142.19 50.77 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.581 175.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -93.37 109.92 21.47 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-O 121.211 0.529 . . . . 0.0 112.014 -176.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.69 HD11 ' HB1' ' A' ' 73' ' ' ALA . 15.9 mt -89.29 120.69 38.4 Favored 'Isoleucine or valine' 0 C--O 1.254 1.319 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.999 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -113.92 146.81 39.54 Favored 'General case' 0 N--CA 1.415 -2.224 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.735 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 0.9 OUTLIER -101.49 131.05 47.83 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 177.611 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' A' ' 40' ' ' LYS . 8.3 tp10 -131.39 154.22 48.85 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 175.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -154.92 -25.96 0.12 Allowed 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 117.919 0.327 . . . . 0.0 110.724 178.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 172.85 77.75 0.0 OUTLIER 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.928 0.891 . . . . 0.0 109.011 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.31 -12.37 66.77 Favored Glycine 0 C--N 1.308 -0.992 0 CA-C-N 116.031 -0.531 . . . . 0.0 113.521 174.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 16.0 mmtp -113.14 114.64 27.08 Favored 'General case' 0 CA--C 1.471 -2.064 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 62.8 mttp -111.87 130.15 55.92 Favored 'General case' 0 N--CA 1.413 -2.292 0 CA-C-N 114.475 -1.238 . . . . 0.0 110.626 174.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.4 m -144.31 162.98 14.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.566 ' HB3' ' HE3' ' A' ' 45' ' ' LYS . 18.3 m120 -72.83 129.51 38.34 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 175.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 67.0 tp -70.76 -13.94 62.25 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-O 121.733 0.777 . . . . 0.0 111.832 -176.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.566 ' HE3' ' HB3' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -87.87 5.45 40.33 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.388 0.613 . . . . 0.0 110.377 176.17 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.1 t -106.09 109.85 21.92 Favored 'General case' 0 N--CA 1.416 -2.152 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.581 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -68.61 -30.57 47.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 27.9 ttt -57.43 -49.04 77.5 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 113.69 -1.596 . . . . 0.0 109.149 175.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.37 -47.0 89.03 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.968 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 91.5 t -57.99 -40.75 78.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 CA-C-O 120.737 0.303 . . . . 0.0 111.457 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -76.69 -9.61 58.79 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 120.161 -0.615 . . . . 0.0 111.669 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.3 m -80.33 -33.52 37.38 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 175.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 mp -73.18 -42.76 62.36 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.977 174.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.4 39.39 87.42 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.443 HG21 ' CG2' ' A' ' 61' ' ' ILE . 7.8 p -65.54 106.35 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.09 0 CA-C-O 121.162 0.506 . . . . 0.0 110.716 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.487 ' HA2' ' OD1' ' A' ' 10' ' ' ASP . . . -138.65 146.2 17.85 Favored Glycine 0 N--CA 1.429 -1.813 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.349 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.582 ' HB3' ' HA ' ' A' ' 11' ' ' GLU . 9.3 ptpp? 21.06 111.37 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.687 0 N-CA-C 117.233 2.308 . . . . 0.0 117.233 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.9 t70 74.8 -0.79 3.25 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.585 1.154 . . . . 0.0 111.97 176.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.4 116.84 10.29 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -81.88 135.68 35.4 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.718 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.56 HG12 ' HB2' ' A' ' 6' ' ' TYR . 19.4 pt -123.91 165.69 20.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 121.461 0.648 . . . . 0.0 111.155 -177.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 4' ' ' GLN . 84.1 m -136.74 118.31 14.88 Favored 'General case' 0 N--CA 1.408 -2.573 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 47.4 mm -96.83 127.76 48.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.731 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 29.7 m-85 -111.74 122.52 48.01 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 123.806 0.691 . . . . 0.0 110.745 177.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.08 112.7 25.8 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 173.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -104.65 106.16 16.54 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.54 ' HA3' ' OG ' ' A' ' 31' ' ' SER . . . -176.11 -166.77 33.97 Favored Glycine 0 C--N 1.296 -1.677 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.106 -174.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.0 m -105.19 -11.27 16.63 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.984 0.897 . . . . 0.0 108.667 172.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -112.45 20.6 16.51 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.219 178.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.65 -45.23 70.15 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -175.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.4 -36.89 81.57 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 122.566 0.346 . . . . 0.0 111.256 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -73.4 -43.61 60.15 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.35 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.69 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -60.4 -43.02 97.1 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.601 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.2 mm -57.71 -46.99 86.74 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 C-N-CA 123.626 0.771 . . . . 0.0 111.22 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -64.47 -38.63 91.68 Favored 'General case' 0 N--CA 1.411 -2.382 0 C-N-CA 124.031 0.932 . . . . 0.0 111.264 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.65 -35.4 77.21 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.37 0.605 . . . . 0.0 110.179 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.8 mm -62.01 -52.24 62.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 124.532 1.133 . . . . 0.0 113.046 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.3 m -56.99 -48.43 78.45 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 120.693 0.282 . . . . 0.0 110.289 -176.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -55.16 -50.26 69.74 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.194 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.9 m -75.08 -30.8 23.75 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 C-N-CA 120.422 -0.511 . . . . 0.0 112.267 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.412 HD22 ' HB2' ' A' ' 86' ' ' LEU . 25.2 mt -68.23 -37.0 80.37 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 87' ' ' THR . 23.2 t -85.54 -16.59 38.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.411 0.624 . . . . 0.0 109.99 178.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -71.17 -34.64 71.13 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 172.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -95.97 -172.65 2.63 Favored 'General case' 0 N--CA 1.418 -2.039 0 CA-C-N 113.273 -1.785 . . . . 0.0 109.905 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -101.61 19.17 51.43 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.243 -0.98 . . . . 0.0 112.748 -177.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.731 ' HA ' HG13 ' A' ' 8' ' ' ILE . 3.4 mp -93.81 -2.17 53.93 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 119.036 -1.065 . . . . 0.0 111.16 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 82' ' ' SER . 98.9 m -158.77 143.39 15.86 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 175.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.42 -1.936 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 172.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.589 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 55.1 ttp . . . . . 0 C--O 1.233 0.236 0 N-CA-C 111.263 0.097 . . . . 0.0 111.263 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -125.66 154.7 41.98 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 174.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.683 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 27.8 pt20 -106.4 143.7 34.15 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.553 0.692 . . . . 0.0 112.842 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' A' ' 62' ' ' THR . 14.1 mm100 -127.48 120.54 28.56 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.706 173.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.8 t -93.6 103.29 15.47 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.529 ' HB2' ' CG1' ' A' ' 61' ' ' ILE . 85.0 m-85 -99.11 112.43 24.57 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.737 -178.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 m -86.37 118.3 25.72 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 175.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.5 mt -98.35 130.61 46.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-O 121.437 0.637 . . . . 0.0 112.59 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.628 HG22 ' O ' ' A' ' 87' ' ' THR . 4.9 tp -95.02 -26.37 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.808 176.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -26.91 97.28 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 -166.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -70.01 -13.46 62.23 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 113.789 -1.55 . . . . 0.0 111.213 -176.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.1 m -66.24 -25.14 66.75 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.28 40.65 6.85 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.496 ' HB2' ' N ' ' A' ' 55' ' ' VAL . . . 90.75 72.05 0.0 OUTLIER 'General case' 0 CA--C 1.482 -1.648 0 C-N-CA 125.568 1.547 . . . . 0.0 112.28 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . 0.254 0.4 OUTLIER -73.97 98.2 2.99 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.568 -1.253 . . . . 0.0 111.1 173.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.52 -23.13 61.73 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.149 -1.387 . . . . 0.0 113.273 -174.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -64.0 -50.61 68.59 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 119.575 -0.85 . . . . 0.0 112.168 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.501 ' HB3' ' HB3' ' A' ' 84' ' ' GLU . 82.7 Cg_exo -55.15 -31.48 75.8 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 122.108 1.872 . . . . 0.0 111.253 171.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.594 ' O ' ' HB3' ' A' ' 22' ' ' LEU . . . -72.25 -22.17 61.27 Favored 'General case' 0 C--O 1.203 -1.346 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.806 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.411 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 3.6 m -75.49 -33.91 60.82 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 51.2 ttm -66.96 -38.59 86.37 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.654 ' HG ' HD21 ' A' ' 44' ' ' LEU . 59.1 tp -56.83 -47.69 79.74 Favored 'General case' 0 CA--C 1.477 -1.848 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.121 174.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 19' ' ' ALA . 13.2 t -53.55 -48.24 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.542 0 CA-C-N 113.503 -1.68 . . . . 0.0 110.607 -178.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.06 -29.79 70.19 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.488 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.7 m -74.3 -49.53 22.64 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -177.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.505 ' HA ' ' CD2' ' A' ' 29' ' ' PHE . . . -61.61 -31.27 71.34 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 174.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.6 m -56.24 -39.28 72.29 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 123.419 0.45 . . . . 0.0 111.766 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.48 7.62 40.37 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -177.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.505 ' CD2' ' HA ' ' A' ' 26' ' ' ALA . 12.7 m-85 -96.33 -16.99 21.0 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 54.29 17.12 1.41 Allowed 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 124.795 1.238 . . . . 0.0 113.955 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.497 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 53.2 m -102.8 160.82 14.26 Favored 'General case' 0 N--CA 1.412 -2.345 0 CA-C-O 121.081 0.467 . . . . 0.0 110.334 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.429 ' HA ' HD21 ' A' ' 43' ' ' ASN . 33.2 t70 -91.47 83.63 5.44 Favored 'General case' 0 N--CA 1.405 -2.702 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.5 HG23 HG23 ' A' ' 63' ' ' ILE . 84.6 mt -94.25 111.52 25.4 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 175.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -103.77 137.86 41.2 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 4.3 tt -101.72 111.48 23.75 Favored 'General case' 0 N--CA 1.392 -3.352 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -103.68 117.11 33.63 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 123.523 0.729 . . . . 0.0 109.278 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.555 ' HB3' HD11 ' A' ' 53' ' ' LEU . 15.5 t80 -135.26 90.58 2.64 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.182 177.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 43.7 64.93 1.11 Allowed 'General case' 0 C--O 1.244 0.769 0 C-N-CA 126.567 1.947 . . . . 0.0 113.13 176.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.76 -29.25 10.59 Favored Glycine 0 N--CA 1.432 -1.625 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.433 175.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -98.6 110.59 23.16 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.597 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 4.3 ptpp? -122.98 131.42 53.71 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 171.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.425 HG21 ' N ' ' A' ' 49' ' ' GLY . 11.6 p -146.63 158.63 10.58 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.54 ' OD1' ' HG2' ' A' ' 45' ' ' LYS . 23.0 t-20 -69.91 125.99 28.38 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 174.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.654 HD21 ' HG ' ' A' ' 22' ' ' LEU . 10.4 tt -62.81 -22.43 66.63 Favored 'General case' 0 N--CA 1.42 -1.936 0 C-N-CA 125.224 1.41 . . . . 0.0 114.209 -171.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.54 ' HG2' ' OD1' ' A' ' 43' ' ' ASN . 8.1 pttp -91.22 4.11 53.12 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 118.51 -1.276 . . . . 0.0 110.423 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.9 t -105.55 129.62 53.78 Favored 'General case' 0 N--CA 1.409 -2.499 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.314 174.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 pp -75.65 2.62 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 123.545 0.738 . . . . 0.0 111.804 -178.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 16.0 tpt -61.83 -48.35 80.97 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 113.35 -1.75 . . . . 0.0 110.186 -174.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.425 ' N ' HG21 ' A' ' 42' ' ' VAL . . . -108.45 -29.96 4.0 Favored Glycine 0 C--N 1.305 -1.171 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.428 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.1 t -61.52 -36.61 74.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -175.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 84.0 mtp -87.5 12.91 11.16 Favored 'General case' 0 C--O 1.22 -0.476 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.264 -178.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.9 m -124.86 5.48 8.06 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.555 HD11 ' HB3' ' A' ' 37' ' ' TYR . 8.2 tp -81.09 105.86 12.63 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.59 66.11 3.57 Favored Glycine 0 CA--C 1.508 -0.386 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 175.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.496 ' N ' ' HB2' ' A' ' 14' ' ' ALA . 4.6 p -89.48 97.82 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 CA-C-O 122.49 1.138 . . . . 0.0 111.452 -173.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.28 -153.99 9.45 Favored Glycine 0 N--CA 1.432 -1.586 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.455 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -61.51 136.06 57.89 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.9 t70 77.99 3.96 2.86 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.972 1.309 . . . . 0.0 111.444 175.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.93 118.74 14.09 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.404 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -95.19 108.34 20.46 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.529 ' CG1' ' HB2' ' A' ' 6' ' ' TYR . 11.4 pt -110.49 157.4 11.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.31 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 4' ' ' GLN . 61.4 m -133.08 124.25 27.25 Favored 'General case' 0 C--N 1.273 -2.74 0 CA-C-O 121.185 0.517 . . . . 0.0 110.986 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.533 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.4 mp -91.85 125.84 44.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 175.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.683 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 45.3 m-85 -110.42 106.76 16.22 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 171.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.589 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -105.37 113.32 26.82 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.208 -176.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -128.29 120.06 26.35 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.497 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -174.66 -172.25 39.55 Favored Glycine 0 CA--C 1.475 -2.419 0 C-N-CA 117.787 -2.149 . . . . 0.0 113.351 -172.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.4 p -73.86 -26.97 60.84 Favored 'General case' 0 N--CA 1.421 -1.913 0 C-N-CA 124.197 0.999 . . . . 0.0 111.002 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -134.63 21.88 3.62 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.465 ' O ' HG12 ' A' ' 74' ' ' ILE . 9.5 pt-20 -42.52 -52.8 4.61 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -172.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.523 ' O ' ' HB ' ' A' ' 74' ' ' ILE . . . -65.24 -42.74 93.07 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -173.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -84.73 -21.97 29.87 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.18 -39.98 95.14 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 172.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.523 ' HB ' ' O ' ' A' ' 71' ' ' ALA . 24.6 mm -56.26 -48.06 80.08 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 CA-C-O 121.731 0.777 . . . . 0.0 109.572 173.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.441 ' HA ' ' OE1' ' A' ' 75' ' ' GLN . 12.2 mm-40 -57.54 -39.49 76.75 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.117 -1.401 . . . . 0.0 111.998 -178.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.36 -41.82 17.76 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.422 HD12 HD13 ' A' ' 33' ' ' ILE . 4.8 tt -62.52 -32.75 56.32 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.082 0 CA-C-O 120.847 0.356 . . . . 0.0 111.199 -174.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.7 m -68.1 -28.45 67.36 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 120.854 0.359 . . . . 0.0 110.762 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.56 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 16.3 t70 -78.44 -47.55 17.26 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -175.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 23.8 m -66.0 -32.13 56.77 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.47 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.8 mt -67.37 -45.94 74.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.141 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.603 ' HA ' ' OG1' ' A' ' 87' ' ' THR . 22.7 t -62.97 -43.53 98.54 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.04 178.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 33.1 mmtp -64.72 -40.53 95.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.956 0.408 . . . . 0.0 110.67 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.501 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . 19.1 mm-40 -77.06 -17.46 58.74 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.06 53.87 2.43 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 120.644 -0.788 . . . . 0.0 111.867 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 79.9 mt -140.56 39.16 1.86 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 122.386 1.088 . . . . 0.0 108.124 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.628 ' O ' HG22 ' A' ' 9' ' ' ILE . 17.4 p -139.87 -155.03 0.55 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 175.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 . . . . . 0 C--N 1.307 -1.24 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 171.58 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.516 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 66.9 mtt . . . . . 0 CA--C 1.491 -1.303 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -98.84 149.63 22.7 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 172.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.757 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 23.7 pt20 -114.19 149.11 36.24 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -176.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.485 ' O ' ' HA ' ' A' ' 62' ' ' THR . 30.6 mm-40 -127.37 129.48 47.66 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 113.707 -1.588 . . . . 0.0 107.89 173.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.2 t -103.23 104.16 14.27 Favored 'General case' 0 N--CA 1.416 -2.147 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 175.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.49 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 31.3 m-85 -95.37 103.4 15.26 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.822 -176.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.2 m -79.61 89.35 5.12 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.52 HG23 ' H ' ' A' ' 10' ' ' ASP . 4.3 mt -69.41 138.2 22.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 114.779 -1.1 . . . . 0.0 113.098 -175.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 pp -96.12 -4.31 10.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.834 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.52 ' H ' HG23 ' A' ' 8' ' ' ILE . 6.5 t70 -59.04 125.82 25.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.177 176.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -124.11 19.33 9.13 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.7 m -87.1 -24.54 24.51 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 113.966 -1.47 . . . . 0.0 108.825 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.67 21.88 10.04 Favored Glycine 0 N--CA 1.434 -1.479 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -178.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.484 ' HB2' ' CG2' ' A' ' 55' ' ' VAL . . . 91.8 92.73 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.14 0 C-N-CA 127.069 2.148 . . . . 0.0 111.34 -178.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . 0.257 2.4 p-80 -69.99 95.81 0.98 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 122.532 1.158 . . . . 0.0 110.666 172.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.28 -29.63 64.07 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 113.36 -1.745 . . . . 0.0 114.407 -170.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.51 -51.26 52.4 Favored Pre-proline 0 CA--C 1.556 1.202 0 CA-C-O 119.147 -0.454 . . . . 0.0 110.241 -178.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -57.73 -37.2 97.46 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 121.758 1.639 . . . . 0.0 110.812 172.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.68 ' O ' ' HG ' ' A' ' 22' ' ' LEU . . . -66.01 -18.84 65.61 Favored 'General case' 0 C--O 1.197 -1.7 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.929 178.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.4 m -70.02 -24.57 63.31 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 49.7 ttm -78.26 -35.26 48.35 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 175.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -64.84 -37.58 88.11 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 176.308 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 45' ' ' LYS . 4.5 t -58.57 -47.43 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.107 176.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -66.18 -19.28 65.79 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.784 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 54.2 m -84.2 -50.38 7.95 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.99 -29.09 69.41 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.6 p -62.71 -19.02 63.49 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -114.09 -145.77 0.4 Allowed 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 69.63 13.23 8.21 Favored 'General case' 0 C--O 1.247 0.921 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 174.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 56.92 27.11 12.59 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.913 0.885 . . . . 0.0 112.648 170.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.528 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 19.3 m -142.69 156.29 45.01 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.806 -177.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -105.57 113.81 27.61 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 175.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 3.1 mp -97.74 126.16 50.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.144 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -104.78 143.84 32.57 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 3.9 tt -96.48 129.69 43.79 Favored 'General case' 0 N--CA 1.403 -2.776 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 173.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.691 ' HA ' ' O ' ' A' ' 40' ' ' LYS . 0.5 OUTLIER -130.2 119.83 23.56 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -150.31 103.12 3.13 Favored 'General case' 0 C--N 1.293 -1.879 0 O-C-N 122.304 -0.248 . . . . 0.0 111.246 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.0 t30 59.56 28.71 18.17 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.84 0.856 . . . . 0.0 111.329 171.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.48 -17.03 8.44 Favored Glycine 0 CA--C 1.495 -1.215 0 C-N-CA 119.821 -1.18 . . . . 0.0 111.608 -178.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.691 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 13.3 mmtp -77.63 140.19 39.6 Favored 'General case' 0 CA--C 1.481 -1.705 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 15.1 ptmm? -143.99 112.56 6.53 Favored 'General case' 0 N--CA 1.413 -2.292 0 CA-C-N 114.299 -1.319 . . . . 0.0 108.594 169.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.3 p -149.04 160.46 5.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.772 -174.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.519 ' ND2' ' HG2' ' A' ' 45' ' ' LYS . 15.6 t30 -66.47 109.0 2.58 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.534 HD11 HD11 ' A' ' 77' ' ' ILE . 3.4 tm? -62.73 -25.93 68.44 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.661 0.784 . . . . 0.0 112.713 -173.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.519 ' HG2' ' ND2' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -88.37 24.61 1.87 Allowed 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 122.249 1.024 . . . . 0.0 110.356 178.945 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 43' ' ' ASN . 52.0 m -122.29 125.94 47.07 Favored 'General case' 0 N--CA 1.4 -2.974 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.145 172.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.46 -23.24 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 47.0 ttp -58.75 -22.02 56.87 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.859 -1.519 . . . . 0.0 110.187 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -84.94 -67.33 1.42 Allowed Glycine 0 N--CA 1.423 -2.211 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 94.4 t -55.09 -40.7 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -175.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 34.5 ttm -77.19 -0.75 26.26 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-O 120.797 0.332 . . . . 0.0 111.537 -175.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 62.8 m -98.89 -19.07 17.56 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 121.692 -0.63 . . . . 0.0 111.748 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.53 ' HB2' ' CG2' ' A' ' 55' ' ' VAL . 4.7 mp -75.13 150.53 38.74 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.5 66.1 3.25 Favored Glycine 0 C--N 1.301 -1.364 0 N-CA-C 107.998 -2.041 . . . . 0.0 107.998 170.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.53 ' CG2' ' HB2' ' A' ' 53' ' ' LEU . 11.1 t -66.98 113.46 3.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 123.996 0.918 . . . . 0.0 110.194 -174.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 10' ' ' ASP . . . -162.22 111.57 0.48 Allowed Glycine 0 N--CA 1.432 -1.587 0 CA-C-O 119.44 -0.644 . . . . 0.0 111.94 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.3 pttp 39.31 -43.9 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.944 0 C-N-CA 129.766 3.226 . . . . 0.0 117.966 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -93.25 7.29 44.93 Favored 'General case' 0 C--N 1.285 -2.212 0 O-C-N 121.336 -0.852 . . . . 0.0 109.399 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.15 89.25 1.15 Allowed 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.173 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 35.5 mt-10 -94.58 93.03 7.35 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 174.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.5 pt -93.69 143.42 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.057 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.538 -174.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 4' ' ' GLN . 25.1 m -106.41 123.24 47.77 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-O 121.273 0.558 . . . . 0.0 109.983 -177.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.3 mp -100.5 129.54 51.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.182 176.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.757 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 38.0 m-85 -115.55 112.87 22.84 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 123.682 0.614 . . . . 0.0 109.925 174.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -106.29 119.88 40.4 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.516 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 26.1 t70 -131.44 117.06 18.31 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.528 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -173.91 -163.92 28.17 Favored Glycine 0 N--CA 1.425 -2.09 0 C-N-CA 119.524 -1.322 . . . . 0.0 112.736 -174.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.5 m -87.59 -22.32 24.84 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.844 0.831 . . . . 0.0 109.373 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -132.39 35.85 3.63 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.838 -177.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.414 ' OE1' ' HA ' ' A' ' 66' ' ' ASP . 11.3 pt-20 -64.28 -38.0 89.47 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -173.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.31 -30.37 68.42 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.136 0.493 . . . . 0.0 110.658 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -76.06 -39.39 55.56 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 177.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.47 -41.23 98.59 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.441 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.466 HD12 ' HG2' ' A' ' 4' ' ' GLN . 16.6 mm -51.71 -51.33 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.279 0.631 . . . . 0.0 111.235 177.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -65.32 -41.53 93.92 Favored 'General case' 0 N--CA 1.405 -2.716 0 C-N-CA 122.799 0.44 . . . . 0.0 110.46 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.464 ' O ' ' HB3' ' A' ' 79' ' ' ASP . . . -67.15 -38.67 85.91 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.578 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.534 HD11 HD11 ' A' ' 44' ' ' LEU . 5.1 tt -72.25 -35.03 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.025 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.856 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.5 m -66.6 -41.62 88.17 Favored 'General case' 0 C--O 1.253 1.285 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 174.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 76' ' ' ALA . 26.3 t70 -51.22 -55.0 20.31 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 114.199 -1.364 . . . . 0.0 110.975 176.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.409 ' HA ' ' HB3' ' A' ' 83' ' ' LYS . 35.0 m -70.42 -34.14 56.71 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.081 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.9 mp -61.89 -50.35 72.57 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 119.278 0.945 . . . . 0.0 110.949 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.6 p -63.46 -39.22 93.88 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.03 0.443 . . . . 0.0 111.58 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 80' ' ' VAL . 36.8 ttmt -59.25 -43.78 92.41 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 124.227 1.011 . . . . 0.0 109.665 176.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -86.22 5.99 31.65 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 124.473 1.109 . . . . 0.0 112.505 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.88 30.76 70.06 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 115.429 0.932 . . . . 0.0 115.429 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.4 mp -90.56 -34.68 15.42 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 118.436 1.118 . . . . 0.0 109.713 174.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 27.1 p -119.49 150.18 40.66 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 . . . . . 0 N--CA 1.424 -1.749 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.387 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.596 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 47.8 ttm . . . . . 0 CA--C 1.508 -0.649 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -139.46 151.81 46.51 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.706 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 2.2 pt20 -103.73 149.05 25.35 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 123.757 0.661 . . . . 0.0 111.243 176.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -138.25 103.68 4.99 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.323 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 48.9 m -91.34 120.16 31.98 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.528 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 73.6 m-85 -109.97 137.82 47.21 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 124.831 1.252 . . . . 0.0 111.726 -174.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.0 m -96.62 109.93 22.45 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 174.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.561 HG12 ' H ' ' A' ' 10' ' ' ASP . 10.8 tt -63.11 152.14 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.87 0 CA-C-O 121.1 0.476 . . . . 0.0 111.552 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.6 pt -116.12 -14.9 10.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 O-C-N 122.033 -0.417 . . . . 0.0 110.879 176.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.561 ' H ' HG12 ' A' ' 8' ' ' ILE . 28.8 t70 -76.39 135.22 39.47 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.356 0.598 . . . . 0.0 111.589 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.414 ' HG2' ' HB3' ' A' ' 57' ' ' LYS . 34.1 mt-10 . . . . . 0 C--N 1.299 -1.597 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.511 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.449 ' O ' ' HD2' ' A' ' 18' ' ' PRO 0.497 0.8 OUTLIER . . . . . 0 CA--C 1.521 -0.157 0 CA-C-O 122.282 1.039 . . . . 0.0 113.778 . . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.72 -31.84 69.99 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.209 -1.36 . . . . 0.0 113.98 -172.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.481 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 13.2 tpp180 -57.01 -56.07 37.32 Favored Pre-proline 0 CA--C 1.559 1.324 0 CA-C-O 118.669 -0.682 . . . . 0.0 112.193 -178.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.504 ' HA ' ' OE2' ' A' ' 84' ' ' GLU . 82.1 Cg_exo -48.83 -45.9 26.67 Favored 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 122.598 2.199 . . . . 0.0 112.347 172.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.44 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -65.36 -27.08 68.32 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.478 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.512 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 18.2 m -72.6 -28.81 63.01 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 61.7 mtt -71.62 -35.23 70.37 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 174.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 22' ' ' LEU . 4.0 mm? -60.22 -41.77 93.79 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.236 172.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.512 ' HB ' ' O ' ' A' ' 20' ' ' THR . 47.8 t -51.85 -56.15 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 O-C-N 124.458 1.099 . . . . 0.0 110.523 175.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -67.65 -26.99 66.49 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 120.812 0.339 . . . . 0.0 111.494 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.0 m -71.05 -52.7 17.98 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.02 -30.57 71.05 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.586 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.5 m -62.15 -31.02 71.46 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.74 8.09 45.08 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -173.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -101.73 150.73 22.83 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.56 176.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -63.37 -42.44 98.85 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 121.819 0.818 . . . . 0.0 108.966 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.521 ' OG ' ' HA3' ' A' ' 67' ' ' GLY . 13.3 m -71.88 149.24 45.35 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.722 -177.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -102.61 130.35 49.47 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.366 173.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.577 HG23 HG23 ' A' ' 63' ' ' ILE . 3.2 mp -108.21 126.04 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.085 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -98.82 136.3 39.04 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 174.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.703 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 40.4 tp -104.04 117.91 35.4 Favored 'General case' 0 C--N 1.277 -2.578 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -114.53 106.52 14.37 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-O 121.185 0.517 . . . . 0.0 110.226 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -131.23 94.58 3.6 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.077 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.6 t30 41.3 69.41 0.35 Allowed 'General case' 0 C--O 1.247 0.961 0 C-N-CA 125.902 1.681 . . . . 0.0 113.753 173.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.18 -26.69 23.57 Favored Glycine 0 CA--C 1.502 -0.749 0 C-N-CA 120.846 -0.693 . . . . 0.0 111.731 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.58 99.78 10.7 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 178.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.703 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -116.55 133.16 56.35 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-N 115.287 -0.869 . . . . 0.0 108.997 171.679 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 p -156.16 155.14 5.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.826 -172.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -62.56 118.17 7.22 Favored 'General case' 0 C--O 1.208 -1.12 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 169.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.7 tp -64.26 -20.13 65.85 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -90.39 3.27 54.24 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 119.332 -0.947 . . . . 0.0 111.024 175.111 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.3 m -115.55 136.19 53.33 Favored 'General case' 0 N--CA 1.415 -2.185 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.3 pp -81.79 9.35 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -173.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 49.7 ttp -88.82 60.13 5.38 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.681 1.229 . . . . 0.0 110.403 -170.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.51 -45.27 0.69 Allowed Glycine 0 N--CA 1.426 -1.97 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 -175.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.32 -34.71 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 114.649 -0.775 . . . . 0.0 111.713 -177.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -76.73 -16.62 59.44 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.778 -173.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.8 m -116.44 17.56 15.43 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.192 0.52 . . . . 0.0 109.643 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.1 tp -62.93 112.51 2.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.121 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.76 56.55 2.61 Favored Glycine 0 C--N 1.31 -0.863 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.081 -176.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.425 HG11 HG21 ' A' ' 61' ' ' ILE . 6.5 m -87.2 138.08 19.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-O 120.937 0.399 . . . . 0.0 112.013 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -158.02 134.92 4.08 Favored Glycine 0 C--O 1.207 -1.569 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.414 ' HB3' ' HG2' ' A' ' 11' ' ' GLU 0.317 14.7 ptmm? 20.12 -64.28 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.09 0 N-CA-C 118.604 2.816 . . . . 0.0 118.604 -176.391 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -77.14 -8.59 57.77 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.78 -0.575 . . . . 0.0 111.769 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.1 109.07 5.64 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.305 0.574 . . . . 0.0 112.27 -175.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.528 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 31.6 mt-10 -98.42 119.46 37.16 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 5' ' ' SER . 17.6 pt -106.16 142.94 17.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.717 -173.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.1 m -114.47 125.93 54.38 Favored 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.95 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.577 HG23 HG23 ' A' ' 33' ' ' ILE . 1.6 mp -99.97 135.33 36.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.706 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 40.5 m-85 -121.5 114.6 21.46 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 172.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.596 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -107.02 125.06 50.52 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -128.97 123.08 31.52 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 177.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.521 ' HA3' ' OG ' ' A' ' 31' ' ' SER . . . 178.36 -171.88 44.27 Favored Glycine 0 N--CA 1.429 -1.78 0 C-N-CA 120.226 -0.988 . . . . 0.0 111.421 -174.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.6 t -85.85 -13.43 48.01 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 174.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -128.82 37.85 4.03 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.646 -178.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.481 ' O ' HG12 ' A' ' 74' ' ' ILE 0.336 0.0 OUTLIER -67.34 -48.17 68.32 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 -173.774 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.17 -32.83 73.5 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.26 0.552 . . . . 0.0 111.026 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 17.2 t70 -74.83 -39.08 61.83 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.707 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.557 ' O ' ' HB ' ' A' ' 77' ' ' ILE . . . -61.71 -41.33 97.47 Favored 'General case' 0 C--O 1.201 -1.488 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 70' ' ' GLU . 28.1 mm -57.26 -49.53 79.58 Favored 'Isoleucine or valine' 0 C--O 1.248 0.974 0 C-N-CA 123.536 0.735 . . . . 0.0 111.271 176.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 18.9 pt20 -67.22 -31.06 71.18 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 120.452 -0.499 . . . . 0.0 112.196 -176.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.17 -42.26 38.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.333 0.587 . . . . 0.0 109.744 175.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.557 ' HB ' ' O ' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -56.32 -43.31 76.69 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 C-N-CA 124.701 1.2 . . . . 0.0 111.758 179.783 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 56.2 m -63.51 -44.69 93.58 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -59.21 -53.54 57.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.763 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.6 m -67.1 -37.73 79.84 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.016 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.795 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.428 HD22 ' HB2' ' A' ' 86' ' ' LEU . 29.9 mt -65.47 -35.26 80.38 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.3 p -75.65 -34.64 60.53 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.398 177.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -62.52 -39.08 92.4 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.528 0.68 . . . . 0.0 109.894 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.504 ' OE2' ' HA ' ' A' ' 18' ' ' PRO . 5.6 mm-40 -87.22 -3.98 59.07 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.962 -177.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.4 15.25 80.31 Favored Glycine 0 C--N 1.317 -0.504 0 N-CA-C 115.746 1.058 . . . . 0.0 115.746 173.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.533 ' HA ' HG13 ' A' ' 8' ' ' ILE . 4.9 mp -88.81 5.59 42.92 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 118.607 1.203 . . . . 0.0 110.474 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' A' ' 6' ' ' TYR . 10.2 t -163.23 156.12 18.83 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.5 176.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 N--CA 1.419 -2.004 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 167.18 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.603 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 90.2 mtp . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -103.58 151.04 23.37 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 174.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.678 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 16.8 pt20 -111.22 150.08 30.06 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-O 121.724 0.774 . . . . 0.0 112.744 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.497 ' O ' ' HA ' ' A' ' 62' ' ' THR . 8.5 mm-40 -128.67 119.46 24.72 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 114.014 -1.448 . . . . 0.0 109.288 176.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.5 t -98.72 97.31 8.57 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 176.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.484 ' OH ' HG23 ' A' ' 77' ' ' ILE . 56.9 m-85 -88.1 127.59 35.41 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.575 -176.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.4 m -88.84 90.1 8.27 Favored 'General case' 0 N--CA 1.409 -2.475 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 172.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.668 ' O ' ' HA ' ' A' ' 57' ' ' LYS . 8.4 mt -71.91 131.13 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.063 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 33.9 pt -125.65 23.3 3.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.576 ' HB2' ' HA ' ' A' ' 86' ' ' LEU . 25.1 t70 -71.4 104.68 3.28 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.572 -177.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 C--N 1.305 -1.368 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -174.891 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 . . . . . 0 C--O 1.24 0.586 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.12 -43.93 73.44 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.5 ' O ' HG22 ' A' ' 20' ' ' THR 0.258 26.9 mmt180 -60.16 -47.66 96.24 Favored Pre-proline 0 N--CA 1.473 0.703 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 -178.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -53.76 -45.39 41.37 Favored 'Trans proline' 0 C--N 1.363 1.324 0 C-N-CA 121.582 1.521 . . . . 0.0 110.401 174.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -67.74 -34.34 76.65 Favored 'General case' 0 C--O 1.205 -1.264 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.593 -178.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.5 HG22 ' O ' ' A' ' 17' ' ' ARG . 1.3 t -71.16 -28.12 64.04 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.183 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.2 mtm -78.37 -28.47 47.1 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 175.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.423 ' HB3' HD22 ' A' ' 44' ' ' LEU . 3.0 mm? -65.12 -42.4 93.96 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 170.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 55.7 t -56.45 -49.51 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.941 173.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.41 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 29.0 tt0 -59.37 -27.48 66.01 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.446 1.098 . . . . 0.0 111.715 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.425 ' O ' ' HD1' ' A' ' 29' ' ' PHE . 94.4 m -80.73 -56.55 4.07 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.62 86.13 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.242 -176.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.8 m -59.09 -29.14 67.12 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -119.05 14.1 13.09 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 -170.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.425 ' HD1' ' O ' ' A' ' 25' ' ' THR . 6.7 m-85 -99.33 9.94 42.38 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.248 -0.581 . . . . 0.0 112.207 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.5 t70 48.97 39.49 14.72 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 123.559 1.647 . . . . 0.0 110.486 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.475 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 21.7 m -143.35 141.22 30.86 Favored 'General case' 0 N--CA 1.393 -3.307 0 CA-C-N 112.897 -1.956 . . . . 0.0 107.18 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -95.64 98.73 10.71 Favored 'General case' 0 N--CA 1.391 -3.423 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 97.9 mt -93.1 125.42 45.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.888 177.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -119.9 147.08 45.16 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.448 ' HG ' HD11 ' A' ' 63' ' ' ILE . 4.3 tt -106.7 112.85 26.03 Favored 'General case' 0 N--CA 1.399 -2.986 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 41' ' ' LYS . 8.6 tp10 -98.76 116.11 30.27 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 175.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -141.08 108.01 5.42 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.354 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 42.02 77.91 0.05 Allowed 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 126.409 1.883 . . . . 0.0 113.476 173.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.33 -52.83 0.64 Allowed Glycine 0 N--CA 1.418 -2.542 0 C-N-CA 119.721 -1.228 . . . . 0.0 112.397 175.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.7 147.65 48.59 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 -173.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.586 ' HD3' ' H ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -103.9 131.48 51.07 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 113.696 -1.593 . . . . 0.0 108.766 177.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.9 p -125.98 137.84 56.46 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.753 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -54.44 125.06 18.04 Favored 'General case' 0 C--O 1.207 -1.144 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 172.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.423 HD22 ' HB3' ' A' ' 22' ' ' LEU . 0.7 OUTLIER -73.23 -14.34 61.32 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 121.633 0.73 . . . . 0.0 111.167 -174.368 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 0.1 OUTLIER -91.2 3.39 54.94 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 121.486 -0.759 . . . . 0.0 110.329 172.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 57.2 m -113.29 124.85 53.46 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.429 177.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.519 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -78.58 8.64 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 123.068 0.547 . . . . 0.0 112.413 -173.635 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 16.5 tpt -105.59 78.08 1.33 Allowed 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -168.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 135.75 -32.71 2.49 Favored Glycine 0 C--N 1.291 -1.958 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -173.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' A' ' 53' ' ' LEU . 88.0 t -80.97 -43.4 20.69 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 CA-C-N 114.965 -0.617 . . . . 0.0 110.529 178.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.5 mtt -65.65 -40.19 92.19 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 119.205 -0.998 . . . . 0.0 111.451 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.4 m -80.57 16.53 1.34 Allowed 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 176.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 7.7 tp -65.92 107.08 1.73 Allowed 'General case' 0 C--O 1.244 0.777 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.93 55.6 4.53 Favored Glycine 0 C--O 1.222 -0.635 0 N-CA-C 110.519 -1.033 . . . . 0.0 110.519 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.4 p -88.13 139.35 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -173.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -122.86 -83.03 0.62 Allowed Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 119.802 -1.189 . . . . 0.0 113.48 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.668 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -169.15 136.49 1.83 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -177.037 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.3 t70 74.83 4.81 4.36 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 123.033 1.397 . . . . 0.0 107.801 -171.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.18 108.61 7.08 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 113.345 -1.752 . . . . 0.0 109.818 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -83.36 110.81 18.45 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 123.627 0.579 . . . . 0.0 110.308 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.467 HG12 ' HB2' ' A' ' 6' ' ' TYR . 25.3 pt -106.09 143.44 17.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 174.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 4' ' ' GLN . 28.1 m -112.94 111.41 22.14 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 121.557 0.694 . . . . 0.0 111.405 -176.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.4 mp -89.56 135.4 26.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.416 177.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.678 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 34.2 m-85 -117.29 119.13 34.22 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 172.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -114.65 122.4 46.35 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.603 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 25.8 t70 -136.05 122.83 21.15 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.5 ' N ' ' HB3' ' A' ' 70' ' ' GLU . . . -178.29 -170.04 39.9 Favored Glycine 0 C--N 1.287 -2.155 0 C-N-CA 119.024 -1.56 . . . . 0.0 112.209 -173.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.0 m -76.83 -30.15 56.24 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.603 0.716 . . . . 0.0 109.31 175.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -124.06 30.17 6.2 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.097 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.556 ' O ' HG12 ' A' ' 74' ' ' ILE . 12.4 pt-20 -54.1 -42.96 69.98 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -175.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.85 -31.93 72.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.594 0.711 . . . . 0.0 110.906 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -83.32 -32.3 26.38 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.138 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.99 -28.74 68.5 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.941 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.556 HG12 ' O ' ' A' ' 70' ' ' GLU . 25.3 mm -54.04 -48.3 64.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 O-C-N 123.857 0.723 . . . . 0.0 110.85 175.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -68.44 -39.65 81.43 Favored 'General case' 0 N--CA 1.403 -2.781 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.86 -47.26 84.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.823 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.484 HG23 ' OH ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -66.74 -36.4 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.868 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.623 -179.615 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 41.0 m -68.03 -40.04 82.99 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 175.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.498 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 20.1 t70 -56.18 -56.15 24.41 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.904 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.1 m -61.76 -36.85 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 38.6 mt -63.47 -48.26 78.38 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.41 -0.218 . . . . 0.0 110.41 176.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.581 ' HA ' ' O ' ' A' ' 87' ' ' THR . 38.1 t -57.66 -47.37 82.47 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.224 0.61 . . . . 0.0 111.333 174.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 32.6 mmtp -57.58 -42.67 83.61 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.641 0.734 . . . . 0.0 110.489 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -77.66 -22.43 50.61 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.922 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.11 14.83 47.19 Favored Glycine 0 C--N 1.301 -1.389 0 C-N-CA 120.358 -0.925 . . . . 0.0 113.797 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.576 ' HA ' ' HB2' ' A' ' 10' ' ' ASP . 5.1 mp -87.05 -25.41 24.21 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.581 ' O ' ' HA ' ' A' ' 82' ' ' SER . 34.3 m -126.7 148.79 49.83 Favored 'General case' 0 N--CA 1.414 -2.233 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 176.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 . . . . . 0 C--N 1.301 -1.505 0 C-N-CA 123.604 0.762 . . . . 0.0 111.124 -176.926 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 mtm . . . . . 0 CA--C 1.504 -0.792 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 31.9 tt0 -100.78 141.45 33.65 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.631 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 3.8 pt20 -106.59 154.27 21.15 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -175.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' A' ' 62' ' ' THR . 28.4 mm-40 -138.53 127.52 23.93 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.458 -1.701 . . . . 0.0 107.367 172.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.7 p -103.6 103.4 13.33 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-O 121.741 0.782 . . . . 0.0 110.109 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.486 ' HB2' HG12 ' A' ' 61' ' ' ILE . 78.3 m-85 -104.69 164.64 11.62 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.716 -177.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.9 m -129.57 130.42 45.68 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 174.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.637 HG23 ' HA ' ' A' ' 57' ' ' LYS . 15.1 tt -90.93 153.71 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.638 0 C-N-CA 121.18 -0.208 . . . . 0.0 111.492 -175.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.438 HG23 ' HG2' ' A' ' 88' ' ' GLU . 36.4 pt -136.49 24.55 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 121.117 0.484 . . . . 0.0 110.667 177.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.469 ' H ' HG12 ' A' ' 8' ' ' ILE . 7.1 p-10 -65.75 -39.96 91.63 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.899 -177.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.438 ' HG2' ' HG2' ' A' ' 57' ' ' LYS . 36.8 mt-10 . . . . . 0 N--CA 1.477 0.912 0 C-N-CA 125.334 1.453 . . . . 0.0 112.191 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . 0.298 9.1 p80 . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.938 0.875 . . . . 0.0 112.945 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.94 80.09 4.39 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -173.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.516 ' H ' ' HD2' ' A' ' 18' ' ' PRO . 2.1 tmt_? -137.77 -51.21 0.02 OUTLIER Pre-proline 0 C--N 1.291 -1.963 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 172.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.516 ' HD2' ' H ' ' A' ' 17' ' ' ARG . 4.9 Cg_endo -53.27 -33.59 66.08 Favored 'Trans proline' 0 C--N 1.384 2.427 0 C-N-CA 121.343 1.362 . . . . 0.0 109.693 168.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.507 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -60.25 -27.8 67.52 Favored 'General case' 0 C--O 1.201 -1.49 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.58 178.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.5 m -65.82 -26.77 67.82 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.229 0.538 . . . . 0.0 110.471 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 55.9 tpp -71.76 -32.0 67.24 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.12 -30.37 63.58 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.197 176.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 19' ' ' ALA . 77.0 t -69.96 -39.9 78.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -70.26 -37.74 74.97 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.321 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.1 m -91.26 -66.79 0.9 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -172.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.657 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . . . -62.97 -32.64 74.01 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -171.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.4 m -61.49 -25.69 67.42 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.34 14.93 30.64 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -176.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.44 ' C ' ' H ' ' A' ' 31' ' ' SER . 28.8 m-85 -105.23 3.7 30.36 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.814 178.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.5 t70 68.78 -36.82 0.34 Allowed 'General case' 0 N--CA 1.507 2.406 0 C-N-CA 124.644 1.177 . . . . 0.0 113.187 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.508 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 19.9 m -58.95 148.95 28.61 Favored 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 125.261 1.424 . . . . 0.0 112.029 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -99.68 102.69 14.25 Favored 'General case' 0 N--CA 1.409 -2.513 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.927 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 2.6 mp -91.48 121.59 42.07 Favored 'Isoleucine or valine' 0 C--O 1.259 1.588 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.844 177.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -119.97 135.63 54.84 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 -174.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.528 HD12 HD13 ' A' ' 44' ' ' LEU . 5.8 tt -101.24 116.26 32.39 Favored 'General case' 0 N--CA 1.406 -2.656 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.451 ' HB3' ' HB ' ' A' ' 62' ' ' THR . 3.4 tm-20 -99.93 105.35 17.05 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.412 ' HB3' HD11 ' A' ' 53' ' ' LEU 0.285 1.2 t80 -110.3 79.83 1.25 Allowed 'General case' 0 C--N 1.287 -2.134 0 CA-C-O 122.149 0.976 . . . . 0.0 110.476 175.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 34.81 79.95 0.03 OUTLIER 'General case' 0 C--O 1.238 0.476 0 CA-C-N 111.949 -2.387 . . . . 0.0 113.711 172.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 135.48 -61.72 0.62 Allowed Glycine 0 CA--C 1.484 -1.848 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.48 ' H ' ' HD2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -127.12 159.21 34.89 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-N 113.871 -1.164 . . . . 0.0 110.285 -174.18 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 38.3 ttpt -142.74 142.71 32.0 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.588 -173.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.68 HG21 ' HA3' ' A' ' 49' ' ' GLY . 10.4 p -151.33 160.16 3.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -61.57 132.72 54.25 Favored 'General case' 0 C--O 1.216 -0.679 0 C-N-CA 122.83 0.452 . . . . 0.0 111.329 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.528 HD13 HD12 ' A' ' 35' ' ' LEU . 34.2 tp -91.33 -15.63 28.77 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.773 0.797 . . . . 0.0 111.423 -178.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.657 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 16.0 pttp -90.06 1.91 55.81 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 122.075 0.94 . . . . 0.0 109.672 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 61.3 m -121.51 139.33 53.63 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-N 113.958 -1.474 . . . . 0.0 108.167 175.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.43 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -78.15 -27.56 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-O 121.611 0.72 . . . . 0.0 110.247 -175.373 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 53.8 ttp -68.19 91.91 0.38 Allowed 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 113.694 -1.594 . . . . 0.0 108.658 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.68 ' HA3' HG21 ' A' ' 42' ' ' VAL . . . 139.79 -58.52 0.59 Allowed Glycine 0 C--N 1.264 -3.458 0 CA-C-N 113.379 -1.737 . . . . 0.0 110.138 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.414 HG21 ' HA ' ' A' ' 44' ' ' LEU . 59.2 t -66.28 -33.95 66.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 114.629 -0.785 . . . . 0.0 112.376 -175.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 55.1 ttm -64.86 -52.17 58.06 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.011 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.2 m -69.25 -16.28 63.55 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 123.655 0.782 . . . . 0.0 112.897 177.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.51 HD21 HD22 ' A' ' 35' ' ' LEU . 11.2 tp -69.02 103.58 1.89 Allowed 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 123.899 0.88 . . . . 0.0 109.291 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.22 62.68 4.23 Favored Glycine 0 C--N 1.31 -0.873 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.893 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.467 ' HB ' HG21 ' A' ' 8' ' ' ILE . 1.2 m -56.94 -62.72 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 C-N-CA 122.187 0.195 . . . . 0.0 110.863 176.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 49.42 75.37 0.21 Allowed Glycine 0 CA--C 1.53 1.001 0 N-CA-C 116.004 1.162 . . . . 0.0 116.004 171.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.637 ' HA ' HG23 ' A' ' 8' ' ' ILE . 0.0 OUTLIER 43.16 -13.8 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.456 0 N-CA-C 119.589 3.181 . . . . 0.0 119.589 177.565 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -102.46 -8.7 20.87 Favored 'General case' 0 C--N 1.285 -2.225 0 O-C-N 121.242 -0.911 . . . . 0.0 109.802 -176.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.1 127.24 32.41 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -171.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -91.54 101.24 13.89 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 169.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.523 ' HB ' HD21 ' A' ' 35' ' ' LEU . 1.4 pt -104.87 126.56 59.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.731 -0.787 . . . . 0.0 109.918 -171.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.451 ' HB ' ' HB3' ' A' ' 36' ' ' GLU . 19.4 m -108.9 118.15 36.05 Favored 'General case' 0 C--N 1.287 -2.114 0 O-C-N 121.913 -0.492 . . . . 0.0 109.838 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.57 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.5 mp -88.71 132.78 32.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.631 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 38.9 m-85 -119.27 125.84 50.08 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.961 171.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.23 120.5 40.67 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.46 ' HA ' ' OE1' ' A' ' 70' ' ' GLU . 29.0 t70 -125.56 108.02 11.18 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.508 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -165.73 -172.89 33.65 Favored Glycine 0 N--CA 1.416 -2.645 0 C-N-CA 119.148 -1.501 . . . . 0.0 113.482 -171.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.3 p -78.75 -26.91 44.64 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 114.582 -0.809 . . . . 0.0 110.027 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -129.2 35.91 4.22 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.286 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.46 ' OE1' ' HA ' ' A' ' 66' ' ' ASP . 11.0 pt-20 -58.53 -36.18 73.44 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -175.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.84 -43.52 95.94 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 121.218 0.532 . . . . 0.0 110.497 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -76.28 -31.13 58.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.786 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.471 ' O ' ' HB ' ' A' ' 77' ' ' ILE . . . -64.27 -36.67 84.84 Favored 'General case' 0 C--O 1.205 -1.265 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.915 176.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.539 ' O ' HG22 ' A' ' 77' ' ' ILE . 25.8 mm -61.22 -43.65 96.86 Favored 'Isoleucine or valine' 0 C--O 1.251 1.143 0 C-N-CA 122.691 0.396 . . . . 0.0 110.784 175.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -53.04 62.68 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.64 -39.17 93.23 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.566 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.539 HG22 ' O ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -64.65 -40.61 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 C-N-CA 123.127 0.571 . . . . 0.0 110.607 -178.024 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.8 m -72.85 -33.91 66.43 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 24.1 t70 -63.26 -46.74 85.42 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.549 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.435 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 35.3 m -77.68 -23.5 14.19 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.262 0 C-N-CA 120.517 -0.473 . . . . 0.0 112.188 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 77' ' ' ILE . 23.6 mt -73.19 -48.02 38.7 Favored 'General case' 0 C--O 1.206 -1.185 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.588 174.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.7 p -61.3 -29.5 69.91 Favored 'General case' 0 C--N 1.316 -0.85 0 O-C-N 121.626 -0.671 . . . . 0.0 111.438 173.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 79' ' ' ASP . 18.4 ttmm -70.94 -39.57 72.55 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.909 176.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -104.53 -82.8 0.51 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -177.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -173.22 -156.9 13.68 Favored Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -176.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.447 ' HA ' HG13 ' A' ' 8' ' ' ILE . 3.2 mp 64.87 19.67 11.91 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 125.276 1.43 . . . . 0.0 112.3 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 60.3 m -154.45 156.89 37.58 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.438 ' HG2' HG23 ' A' ' 9' ' ' ILE . 41.7 mt-10 . . . . . 0 C--O 1.25 1.096 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.462 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 1.1 mpt? . . . . . 0 CA--C 1.502 -0.9 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -105.23 145.35 30.76 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 118.908 -1.117 . . . . 0.0 113.118 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.758 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 3.5 pt20 -111.82 151.88 28.54 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -172.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' A' ' 62' ' ' THR . 13.8 mm100 -137.16 131.57 32.74 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.224 -1.353 . . . . 0.0 108.369 173.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.8 t -98.71 121.29 40.47 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 82.4 m-85 -113.34 159.51 19.34 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 122.662 0.385 . . . . 0.0 110.933 -177.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.2 m -131.68 106.36 8.1 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 174.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.59 HG21 ' HB3' ' A' ' 59' ' ' ALA . 9.7 tp -66.83 144.96 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.603 0 C-N-CA 123.229 0.612 . . . . 0.0 110.353 -176.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.0 pt -109.52 -14.74 10.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-O 121.744 0.783 . . . . 0.0 109.154 174.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.471 ' O ' ' HA2' ' A' ' 56' ' ' GLY . 9.9 t70 -73.28 149.67 42.54 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.583 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 . . . . . 0 C--N 1.316 -0.877 0 CA-C-O 121.626 0.727 . . . . 0.0 109.516 178.158 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . 0.494 30.9 p-80 . . . . . 0 CA--C 1.542 0.652 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.47 -55.99 23.32 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 116.36 1.985 . . . . 0.0 116.36 -166.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.402 ' HD3' ' HA ' ' A' ' 17' ' ' ARG . 28.5 mmt180 -54.89 -53.41 61.27 Favored Pre-proline 0 N--CA 1.48 1.04 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -172.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.17 -37.44 83.56 Favored 'Trans proline' 0 C--N 1.36 1.175 0 C-N-CA 121.671 1.58 . . . . 0.0 110.978 177.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.511 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -68.81 -27.54 65.95 Favored 'General case' 0 C--O 1.21 -1.023 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.03 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.522 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 14.8 m -74.87 -27.46 60.26 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 97.0 mmm -71.23 -37.82 71.99 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 173.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.429 HD12 HD21 ' A' ' 44' ' ' LEU . 4.5 mm? -61.96 -35.98 80.07 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.442 172.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.522 ' HB ' ' O ' ' A' ' 20' ' ' THR . 52.9 t -56.43 -53.98 33.88 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.698 0 O-C-N 123.669 0.606 . . . . 0.0 109.72 174.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -64.04 -26.28 68.49 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-O 121.264 0.554 . . . . 0.0 111.218 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.567 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 37.1 m -79.55 -62.66 1.62 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.577 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.712 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . . . -67.52 -26.82 66.52 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -175.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 27.1 m -72.48 -10.83 60.27 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 177.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.567 ' HG3' ' O ' ' A' ' 25' ' ' THR . 0.0 OUTLIER -100.14 -2.7 33.43 Favored 'General case' 0 CA--C 1.504 -0.813 0 C-N-CA 119.514 -0.875 . . . . 0.0 112.369 179.213 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -99.09 144.65 28.0 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -88.02 65.52 8.26 Favored 'General case' 0 CA--C 1.484 -1.576 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 173.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.551 ' OG ' ' HA3' ' A' ' 67' ' ' GLY . 23.2 m -161.56 135.97 7.02 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-N 113.397 -1.729 . . . . 0.0 107.455 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -102.35 112.77 25.61 Favored 'General case' 0 C--N 1.278 -2.504 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.62 175.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.515 HG23 HG23 ' A' ' 63' ' ' ILE . 59.3 mt -80.58 112.59 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.002 0 CA-C-N 114.142 -1.39 . . . . 0.0 107.636 175.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 35.2 mt-30 -97.08 127.51 43.12 Favored 'General case' 0 N--CA 1.403 -2.814 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.662 HD22 HD21 ' A' ' 53' ' ' LEU . 1.6 tt -91.63 115.09 27.75 Favored 'General case' 0 N--CA 1.4 -2.946 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 176.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -110.11 113.19 25.68 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 124.947 1.299 . . . . 0.0 108.732 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -133.88 94.35 3.25 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-O 121.52 0.676 . . . . 0.0 110.638 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 50.89 67.68 0.9 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.524 -1.671 . . . . 0.0 112.166 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.4 -23.57 31.42 Favored Glycine 0 N--CA 1.438 -1.186 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.699 175.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 40' ' ' LYS . 10.1 mmtp -99.04 109.95 22.62 Favored 'General case' 0 CA--C 1.476 -1.879 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 6.5 ptpp? -114.93 128.21 56.15 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.806 175.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 34' ' ' GLN . 6.0 m -135.95 -175.18 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.937 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.536 ' HB2' ' HB2' ' A' ' 46' ' ' SER . 19.6 m120 -94.22 120.51 34.57 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.429 HD21 HD12 ' A' ' 22' ' ' LEU . 7.4 tt -74.12 -21.97 59.66 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-O 121.241 0.543 . . . . 0.0 111.381 -178.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.712 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 14.5 pttp -87.93 6.86 33.68 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 122.255 1.026 . . . . 0.0 109.647 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.536 ' HB2' ' HB2' ' A' ' 43' ' ' ASN . 73.7 m -117.14 133.64 55.75 Favored 'General case' 0 N--CA 1.398 -3.029 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.137 175.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.759 ' H ' HD12 ' A' ' 47' ' ' ILE . 1.4 mp -75.17 -38.01 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.209 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -172.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 44.3 ttm -51.7 -37.39 50.58 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 112.688 -2.051 . . . . 0.0 110.571 175.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.5 -60.43 3.48 Favored Glycine 0 N--CA 1.426 -2.02 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.885 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.438 HG22 HD12 ' A' ' 35' ' ' LEU . 90.7 t -57.49 -40.96 77.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 96.4 mmm -75.33 2.86 10.16 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 51.9 m -92.82 -21.38 19.93 Favored 'General case' 0 C--N 1.31 -1.11 0 O-C-N 122.061 -0.399 . . . . 0.0 110.607 176.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.662 HD21 HD22 ' A' ' 35' ' ' LEU . 6.9 mp -79.93 155.89 27.51 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.045 0.45 . . . . 0.0 110.704 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.16 69.22 0.79 Allowed Glycine 0 N--CA 1.426 -1.969 0 N-CA-C 107.5 -2.24 . . . . 0.0 107.5 169.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.5 t -77.25 80.72 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -175.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 10' ' ' ASP . . . -134.92 135.22 7.79 Favored Glycine 0 N--CA 1.425 -2.052 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt 28.08 -57.89 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 129.817 3.247 . . . . 0.0 118.837 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -90.11 -0.84 57.81 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.743 0.782 . . . . 0.0 110.581 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.59 ' HB3' HG21 ' A' ' 8' ' ' ILE . . . -72.24 96.72 1.86 Allowed 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 121.927 0.87 . . . . 0.0 112.569 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 36.0 mt-10 -92.58 105.6 17.74 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 175.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.5 HD12 HD21 ' A' ' 35' ' ' LEU . 29.3 pt -103.23 157.2 5.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.458 -172.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 4' ' ' GLN . 34.1 m -122.89 127.66 49.26 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-O 121.254 0.55 . . . . 0.0 109.762 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.758 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.4 mp -97.31 130.08 46.48 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 177.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.423 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 27.4 m-85 -116.8 107.04 14.14 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 123.733 0.646 . . . . 0.0 109.48 171.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -93.63 111.42 23.1 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -113.77 110.19 19.76 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.551 ' HA3' ' OG ' ' A' ' 31' ' ' SER . . . -174.05 -168.49 35.05 Favored Glycine 0 N--CA 1.41 -3.069 0 C-N-CA 118.93 -1.605 . . . . 0.0 113.819 -175.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.2 m -94.79 -17.18 22.36 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 175.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -119.05 18.55 13.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.401 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.46 ' O ' HG12 ' A' ' 74' ' ' ILE . 4.7 pt-20 -57.24 -37.66 72.62 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -174.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.91 -42.58 99.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.111 0.481 . . . . 0.0 111.052 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -78.99 -26.87 43.34 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.36 0.6 . . . . 0.0 109.508 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.59 -41.38 98.35 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.357 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 70' ' ' GLU . 35.4 mm -60.09 -46.26 94.61 Favored 'Isoleucine or valine' 0 C--O 1.255 1.384 0 CA-C-O 121.542 0.686 . . . . 0.0 109.745 175.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -58.59 -40.1 82.26 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.43 -1.259 . . . . 0.0 112.657 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.06 -44.48 17.96 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.5 HG13 HD13 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -59.25 -36.97 66.27 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.55 0 C-N-CA 123.59 0.756 . . . . 0.0 112.459 -173.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.7 p -73.74 -43.16 59.87 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.263 0.554 . . . . 0.0 110.248 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.547 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 24.5 t70 -60.8 -47.77 84.84 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.288 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.528 ' HA ' ' HG2' ' A' ' 83' ' ' LYS . 27.9 m -66.01 -39.21 83.91 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.516 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.928 177.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 81' ' ' LEU . 15.5 mt -64.12 -35.62 81.36 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 177.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.4 p -70.29 -44.97 67.26 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 118.345 0.521 . . . . 0.0 112.075 174.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.547 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 12.9 ptmm? -67.29 -28.26 67.86 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.684 177.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 80' ' ' VAL . 24.2 mm-40 -81.14 -26.46 36.08 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.056 0.455 . . . . 0.0 110.687 175.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.24 41.31 8.03 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 116.136 -0.484 . . . . 0.0 113.663 175.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.449 ' O ' HD12 ' A' ' 8' ' ' ILE . 8.8 mp -91.71 -46.41 7.92 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.183 176.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.2 t -101.84 168.69 9.27 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -176.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 C--N 1.309 -1.16 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 176.883 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.599 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 91.0 mtp . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -105.18 148.16 27.21 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 169.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.701 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 3.9 pt20 -107.16 143.34 35.49 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -132.88 99.92 4.75 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.032 174.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 49.1 m -87.91 116.2 25.91 Favored 'General case' 0 C--N 1.286 -2.175 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.428 176.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.497 ' HB2' HG12 ' A' ' 61' ' ' ILE . 78.3 m-85 -102.03 139.02 38.22 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.031 -173.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.9 m -101.65 100.54 10.94 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 171.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.692 ' O ' ' HA ' ' A' ' 57' ' ' LYS 0.262 3.0 mt -74.75 135.41 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 119.97 -0.692 . . . . 0.0 112.028 -179.014 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.9 pt -107.09 -7.39 10.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.334 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.514 ' H ' HG23 ' A' ' 8' ' ' ILE . 12.0 t70 -76.65 125.15 28.75 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.74 -178.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.7 mp0 . . . . . 0 C--N 1.318 -0.777 0 C-N-CA 120.536 -0.465 . . . . 0.0 111.977 178.772 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 . . . . . 0 C--O 1.219 -0.54 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.95 -76.33 0.59 Allowed 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.426 ' HD3' ' HA ' ' A' ' 17' ' ' ARG 0.257 33.9 mmt180 -69.36 -52.73 14.44 Favored Pre-proline 0 C--N 1.315 -0.911 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -176.392 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -59.55 -29.52 90.14 Favored 'Trans proline' 0 C--N 1.36 1.174 0 CA-C-N 120.838 1.335 . . . . 0.0 110.782 174.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.417 ' HA ' HD23 ' A' ' 22' ' ' LEU . . . -68.68 -28.45 66.88 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.231 176.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.401 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 57.1 m -70.59 -26.29 63.45 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 175.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 83.8 mtp -70.03 -31.84 69.68 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.457 HD21 HD21 ' A' ' 81' ' ' LEU . 4.1 mm? -66.32 -44.31 83.74 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 172.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' A' ' 20' ' ' THR . 84.4 t -54.01 -55.29 14.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 123.963 0.79 . . . . 0.0 109.497 174.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -53.41 -44.36 68.67 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 124.403 1.081 . . . . 0.0 112.317 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.1 m -81.31 -58.91 2.84 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -175.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.632 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . . . -64.86 -27.82 69.13 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -173.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.6 m -69.64 -16.11 63.31 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.256 0.0 OUTLIER -108.25 6.34 26.52 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 -175.606 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -101.43 137.62 39.52 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 174.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -84.78 73.07 10.67 Favored 'General case' 0 CA--C 1.496 -1.112 0 CA-C-O 122.749 1.262 . . . . 0.0 109.349 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.557 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 33.8 m -161.5 152.88 18.73 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 112.871 -1.968 . . . . 0.0 105.908 177.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -113.36 109.4 18.65 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.0 mp -89.87 125.57 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.272 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 -98.09 136.07 38.86 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.7 tp -99.94 114.94 28.54 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.62 ' HA ' ' O ' ' A' ' 40' ' ' LYS . 9.2 tt0 -111.66 136.34 51.02 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.706 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.448 ' CD2' ' HG ' ' A' ' 53' ' ' LEU . 50.7 t80 -165.24 104.5 0.75 Allowed 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 123.386 0.674 . . . . 0.0 110.572 178.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.7 t30 48.07 74.84 0.15 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.804 1.242 . . . . 0.0 113.025 176.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.98 -13.12 33.0 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 121.001 -0.618 . . . . 0.0 113.114 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -94.6 123.56 38.11 Favored 'General case' 0 CA--C 1.48 -1.729 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -179.588 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -119.57 113.42 20.68 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 169.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.7 p -143.53 167.14 13.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -175.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.552 HD21 ' HE3' ' A' ' 45' ' ' LYS . 19.3 t-20 -78.92 133.38 36.92 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 117.864 0.302 . . . . 0.0 111.184 -177.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.6 tp -75.97 -35.01 59.81 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.632 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -87.39 9.36 20.89 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.691 -178.358 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 75.6 m -106.68 125.01 50.46 Favored 'General case' 0 N--CA 1.392 -3.37 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 173.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.46 -25.47 38.44 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 CA-C-O 121.39 0.614 . . . . 0.0 111.636 -175.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 49.7 ttp -55.47 -27.04 45.85 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 125.429 1.492 . . . . 0.0 110.468 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.22 -60.62 4.35 Favored Glycine 0 N--CA 1.42 -2.423 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.515 178.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.0 t -64.04 -36.1 75.75 Favored 'Isoleucine or valine' 0 C--O 1.249 1.045 0 O-C-N 122.688 -0.301 . . . . 0.0 110.876 -176.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.2 mmt -57.84 -34.79 70.08 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.267 0.627 . . . . 0.0 112.237 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.1 p -85.03 -31.43 23.45 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.84 -175.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.448 ' HG ' ' CD2' ' A' ' 37' ' ' TYR . 11.0 mp -59.09 -61.95 2.25 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.95 0.405 . . . . 0.0 111.833 176.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.38 46.53 55.98 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 -171.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.6 p -69.88 123.68 24.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 C-N-CA 123.666 0.786 . . . . 0.0 111.586 -176.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.41 -172.24 14.69 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.692 ' HA ' ' O ' ' A' ' 8' ' ' ILE 0.272 55.0 pttt -64.88 136.02 56.38 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 118.226 1.013 . . . . 0.0 113.689 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t70 84.31 -7.1 1.02 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 126.32 1.848 . . . . 0.0 111.087 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.45 113.0 6.35 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.609 177.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -81.69 115.85 21.14 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.773 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.497 HG12 ' HB2' ' A' ' 6' ' ' TYR . 17.3 pt -116.04 160.07 15.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 5' ' ' SER . 98.6 m -129.18 128.04 42.57 Favored 'General case' 0 C--N 1.275 -2.648 0 CA-C-O 120.878 0.37 . . . . 0.0 110.305 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.4 mp -101.8 131.59 49.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.701 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 34.8 m-85 -121.56 113.76 20.24 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 123.574 0.547 . . . . 0.0 109.684 173.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.599 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -104.0 119.86 39.82 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.485 ' OD1' ' HG3' ' A' ' 1' ' ' MET . 15.7 t70 -126.08 115.43 19.82 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.557 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -179.22 -171.67 42.6 Favored Glycine 0 N--CA 1.431 -1.675 0 C-N-CA 119.952 -1.118 . . . . 0.0 113.171 -175.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.4 m -89.13 -7.18 56.23 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.474 0.654 . . . . 0.0 109.642 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -130.37 29.37 4.86 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.596 ' O ' HG12 ' A' ' 74' ' ' ILE . 9.7 pt-20 -69.21 -44.01 72.95 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -168.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.2 -31.88 69.53 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.212 0.529 . . . . 0.0 110.357 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -75.01 -33.58 61.83 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-O 121.556 0.693 . . . . 0.0 109.779 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.19 -36.15 82.31 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.969 176.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.596 HG12 ' O ' ' A' ' 70' ' ' GLU . 38.0 mm -54.1 -39.29 41.28 Favored 'Isoleucine or valine' 0 C--O 1.25 1.119 0 C-N-CA 123.503 0.721 . . . . 0.0 111.431 178.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -67.32 -44.26 79.58 Favored 'General case' 0 N--CA 1.402 -2.855 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.231 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.33 -39.36 47.93 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.485 -175.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.435 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -64.11 -41.78 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -178.367 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 33.0 m -67.78 -43.45 79.75 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.419 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 32.3 t70 -55.34 -48.13 74.66 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.3 m -67.22 -29.96 47.68 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.593 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.736 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.457 HD21 HD21 ' A' ' 22' ' ' LEU . 40.4 mt -79.56 -2.29 41.71 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.983 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 21.6 m -118.38 -16.36 9.6 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.437 0.637 . . . . 0.0 110.253 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 75.2 mmtt -78.46 -27.47 46.37 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 169.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -104.75 172.53 6.74 Favored 'General case' 0 N--CA 1.41 -2.431 0 CA-C-N 112.921 -1.945 . . . . 0.0 107.41 175.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -104.3 51.51 0.8 Allowed Glycine 0 C--N 1.291 -1.967 0 C-N-CA 119.893 -1.146 . . . . 0.0 113.364 -175.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.433 HD22 HD22 ' A' ' 81' ' ' LEU . 4.8 mp -92.74 -53.43 4.18 Favored 'General case' 0 C--O 1.213 -0.847 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.303 176.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.412 HG22 ' HB3' ' A' ' 81' ' ' LEU . 14.6 t -116.51 148.29 40.95 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.916 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 . . . . . 0 N--CA 1.429 -1.523 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.709 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.639 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 52.9 ttm . . . . . 0 CA--C 1.514 -0.415 0 N-CA-C 110.581 -0.155 . . . . 0.0 110.581 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -114.83 157.35 23.4 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 176.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.645 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 4.1 pt20 -111.35 153.96 25.24 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -142.36 103.73 4.31 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.697 -1.592 . . . . 0.0 107.59 173.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 50.2 m -91.49 89.45 7.21 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 122.293 1.044 . . . . 0.0 110.451 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 73.8 m-85 -72.87 130.02 39.47 Favored 'General case' 0 CA--C 1.488 -1.433 0 CA-C-N 113.493 -1.685 . . . . 0.0 112.146 -175.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.2 m -88.88 101.01 13.63 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 170.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.577 HG23 ' H ' ' A' ' 10' ' ' ASP . 4.5 mt -77.22 136.49 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.9 -178.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 35.4 pt -119.03 6.55 6.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.577 ' H ' HG23 ' A' ' 8' ' ' ILE . 31.2 t70 -71.39 127.11 31.48 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.505 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 C--N 1.298 -1.648 0 CA-C-O 121.609 0.718 . . . . 0.0 110.368 -179.225 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 . . . . . 0 CA--C 1.535 0.367 0 CA-C-O 121.349 0.595 . . . . 0.0 111.827 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.81 -34.42 66.86 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -170.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.432 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 13.9 tpp180 -63.45 -52.95 56.39 Favored Pre-proline 0 C--N 1.317 -0.839 0 C-N-CA 119.594 -0.842 . . . . 0.0 112.448 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.563 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 31.8 Cg_exo -66.72 -10.86 29.65 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 121.573 1.516 . . . . 0.0 112.645 174.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.429 ' HA ' HD23 ' A' ' 22' ' ' LEU . . . -74.54 -15.47 60.86 Favored 'General case' 0 C--O 1.216 -0.682 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.411 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 7.7 m -66.73 -27.16 67.39 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 174.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.563 ' SD ' ' HA ' ' A' ' 18' ' ' PRO . 1.4 mpt? -67.69 -34.88 77.76 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 174.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 19' ' ' ALA . 4.4 mm? -69.27 -38.1 78.21 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.938 175.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 81.9 t -55.69 -49.84 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 O-C-N 124.113 0.883 . . . . 0.0 109.351 175.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.12 -64.33 0.99 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.18 177.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.7 m -42.35 -63.16 0.8 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.734 1.214 . . . . 0.0 113.81 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . . . -66.05 -43.05 88.61 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -174.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.7 t -60.75 -39.09 87.41 Favored 'General case' 0 C--N 1.322 -0.594 0 O-C-N 123.27 0.356 . . . . 0.0 111.37 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.269 0.6 OUTLIER -82.5 3.0 30.11 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -174.198 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -95.16 -3.25 48.21 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.764 177.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.4 t70 59.52 24.34 13.04 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 123.377 1.56 . . . . 0.0 109.403 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.521 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 19.3 m -118.8 146.29 44.95 Favored 'General case' 0 N--CA 1.408 -2.53 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.183 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.415 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . 7.6 t70 -105.76 112.69 25.85 Favored 'General case' 0 N--CA 1.392 -3.366 0 C-N-CA 118.706 -1.197 . . . . 0.0 108.771 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 2.9 mp -100.77 130.25 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.807 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.678 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -106.12 132.13 52.56 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.8 tt -98.01 100.16 11.47 Favored 'General case' 0 N--CA 1.407 -2.576 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 173.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.38 112.53 23.67 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.621 ' HB3' HD11 ' A' ' 53' ' ' LEU . 55.4 t80 -139.77 85.17 2.02 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 176.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.9 t30 60.56 90.2 0.06 Allowed 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 125.365 1.466 . . . . 0.0 113.656 170.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.85 -48.13 3.99 Favored Glycine 0 C--N 1.311 -0.813 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.641 175.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.21 144.94 43.53 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 120.851 0.358 . . . . 0.0 111.909 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.11 147.35 50.95 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 176.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.8 p -120.8 143.59 32.46 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.76 -177.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.474 HD21 ' HG2' ' A' ' 45' ' ' LYS . 16.1 t30 -61.55 110.23 1.41 Allowed 'General case' 0 C--O 1.208 -1.124 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 171.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.423 HD13 ' O ' ' A' ' 44' ' ' LEU . 3.4 tm? -60.37 -23.5 64.35 Favored 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -171.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -90.56 21.99 3.7 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.179 -0.951 . . . . 0.0 110.757 174.359 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.0 m -134.43 146.44 49.84 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.645 176.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.734 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -94.83 -20.11 6.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.289 -178.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 50.3 ttm -64.21 81.53 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 125.622 1.569 . . . . 0.0 110.115 175.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 137.43 -32.08 2.44 Favored Glycine 0 C--N 1.291 -1.927 0 CA-C-N 113.616 -1.629 . . . . 0.0 110.431 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 85.5 t -73.51 -35.76 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 69.8 mtm -64.0 -54.2 38.04 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.09 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.1 m -81.06 2.63 26.38 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.621 HD11 ' HB3' ' A' ' 37' ' ' TYR . 22.5 tp -39.75 -47.32 2.05 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 124.589 1.156 . . . . 0.0 113.286 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.73 34.19 25.54 Favored Glycine 0 N--CA 1.439 -1.128 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.416 ' HB ' HD23 ' A' ' 53' ' ' LEU . 0.8 OUTLIER -89.4 151.48 3.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -175.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -157.61 -170.72 22.76 Favored Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -64.03 138.71 58.59 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 117.97 0.885 . . . . 0.0 111.331 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.7 t70 79.88 -5.4 1.86 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.395 1.478 . . . . 0.0 111.328 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.57 123.08 21.68 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.584 176.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -98.55 116.86 31.69 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.6 -178.649 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.45 HG12 ' HB2' ' A' ' 6' ' ' TYR . 20.1 pt -110.73 137.42 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.18 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 5' ' ' SER . 85.1 m -108.49 112.98 25.66 Favored 'General case' 0 C--N 1.276 -2.588 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.37 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.612 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.3 mp -84.78 130.32 36.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.645 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 51.6 m-85 -117.06 106.83 13.8 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 173.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.639 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -101.4 117.04 34.15 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -128.62 115.75 18.55 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.521 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -172.67 -169.86 35.76 Favored Glycine 0 C--N 1.293 -1.84 0 C-N-CA 119.535 -1.317 . . . . 0.0 112.345 -175.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.4 t -81.9 -22.65 36.71 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -131.79 33.38 3.99 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.775 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -58.05 -35.91 72.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -175.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.55 -43.63 96.52 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.001 0.429 . . . . 0.0 110.78 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -82.62 -19.91 37.39 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.06 0.457 . . . . 0.0 109.945 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.62 -42.32 98.19 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 30.4 mm -57.45 -45.45 85.72 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.347 173.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -60.82 -42.81 98.43 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.573 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.1 -47.95 75.41 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.439 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 33.4 mt -60.82 -48.32 89.37 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.912 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 13.6 p -58.04 -35.24 71.03 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.457 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 26.8 t70 -70.71 -52.84 18.37 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 120.875 0.369 . . . . 0.0 110.103 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.43 -27.61 40.91 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.435 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 77' ' ' ILE . 14.0 mt -79.89 -6.2 56.97 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 122.412 0.285 . . . . 0.0 110.64 177.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.1 t -102.92 -41.0 6.28 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 31.7 mmmt -65.35 -29.23 69.94 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.372 0.606 . . . . 0.0 109.413 176.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -93.26 -17.31 23.79 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.874 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.22 49.7 60.36 Favored Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 115.524 -0.762 . . . . 0.0 114.548 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.419 ' HA ' ' HB2' ' A' ' 10' ' ' ASP . 6.0 mp -88.56 -27.52 21.33 Favored 'General case' 0 CA--C 1.491 -1.307 0 C-N-CA 118.462 -1.295 . . . . 0.0 108.498 174.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.0 t -133.74 -171.01 2.62 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 . . . . . 0 C--N 1.301 -1.522 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.01 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.552 ' HG3' ' HA ' ' A' ' 66' ' ' ASP . 1.1 mpt? . . . . . 0 CA--C 1.49 -1.362 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.44 ' HG2' ' N ' ' A' ' 3' ' ' GLN . 36.7 tt0 -125.76 158.95 33.62 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.719 -172.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.794 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 12.4 pt20 -115.15 140.22 49.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 124.068 0.855 . . . . 0.0 110.824 173.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.401 ' O ' ' HA ' ' A' ' 62' ' ' THR . 73.5 mm-40 -121.09 107.76 13.01 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.171 175.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.0 p -88.13 92.22 9.07 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-O 121.441 0.639 . . . . 0.0 109.544 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.458 ' HB2' ' CG1' ' A' ' 61' ' ' ILE . 80.8 m-85 -80.56 113.67 18.91 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.679 -176.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.8 m -91.09 102.12 14.86 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.491 HG21 ' O ' ' A' ' 55' ' ' VAL . 1.5 mp -71.93 122.9 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.862 0 CA-C-O 122.207 1.003 . . . . 0.0 112.031 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.608 HD13 ' H ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -116.39 9.05 7.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 114.109 -1.405 . . . . 0.0 107.852 -177.596 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -123.93 158.7 31.38 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.422 -170.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 . . . . . 0 C--O 1.235 0.326 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 178.888 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.592 ' O ' ' HD2' ' A' ' 18' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.432 -1.326 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.56 81.68 3.23 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -170.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -162.66 -47.47 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.206 1.002 . . . . 0.0 108.568 169.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.592 ' HD2' ' O ' ' A' ' 15' ' ' HIS . 84.0 Cg_exo -54.88 -24.56 39.42 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 121.849 1.7 . . . . 0.0 111.362 170.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.409 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -65.39 -21.24 66.65 Favored 'General case' 0 C--O 1.201 -1.474 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.048 177.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.41 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 8.3 m -70.11 -27.35 64.52 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-O 121.296 0.57 . . . . 0.0 110.032 177.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 48.5 ttm -69.46 -32.19 70.96 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 174.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.411 ' HB3' HD21 ' A' ' 44' ' ' LEU . 4.5 mm? -73.14 -36.95 66.77 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.172 -1.377 . . . . 0.0 110.306 175.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 45.0 t -55.96 -48.66 78.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -61.82 -58.36 8.28 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.585 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.581 ' O ' ' HB3' ' A' ' 28' ' ' LYS . 36.4 m -49.86 -43.57 49.22 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 176.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.73 -37.21 84.21 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.573 -0.705 . . . . 0.0 111.337 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.471 ' OG ' ' HB2' ' A' ' 45' ' ' LYS . 19.3 m -67.49 -32.36 73.13 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 122.022 0.915 . . . . 0.0 110.036 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.581 ' HB3' ' O ' ' A' ' 25' ' ' THR . 12.6 tmtt? -65.9 -33.57 76.12 Favored 'General case' 0 N--CA 1.424 -1.758 0 C-N-CA 126.196 1.798 . . . . 0.0 111.879 -176.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -96.37 150.12 20.94 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.885 -177.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.93 59.37 5.59 Favored 'General case' 0 CA--C 1.491 -1.314 0 CA-C-O 122.384 1.088 . . . . 0.0 108.96 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.561 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 40.9 m -150.83 141.31 22.49 Favored 'General case' 0 N--CA 1.41 -2.445 0 CA-C-N 114.021 -1.445 . . . . 0.0 108.439 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -98.15 99.43 10.68 Favored 'General case' 0 N--CA 1.394 -3.262 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.545 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 44.0 mt -84.91 124.76 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.875 0 CA-C-N 114.425 -1.262 . . . . 0.0 108.254 175.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -109.72 131.05 55.42 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 3.6 tt -97.77 124.82 42.28 Favored 'General case' 0 N--CA 1.402 -2.862 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.556 ' HB3' ' HB ' ' A' ' 62' ' ' THR . 0.8 OUTLIER -113.16 107.19 15.58 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -178.157 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.554 ' CD2' ' HG ' ' A' ' 53' ' ' LEU . 25.9 t80 -138.88 103.82 4.91 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.413 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 46.12 77.7 0.08 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.881 1.672 . . . . 0.0 113.155 173.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.21 -28.78 5.96 Favored Glycine 0 C--N 1.306 -1.122 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.233 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.453 ' HA ' ' HE3' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -105.32 113.5 27.12 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -179.272 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 18.7 ptpt -110.33 116.37 31.33 Favored 'General case' 0 N--CA 1.415 -2.187 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 168.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.9 p -130.03 146.07 34.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.697 -170.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.444 ' HB2' ' HB2' ' A' ' 46' ' ' SER . 19.7 m120 -58.27 112.39 1.53 Allowed 'General case' 0 C--O 1.197 -1.703 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 171.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.522 HD23 ' O ' ' A' ' 44' ' ' LEU . 5.4 tt -60.45 -29.0 68.76 Favored 'General case' 0 C--O 1.218 -0.568 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -170.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.471 ' HB2' ' OG ' ' A' ' 27' ' ' SER . 0.5 OUTLIER -85.67 -0.63 55.67 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.001 179.359 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.444 ' HB2' ' HB2' ' A' ' 43' ' ' ASN . 43.8 m -108.19 124.11 49.77 Favored 'General case' 0 N--CA 1.396 -3.168 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 175.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 pp -73.19 7.99 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -172.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 15.6 tpt -94.39 61.08 2.74 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 122.286 1.041 . . . . 0.0 109.232 -167.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.8 -41.67 0.81 Allowed Glycine 0 C--N 1.292 -1.885 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 -174.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 89.7 t -65.01 -35.01 74.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 114.884 -0.658 . . . . 0.0 110.968 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 49.2 ttm -77.3 0.83 20.7 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 121.196 0.522 . . . . 0.0 110.962 -177.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.2 m -104.27 6.72 35.61 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.011 0.434 . . . . 0.0 111.327 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.554 ' HG ' ' CD2' ' A' ' 37' ' ' TYR . 8.8 mp -78.89 105.91 10.54 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.194 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.72 -49.38 24.05 Favored Glycine 0 CA--C 1.495 -1.175 0 N-CA-C 106.795 -2.522 . . . . 0.0 106.795 169.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.491 ' O ' HG21 ' A' ' 8' ' ' ILE . 9.9 p 51.07 25.95 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.323 0 C-N-CA 126.816 2.046 . . . . 0.0 114.801 169.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.78 112.72 3.74 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.353 -0.927 . . . . 0.0 110.92 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? 49.14 154.29 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 C-N-CA 127.706 2.402 . . . . 0.0 115.664 -176.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.0 t70 68.82 -16.65 0.21 Allowed 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 126.054 1.742 . . . . 0.0 114.16 172.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.37 121.27 15.39 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 123.57 0.748 . . . . 0.0 112.326 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -102.8 97.7 7.81 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 175.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.458 ' CG1' ' HB2' ' A' ' 6' ' ' TYR . 29.8 pt -96.81 124.8 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.817 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -177.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' A' ' 36' ' ' GLU . 4.7 m -100.35 120.21 39.6 Favored 'General case' 0 C--N 1.283 -2.31 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.849 -176.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.6 mp -95.68 121.17 45.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 176.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.794 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 30.7 m-85 -104.92 123.9 48.55 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 174.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -111.19 103.01 11.39 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.552 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 10.9 t70 -113.37 103.21 11.07 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.561 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -166.74 -163.81 21.19 Favored Glycine 0 N--CA 1.423 -2.227 0 C-N-CA 119.424 -1.369 . . . . 0.0 112.751 -173.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.3 m -105.51 -7.69 18.5 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.409 0.623 . . . . 0.0 109.508 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -127.33 18.92 6.94 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.506 ' O ' HG12 ' A' ' 74' ' ' ILE 0.27 0.0 OUTLIER -52.43 -44.62 65.56 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 -171.184 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.65 -41.45 98.23 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.859 0.361 . . . . 0.0 111.433 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -78.05 -28.15 48.86 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 121.584 0.707 . . . . 0.0 109.866 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.469 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -64.98 -38.8 92.16 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.65 174.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 70' ' ' GLU . 33.8 mm -60.91 -47.05 95.19 Favored 'Isoleucine or valine' 0 C--O 1.254 1.317 0 CA-C-O 121.38 0.609 . . . . 0.0 109.973 175.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -51.74 -54.34 29.48 Favored 'General case' 0 N--CA 1.412 -2.367 0 C-N-CA 125.032 1.333 . . . . 0.0 109.716 176.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.42 ' O ' HG22 ' A' ' 80' ' ' VAL . . . -69.21 -45.09 70.74 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.467 HG22 ' HA ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -58.86 -40.14 79.3 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 C-N-CA 123.445 0.698 . . . . 0.0 111.054 -176.198 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.6 m -73.1 -37.6 66.66 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -61.38 -50.0 74.63 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.767 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.551 ' HA ' ' HG2' ' A' ' 83' ' ' LYS . 28.4 m -74.08 -32.25 32.26 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.35 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.996 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.42 HD22 ' CG ' ' A' ' 86' ' ' LEU . 15.3 mt -63.87 -45.05 91.14 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 121.388 -0.82 . . . . 0.0 111.353 175.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.9 p -63.19 -35.91 81.87 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.551 ' HG2' ' HA ' ' A' ' 80' ' ' VAL . 12.3 ptmm? -70.39 -30.94 67.97 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 80' ' ' VAL . 21.8 mm-40 -76.71 -27.16 55.37 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.436 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.88 -1.37 22.99 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.472 -0.871 . . . . 0.0 114.713 173.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.476 HD23 ' H ' ' A' ' 86' ' ' LEU . 1.2 pt? -99.62 26.87 5.76 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -177.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 35.8 m -148.41 109.68 4.36 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 121.652 -0.655 . . . . 0.0 110.016 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 C--O 1.255 1.386 0 C-N-CA 125.918 1.687 . . . . 0.0 112.173 -178.302 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.8 mtm . . . . . 0 CA--C 1.479 -1.75 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -113.17 147.9 36.49 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 176.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.731 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 15.6 pt20 -119.77 161.17 21.22 Favored 'General case' 0 N--CA 1.438 -1.031 0 O-C-N 123.802 0.689 . . . . 0.0 111.83 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.616 ' O ' ' HA ' ' A' ' 62' ' ' THR . 14.9 mm100 -141.16 138.0 33.09 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.167 -1.378 . . . . 0.0 108.279 174.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.8 t -100.58 131.27 46.58 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.56 ' HB2' HG12 ' A' ' 61' ' ' ILE . 57.8 m-85 -138.0 170.88 15.27 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -177.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.1 m -139.12 127.21 22.47 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 174.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.731 HG13 ' HA ' ' A' ' 86' ' ' LEU . 6.6 tt -82.8 147.22 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.542 -176.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.4 pt -133.69 26.87 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.531 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.3 OUTLIER -64.8 -38.59 91.5 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.436 -174.136 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.582 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 46.7 mt-10 . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 176.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.532 ' O ' ' HD2' ' A' ' 18' ' ' PRO 0.386 56.6 p-80 . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 122.452 1.12 . . . . 0.0 112.269 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.68 -30.6 22.59 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 -168.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.442 ' HD3' ' HA ' ' A' ' 17' ' ' ARG 0.314 26.1 mmt180 -62.39 -55.64 37.84 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -177.076 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.532 ' HD2' ' O ' ' A' ' 15' ' ' HIS . 61.4 Cg_exo -53.96 -37.73 86.05 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 121.85 1.7 . . . . 0.0 111.454 170.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.434 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -66.42 -19.61 65.84 Favored 'General case' 0 C--O 1.209 -1.063 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.154 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 29.7 m -77.12 -23.19 51.77 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.721 0.772 . . . . 0.0 108.954 176.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.4 ttt -71.63 -34.14 69.54 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 171.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 22' ' ' LEU . 4.2 mm? -67.8 -37.21 81.7 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.655 173.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 76.7 t -54.99 -55.26 16.98 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.084 0 O-C-N 123.92 0.763 . . . . 0.0 108.986 173.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -60.24 -25.85 65.98 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 123.387 0.675 . . . . 0.0 112.089 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.409 ' HA ' ' NZ ' ' A' ' 28' ' ' LYS . 88.1 m -78.95 -61.87 1.88 Allowed 'General case' 0 N--CA 1.423 -1.799 0 O-C-N 122.18 -0.325 . . . . 0.0 110.372 177.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.25 -43.68 94.13 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -177.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.4 t -59.09 -30.62 68.22 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.644 0.778 . . . . 0.0 112.916 -174.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.409 ' NZ ' ' HA ' ' A' ' 25' ' ' THR 0.27 0.9 OUTLIER -87.35 2.76 49.37 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -178.076 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -97.92 142.83 29.17 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -70.57 -35.3 72.98 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.38 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.54 ' OG ' ' HA3' ' A' ' 67' ' ' GLY . 50.7 m -71.12 142.19 50.77 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.581 175.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -93.37 109.92 21.47 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-O 121.211 0.529 . . . . 0.0 112.014 -176.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.69 HD11 ' HB1' ' A' ' 73' ' ' ALA . 15.9 mt -89.29 120.69 38.4 Favored 'Isoleucine or valine' 0 C--O 1.254 1.319 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.999 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -113.92 146.81 39.54 Favored 'General case' 0 N--CA 1.415 -2.224 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.735 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 0.9 OUTLIER -101.49 131.05 47.83 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 177.611 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' A' ' 40' ' ' LYS . 8.3 tp10 -131.39 154.22 48.85 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 175.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -154.92 -25.96 0.12 Allowed 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 117.919 0.327 . . . . 0.0 110.724 178.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 172.85 77.75 0.0 OUTLIER 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.928 0.891 . . . . 0.0 109.011 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.31 -12.37 66.77 Favored Glycine 0 C--N 1.308 -0.992 0 CA-C-N 116.031 -0.531 . . . . 0.0 113.521 174.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 16.0 mmtp -113.14 114.64 27.08 Favored 'General case' 0 CA--C 1.471 -2.064 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 62.8 mttp -111.87 130.15 55.92 Favored 'General case' 0 N--CA 1.413 -2.292 0 CA-C-N 114.475 -1.238 . . . . 0.0 110.626 174.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.4 m -144.31 162.98 14.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.566 ' HB3' ' HE3' ' A' ' 45' ' ' LYS . 18.3 m120 -72.83 129.51 38.34 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 175.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 67.0 tp -70.76 -13.94 62.25 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-O 121.733 0.777 . . . . 0.0 111.832 -176.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.566 ' HE3' ' HB3' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -87.87 5.45 40.33 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.388 0.613 . . . . 0.0 110.377 176.17 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.1 t -106.09 109.85 21.92 Favored 'General case' 0 N--CA 1.416 -2.152 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.581 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -68.61 -30.57 47.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 27.9 ttt -57.43 -49.04 77.5 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 113.69 -1.596 . . . . 0.0 109.149 175.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.37 -47.0 89.03 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.968 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 91.5 t -57.99 -40.75 78.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 CA-C-O 120.737 0.303 . . . . 0.0 111.457 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -76.69 -9.61 58.79 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 120.161 -0.615 . . . . 0.0 111.669 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.3 m -80.33 -33.52 37.38 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 175.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 mp -73.18 -42.76 62.36 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.977 174.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.4 39.39 87.42 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.443 HG21 ' CG2' ' A' ' 61' ' ' ILE . 7.8 p -65.54 106.35 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.09 0 CA-C-O 121.162 0.506 . . . . 0.0 110.716 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.487 ' HA2' ' OD1' ' A' ' 10' ' ' ASP . . . -138.65 146.2 17.85 Favored Glycine 0 N--CA 1.429 -1.813 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.349 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.582 ' HB3' ' HA ' ' A' ' 11' ' ' GLU . 9.3 ptpp? 21.06 111.37 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.687 0 N-CA-C 117.233 2.308 . . . . 0.0 117.233 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.9 t70 74.8 -0.79 3.25 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.585 1.154 . . . . 0.0 111.97 176.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.4 116.84 10.29 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -81.88 135.68 35.4 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.718 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.56 HG12 ' HB2' ' A' ' 6' ' ' TYR . 19.4 pt -123.91 165.69 20.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 121.461 0.648 . . . . 0.0 111.155 -177.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 4' ' ' GLN . 84.1 m -136.74 118.31 14.88 Favored 'General case' 0 N--CA 1.408 -2.573 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 47.4 mm -96.83 127.76 48.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.731 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 29.7 m-85 -111.74 122.52 48.01 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 123.806 0.691 . . . . 0.0 110.745 177.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.08 112.7 25.8 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 173.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -104.65 106.16 16.54 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.54 ' HA3' ' OG ' ' A' ' 31' ' ' SER . . . -176.11 -166.77 33.97 Favored Glycine 0 C--N 1.296 -1.677 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.106 -174.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.0 m -105.19 -11.27 16.63 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.984 0.897 . . . . 0.0 108.667 172.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -112.45 20.6 16.51 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.219 178.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.65 -45.23 70.15 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -175.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.4 -36.89 81.57 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 122.566 0.346 . . . . 0.0 111.256 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -73.4 -43.61 60.15 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.35 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.69 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -60.4 -43.02 97.1 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.601 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.2 mm -57.71 -46.99 86.74 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 C-N-CA 123.626 0.771 . . . . 0.0 111.22 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -64.47 -38.63 91.68 Favored 'General case' 0 N--CA 1.411 -2.382 0 C-N-CA 124.031 0.932 . . . . 0.0 111.264 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.65 -35.4 77.21 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.37 0.605 . . . . 0.0 110.179 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.8 mm -62.01 -52.24 62.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 124.532 1.133 . . . . 0.0 113.046 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.3 m -56.99 -48.43 78.45 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 120.693 0.282 . . . . 0.0 110.289 -176.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -55.16 -50.26 69.74 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.194 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.9 m -75.08 -30.8 23.75 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 C-N-CA 120.422 -0.511 . . . . 0.0 112.267 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.412 HD22 ' HB2' ' A' ' 86' ' ' LEU . 25.2 mt -68.23 -37.0 80.37 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 87' ' ' THR . 23.2 t -85.54 -16.59 38.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.411 0.624 . . . . 0.0 109.99 178.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -71.17 -34.64 71.13 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 172.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -95.97 -172.65 2.63 Favored 'General case' 0 N--CA 1.418 -2.039 0 CA-C-N 113.273 -1.785 . . . . 0.0 109.905 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -101.61 19.17 51.43 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.243 -0.98 . . . . 0.0 112.748 -177.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.731 ' HA ' HG13 ' A' ' 8' ' ' ILE . 3.4 mp -93.81 -2.17 53.93 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 119.036 -1.065 . . . . 0.0 111.16 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 82' ' ' SER . 98.9 m -158.77 143.39 15.86 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 175.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.42 -1.936 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 172.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.589 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 55.1 ttp . . . . . 0 C--O 1.233 0.236 0 N-CA-C 111.263 0.097 . . . . 0.0 111.263 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -125.66 154.7 41.98 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 174.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.683 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 3.8 pt20 -106.4 143.7 34.15 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.553 0.692 . . . . 0.0 112.842 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' A' ' 62' ' ' THR . 14.1 mm100 -127.48 120.54 28.56 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.706 173.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.8 t -93.6 103.29 15.47 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.529 ' HB2' ' CG1' ' A' ' 61' ' ' ILE . 85.0 m-85 -99.11 112.43 24.57 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.737 -178.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 m -86.37 118.3 25.72 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 175.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.5 mt -98.35 130.61 46.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-O 121.437 0.637 . . . . 0.0 112.59 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.628 HG22 ' O ' ' A' ' 87' ' ' THR . 4.9 tp -95.02 -26.37 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.808 176.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -26.91 97.28 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 -166.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 C--N 1.313 -0.98 0 CA-C-N 113.789 -1.55 . . . . 0.0 111.213 -176.473 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . 0.254 0.4 OUTLIER . . . . . 0 N--CA 1.437 -1.107 0 CA-C-O 121.987 0.899 . . . . 0.0 111.1 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.52 -23.13 61.73 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.149 -1.387 . . . . 0.0 113.273 -174.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -64.0 -50.61 68.59 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 119.575 -0.85 . . . . 0.0 112.168 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.501 ' HB3' ' HB3' ' A' ' 84' ' ' GLU . 82.7 Cg_exo -55.15 -31.48 75.8 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 122.108 1.872 . . . . 0.0 111.253 171.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.594 ' O ' ' HB3' ' A' ' 22' ' ' LEU . . . -72.25 -22.17 61.27 Favored 'General case' 0 C--O 1.203 -1.346 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.806 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.411 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 3.6 m -75.49 -33.91 60.82 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 51.2 ttm -66.96 -38.59 86.37 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.654 ' HG ' HD21 ' A' ' 44' ' ' LEU . 59.1 tp -56.83 -47.69 79.74 Favored 'General case' 0 CA--C 1.477 -1.848 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.121 174.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 19' ' ' ALA . 13.2 t -53.55 -48.24 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.542 0 CA-C-N 113.503 -1.68 . . . . 0.0 110.607 -178.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.06 -29.79 70.19 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.488 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.7 m -74.3 -49.53 22.64 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -177.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.505 ' HA ' ' CD2' ' A' ' 29' ' ' PHE . . . -61.61 -31.27 71.34 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 174.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.6 m -56.24 -39.28 72.29 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 123.419 0.45 . . . . 0.0 111.766 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.48 7.62 40.37 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -177.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.505 ' CD2' ' HA ' ' A' ' 26' ' ' ALA . 12.7 m-85 -96.33 -16.99 21.0 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 54.29 17.12 1.41 Allowed 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 124.795 1.238 . . . . 0.0 113.955 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.497 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 53.2 m -102.8 160.82 14.26 Favored 'General case' 0 N--CA 1.412 -2.345 0 CA-C-O 121.081 0.467 . . . . 0.0 110.334 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.429 ' HA ' HD21 ' A' ' 43' ' ' ASN . 33.2 t70 -91.47 83.63 5.44 Favored 'General case' 0 N--CA 1.405 -2.702 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.5 HG23 HG23 ' A' ' 63' ' ' ILE . 84.6 mt -94.25 111.52 25.4 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 175.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -103.77 137.86 41.2 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 4.3 tt -101.72 111.48 23.75 Favored 'General case' 0 N--CA 1.392 -3.352 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -103.68 117.11 33.63 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 123.523 0.729 . . . . 0.0 109.278 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.555 ' HB3' HD11 ' A' ' 53' ' ' LEU . 15.5 t80 -135.26 90.58 2.64 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.182 177.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 43.7 64.93 1.11 Allowed 'General case' 0 C--O 1.244 0.769 0 C-N-CA 126.567 1.947 . . . . 0.0 113.13 176.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.76 -29.25 10.59 Favored Glycine 0 N--CA 1.432 -1.625 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.433 175.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -98.6 110.59 23.16 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.597 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 4.3 ptpp? -122.98 131.42 53.71 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 171.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.425 HG21 ' N ' ' A' ' 49' ' ' GLY . 11.6 p -146.63 158.63 10.58 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.54 ' OD1' ' HG2' ' A' ' 45' ' ' LYS . 23.0 t-20 -69.91 125.99 28.38 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 174.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.654 HD21 ' HG ' ' A' ' 22' ' ' LEU . 10.4 tt -62.81 -22.43 66.63 Favored 'General case' 0 N--CA 1.42 -1.936 0 C-N-CA 125.224 1.41 . . . . 0.0 114.209 -171.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.54 ' HG2' ' OD1' ' A' ' 43' ' ' ASN . 8.1 pttp -91.22 4.11 53.12 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 118.51 -1.276 . . . . 0.0 110.423 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.9 t -105.55 129.62 53.78 Favored 'General case' 0 N--CA 1.409 -2.499 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.314 174.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 pp -75.65 2.62 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 123.545 0.738 . . . . 0.0 111.804 -178.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 16.0 tpt -61.83 -48.35 80.97 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 113.35 -1.75 . . . . 0.0 110.186 -174.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.425 ' N ' HG21 ' A' ' 42' ' ' VAL . . . -108.45 -29.96 4.0 Favored Glycine 0 C--N 1.305 -1.171 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.428 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.1 t -61.52 -36.61 74.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -175.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 84.0 mtp -87.5 12.91 11.16 Favored 'General case' 0 C--O 1.22 -0.476 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.264 -178.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.9 m -124.86 5.48 8.06 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.555 HD11 ' HB3' ' A' ' 37' ' ' TYR . 8.2 tp -81.09 105.86 12.63 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.59 66.11 3.57 Favored Glycine 0 CA--C 1.508 -0.386 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 175.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.6 p -89.48 97.82 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 CA-C-O 122.49 1.138 . . . . 0.0 111.452 -173.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.28 -153.99 9.45 Favored Glycine 0 N--CA 1.432 -1.586 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.455 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -61.51 136.06 57.89 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.9 t70 77.99 3.96 2.86 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.972 1.309 . . . . 0.0 111.444 175.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.93 118.74 14.09 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.404 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -95.19 108.34 20.46 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.529 ' CG1' ' HB2' ' A' ' 6' ' ' TYR . 11.4 pt -110.49 157.4 11.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.31 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 4' ' ' GLN . 61.4 m -133.08 124.25 27.25 Favored 'General case' 0 C--N 1.273 -2.74 0 CA-C-O 121.185 0.517 . . . . 0.0 110.986 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.533 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.4 mp -91.85 125.84 44.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 175.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.683 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 45.3 m-85 -110.42 106.76 16.22 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 171.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.589 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -105.37 113.32 26.82 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.208 -176.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -128.29 120.06 26.35 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.497 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -174.66 -172.25 39.55 Favored Glycine 0 CA--C 1.475 -2.419 0 C-N-CA 117.787 -2.149 . . . . 0.0 113.351 -172.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.4 p -73.86 -26.97 60.84 Favored 'General case' 0 N--CA 1.421 -1.913 0 C-N-CA 124.197 0.999 . . . . 0.0 111.002 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -134.63 21.88 3.62 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.465 ' O ' HG12 ' A' ' 74' ' ' ILE . 9.5 pt-20 -42.52 -52.8 4.61 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -172.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.523 ' O ' ' HB ' ' A' ' 74' ' ' ILE . . . -65.24 -42.74 93.07 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -173.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -84.73 -21.97 29.87 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.18 -39.98 95.14 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 172.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.523 ' HB ' ' O ' ' A' ' 71' ' ' ALA . 24.6 mm -56.26 -48.06 80.08 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 CA-C-O 121.731 0.777 . . . . 0.0 109.572 173.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.441 ' HA ' ' OE1' ' A' ' 75' ' ' GLN . 12.2 mm-40 -57.54 -39.49 76.75 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.117 -1.401 . . . . 0.0 111.998 -178.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.36 -41.82 17.76 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.422 HD12 HD13 ' A' ' 33' ' ' ILE . 4.8 tt -62.52 -32.75 56.32 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.082 0 CA-C-O 120.847 0.356 . . . . 0.0 111.199 -174.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.7 m -68.1 -28.45 67.36 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 120.854 0.359 . . . . 0.0 110.762 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.56 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 16.3 t70 -78.44 -47.55 17.26 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -175.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 23.8 m -66.0 -32.13 56.77 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.47 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.8 mt -67.37 -45.94 74.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.141 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.603 ' HA ' ' OG1' ' A' ' 87' ' ' THR . 22.7 t -62.97 -43.53 98.54 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.04 178.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 33.1 mmtp -64.72 -40.53 95.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.956 0.408 . . . . 0.0 110.67 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.501 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . 19.1 mm-40 -77.06 -17.46 58.74 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.06 53.87 2.43 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 120.644 -0.788 . . . . 0.0 111.867 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 79.9 mt -140.56 39.16 1.86 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 122.386 1.088 . . . . 0.0 108.124 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.628 ' O ' HG22 ' A' ' 9' ' ' ILE . 17.4 p -139.87 -155.03 0.55 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 175.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 . . . . . 0 C--N 1.307 -1.24 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 171.58 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.516 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 66.9 mtt . . . . . 0 CA--C 1.491 -1.303 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -98.84 149.63 22.7 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 172.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.757 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 4.0 pt20 -114.19 149.11 36.24 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -176.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.485 ' O ' ' HA ' ' A' ' 62' ' ' THR . 30.6 mm-40 -127.37 129.48 47.66 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 113.707 -1.588 . . . . 0.0 107.89 173.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.2 t -103.23 104.16 14.27 Favored 'General case' 0 N--CA 1.416 -2.147 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 175.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.49 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 31.3 m-85 -95.37 103.4 15.26 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.822 -176.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.2 m -79.61 89.35 5.12 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.52 HG23 ' H ' ' A' ' 10' ' ' ASP . 4.3 mt -69.41 138.2 22.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 114.779 -1.1 . . . . 0.0 113.098 -175.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 pp -96.12 -4.31 10.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.834 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.52 ' H ' HG23 ' A' ' 8' ' ' ILE . 6.5 t70 -59.04 125.82 25.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.177 176.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 . . . . . 0 C--N 1.301 -1.521 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.087 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . 0.257 2.4 p-80 . . . . . 0 N--CA 1.446 -0.647 0 CA-C-O 122.532 1.158 . . . . 0.0 110.666 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.28 -29.63 64.07 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 113.36 -1.745 . . . . 0.0 114.407 -170.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.51 -51.26 52.4 Favored Pre-proline 0 CA--C 1.556 1.202 0 CA-C-O 119.147 -0.454 . . . . 0.0 110.241 -178.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -57.73 -37.2 97.46 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 121.758 1.639 . . . . 0.0 110.812 172.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.68 ' O ' ' HG ' ' A' ' 22' ' ' LEU . . . -66.01 -18.84 65.61 Favored 'General case' 0 C--O 1.197 -1.7 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.929 178.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.4 m -70.02 -24.57 63.31 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 49.7 ttm -78.26 -35.26 48.35 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 175.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -64.84 -37.58 88.11 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 176.308 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 45' ' ' LYS . 4.5 t -58.57 -47.43 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.107 176.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -66.18 -19.28 65.79 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.784 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 54.2 m -84.2 -50.38 7.95 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.99 -29.09 69.41 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.6 p -62.71 -19.02 63.49 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -114.09 -145.77 0.4 Allowed 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 69.63 13.23 8.21 Favored 'General case' 0 C--O 1.247 0.921 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 174.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 56.92 27.11 12.59 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.913 0.885 . . . . 0.0 112.648 170.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.528 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 19.3 m -142.69 156.29 45.01 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.806 -177.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -105.57 113.81 27.61 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 175.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 3.1 mp -97.74 126.16 50.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.144 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -104.78 143.84 32.57 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 3.9 tt -96.48 129.69 43.79 Favored 'General case' 0 N--CA 1.403 -2.776 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 173.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.691 ' HA ' ' O ' ' A' ' 40' ' ' LYS . 0.5 OUTLIER -130.2 119.83 23.56 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -150.31 103.12 3.13 Favored 'General case' 0 C--N 1.293 -1.879 0 O-C-N 122.304 -0.248 . . . . 0.0 111.246 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.0 t30 59.56 28.71 18.17 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.84 0.856 . . . . 0.0 111.329 171.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.48 -17.03 8.44 Favored Glycine 0 CA--C 1.495 -1.215 0 C-N-CA 119.821 -1.18 . . . . 0.0 111.608 -178.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.691 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 13.3 mmtp -77.63 140.19 39.6 Favored 'General case' 0 CA--C 1.481 -1.705 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 15.1 ptmm? -143.99 112.56 6.53 Favored 'General case' 0 N--CA 1.413 -2.292 0 CA-C-N 114.299 -1.319 . . . . 0.0 108.594 169.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.3 p -149.04 160.46 5.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.772 -174.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.519 ' ND2' ' HG2' ' A' ' 45' ' ' LYS . 15.6 t30 -66.47 109.0 2.58 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.534 HD11 HD11 ' A' ' 77' ' ' ILE . 3.4 tm? -62.73 -25.93 68.44 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.661 0.784 . . . . 0.0 112.713 -173.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.519 ' HG2' ' ND2' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -88.37 24.61 1.87 Allowed 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 122.249 1.024 . . . . 0.0 110.356 178.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 43' ' ' ASN . 52.0 m -122.29 125.94 47.07 Favored 'General case' 0 N--CA 1.4 -2.974 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.145 172.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.46 -23.24 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 47.0 ttp -58.75 -22.02 56.87 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.859 -1.519 . . . . 0.0 110.187 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -84.94 -67.33 1.42 Allowed Glycine 0 N--CA 1.423 -2.211 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 94.4 t -55.09 -40.7 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -175.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 34.5 ttm -77.19 -0.75 26.26 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-O 120.797 0.332 . . . . 0.0 111.537 -175.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 62.8 m -98.89 -19.07 17.56 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 121.692 -0.63 . . . . 0.0 111.748 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.53 ' HB2' ' CG2' ' A' ' 55' ' ' VAL . 4.7 mp -75.13 150.53 38.74 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.5 66.1 3.25 Favored Glycine 0 C--N 1.301 -1.364 0 N-CA-C 107.998 -2.041 . . . . 0.0 107.998 170.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.53 ' CG2' ' HB2' ' A' ' 53' ' ' LEU . 11.1 t -66.98 113.46 3.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 123.996 0.918 . . . . 0.0 110.194 -174.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 10' ' ' ASP . . . -162.22 111.57 0.48 Allowed Glycine 0 N--CA 1.432 -1.587 0 CA-C-O 119.44 -0.644 . . . . 0.0 111.94 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.3 pttp 39.31 -43.9 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.944 0 C-N-CA 129.766 3.226 . . . . 0.0 117.966 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -93.25 7.29 44.93 Favored 'General case' 0 C--N 1.285 -2.212 0 O-C-N 121.336 -0.852 . . . . 0.0 109.399 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.15 89.25 1.15 Allowed 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.173 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 35.5 mt-10 -94.58 93.03 7.35 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 174.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.5 pt -93.69 143.42 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.057 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.538 -174.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 4' ' ' GLN . 25.1 m -106.41 123.24 47.77 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-O 121.273 0.558 . . . . 0.0 109.983 -177.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.3 mp -100.5 129.54 51.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.182 176.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.757 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 38.0 m-85 -115.55 112.87 22.84 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 123.682 0.614 . . . . 0.0 109.925 174.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -106.29 119.88 40.4 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.516 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 26.1 t70 -131.44 117.06 18.31 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.528 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -173.91 -163.92 28.17 Favored Glycine 0 N--CA 1.425 -2.09 0 C-N-CA 119.524 -1.322 . . . . 0.0 112.736 -174.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.5 m -87.59 -22.32 24.84 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.844 0.831 . . . . 0.0 109.373 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -132.39 35.85 3.63 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.838 -177.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.414 ' OE1' ' HA ' ' A' ' 66' ' ' ASP . 11.3 pt-20 -64.28 -38.0 89.47 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -173.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.31 -30.37 68.42 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.136 0.493 . . . . 0.0 110.658 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -76.06 -39.39 55.56 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 177.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.47 -41.23 98.59 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.441 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.466 HD12 ' HG2' ' A' ' 4' ' ' GLN . 16.6 mm -51.71 -51.33 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.279 0.631 . . . . 0.0 111.235 177.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -65.32 -41.53 93.92 Favored 'General case' 0 N--CA 1.405 -2.716 0 C-N-CA 122.799 0.44 . . . . 0.0 110.46 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.464 ' O ' ' HB3' ' A' ' 79' ' ' ASP . . . -67.15 -38.67 85.91 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.578 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.534 HD11 HD11 ' A' ' 44' ' ' LEU . 5.1 tt -72.25 -35.03 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.025 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.856 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.5 m -66.6 -41.62 88.17 Favored 'General case' 0 C--O 1.253 1.285 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 174.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 76' ' ' ALA . 26.3 t70 -51.22 -55.0 20.31 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 114.199 -1.364 . . . . 0.0 110.975 176.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.409 ' HA ' ' HB3' ' A' ' 83' ' ' LYS . 35.0 m -70.42 -34.14 56.71 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.081 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.9 mp -61.89 -50.35 72.57 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 119.278 0.945 . . . . 0.0 110.949 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.6 p -63.46 -39.22 93.88 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.03 0.443 . . . . 0.0 111.58 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 80' ' ' VAL . 36.8 ttmt -59.25 -43.78 92.41 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 124.227 1.011 . . . . 0.0 109.665 176.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -86.22 5.99 31.65 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 124.473 1.109 . . . . 0.0 112.505 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.88 30.76 70.06 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 115.429 0.932 . . . . 0.0 115.429 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.4 mp -90.56 -34.68 15.42 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 118.436 1.118 . . . . 0.0 109.713 174.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 27.1 p -119.49 150.18 40.66 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 . . . . . 0 N--CA 1.424 -1.749 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.387 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.596 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 47.8 ttm . . . . . 0 CA--C 1.508 -0.649 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -139.46 151.81 46.51 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.706 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 2.2 pt20 -103.73 149.05 25.35 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 123.757 0.661 . . . . 0.0 111.243 176.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -138.25 103.68 4.99 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.323 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 48.9 m -91.34 120.16 31.98 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.528 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 73.6 m-85 -109.97 137.82 47.21 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 124.831 1.252 . . . . 0.0 111.726 -174.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.0 m -96.62 109.93 22.45 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 174.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.561 HG12 ' H ' ' A' ' 10' ' ' ASP . 10.8 tt -63.11 152.14 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.87 0 CA-C-O 121.1 0.476 . . . . 0.0 111.552 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.6 pt -116.12 -14.9 10.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 O-C-N 122.033 -0.417 . . . . 0.0 110.879 176.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.561 ' H ' HG12 ' A' ' 8' ' ' ILE . 28.8 t70 -76.39 135.22 39.47 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.356 0.598 . . . . 0.0 111.589 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.414 ' HG2' ' HB3' ' A' ' 57' ' ' LYS . 34.1 mt-10 -116.7 -5.22 11.6 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.511 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.8 m -70.51 -29.9 66.53 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.402 -177.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.44 33.26 0.83 Allowed Glycine 0 N--CA 1.435 -1.388 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.993 174.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 87.89 -53.81 0.04 OUTLIER 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 124.802 1.241 . . . . 0.0 112.008 174.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.449 ' O ' ' HD2' ' A' ' 18' ' ' PRO 0.497 0.8 OUTLIER 59.57 111.9 0.02 OUTLIER 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.542 1.137 . . . . 0.0 113.778 -173.602 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.72 -31.84 69.99 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.209 -1.36 . . . . 0.0 113.98 -172.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.481 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 13.2 tpp180 -57.01 -56.07 37.32 Favored Pre-proline 0 CA--C 1.559 1.324 0 CA-C-O 118.669 -0.682 . . . . 0.0 112.193 -178.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.504 ' HA ' ' OE2' ' A' ' 84' ' ' GLU . 82.1 Cg_exo -48.83 -45.9 26.67 Favored 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 122.598 2.199 . . . . 0.0 112.347 172.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.44 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -65.36 -27.08 68.32 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.478 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.512 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 18.2 m -72.6 -28.81 63.01 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 61.7 mtt -71.62 -35.23 70.37 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 174.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 22' ' ' LEU . 4.0 mm? -60.22 -41.77 93.79 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.236 172.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.512 ' HB ' ' O ' ' A' ' 20' ' ' THR . 47.8 t -51.85 -56.15 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 O-C-N 124.458 1.099 . . . . 0.0 110.523 175.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -67.65 -26.99 66.49 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 120.812 0.339 . . . . 0.0 111.494 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.0 m -71.05 -52.7 17.98 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.02 -30.57 71.05 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.586 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.5 m -62.15 -31.02 71.46 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.74 8.09 45.08 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -173.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -101.73 150.73 22.83 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.56 176.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -63.37 -42.44 98.85 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 121.819 0.818 . . . . 0.0 108.966 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.521 ' OG ' ' HA3' ' A' ' 67' ' ' GLY . 13.3 m -71.88 149.24 45.35 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.722 -177.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -102.61 130.35 49.47 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.366 173.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.577 HG23 HG23 ' A' ' 63' ' ' ILE . 3.2 mp -108.21 126.04 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.085 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -98.82 136.3 39.04 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 174.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.703 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 40.4 tp -104.04 117.91 35.4 Favored 'General case' 0 C--N 1.277 -2.578 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -114.53 106.52 14.37 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-O 121.185 0.517 . . . . 0.0 110.226 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -131.23 94.58 3.6 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.077 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.6 t30 41.3 69.41 0.35 Allowed 'General case' 0 C--O 1.247 0.961 0 C-N-CA 125.902 1.681 . . . . 0.0 113.753 173.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.18 -26.69 23.57 Favored Glycine 0 CA--C 1.502 -0.749 0 C-N-CA 120.846 -0.693 . . . . 0.0 111.731 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.58 99.78 10.7 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 178.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.703 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -116.55 133.16 56.35 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-N 115.287 -0.869 . . . . 0.0 108.997 171.679 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 p -156.16 155.14 5.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.826 -172.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -62.56 118.17 7.22 Favored 'General case' 0 C--O 1.208 -1.12 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 169.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.7 tp -64.26 -20.13 65.85 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -90.39 3.27 54.24 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 119.332 -0.947 . . . . 0.0 111.024 175.111 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.3 m -115.55 136.19 53.33 Favored 'General case' 0 N--CA 1.415 -2.185 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.3 pp -81.79 9.35 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -173.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 49.7 ttp -88.82 60.13 5.38 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.681 1.229 . . . . 0.0 110.403 -170.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.51 -45.27 0.69 Allowed Glycine 0 N--CA 1.426 -1.97 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 -175.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.32 -34.71 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 114.649 -0.775 . . . . 0.0 111.713 -177.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -76.73 -16.62 59.44 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.778 -173.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.8 m -116.44 17.56 15.43 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.192 0.52 . . . . 0.0 109.643 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.1 tp -62.93 112.51 2.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.121 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.76 56.55 2.61 Favored Glycine 0 C--N 1.31 -0.863 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.081 -176.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.425 HG11 HG21 ' A' ' 61' ' ' ILE . 6.5 m -87.2 138.08 19.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-O 120.937 0.399 . . . . 0.0 112.013 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -158.02 134.92 4.08 Favored Glycine 0 C--O 1.207 -1.569 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.414 ' HB3' ' HG2' ' A' ' 11' ' ' GLU 0.317 14.7 ptmm? 20.12 -64.28 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.09 0 N-CA-C 118.604 2.816 . . . . 0.0 118.604 -176.391 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -77.14 -8.59 57.77 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.78 -0.575 . . . . 0.0 111.769 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.1 109.07 5.64 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.305 0.574 . . . . 0.0 112.27 -175.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.528 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 31.6 mt-10 -98.42 119.46 37.16 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 5' ' ' SER . 17.6 pt -106.16 142.94 17.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.717 -173.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.1 m -114.47 125.93 54.38 Favored 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.95 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.577 HG23 HG23 ' A' ' 33' ' ' ILE . 1.6 mp -99.97 135.33 36.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.706 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 40.5 m-85 -121.5 114.6 21.46 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 172.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.596 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -107.02 125.06 50.52 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -128.97 123.08 31.52 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 177.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.521 ' HA3' ' OG ' ' A' ' 31' ' ' SER . . . 178.36 -171.88 44.27 Favored Glycine 0 N--CA 1.429 -1.78 0 C-N-CA 120.226 -0.988 . . . . 0.0 111.421 -174.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.6 t -85.85 -13.43 48.01 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 174.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -128.82 37.85 4.03 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.646 -178.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.481 ' O ' HG12 ' A' ' 74' ' ' ILE 0.336 0.0 OUTLIER -67.34 -48.17 68.32 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 -173.774 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.17 -32.83 73.5 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.26 0.552 . . . . 0.0 111.026 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 17.2 t70 -74.83 -39.08 61.83 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.707 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.557 ' O ' ' HB ' ' A' ' 77' ' ' ILE . . . -61.71 -41.33 97.47 Favored 'General case' 0 C--O 1.201 -1.488 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 70' ' ' GLU . 28.1 mm -57.26 -49.53 79.58 Favored 'Isoleucine or valine' 0 C--O 1.248 0.974 0 C-N-CA 123.536 0.735 . . . . 0.0 111.271 176.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 18.9 pt20 -67.22 -31.06 71.18 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 120.452 -0.499 . . . . 0.0 112.196 -176.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.17 -42.26 38.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.333 0.587 . . . . 0.0 109.744 175.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.557 ' HB ' ' O ' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -56.32 -43.31 76.69 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 C-N-CA 124.701 1.2 . . . . 0.0 111.758 179.783 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 56.2 m -63.51 -44.69 93.58 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -59.21 -53.54 57.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.763 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.6 m -67.1 -37.73 79.84 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.016 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.795 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.428 HD22 ' HB2' ' A' ' 86' ' ' LEU . 29.9 mt -65.47 -35.26 80.38 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.3 p -75.65 -34.64 60.53 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.398 177.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -62.52 -39.08 92.4 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.528 0.68 . . . . 0.0 109.894 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.504 ' OE2' ' HA ' ' A' ' 18' ' ' PRO . 5.6 mm-40 -87.22 -3.98 59.07 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.962 -177.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.4 15.25 80.31 Favored Glycine 0 C--N 1.317 -0.504 0 N-CA-C 115.746 1.058 . . . . 0.0 115.746 173.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.533 ' HA ' HG13 ' A' ' 8' ' ' ILE . 4.9 mp -88.81 5.59 42.92 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 118.607 1.203 . . . . 0.0 110.474 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' A' ' 6' ' ' TYR . 10.2 t -163.23 156.12 18.83 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.5 176.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 N--CA 1.419 -2.004 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 167.18 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.603 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 90.2 mtp . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -103.58 151.04 23.37 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 174.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.678 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 16.8 pt20 -111.22 150.08 30.06 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-O 121.724 0.774 . . . . 0.0 112.744 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.497 ' O ' ' HA ' ' A' ' 62' ' ' THR . 8.5 mm-40 -128.67 119.46 24.72 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 114.014 -1.448 . . . . 0.0 109.288 176.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.5 t -98.72 97.31 8.57 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 176.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.484 ' OH ' HG23 ' A' ' 77' ' ' ILE . 56.9 m-85 -88.1 127.59 35.41 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.575 -176.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.4 m -88.84 90.1 8.27 Favored 'General case' 0 N--CA 1.409 -2.475 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 172.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.668 ' O ' ' HA ' ' A' ' 57' ' ' LYS . 8.4 mt -71.91 131.13 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.063 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 33.9 pt -125.65 23.3 3.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.576 ' HB2' ' HA ' ' A' ' 86' ' ' LEU . 25.1 t70 -71.4 104.68 3.28 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.572 -177.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -79.7 -0.36 33.78 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -174.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 p -90.4 -7.03 54.22 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.336 0.589 . . . . 0.0 110.404 170.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.84 25.48 71.66 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.582 -0.736 . . . . 0.0 113.573 175.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 79.48 111.12 0.07 Allowed 'General case' 0 C--O 1.245 0.817 0 C-N-CA 124.442 1.097 . . . . 0.0 112.418 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -95.15 166.75 11.76 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.12 -43.93 73.44 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.5 ' O ' HG22 ' A' ' 20' ' ' THR 0.258 26.9 mmt180 -60.16 -47.66 96.24 Favored Pre-proline 0 N--CA 1.473 0.703 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 -178.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -53.76 -45.39 41.37 Favored 'Trans proline' 0 C--N 1.363 1.324 0 C-N-CA 121.582 1.521 . . . . 0.0 110.401 174.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -67.74 -34.34 76.65 Favored 'General case' 0 C--O 1.205 -1.264 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.593 -178.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.5 HG22 ' O ' ' A' ' 17' ' ' ARG . 1.3 t -71.16 -28.12 64.04 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.183 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.2 mtm -78.37 -28.47 47.1 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 175.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.423 ' HB3' HD22 ' A' ' 44' ' ' LEU . 3.0 mm? -65.12 -42.4 93.96 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 170.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 55.7 t -56.45 -49.51 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.941 173.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.41 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 29.0 tt0 -59.37 -27.48 66.01 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.446 1.098 . . . . 0.0 111.715 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.425 ' O ' ' HD1' ' A' ' 29' ' ' PHE . 94.4 m -80.73 -56.55 4.07 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.62 86.13 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.242 -176.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.8 m -59.09 -29.14 67.12 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -119.05 14.1 13.09 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 -170.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.425 ' HD1' ' O ' ' A' ' 25' ' ' THR . 6.7 m-85 -99.33 9.94 42.38 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.248 -0.581 . . . . 0.0 112.207 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.5 t70 48.97 39.49 14.72 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 123.559 1.647 . . . . 0.0 110.486 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.475 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 21.7 m -143.35 141.22 30.86 Favored 'General case' 0 N--CA 1.393 -3.307 0 CA-C-N 112.897 -1.956 . . . . 0.0 107.18 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -95.64 98.73 10.71 Favored 'General case' 0 N--CA 1.391 -3.423 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 97.9 mt -93.1 125.42 45.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.888 177.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -119.9 147.08 45.16 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.448 ' HG ' HD11 ' A' ' 63' ' ' ILE . 4.3 tt -106.7 112.85 26.03 Favored 'General case' 0 N--CA 1.399 -2.986 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 41' ' ' LYS . 8.6 tp10 -98.76 116.11 30.27 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 175.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -141.08 108.01 5.42 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.354 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 42.02 77.91 0.05 Allowed 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 126.409 1.883 . . . . 0.0 113.476 173.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.33 -52.83 0.64 Allowed Glycine 0 N--CA 1.418 -2.542 0 C-N-CA 119.721 -1.228 . . . . 0.0 112.397 175.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.7 147.65 48.59 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 -173.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.586 ' HD3' ' H ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -103.9 131.48 51.07 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 113.696 -1.593 . . . . 0.0 108.766 177.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.9 p -125.98 137.84 56.46 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.753 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -54.44 125.06 18.04 Favored 'General case' 0 C--O 1.207 -1.144 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 172.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.423 HD22 ' HB3' ' A' ' 22' ' ' LEU . 0.7 OUTLIER -73.23 -14.34 61.32 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 121.633 0.73 . . . . 0.0 111.167 -174.368 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 0.1 OUTLIER -91.2 3.39 54.94 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 121.486 -0.759 . . . . 0.0 110.329 172.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 57.2 m -113.29 124.85 53.46 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.429 177.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.519 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -78.58 8.64 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 123.068 0.547 . . . . 0.0 112.413 -173.635 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 16.5 tpt -105.59 78.08 1.33 Allowed 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -168.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 135.75 -32.71 2.49 Favored Glycine 0 C--N 1.291 -1.958 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -173.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' A' ' 53' ' ' LEU . 88.0 t -80.97 -43.4 20.69 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 CA-C-N 114.965 -0.617 . . . . 0.0 110.529 178.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.5 mtt -65.65 -40.19 92.19 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 119.205 -0.998 . . . . 0.0 111.451 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.4 m -80.57 16.53 1.34 Allowed 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 176.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 7.7 tp -65.92 107.08 1.73 Allowed 'General case' 0 C--O 1.244 0.777 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.93 55.6 4.53 Favored Glycine 0 C--O 1.222 -0.635 0 N-CA-C 110.519 -1.033 . . . . 0.0 110.519 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.4 p -88.13 139.35 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -173.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -122.86 -83.03 0.62 Allowed Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 119.802 -1.189 . . . . 0.0 113.48 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.668 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -169.15 136.49 1.83 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -177.037 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.3 t70 74.83 4.81 4.36 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 123.033 1.397 . . . . 0.0 107.801 -171.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.18 108.61 7.08 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 113.345 -1.752 . . . . 0.0 109.818 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -83.36 110.81 18.45 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 123.627 0.579 . . . . 0.0 110.308 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.467 HG12 ' HB2' ' A' ' 6' ' ' TYR . 25.3 pt -106.09 143.44 17.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 174.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 4' ' ' GLN . 28.1 m -112.94 111.41 22.14 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 121.557 0.694 . . . . 0.0 111.405 -176.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.4 mp -89.56 135.4 26.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.416 177.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.678 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 34.2 m-85 -117.29 119.13 34.22 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 172.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -114.65 122.4 46.35 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.603 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 25.8 t70 -136.05 122.83 21.15 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.5 ' N ' ' HB3' ' A' ' 70' ' ' GLU . . . -178.29 -170.04 39.9 Favored Glycine 0 C--N 1.287 -2.155 0 C-N-CA 119.024 -1.56 . . . . 0.0 112.209 -173.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.0 m -76.83 -30.15 56.24 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.603 0.716 . . . . 0.0 109.31 175.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -124.06 30.17 6.2 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.097 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.556 ' O ' HG12 ' A' ' 74' ' ' ILE . 12.4 pt-20 -54.1 -42.96 69.98 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -175.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.85 -31.93 72.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.594 0.711 . . . . 0.0 110.906 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -83.32 -32.3 26.38 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.138 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.99 -28.74 68.5 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.941 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.556 HG12 ' O ' ' A' ' 70' ' ' GLU . 25.3 mm -54.04 -48.3 64.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 O-C-N 123.857 0.723 . . . . 0.0 110.85 175.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -68.44 -39.65 81.43 Favored 'General case' 0 N--CA 1.403 -2.781 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.86 -47.26 84.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.823 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.484 HG23 ' OH ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -66.74 -36.4 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.868 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.623 -179.615 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 41.0 m -68.03 -40.04 82.99 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 175.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.498 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 20.1 t70 -56.18 -56.15 24.41 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.904 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.1 m -61.76 -36.85 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 38.6 mt -63.47 -48.26 78.38 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.41 -0.218 . . . . 0.0 110.41 176.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.581 ' HA ' ' O ' ' A' ' 87' ' ' THR . 38.1 t -57.66 -47.37 82.47 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.224 0.61 . . . . 0.0 111.333 174.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 32.6 mmtp -57.58 -42.67 83.61 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.641 0.734 . . . . 0.0 110.489 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -77.66 -22.43 50.61 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.922 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.11 14.83 47.19 Favored Glycine 0 C--N 1.301 -1.389 0 C-N-CA 120.358 -0.925 . . . . 0.0 113.797 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.576 ' HA ' ' HB2' ' A' ' 10' ' ' ASP . 5.1 mp -87.05 -25.41 24.21 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.581 ' O ' ' HA ' ' A' ' 82' ' ' SER . 34.3 m -126.7 148.79 49.83 Favored 'General case' 0 N--CA 1.414 -2.233 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 176.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 . . . . . 0 C--N 1.301 -1.505 0 C-N-CA 123.604 0.762 . . . . 0.0 111.124 -176.926 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 mtm . . . . . 0 CA--C 1.504 -0.792 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 31.9 tt0 -100.78 141.45 33.65 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.631 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 3.8 pt20 -106.59 154.27 21.15 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -175.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' A' ' 62' ' ' THR . 28.4 mm-40 -138.53 127.52 23.93 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.458 -1.701 . . . . 0.0 107.367 172.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.7 p -103.6 103.4 13.33 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-O 121.741 0.782 . . . . 0.0 110.109 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.486 ' HB2' HG12 ' A' ' 61' ' ' ILE . 78.3 m-85 -104.69 164.64 11.62 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.716 -177.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.9 m -129.57 130.42 45.68 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 174.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.637 HG23 ' HA ' ' A' ' 57' ' ' LYS . 15.1 tt -90.93 153.71 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.638 0 C-N-CA 121.18 -0.208 . . . . 0.0 111.492 -175.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.438 HG23 ' HG2' ' A' ' 88' ' ' GLU . 36.4 pt -136.49 24.55 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 121.117 0.484 . . . . 0.0 110.667 177.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.469 ' H ' HG12 ' A' ' 8' ' ' ILE . 7.1 p-10 -65.75 -39.96 91.63 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.899 -177.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.438 ' HG2' ' HG2' ' A' ' 57' ' ' LYS . 36.8 mt-10 65.61 6.66 3.95 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.334 1.453 . . . . 0.0 112.191 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.4 m -108.75 -37.99 5.74 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.268 0.556 . . . . 0.0 111.55 -172.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 117.25 40.19 0.76 Allowed Glycine 0 N--CA 1.427 -1.909 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.418 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . 93.37 -67.21 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.652 1.581 . . . . 0.0 114.14 175.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . 0.298 9.1 p80 49.02 107.11 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 125.4 1.48 . . . . 0.0 112.945 -172.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.94 80.09 4.39 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -173.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.516 ' H ' ' HD2' ' A' ' 18' ' ' PRO . 2.1 tmt_? -137.77 -51.21 0.02 OUTLIER Pre-proline 0 C--N 1.291 -1.963 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 172.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.516 ' HD2' ' H ' ' A' ' 17' ' ' ARG . 4.9 Cg_endo -53.27 -33.59 66.08 Favored 'Trans proline' 0 C--N 1.384 2.427 0 C-N-CA 121.343 1.362 . . . . 0.0 109.693 168.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.507 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -60.25 -27.8 67.52 Favored 'General case' 0 C--O 1.201 -1.49 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.58 178.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.5 m -65.82 -26.77 67.82 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.229 0.538 . . . . 0.0 110.471 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 55.9 tpp -71.76 -32.0 67.24 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.12 -30.37 63.58 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.197 176.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 19' ' ' ALA . 77.0 t -69.96 -39.9 78.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -70.26 -37.74 74.97 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.321 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.1 m -91.26 -66.79 0.9 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -172.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.657 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . . . -62.97 -32.64 74.01 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -171.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.4 m -61.49 -25.69 67.42 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.34 14.93 30.64 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -176.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.44 ' C ' ' H ' ' A' ' 31' ' ' SER . 28.8 m-85 -105.23 3.7 30.36 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.814 178.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.5 t70 68.78 -36.82 0.34 Allowed 'General case' 0 N--CA 1.507 2.406 0 C-N-CA 124.644 1.177 . . . . 0.0 113.187 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.508 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 19.9 m -58.95 148.95 28.61 Favored 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 125.261 1.424 . . . . 0.0 112.029 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -99.68 102.69 14.25 Favored 'General case' 0 N--CA 1.409 -2.513 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.927 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 2.6 mp -91.48 121.59 42.07 Favored 'Isoleucine or valine' 0 C--O 1.259 1.588 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.844 177.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -119.97 135.63 54.84 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 -174.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.528 HD12 HD13 ' A' ' 44' ' ' LEU . 5.8 tt -101.24 116.26 32.39 Favored 'General case' 0 N--CA 1.406 -2.656 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.451 ' HB3' ' HB ' ' A' ' 62' ' ' THR . 3.4 tm-20 -99.93 105.35 17.05 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.412 ' HB3' HD11 ' A' ' 53' ' ' LEU 0.285 1.2 t80 -110.3 79.83 1.25 Allowed 'General case' 0 C--N 1.287 -2.134 0 CA-C-O 122.149 0.976 . . . . 0.0 110.476 175.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 34.81 79.95 0.03 OUTLIER 'General case' 0 C--O 1.238 0.476 0 CA-C-N 111.949 -2.387 . . . . 0.0 113.711 172.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 135.48 -61.72 0.62 Allowed Glycine 0 CA--C 1.484 -1.848 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.48 ' H ' ' HD2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -127.12 159.21 34.89 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-N 113.871 -1.164 . . . . 0.0 110.285 -174.18 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 38.3 ttpt -142.74 142.71 32.0 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.588 -173.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.68 HG21 ' HA3' ' A' ' 49' ' ' GLY . 10.4 p -151.33 160.16 3.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -61.57 132.72 54.25 Favored 'General case' 0 C--O 1.216 -0.679 0 C-N-CA 122.83 0.452 . . . . 0.0 111.329 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.528 HD13 HD12 ' A' ' 35' ' ' LEU . 34.2 tp -91.33 -15.63 28.77 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.773 0.797 . . . . 0.0 111.423 -178.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.657 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 16.0 pttp -90.06 1.91 55.81 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 122.075 0.94 . . . . 0.0 109.672 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 61.3 m -121.51 139.33 53.63 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-N 113.958 -1.474 . . . . 0.0 108.167 175.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.43 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -78.15 -27.56 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-O 121.611 0.72 . . . . 0.0 110.247 -175.373 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 53.8 ttp -68.19 91.91 0.38 Allowed 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 113.694 -1.594 . . . . 0.0 108.658 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.68 ' HA3' HG21 ' A' ' 42' ' ' VAL . . . 139.79 -58.52 0.59 Allowed Glycine 0 C--N 1.264 -3.458 0 CA-C-N 113.379 -1.737 . . . . 0.0 110.138 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.414 HG21 ' HA ' ' A' ' 44' ' ' LEU . 59.2 t -66.28 -33.95 66.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 114.629 -0.785 . . . . 0.0 112.376 -175.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 55.1 ttm -64.86 -52.17 58.06 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.011 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.2 m -69.25 -16.28 63.55 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 123.655 0.782 . . . . 0.0 112.897 177.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.51 HD21 HD22 ' A' ' 35' ' ' LEU . 11.2 tp -69.02 103.58 1.89 Allowed 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 123.899 0.88 . . . . 0.0 109.291 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.22 62.68 4.23 Favored Glycine 0 C--N 1.31 -0.873 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.893 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.467 ' HB ' HG21 ' A' ' 8' ' ' ILE . 1.2 m -56.94 -62.72 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 C-N-CA 122.187 0.195 . . . . 0.0 110.863 176.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 49.42 75.37 0.21 Allowed Glycine 0 CA--C 1.53 1.001 0 N-CA-C 116.004 1.162 . . . . 0.0 116.004 171.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.637 ' HA ' HG23 ' A' ' 8' ' ' ILE . 0.0 OUTLIER 43.16 -13.8 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.456 0 N-CA-C 119.589 3.181 . . . . 0.0 119.589 177.565 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -102.46 -8.7 20.87 Favored 'General case' 0 C--N 1.285 -2.225 0 O-C-N 121.242 -0.911 . . . . 0.0 109.802 -176.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.1 127.24 32.41 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -171.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -91.54 101.24 13.89 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 169.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.523 ' HB ' HD21 ' A' ' 35' ' ' LEU . 1.4 pt -104.87 126.56 59.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.731 -0.787 . . . . 0.0 109.918 -171.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.451 ' HB ' ' HB3' ' A' ' 36' ' ' GLU . 19.4 m -108.9 118.15 36.05 Favored 'General case' 0 C--N 1.287 -2.114 0 O-C-N 121.913 -0.492 . . . . 0.0 109.838 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.57 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.5 mp -88.71 132.78 32.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.631 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 38.9 m-85 -119.27 125.84 50.08 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.961 171.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.23 120.5 40.67 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.46 ' HA ' ' OE1' ' A' ' 70' ' ' GLU . 29.0 t70 -125.56 108.02 11.18 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.508 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -165.73 -172.89 33.65 Favored Glycine 0 N--CA 1.416 -2.645 0 C-N-CA 119.148 -1.501 . . . . 0.0 113.482 -171.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.3 p -78.75 -26.91 44.64 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 114.582 -0.809 . . . . 0.0 110.027 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -129.2 35.91 4.22 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.286 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.46 ' OE1' ' HA ' ' A' ' 66' ' ' ASP . 11.0 pt-20 -58.53 -36.18 73.44 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -175.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.84 -43.52 95.94 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 121.218 0.532 . . . . 0.0 110.497 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -76.28 -31.13 58.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.786 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.471 ' O ' ' HB ' ' A' ' 77' ' ' ILE . . . -64.27 -36.67 84.84 Favored 'General case' 0 C--O 1.205 -1.265 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.915 176.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.539 ' O ' HG22 ' A' ' 77' ' ' ILE . 25.8 mm -61.22 -43.65 96.86 Favored 'Isoleucine or valine' 0 C--O 1.251 1.143 0 C-N-CA 122.691 0.396 . . . . 0.0 110.784 175.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -53.04 62.68 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.64 -39.17 93.23 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.566 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.539 HG22 ' O ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -64.65 -40.61 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 C-N-CA 123.127 0.571 . . . . 0.0 110.607 -178.024 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.8 m -72.85 -33.91 66.43 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 24.1 t70 -63.26 -46.74 85.42 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.549 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.435 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 35.3 m -77.68 -23.5 14.19 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.262 0 C-N-CA 120.517 -0.473 . . . . 0.0 112.188 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 77' ' ' ILE . 23.6 mt -73.19 -48.02 38.7 Favored 'General case' 0 C--O 1.206 -1.185 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.588 174.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.7 p -61.3 -29.5 69.91 Favored 'General case' 0 C--N 1.316 -0.85 0 O-C-N 121.626 -0.671 . . . . 0.0 111.438 173.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 79' ' ' ASP . 18.4 ttmm -70.94 -39.57 72.55 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.909 176.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -104.53 -82.8 0.51 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -177.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -173.22 -156.9 13.68 Favored Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -176.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.447 ' HA ' HG13 ' A' ' 8' ' ' ILE . 3.2 mp 64.87 19.67 11.91 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 125.276 1.43 . . . . 0.0 112.3 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 60.3 m -154.45 156.89 37.58 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.438 ' HG2' HG23 ' A' ' 9' ' ' ILE . 41.7 mt-10 . . . . . 0 C--O 1.25 1.096 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.462 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 1.1 mpt? . . . . . 0 CA--C 1.502 -0.9 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -105.23 145.35 30.76 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 118.908 -1.117 . . . . 0.0 113.118 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.758 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 3.5 pt20 -111.82 151.88 28.54 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -172.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' A' ' 62' ' ' THR . 13.8 mm100 -137.16 131.57 32.74 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.224 -1.353 . . . . 0.0 108.369 173.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.8 t -98.71 121.29 40.47 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 82.4 m-85 -113.34 159.51 19.34 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 122.662 0.385 . . . . 0.0 110.933 -177.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.2 m -131.68 106.36 8.1 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 174.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.59 HG21 ' HB3' ' A' ' 59' ' ' ALA . 9.7 tp -66.83 144.96 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.603 0 C-N-CA 123.229 0.612 . . . . 0.0 110.353 -176.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.0 pt -109.52 -14.74 10.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-O 121.744 0.783 . . . . 0.0 109.154 174.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.471 ' O ' ' HA2' ' A' ' 56' ' ' GLY . 9.9 t70 -73.28 149.67 42.54 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.583 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -129.19 27.58 5.35 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.626 0.727 . . . . 0.0 109.516 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.4 m -106.92 -32.32 7.95 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.295 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.34 34.5 1.1 Allowed Glycine 0 N--CA 1.427 -1.921 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 -177.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 89.43 -34.26 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 127.201 2.2 . . . . 0.0 110.786 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . 0.494 30.9 p-80 67.42 135.95 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 126.632 1.973 . . . . 0.0 114.33 -178.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.47 -55.99 23.32 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 116.36 1.985 . . . . 0.0 116.36 -166.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.402 ' HD3' ' HA ' ' A' ' 17' ' ' ARG . 28.5 mmt180 -54.89 -53.41 61.27 Favored Pre-proline 0 N--CA 1.48 1.04 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -172.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.17 -37.44 83.56 Favored 'Trans proline' 0 C--N 1.36 1.175 0 C-N-CA 121.671 1.58 . . . . 0.0 110.978 177.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.511 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -68.81 -27.54 65.95 Favored 'General case' 0 C--O 1.21 -1.023 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.03 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.522 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 14.8 m -74.87 -27.46 60.26 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 97.0 mmm -71.23 -37.82 71.99 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 173.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.429 HD12 HD21 ' A' ' 44' ' ' LEU . 4.5 mm? -61.96 -35.98 80.07 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.442 172.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.522 ' HB ' ' O ' ' A' ' 20' ' ' THR . 52.9 t -56.43 -53.98 33.88 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.698 0 O-C-N 123.669 0.606 . . . . 0.0 109.72 174.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -64.04 -26.28 68.49 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-O 121.264 0.554 . . . . 0.0 111.218 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.567 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 37.1 m -79.55 -62.66 1.62 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.577 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.712 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . . . -67.52 -26.82 66.52 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -175.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 27.1 m -72.48 -10.83 60.27 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 177.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.567 ' HG3' ' O ' ' A' ' 25' ' ' THR . 0.0 OUTLIER -100.14 -2.7 33.43 Favored 'General case' 0 CA--C 1.504 -0.813 0 C-N-CA 119.514 -0.875 . . . . 0.0 112.369 179.213 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -99.09 144.65 28.0 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -88.02 65.52 8.26 Favored 'General case' 0 CA--C 1.484 -1.576 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 173.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.551 ' OG ' ' HA3' ' A' ' 67' ' ' GLY . 23.2 m -161.56 135.97 7.02 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-N 113.397 -1.729 . . . . 0.0 107.455 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -102.35 112.77 25.61 Favored 'General case' 0 C--N 1.278 -2.504 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.62 175.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.515 HG23 HG23 ' A' ' 63' ' ' ILE . 59.3 mt -80.58 112.59 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.002 0 CA-C-N 114.142 -1.39 . . . . 0.0 107.636 175.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 35.2 mt-30 -97.08 127.51 43.12 Favored 'General case' 0 N--CA 1.403 -2.814 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.662 HD22 HD21 ' A' ' 53' ' ' LEU . 1.6 tt -91.63 115.09 27.75 Favored 'General case' 0 N--CA 1.4 -2.946 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 176.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -110.11 113.19 25.68 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 124.947 1.299 . . . . 0.0 108.732 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -133.88 94.35 3.25 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-O 121.52 0.676 . . . . 0.0 110.638 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 50.89 67.68 0.9 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.524 -1.671 . . . . 0.0 112.166 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.4 -23.57 31.42 Favored Glycine 0 N--CA 1.438 -1.186 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.699 175.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 40' ' ' LYS . 10.1 mmtp -99.04 109.95 22.62 Favored 'General case' 0 CA--C 1.476 -1.879 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 6.5 ptpp? -114.93 128.21 56.15 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.806 175.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 34' ' ' GLN . 6.0 m -135.95 -175.18 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.937 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.536 ' HB2' ' HB2' ' A' ' 46' ' ' SER . 19.6 m120 -94.22 120.51 34.57 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.429 HD21 HD12 ' A' ' 22' ' ' LEU . 7.4 tt -74.12 -21.97 59.66 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-O 121.241 0.543 . . . . 0.0 111.381 -178.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.712 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 14.5 pttp -87.93 6.86 33.68 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 122.255 1.026 . . . . 0.0 109.647 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.536 ' HB2' ' HB2' ' A' ' 43' ' ' ASN . 73.7 m -117.14 133.64 55.75 Favored 'General case' 0 N--CA 1.398 -3.029 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.137 175.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.759 ' H ' HD12 ' A' ' 47' ' ' ILE . 1.4 mp -75.17 -38.01 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.209 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -172.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 44.3 ttm -51.7 -37.39 50.58 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 112.688 -2.051 . . . . 0.0 110.571 175.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.5 -60.43 3.48 Favored Glycine 0 N--CA 1.426 -2.02 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.885 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.438 HG22 HD12 ' A' ' 35' ' ' LEU . 90.7 t -57.49 -40.96 77.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 96.4 mmm -75.33 2.86 10.16 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 51.9 m -92.82 -21.38 19.93 Favored 'General case' 0 C--N 1.31 -1.11 0 O-C-N 122.061 -0.399 . . . . 0.0 110.607 176.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.662 HD21 HD22 ' A' ' 35' ' ' LEU . 6.9 mp -79.93 155.89 27.51 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.045 0.45 . . . . 0.0 110.704 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.16 69.22 0.79 Allowed Glycine 0 N--CA 1.426 -1.969 0 N-CA-C 107.5 -2.24 . . . . 0.0 107.5 169.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.5 t -77.25 80.72 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -175.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 10' ' ' ASP . . . -134.92 135.22 7.79 Favored Glycine 0 N--CA 1.425 -2.052 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt 28.08 -57.89 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 129.817 3.247 . . . . 0.0 118.837 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -90.11 -0.84 57.81 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.743 0.782 . . . . 0.0 110.581 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.59 ' HB3' HG21 ' A' ' 8' ' ' ILE . . . -72.24 96.72 1.86 Allowed 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 121.927 0.87 . . . . 0.0 112.569 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 36.0 mt-10 -92.58 105.6 17.74 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 175.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.5 HD12 HD21 ' A' ' 35' ' ' LEU . 29.3 pt -103.23 157.2 5.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.458 -172.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 4' ' ' GLN . 34.1 m -122.89 127.66 49.26 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-O 121.254 0.55 . . . . 0.0 109.762 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.758 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.4 mp -97.31 130.08 46.48 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 177.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.423 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 27.4 m-85 -116.8 107.04 14.14 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 123.733 0.646 . . . . 0.0 109.48 171.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -93.63 111.42 23.1 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -113.77 110.19 19.76 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.551 ' HA3' ' OG ' ' A' ' 31' ' ' SER . . . -174.05 -168.49 35.05 Favored Glycine 0 N--CA 1.41 -3.069 0 C-N-CA 118.93 -1.605 . . . . 0.0 113.819 -175.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.2 m -94.79 -17.18 22.36 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 175.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -119.05 18.55 13.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.401 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.46 ' O ' HG12 ' A' ' 74' ' ' ILE . 4.7 pt-20 -57.24 -37.66 72.62 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -174.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.91 -42.58 99.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.111 0.481 . . . . 0.0 111.052 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -78.99 -26.87 43.34 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.36 0.6 . . . . 0.0 109.508 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.59 -41.38 98.35 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.357 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 70' ' ' GLU . 35.4 mm -60.09 -46.26 94.61 Favored 'Isoleucine or valine' 0 C--O 1.255 1.384 0 CA-C-O 121.542 0.686 . . . . 0.0 109.745 175.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -58.59 -40.1 82.26 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.43 -1.259 . . . . 0.0 112.657 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.06 -44.48 17.96 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.5 HG13 HD13 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -59.25 -36.97 66.27 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.55 0 C-N-CA 123.59 0.756 . . . . 0.0 112.459 -173.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.7 p -73.74 -43.16 59.87 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.263 0.554 . . . . 0.0 110.248 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.547 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 24.5 t70 -60.8 -47.77 84.84 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.288 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.528 ' HA ' ' HG2' ' A' ' 83' ' ' LYS . 27.9 m -66.01 -39.21 83.91 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.516 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.928 177.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 81' ' ' LEU . 15.5 mt -64.12 -35.62 81.36 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 177.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.4 p -70.29 -44.97 67.26 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 118.345 0.521 . . . . 0.0 112.075 174.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.547 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 12.9 ptmm? -67.29 -28.26 67.86 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.684 177.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 80' ' ' VAL . 24.2 mm-40 -81.14 -26.46 36.08 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.056 0.455 . . . . 0.0 110.687 175.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.24 41.31 8.03 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 116.136 -0.484 . . . . 0.0 113.663 175.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.449 ' O ' HD12 ' A' ' 8' ' ' ILE . 8.8 mp -91.71 -46.41 7.92 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.183 176.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.2 t -101.84 168.69 9.27 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -176.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 C--N 1.309 -1.16 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 176.883 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.599 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 91.0 mtp . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -105.18 148.16 27.21 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 169.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.701 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 3.9 pt20 -107.16 143.34 35.49 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -132.88 99.92 4.75 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.032 174.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 49.1 m -87.91 116.2 25.91 Favored 'General case' 0 C--N 1.286 -2.175 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.428 176.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.497 ' HB2' HG12 ' A' ' 61' ' ' ILE . 78.3 m-85 -102.03 139.02 38.22 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.031 -173.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.9 m -101.65 100.54 10.94 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 171.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.692 ' O ' ' HA ' ' A' ' 57' ' ' LYS 0.262 3.0 mt -74.75 135.41 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 119.97 -0.692 . . . . 0.0 112.028 -179.014 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.9 pt -107.09 -7.39 10.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.334 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.514 ' H ' HG23 ' A' ' 8' ' ' ILE . 12.0 t70 -76.65 125.15 28.75 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.74 -178.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.7 mp0 -77.05 74.72 3.62 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.536 -0.465 . . . . 0.0 111.977 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.0 p 57.41 11.05 1.06 Allowed 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 117.124 2.268 . . . . 0.0 117.124 172.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.86 -32.49 10.95 Favored Glycine 0 CA--C 1.484 -1.869 0 C-N-CA 119.549 -1.31 . . . . 0.0 111.191 -174.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.65 10.21 0.1 Allowed 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 115.483 1.661 . . . . 0.0 115.483 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -80.89 -4.1 53.67 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -173.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.95 -76.33 0.59 Allowed 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.426 ' HD3' ' HA ' ' A' ' 17' ' ' ARG 0.257 33.9 mmt180 -69.36 -52.73 14.44 Favored Pre-proline 0 C--N 1.315 -0.911 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -176.392 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -59.55 -29.52 90.14 Favored 'Trans proline' 0 C--N 1.36 1.174 0 CA-C-N 120.838 1.335 . . . . 0.0 110.782 174.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.417 ' HA ' HD23 ' A' ' 22' ' ' LEU . . . -68.68 -28.45 66.88 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.231 176.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.401 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 57.1 m -70.59 -26.29 63.45 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 175.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 83.8 mtp -70.03 -31.84 69.68 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.457 HD21 HD21 ' A' ' 81' ' ' LEU . 4.1 mm? -66.32 -44.31 83.74 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 172.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' A' ' 20' ' ' THR . 84.4 t -54.01 -55.29 14.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 123.963 0.79 . . . . 0.0 109.497 174.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -53.41 -44.36 68.67 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 124.403 1.081 . . . . 0.0 112.317 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.1 m -81.31 -58.91 2.84 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -175.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.632 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . . . -64.86 -27.82 69.13 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -173.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.6 m -69.64 -16.11 63.31 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.256 0.0 OUTLIER -108.25 6.34 26.52 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 -175.606 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -101.43 137.62 39.52 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 174.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -84.78 73.07 10.67 Favored 'General case' 0 CA--C 1.496 -1.112 0 CA-C-O 122.749 1.262 . . . . 0.0 109.349 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.557 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 33.8 m -161.5 152.88 18.73 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 112.871 -1.968 . . . . 0.0 105.908 177.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -113.36 109.4 18.65 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.0 mp -89.87 125.57 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.272 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 -98.09 136.07 38.86 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.7 tp -99.94 114.94 28.54 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.62 ' HA ' ' O ' ' A' ' 40' ' ' LYS . 9.2 tt0 -111.66 136.34 51.02 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.706 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.448 ' CD2' ' HG ' ' A' ' 53' ' ' LEU . 50.7 t80 -165.24 104.5 0.75 Allowed 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 123.386 0.674 . . . . 0.0 110.572 178.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.7 t30 48.07 74.84 0.15 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.804 1.242 . . . . 0.0 113.025 176.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.98 -13.12 33.0 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 121.001 -0.618 . . . . 0.0 113.114 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -94.6 123.56 38.11 Favored 'General case' 0 CA--C 1.48 -1.729 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -179.588 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -119.57 113.42 20.68 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 169.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.7 p -143.53 167.14 13.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -175.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.552 HD21 ' HE3' ' A' ' 45' ' ' LYS . 19.3 t-20 -78.92 133.38 36.92 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 117.864 0.302 . . . . 0.0 111.184 -177.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.6 tp -75.97 -35.01 59.81 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.632 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -87.39 9.36 20.89 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.691 -178.358 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 75.6 m -106.68 125.01 50.46 Favored 'General case' 0 N--CA 1.392 -3.37 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 173.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.46 -25.47 38.44 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 CA-C-O 121.39 0.614 . . . . 0.0 111.636 -175.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 49.7 ttp -55.47 -27.04 45.85 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 125.429 1.492 . . . . 0.0 110.468 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.22 -60.62 4.35 Favored Glycine 0 N--CA 1.42 -2.423 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.515 178.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.0 t -64.04 -36.1 75.75 Favored 'Isoleucine or valine' 0 C--O 1.249 1.045 0 O-C-N 122.688 -0.301 . . . . 0.0 110.876 -176.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.2 mmt -57.84 -34.79 70.08 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.267 0.627 . . . . 0.0 112.237 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.1 p -85.03 -31.43 23.45 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.84 -175.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.448 ' HG ' ' CD2' ' A' ' 37' ' ' TYR . 11.0 mp -59.09 -61.95 2.25 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.95 0.405 . . . . 0.0 111.833 176.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.38 46.53 55.98 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 -171.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.6 p -69.88 123.68 24.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 C-N-CA 123.666 0.786 . . . . 0.0 111.586 -176.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.41 -172.24 14.69 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.692 ' HA ' ' O ' ' A' ' 8' ' ' ILE 0.272 55.0 pttt -64.88 136.02 56.38 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 118.226 1.013 . . . . 0.0 113.689 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t70 84.31 -7.1 1.02 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 126.32 1.848 . . . . 0.0 111.087 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.45 113.0 6.35 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.609 177.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -81.69 115.85 21.14 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.773 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.497 HG12 ' HB2' ' A' ' 6' ' ' TYR . 17.3 pt -116.04 160.07 15.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 5' ' ' SER . 98.6 m -129.18 128.04 42.57 Favored 'General case' 0 C--N 1.275 -2.648 0 CA-C-O 120.878 0.37 . . . . 0.0 110.305 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.4 mp -101.8 131.59 49.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.701 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 34.8 m-85 -121.56 113.76 20.24 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 123.574 0.547 . . . . 0.0 109.684 173.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.599 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -104.0 119.86 39.82 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.485 ' OD1' ' HG3' ' A' ' 1' ' ' MET . 15.7 t70 -126.08 115.43 19.82 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.557 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -179.22 -171.67 42.6 Favored Glycine 0 N--CA 1.431 -1.675 0 C-N-CA 119.952 -1.118 . . . . 0.0 113.171 -175.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.4 m -89.13 -7.18 56.23 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.474 0.654 . . . . 0.0 109.642 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -130.37 29.37 4.86 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.596 ' O ' HG12 ' A' ' 74' ' ' ILE . 9.7 pt-20 -69.21 -44.01 72.95 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -168.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.2 -31.88 69.53 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.212 0.529 . . . . 0.0 110.357 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -75.01 -33.58 61.83 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-O 121.556 0.693 . . . . 0.0 109.779 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.19 -36.15 82.31 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.969 176.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.596 HG12 ' O ' ' A' ' 70' ' ' GLU . 38.0 mm -54.1 -39.29 41.28 Favored 'Isoleucine or valine' 0 C--O 1.25 1.119 0 C-N-CA 123.503 0.721 . . . . 0.0 111.431 178.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -67.32 -44.26 79.58 Favored 'General case' 0 N--CA 1.402 -2.855 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.231 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.33 -39.36 47.93 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.485 -175.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.435 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -64.11 -41.78 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -178.367 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 33.0 m -67.78 -43.45 79.75 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.419 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 32.3 t70 -55.34 -48.13 74.66 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.3 m -67.22 -29.96 47.68 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.593 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.736 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.457 HD21 HD21 ' A' ' 22' ' ' LEU . 40.4 mt -79.56 -2.29 41.71 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.983 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 21.6 m -118.38 -16.36 9.6 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.437 0.637 . . . . 0.0 110.253 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 75.2 mmtt -78.46 -27.47 46.37 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 169.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -104.75 172.53 6.74 Favored 'General case' 0 N--CA 1.41 -2.431 0 CA-C-N 112.921 -1.945 . . . . 0.0 107.41 175.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -104.3 51.51 0.8 Allowed Glycine 0 C--N 1.291 -1.967 0 C-N-CA 119.893 -1.146 . . . . 0.0 113.364 -175.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.433 HD22 HD22 ' A' ' 81' ' ' LEU . 4.8 mp -92.74 -53.43 4.18 Favored 'General case' 0 C--O 1.213 -0.847 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.303 176.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.412 HG22 ' HB3' ' A' ' 81' ' ' LEU . 14.6 t -116.51 148.29 40.95 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.916 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 . . . . . 0 N--CA 1.429 -1.523 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.709 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.639 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 52.9 ttm . . . . . 0 CA--C 1.514 -0.415 0 N-CA-C 110.581 -0.155 . . . . 0.0 110.581 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -114.83 157.35 23.4 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 176.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.645 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 4.1 pt20 -111.35 153.96 25.24 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -142.36 103.73 4.31 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.697 -1.592 . . . . 0.0 107.59 173.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 50.2 m -91.49 89.45 7.21 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 122.293 1.044 . . . . 0.0 110.451 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 73.8 m-85 -72.87 130.02 39.47 Favored 'General case' 0 CA--C 1.488 -1.433 0 CA-C-N 113.493 -1.685 . . . . 0.0 112.146 -175.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.2 m -88.88 101.01 13.63 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 170.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.577 HG23 ' H ' ' A' ' 10' ' ' ASP . 4.5 mt -77.22 136.49 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.9 -178.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 35.4 pt -119.03 6.55 6.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.577 ' H ' HG23 ' A' ' 8' ' ' ILE . 31.2 t70 -71.39 127.11 31.48 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.505 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -112.11 13.23 20.61 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.609 0.718 . . . . 0.0 110.368 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -84.63 -33.7 23.23 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.04 37.48 3.86 Favored Glycine 0 N--CA 1.425 -2.033 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 72.28 79.03 0.15 Allowed 'General case' 0 CA--C 1.508 -0.643 0 C-N-CA 124.203 1.001 . . . . 0.0 110.743 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -55.6 113.88 1.63 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.827 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.81 -34.42 66.86 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -170.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.432 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 13.9 tpp180 -63.45 -52.95 56.39 Favored Pre-proline 0 C--N 1.317 -0.839 0 C-N-CA 119.594 -0.842 . . . . 0.0 112.448 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.563 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 31.8 Cg_exo -66.72 -10.86 29.65 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 121.573 1.516 . . . . 0.0 112.645 174.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.429 ' HA ' HD23 ' A' ' 22' ' ' LEU . . . -74.54 -15.47 60.86 Favored 'General case' 0 C--O 1.216 -0.682 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.411 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 7.7 m -66.73 -27.16 67.39 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 174.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.563 ' SD ' ' HA ' ' A' ' 18' ' ' PRO . 1.4 mpt? -67.69 -34.88 77.76 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 174.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 19' ' ' ALA . 4.4 mm? -69.27 -38.1 78.21 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.938 175.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 81.9 t -55.69 -49.84 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 O-C-N 124.113 0.883 . . . . 0.0 109.351 175.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.12 -64.33 0.99 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.18 177.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.7 m -42.35 -63.16 0.8 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.734 1.214 . . . . 0.0 113.81 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . . . -66.05 -43.05 88.61 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -174.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.7 t -60.75 -39.09 87.41 Favored 'General case' 0 C--N 1.322 -0.594 0 O-C-N 123.27 0.356 . . . . 0.0 111.37 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.269 0.6 OUTLIER -82.5 3.0 30.11 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -174.198 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -95.16 -3.25 48.21 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.764 177.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.4 t70 59.52 24.34 13.04 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 123.377 1.56 . . . . 0.0 109.403 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.521 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 19.3 m -118.8 146.29 44.95 Favored 'General case' 0 N--CA 1.408 -2.53 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.183 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.415 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . 7.6 t70 -105.76 112.69 25.85 Favored 'General case' 0 N--CA 1.392 -3.366 0 C-N-CA 118.706 -1.197 . . . . 0.0 108.771 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 2.9 mp -100.77 130.25 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.807 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.678 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -106.12 132.13 52.56 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.8 tt -98.01 100.16 11.47 Favored 'General case' 0 N--CA 1.407 -2.576 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 173.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.38 112.53 23.67 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.621 ' HB3' HD11 ' A' ' 53' ' ' LEU . 55.4 t80 -139.77 85.17 2.02 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 176.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.9 t30 60.56 90.2 0.06 Allowed 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 125.365 1.466 . . . . 0.0 113.656 170.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.85 -48.13 3.99 Favored Glycine 0 C--N 1.311 -0.813 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.641 175.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.21 144.94 43.53 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 120.851 0.358 . . . . 0.0 111.909 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.11 147.35 50.95 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 176.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.8 p -120.8 143.59 32.46 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.76 -177.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.474 HD21 ' HG2' ' A' ' 45' ' ' LYS . 16.1 t30 -61.55 110.23 1.41 Allowed 'General case' 0 C--O 1.208 -1.124 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 171.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.423 HD13 ' O ' ' A' ' 44' ' ' LEU . 3.4 tm? -60.37 -23.5 64.35 Favored 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -171.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -90.56 21.99 3.7 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.179 -0.951 . . . . 0.0 110.757 174.359 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.0 m -134.43 146.44 49.84 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.645 176.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.734 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -94.83 -20.11 6.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.289 -178.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 50.3 ttm -64.21 81.53 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 125.622 1.569 . . . . 0.0 110.115 175.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 137.43 -32.08 2.44 Favored Glycine 0 C--N 1.291 -1.927 0 CA-C-N 113.616 -1.629 . . . . 0.0 110.431 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 85.5 t -73.51 -35.76 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 69.8 mtm -64.0 -54.2 38.04 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.09 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.1 m -81.06 2.63 26.38 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.621 HD11 ' HB3' ' A' ' 37' ' ' TYR . 22.5 tp -39.75 -47.32 2.05 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 124.589 1.156 . . . . 0.0 113.286 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.73 34.19 25.54 Favored Glycine 0 N--CA 1.439 -1.128 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.416 ' HB ' HD23 ' A' ' 53' ' ' LEU . 0.8 OUTLIER -89.4 151.48 3.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -175.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -157.61 -170.72 22.76 Favored Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -64.03 138.71 58.59 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 117.97 0.885 . . . . 0.0 111.331 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.7 t70 79.88 -5.4 1.86 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.395 1.478 . . . . 0.0 111.328 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.57 123.08 21.68 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.584 176.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -98.55 116.86 31.69 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.6 -178.649 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.45 HG12 ' HB2' ' A' ' 6' ' ' TYR . 20.1 pt -110.73 137.42 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.18 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 5' ' ' SER . 85.1 m -108.49 112.98 25.66 Favored 'General case' 0 C--N 1.276 -2.588 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.37 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.612 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.3 mp -84.78 130.32 36.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.645 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 51.6 m-85 -117.06 106.83 13.8 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 173.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.639 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -101.4 117.04 34.15 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -128.62 115.75 18.55 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.521 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -172.67 -169.86 35.76 Favored Glycine 0 C--N 1.293 -1.84 0 C-N-CA 119.535 -1.317 . . . . 0.0 112.345 -175.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.4 t -81.9 -22.65 36.71 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -131.79 33.38 3.99 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.775 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -58.05 -35.91 72.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -175.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.55 -43.63 96.52 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.001 0.429 . . . . 0.0 110.78 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -82.62 -19.91 37.39 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.06 0.457 . . . . 0.0 109.945 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.62 -42.32 98.19 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 30.4 mm -57.45 -45.45 85.72 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.347 173.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -60.82 -42.81 98.43 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.573 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.1 -47.95 75.41 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.439 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 33.4 mt -60.82 -48.32 89.37 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.912 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 13.6 p -58.04 -35.24 71.03 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.457 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 26.8 t70 -70.71 -52.84 18.37 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 120.875 0.369 . . . . 0.0 110.103 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.43 -27.61 40.91 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.435 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 77' ' ' ILE . 14.0 mt -79.89 -6.2 56.97 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 122.412 0.285 . . . . 0.0 110.64 177.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.1 t -102.92 -41.0 6.28 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 31.7 mmmt -65.35 -29.23 69.94 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.372 0.606 . . . . 0.0 109.413 176.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -93.26 -17.31 23.79 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.874 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.22 49.7 60.36 Favored Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 115.524 -0.762 . . . . 0.0 114.548 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.419 ' HA ' ' HB2' ' A' ' 10' ' ' ASP . 6.0 mp -88.56 -27.52 21.33 Favored 'General case' 0 CA--C 1.491 -1.307 0 C-N-CA 118.462 -1.295 . . . . 0.0 108.498 174.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.0 t -133.74 -171.01 2.62 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 . . . . . 0 C--N 1.301 -1.522 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.01 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.552 ' HG3' ' HA ' ' A' ' 66' ' ' ASP . 1.1 mpt? . . . . . 0 CA--C 1.49 -1.362 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.44 ' HG2' ' N ' ' A' ' 3' ' ' GLN . 36.7 tt0 -125.76 158.95 33.62 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.719 -172.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.794 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 12.4 pt20 -115.15 140.22 49.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 124.068 0.855 . . . . 0.0 110.824 173.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.401 ' O ' ' HA ' ' A' ' 62' ' ' THR . 73.5 mm-40 -121.09 107.76 13.01 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.171 175.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.0 p -88.13 92.22 9.07 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-O 121.441 0.639 . . . . 0.0 109.544 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.458 ' HB2' ' CG1' ' A' ' 61' ' ' ILE . 80.8 m-85 -80.56 113.67 18.91 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.679 -176.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.8 m -91.09 102.12 14.86 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.491 HG21 ' O ' ' A' ' 55' ' ' VAL . 1.5 mp -71.93 122.9 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.862 0 CA-C-O 122.207 1.003 . . . . 0.0 112.031 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.608 HD13 ' H ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -116.39 9.05 7.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 114.109 -1.405 . . . . 0.0 107.852 -177.596 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -123.93 158.7 31.38 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.422 -170.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -131.56 1.04 4.05 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.0 p -117.22 -36.0 3.89 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -175.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.57 -39.68 8.14 Favored Glycine 0 N--CA 1.425 -2.076 0 N-CA-C 106.215 -2.754 . . . . 0.0 106.215 174.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.81 78.19 0.3 Allowed 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.845 -1.177 . . . . 0.0 110.532 171.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.592 ' O ' ' HD2' ' A' ' 18' ' ' PRO . 0.7 OUTLIER -154.31 151.23 28.84 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 176.786 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.56 81.68 3.23 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -170.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -162.66 -47.47 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.206 1.002 . . . . 0.0 108.568 169.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.592 ' HD2' ' O ' ' A' ' 15' ' ' HIS . 84.0 Cg_exo -54.88 -24.56 39.42 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 121.849 1.7 . . . . 0.0 111.362 170.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.409 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -65.39 -21.24 66.65 Favored 'General case' 0 C--O 1.201 -1.474 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.048 177.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.41 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 8.3 m -70.11 -27.35 64.52 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-O 121.296 0.57 . . . . 0.0 110.032 177.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 48.5 ttm -69.46 -32.19 70.96 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 174.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.411 ' HB3' HD21 ' A' ' 44' ' ' LEU . 4.5 mm? -73.14 -36.95 66.77 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.172 -1.377 . . . . 0.0 110.306 175.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 45.0 t -55.96 -48.66 78.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -61.82 -58.36 8.28 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.585 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.581 ' O ' ' HB3' ' A' ' 28' ' ' LYS . 36.4 m -49.86 -43.57 49.22 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 176.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.73 -37.21 84.21 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.573 -0.705 . . . . 0.0 111.337 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.471 ' OG ' ' HB2' ' A' ' 45' ' ' LYS . 19.3 m -67.49 -32.36 73.13 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 122.022 0.915 . . . . 0.0 110.036 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.581 ' HB3' ' O ' ' A' ' 25' ' ' THR . 12.6 tmtt? -65.9 -33.57 76.12 Favored 'General case' 0 N--CA 1.424 -1.758 0 C-N-CA 126.196 1.798 . . . . 0.0 111.879 -176.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -96.37 150.12 20.94 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.885 -177.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.93 59.37 5.59 Favored 'General case' 0 CA--C 1.491 -1.314 0 CA-C-O 122.384 1.088 . . . . 0.0 108.96 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.561 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 40.9 m -150.83 141.31 22.49 Favored 'General case' 0 N--CA 1.41 -2.445 0 CA-C-N 114.021 -1.445 . . . . 0.0 108.439 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -98.15 99.43 10.68 Favored 'General case' 0 N--CA 1.394 -3.262 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.545 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 44.0 mt -84.91 124.76 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.875 0 CA-C-N 114.425 -1.262 . . . . 0.0 108.254 175.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -109.72 131.05 55.42 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 3.6 tt -97.77 124.82 42.28 Favored 'General case' 0 N--CA 1.402 -2.862 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.556 ' HB3' ' HB ' ' A' ' 62' ' ' THR . 0.8 OUTLIER -113.16 107.19 15.58 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -178.157 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.554 ' CD2' ' HG ' ' A' ' 53' ' ' LEU . 25.9 t80 -138.88 103.82 4.91 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.413 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 46.12 77.7 0.08 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.881 1.672 . . . . 0.0 113.155 173.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.21 -28.78 5.96 Favored Glycine 0 C--N 1.306 -1.122 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.233 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.453 ' HA ' ' HE3' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -105.32 113.5 27.12 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -179.272 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 18.7 ptpt -110.33 116.37 31.33 Favored 'General case' 0 N--CA 1.415 -2.187 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 168.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.9 p -130.03 146.07 34.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.697 -170.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.444 ' HB2' ' HB2' ' A' ' 46' ' ' SER . 19.7 m120 -58.27 112.39 1.53 Allowed 'General case' 0 C--O 1.197 -1.703 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 171.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.522 HD23 ' O ' ' A' ' 44' ' ' LEU . 5.4 tt -60.45 -29.0 68.76 Favored 'General case' 0 C--O 1.218 -0.568 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -170.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.471 ' HB2' ' OG ' ' A' ' 27' ' ' SER . 0.5 OUTLIER -85.67 -0.63 55.67 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.001 179.359 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.444 ' HB2' ' HB2' ' A' ' 43' ' ' ASN . 43.8 m -108.19 124.11 49.77 Favored 'General case' 0 N--CA 1.396 -3.168 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 175.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 pp -73.19 7.99 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -172.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 15.6 tpt -94.39 61.08 2.74 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 122.286 1.041 . . . . 0.0 109.232 -167.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.8 -41.67 0.81 Allowed Glycine 0 C--N 1.292 -1.885 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 -174.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 89.7 t -65.01 -35.01 74.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 114.884 -0.658 . . . . 0.0 110.968 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 49.2 ttm -77.3 0.83 20.7 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 121.196 0.522 . . . . 0.0 110.962 -177.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.2 m -104.27 6.72 35.61 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.011 0.434 . . . . 0.0 111.327 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.554 ' HG ' ' CD2' ' A' ' 37' ' ' TYR . 8.8 mp -78.89 105.91 10.54 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.194 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.72 -49.38 24.05 Favored Glycine 0 CA--C 1.495 -1.175 0 N-CA-C 106.795 -2.522 . . . . 0.0 106.795 169.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.491 ' O ' HG21 ' A' ' 8' ' ' ILE . 9.9 p 51.07 25.95 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.323 0 C-N-CA 126.816 2.046 . . . . 0.0 114.801 169.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.78 112.72 3.74 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.353 -0.927 . . . . 0.0 110.92 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? 49.14 154.29 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 C-N-CA 127.706 2.402 . . . . 0.0 115.664 -176.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.0 t70 68.82 -16.65 0.21 Allowed 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 126.054 1.742 . . . . 0.0 114.16 172.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.37 121.27 15.39 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 123.57 0.748 . . . . 0.0 112.326 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -102.8 97.7 7.81 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 175.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.458 ' CG1' ' HB2' ' A' ' 6' ' ' TYR . 29.8 pt -96.81 124.8 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.817 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -177.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' A' ' 36' ' ' GLU . 4.7 m -100.35 120.21 39.6 Favored 'General case' 0 C--N 1.283 -2.31 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.849 -176.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.6 mp -95.68 121.17 45.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 176.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.794 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 30.7 m-85 -104.92 123.9 48.55 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 174.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -111.19 103.01 11.39 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.552 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 10.9 t70 -113.37 103.21 11.07 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.561 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -166.74 -163.81 21.19 Favored Glycine 0 N--CA 1.423 -2.227 0 C-N-CA 119.424 -1.369 . . . . 0.0 112.751 -173.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.3 m -105.51 -7.69 18.5 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.409 0.623 . . . . 0.0 109.508 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -127.33 18.92 6.94 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.506 ' O ' HG12 ' A' ' 74' ' ' ILE 0.27 0.0 OUTLIER -52.43 -44.62 65.56 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 -171.184 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.65 -41.45 98.23 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.859 0.361 . . . . 0.0 111.433 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -78.05 -28.15 48.86 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 121.584 0.707 . . . . 0.0 109.866 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.469 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -64.98 -38.8 92.16 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.65 174.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 70' ' ' GLU . 33.8 mm -60.91 -47.05 95.19 Favored 'Isoleucine or valine' 0 C--O 1.254 1.317 0 CA-C-O 121.38 0.609 . . . . 0.0 109.973 175.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -51.74 -54.34 29.48 Favored 'General case' 0 N--CA 1.412 -2.367 0 C-N-CA 125.032 1.333 . . . . 0.0 109.716 176.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.42 ' O ' HG22 ' A' ' 80' ' ' VAL . . . -69.21 -45.09 70.74 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.467 HG22 ' HA ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -58.86 -40.14 79.3 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 C-N-CA 123.445 0.698 . . . . 0.0 111.054 -176.198 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.6 m -73.1 -37.6 66.66 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -61.38 -50.0 74.63 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.767 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.551 ' HA ' ' HG2' ' A' ' 83' ' ' LYS . 28.4 m -74.08 -32.25 32.26 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.35 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.996 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.42 HD22 ' CG ' ' A' ' 86' ' ' LEU . 15.3 mt -63.87 -45.05 91.14 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 121.388 -0.82 . . . . 0.0 111.353 175.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.9 p -63.19 -35.91 81.87 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.551 ' HG2' ' HA ' ' A' ' 80' ' ' VAL . 12.3 ptmm? -70.39 -30.94 67.97 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 80' ' ' VAL . 21.8 mm-40 -76.71 -27.16 55.37 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.436 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.88 -1.37 22.99 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.472 -0.871 . . . . 0.0 114.713 173.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.476 HD23 ' H ' ' A' ' 86' ' ' LEU . 1.2 pt? -99.62 26.87 5.76 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -177.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 35.8 m -148.41 109.68 4.36 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 121.652 -0.655 . . . . 0.0 110.016 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 C--O 1.255 1.386 0 C-N-CA 125.918 1.687 . . . . 0.0 112.173 -178.302 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.8 mtm . . . . . 0 CA--C 1.479 -1.75 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -113.17 147.9 36.49 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 176.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.731 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 15.6 pt20 -119.77 161.17 21.22 Favored 'General case' 0 N--CA 1.438 -1.031 0 O-C-N 123.802 0.689 . . . . 0.0 111.83 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.616 ' O ' ' HA ' ' A' ' 62' ' ' THR . 14.9 mm100 -141.16 138.0 33.09 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.167 -1.378 . . . . 0.0 108.279 174.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.8 t -100.58 131.27 46.58 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.56 ' HB2' HG12 ' A' ' 61' ' ' ILE . 57.8 m-85 -138.0 170.88 15.27 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -177.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.1 m -139.12 127.21 22.47 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 174.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.731 HG13 ' HA ' ' A' ' 86' ' ' LEU . 6.6 tt -82.8 147.22 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.542 -176.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.4 pt -133.69 26.87 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.531 ' HB2' ' CE1' ' A' ' 15' ' ' HIS . 0.3 OUTLIER -64.8 -38.59 91.5 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.436 -174.136 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.582 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 46.7 mt-10 68.82 4.08 4.27 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 176.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.5 m -109.29 -42.05 4.48 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.797 -0.564 . . . . 0.0 110.319 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 128.89 49.23 0.14 Allowed Glycine 0 C--N 1.303 -1.258 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 89.67 -53.55 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.21 0 C-N-CA 126.89 2.076 . . . . 0.0 109.923 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.532 ' O ' ' HD2' ' A' ' 18' ' ' PRO 0.386 56.6 p-80 53.02 99.26 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.137 -1.392 . . . . 0.0 112.269 -175.337 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.68 -30.6 22.59 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 -168.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.442 ' HD3' ' HA ' ' A' ' 17' ' ' ARG 0.314 26.1 mmt180 -62.39 -55.64 37.84 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -177.076 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.532 ' HD2' ' O ' ' A' ' 15' ' ' HIS . 61.4 Cg_exo -53.96 -37.73 86.05 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 121.85 1.7 . . . . 0.0 111.454 170.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.434 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -66.42 -19.61 65.84 Favored 'General case' 0 C--O 1.209 -1.063 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.154 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 29.7 m -77.12 -23.19 51.77 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.721 0.772 . . . . 0.0 108.954 176.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.4 ttt -71.63 -34.14 69.54 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 171.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 22' ' ' LEU . 4.2 mm? -67.8 -37.21 81.7 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.655 173.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 76.7 t -54.99 -55.26 16.98 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.084 0 O-C-N 123.92 0.763 . . . . 0.0 108.986 173.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -60.24 -25.85 65.98 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 123.387 0.675 . . . . 0.0 112.089 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.409 ' HA ' ' NZ ' ' A' ' 28' ' ' LYS . 88.1 m -78.95 -61.87 1.88 Allowed 'General case' 0 N--CA 1.423 -1.799 0 O-C-N 122.18 -0.325 . . . . 0.0 110.372 177.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.25 -43.68 94.13 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -177.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.4 t -59.09 -30.62 68.22 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.644 0.778 . . . . 0.0 112.916 -174.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.409 ' NZ ' ' HA ' ' A' ' 25' ' ' THR 0.27 0.9 OUTLIER -87.35 2.76 49.37 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -178.076 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -97.92 142.83 29.17 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -70.57 -35.3 72.98 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.38 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.54 ' OG ' ' HA3' ' A' ' 67' ' ' GLY . 50.7 m -71.12 142.19 50.77 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.581 175.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -93.37 109.92 21.47 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-O 121.211 0.529 . . . . 0.0 112.014 -176.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.69 HD11 ' HB1' ' A' ' 73' ' ' ALA . 15.9 mt -89.29 120.69 38.4 Favored 'Isoleucine or valine' 0 C--O 1.254 1.319 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.999 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -113.92 146.81 39.54 Favored 'General case' 0 N--CA 1.415 -2.224 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.735 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 0.9 OUTLIER -101.49 131.05 47.83 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 177.611 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' A' ' 40' ' ' LYS . 8.3 tp10 -131.39 154.22 48.85 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 175.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -154.92 -25.96 0.12 Allowed 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 117.919 0.327 . . . . 0.0 110.724 178.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 172.85 77.75 0.0 OUTLIER 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.928 0.891 . . . . 0.0 109.011 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.31 -12.37 66.77 Favored Glycine 0 C--N 1.308 -0.992 0 CA-C-N 116.031 -0.531 . . . . 0.0 113.521 174.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 16.0 mmtp -113.14 114.64 27.08 Favored 'General case' 0 CA--C 1.471 -2.064 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 62.8 mttp -111.87 130.15 55.92 Favored 'General case' 0 N--CA 1.413 -2.292 0 CA-C-N 114.475 -1.238 . . . . 0.0 110.626 174.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.4 m -144.31 162.98 14.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.566 ' HB3' ' HE3' ' A' ' 45' ' ' LYS . 18.3 m120 -72.83 129.51 38.34 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 175.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 67.0 tp -70.76 -13.94 62.25 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-O 121.733 0.777 . . . . 0.0 111.832 -176.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.566 ' HE3' ' HB3' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -87.87 5.45 40.33 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.388 0.613 . . . . 0.0 110.377 176.17 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.1 t -106.09 109.85 21.92 Favored 'General case' 0 N--CA 1.416 -2.152 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.581 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -68.61 -30.57 47.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 27.9 ttt -57.43 -49.04 77.5 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 113.69 -1.596 . . . . 0.0 109.149 175.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.37 -47.0 89.03 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.968 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 91.5 t -57.99 -40.75 78.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 CA-C-O 120.737 0.303 . . . . 0.0 111.457 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -76.69 -9.61 58.79 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 120.161 -0.615 . . . . 0.0 111.669 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.3 m -80.33 -33.52 37.38 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 175.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 mp -73.18 -42.76 62.36 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.977 174.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.4 39.39 87.42 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.443 HG21 ' CG2' ' A' ' 61' ' ' ILE . 7.8 p -65.54 106.35 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.09 0 CA-C-O 121.162 0.506 . . . . 0.0 110.716 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.487 ' HA2' ' OD1' ' A' ' 10' ' ' ASP . . . -138.65 146.2 17.85 Favored Glycine 0 N--CA 1.429 -1.813 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.349 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.582 ' HB3' ' HA ' ' A' ' 11' ' ' GLU . 9.3 ptpp? 21.06 111.37 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.687 0 N-CA-C 117.233 2.308 . . . . 0.0 117.233 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.9 t70 74.8 -0.79 3.25 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.585 1.154 . . . . 0.0 111.97 176.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.4 116.84 10.29 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -81.88 135.68 35.4 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.718 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.56 HG12 ' HB2' ' A' ' 6' ' ' TYR . 19.4 pt -123.91 165.69 20.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 121.461 0.648 . . . . 0.0 111.155 -177.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 4' ' ' GLN . 84.1 m -136.74 118.31 14.88 Favored 'General case' 0 N--CA 1.408 -2.573 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 47.4 mm -96.83 127.76 48.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.731 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 29.7 m-85 -111.74 122.52 48.01 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 123.806 0.691 . . . . 0.0 110.745 177.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.08 112.7 25.8 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 173.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -104.65 106.16 16.54 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.54 ' HA3' ' OG ' ' A' ' 31' ' ' SER . . . -176.11 -166.77 33.97 Favored Glycine 0 C--N 1.296 -1.677 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.106 -174.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.0 m -105.19 -11.27 16.63 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.984 0.897 . . . . 0.0 108.667 172.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -112.45 20.6 16.51 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.219 178.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.65 -45.23 70.15 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -175.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.4 -36.89 81.57 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 122.566 0.346 . . . . 0.0 111.256 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -73.4 -43.61 60.15 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.35 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.69 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -60.4 -43.02 97.1 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.601 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.2 mm -57.71 -46.99 86.74 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 C-N-CA 123.626 0.771 . . . . 0.0 111.22 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -64.47 -38.63 91.68 Favored 'General case' 0 N--CA 1.411 -2.382 0 C-N-CA 124.031 0.932 . . . . 0.0 111.264 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.65 -35.4 77.21 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.37 0.605 . . . . 0.0 110.179 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.8 mm -62.01 -52.24 62.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 124.532 1.133 . . . . 0.0 113.046 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.3 m -56.99 -48.43 78.45 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 120.693 0.282 . . . . 0.0 110.289 -176.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -55.16 -50.26 69.74 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.194 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.9 m -75.08 -30.8 23.75 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 C-N-CA 120.422 -0.511 . . . . 0.0 112.267 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.412 HD22 ' HB2' ' A' ' 86' ' ' LEU . 25.2 mt -68.23 -37.0 80.37 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 87' ' ' THR . 23.2 t -85.54 -16.59 38.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.411 0.624 . . . . 0.0 109.99 178.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -71.17 -34.64 71.13 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 172.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -95.97 -172.65 2.63 Favored 'General case' 0 N--CA 1.418 -2.039 0 CA-C-N 113.273 -1.785 . . . . 0.0 109.905 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -101.61 19.17 51.43 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.243 -0.98 . . . . 0.0 112.748 -177.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.731 ' HA ' HG13 ' A' ' 8' ' ' ILE . 3.4 mp -93.81 -2.17 53.93 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 119.036 -1.065 . . . . 0.0 111.16 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 82' ' ' SER . 98.9 m -158.77 143.39 15.86 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 175.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.42 -1.936 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 172.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.589 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 55.1 ttp . . . . . 0 C--O 1.233 0.236 0 N-CA-C 111.263 0.097 . . . . 0.0 111.263 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -125.66 154.7 41.98 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 174.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.683 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 3.8 pt20 -106.4 143.7 34.15 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.553 0.692 . . . . 0.0 112.842 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' A' ' 62' ' ' THR . 14.1 mm100 -127.48 120.54 28.56 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.706 173.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.8 t -93.6 103.29 15.47 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.529 ' HB2' ' CG1' ' A' ' 61' ' ' ILE . 85.0 m-85 -99.11 112.43 24.57 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.737 -178.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 m -86.37 118.3 25.72 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 175.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.5 mt -98.35 130.61 46.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-O 121.437 0.637 . . . . 0.0 112.59 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.628 HG22 ' O ' ' A' ' 87' ' ' THR . 4.9 tp -95.02 -26.37 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.808 176.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -26.91 97.28 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 -166.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -70.01 -13.46 62.23 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 113.789 -1.55 . . . . 0.0 111.213 -176.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.1 m -66.24 -25.14 66.75 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.28 40.65 6.85 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.496 ' HB2' ' N ' ' A' ' 55' ' ' VAL . . . 90.75 72.05 0.0 OUTLIER 'General case' 0 CA--C 1.482 -1.648 0 C-N-CA 125.568 1.547 . . . . 0.0 112.28 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . 0.254 0.4 OUTLIER -73.97 98.2 2.99 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.568 -1.253 . . . . 0.0 111.1 173.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.52 -23.13 61.73 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.149 -1.387 . . . . 0.0 113.273 -174.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -64.0 -50.61 68.59 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 119.575 -0.85 . . . . 0.0 112.168 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.501 ' HB3' ' HB3' ' A' ' 84' ' ' GLU . 82.7 Cg_exo -55.15 -31.48 75.8 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 122.108 1.872 . . . . 0.0 111.253 171.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.594 ' O ' ' HB3' ' A' ' 22' ' ' LEU . . . -72.25 -22.17 61.27 Favored 'General case' 0 C--O 1.203 -1.346 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.806 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.411 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 3.6 m -75.49 -33.91 60.82 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 51.2 ttm -66.96 -38.59 86.37 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.654 ' HG ' HD21 ' A' ' 44' ' ' LEU . 59.1 tp -56.83 -47.69 79.74 Favored 'General case' 0 CA--C 1.477 -1.848 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.121 174.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 19' ' ' ALA . 13.2 t -53.55 -48.24 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.542 0 CA-C-N 113.503 -1.68 . . . . 0.0 110.607 -178.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.06 -29.79 70.19 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.488 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.7 m -74.3 -49.53 22.64 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -177.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.505 ' HA ' ' CD2' ' A' ' 29' ' ' PHE . . . -61.61 -31.27 71.34 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 174.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.6 m -56.24 -39.28 72.29 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 123.419 0.45 . . . . 0.0 111.766 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.48 7.62 40.37 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -177.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.505 ' CD2' ' HA ' ' A' ' 26' ' ' ALA . 12.7 m-85 -96.33 -16.99 21.0 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 54.29 17.12 1.41 Allowed 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 124.795 1.238 . . . . 0.0 113.955 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.497 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 53.2 m -102.8 160.82 14.26 Favored 'General case' 0 N--CA 1.412 -2.345 0 CA-C-O 121.081 0.467 . . . . 0.0 110.334 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.429 ' HA ' HD21 ' A' ' 43' ' ' ASN . 33.2 t70 -91.47 83.63 5.44 Favored 'General case' 0 N--CA 1.405 -2.702 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.5 HG23 HG23 ' A' ' 63' ' ' ILE . 84.6 mt -94.25 111.52 25.4 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 175.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -103.77 137.86 41.2 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 4.3 tt -101.72 111.48 23.75 Favored 'General case' 0 N--CA 1.392 -3.352 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -103.68 117.11 33.63 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 123.523 0.729 . . . . 0.0 109.278 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.555 ' HB3' HD11 ' A' ' 53' ' ' LEU . 15.5 t80 -135.26 90.58 2.64 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.182 177.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 43.7 64.93 1.11 Allowed 'General case' 0 C--O 1.244 0.769 0 C-N-CA 126.567 1.947 . . . . 0.0 113.13 176.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.76 -29.25 10.59 Favored Glycine 0 N--CA 1.432 -1.625 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.433 175.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -98.6 110.59 23.16 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.597 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 4.3 ptpp? -122.98 131.42 53.71 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 171.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.425 HG21 ' N ' ' A' ' 49' ' ' GLY . 11.6 p -146.63 158.63 10.58 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.54 ' OD1' ' HG2' ' A' ' 45' ' ' LYS . 23.0 t-20 -69.91 125.99 28.38 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 174.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.654 HD21 ' HG ' ' A' ' 22' ' ' LEU . 10.4 tt -62.81 -22.43 66.63 Favored 'General case' 0 N--CA 1.42 -1.936 0 C-N-CA 125.224 1.41 . . . . 0.0 114.209 -171.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.54 ' HG2' ' OD1' ' A' ' 43' ' ' ASN . 8.1 pttp -91.22 4.11 53.12 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 118.51 -1.276 . . . . 0.0 110.423 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.9 t -105.55 129.62 53.78 Favored 'General case' 0 N--CA 1.409 -2.499 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.314 174.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 pp -75.65 2.62 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 123.545 0.738 . . . . 0.0 111.804 -178.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 16.0 tpt -61.83 -48.35 80.97 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 113.35 -1.75 . . . . 0.0 110.186 -174.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.425 ' N ' HG21 ' A' ' 42' ' ' VAL . . . -108.45 -29.96 4.0 Favored Glycine 0 C--N 1.305 -1.171 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.428 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.1 t -61.52 -36.61 74.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -175.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 84.0 mtp -87.5 12.91 11.16 Favored 'General case' 0 C--O 1.22 -0.476 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.264 -178.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.9 m -124.86 5.48 8.06 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.555 HD11 ' HB3' ' A' ' 37' ' ' TYR . 8.2 tp -81.09 105.86 12.63 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.59 66.11 3.57 Favored Glycine 0 CA--C 1.508 -0.386 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 175.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.496 ' N ' ' HB2' ' A' ' 14' ' ' ALA . 4.6 p -89.48 97.82 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 CA-C-O 122.49 1.138 . . . . 0.0 111.452 -173.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.28 -153.99 9.45 Favored Glycine 0 N--CA 1.432 -1.586 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.455 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -61.51 136.06 57.89 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.9 t70 77.99 3.96 2.86 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.972 1.309 . . . . 0.0 111.444 175.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.93 118.74 14.09 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.404 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -95.19 108.34 20.46 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.529 ' CG1' ' HB2' ' A' ' 6' ' ' TYR . 11.4 pt -110.49 157.4 11.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.31 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 4' ' ' GLN . 61.4 m -133.08 124.25 27.25 Favored 'General case' 0 C--N 1.273 -2.74 0 CA-C-O 121.185 0.517 . . . . 0.0 110.986 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.533 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.4 mp -91.85 125.84 44.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 175.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.683 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 45.3 m-85 -110.42 106.76 16.22 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 171.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.589 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -105.37 113.32 26.82 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.208 -176.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -128.29 120.06 26.35 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.497 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -174.66 -172.25 39.55 Favored Glycine 0 CA--C 1.475 -2.419 0 C-N-CA 117.787 -2.149 . . . . 0.0 113.351 -172.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.4 p -73.86 -26.97 60.84 Favored 'General case' 0 N--CA 1.421 -1.913 0 C-N-CA 124.197 0.999 . . . . 0.0 111.002 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -134.63 21.88 3.62 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.465 ' O ' HG12 ' A' ' 74' ' ' ILE . 9.5 pt-20 -42.52 -52.8 4.61 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -172.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.523 ' O ' ' HB ' ' A' ' 74' ' ' ILE . . . -65.24 -42.74 93.07 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -173.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -84.73 -21.97 29.87 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.18 -39.98 95.14 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 172.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.523 ' HB ' ' O ' ' A' ' 71' ' ' ALA . 24.6 mm -56.26 -48.06 80.08 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 CA-C-O 121.731 0.777 . . . . 0.0 109.572 173.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.441 ' HA ' ' OE1' ' A' ' 75' ' ' GLN . 12.2 mm-40 -57.54 -39.49 76.75 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.117 -1.401 . . . . 0.0 111.998 -178.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.36 -41.82 17.76 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.422 HD12 HD13 ' A' ' 33' ' ' ILE . 4.8 tt -62.52 -32.75 56.32 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.082 0 CA-C-O 120.847 0.356 . . . . 0.0 111.199 -174.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.7 m -68.1 -28.45 67.36 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 120.854 0.359 . . . . 0.0 110.762 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.56 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 16.3 t70 -78.44 -47.55 17.26 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -175.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 23.8 m -66.0 -32.13 56.77 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.47 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.8 mt -67.37 -45.94 74.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.141 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.603 ' HA ' ' OG1' ' A' ' 87' ' ' THR . 22.7 t -62.97 -43.53 98.54 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.04 178.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' A' ' 79' ' ' ASP . 33.1 mmtp -64.72 -40.53 95.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.956 0.408 . . . . 0.0 110.67 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.501 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . 19.1 mm-40 -77.06 -17.46 58.74 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.06 53.87 2.43 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 120.644 -0.788 . . . . 0.0 111.867 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 79.9 mt -140.56 39.16 1.86 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 122.386 1.088 . . . . 0.0 108.124 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.628 ' O ' HG22 ' A' ' 9' ' ' ILE . 17.4 p -139.87 -155.03 0.55 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 175.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 . . . . . 0 C--N 1.307 -1.24 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 171.58 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.516 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 66.9 mtt . . . . . 0 CA--C 1.491 -1.303 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -98.84 149.63 22.7 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 172.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.757 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 4.0 pt20 -114.19 149.11 36.24 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -176.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.485 ' O ' ' HA ' ' A' ' 62' ' ' THR . 30.6 mm-40 -127.37 129.48 47.66 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 113.707 -1.588 . . . . 0.0 107.89 173.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.2 t -103.23 104.16 14.27 Favored 'General case' 0 N--CA 1.416 -2.147 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 175.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.49 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 31.3 m-85 -95.37 103.4 15.26 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.822 -176.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.2 m -79.61 89.35 5.12 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.52 HG23 ' H ' ' A' ' 10' ' ' ASP . 4.3 mt -69.41 138.2 22.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 114.779 -1.1 . . . . 0.0 113.098 -175.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 pp -96.12 -4.31 10.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.834 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.52 ' H ' HG23 ' A' ' 8' ' ' ILE . 6.5 t70 -59.04 125.82 25.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.177 176.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -124.11 19.33 9.13 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.7 m -87.1 -24.54 24.51 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 113.966 -1.47 . . . . 0.0 108.825 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.67 21.88 10.04 Favored Glycine 0 N--CA 1.434 -1.479 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -178.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.484 ' HB2' ' CG2' ' A' ' 55' ' ' VAL . . . 91.8 92.73 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.14 0 C-N-CA 127.069 2.148 . . . . 0.0 111.34 -178.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . 0.257 2.4 p-80 -69.99 95.81 0.98 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 122.532 1.158 . . . . 0.0 110.666 172.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.28 -29.63 64.07 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 113.36 -1.745 . . . . 0.0 114.407 -170.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.51 -51.26 52.4 Favored Pre-proline 0 CA--C 1.556 1.202 0 CA-C-O 119.147 -0.454 . . . . 0.0 110.241 -178.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -57.73 -37.2 97.46 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 121.758 1.639 . . . . 0.0 110.812 172.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.68 ' O ' ' HG ' ' A' ' 22' ' ' LEU . . . -66.01 -18.84 65.61 Favored 'General case' 0 C--O 1.197 -1.7 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.929 178.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.4 m -70.02 -24.57 63.31 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 49.7 ttm -78.26 -35.26 48.35 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 175.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -64.84 -37.58 88.11 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 176.308 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 45' ' ' LYS . 4.5 t -58.57 -47.43 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.107 176.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -66.18 -19.28 65.79 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.784 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 54.2 m -84.2 -50.38 7.95 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.99 -29.09 69.41 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.6 p -62.71 -19.02 63.49 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -114.09 -145.77 0.4 Allowed 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 69.63 13.23 8.21 Favored 'General case' 0 C--O 1.247 0.921 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 174.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 56.92 27.11 12.59 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.913 0.885 . . . . 0.0 112.648 170.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.528 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 19.3 m -142.69 156.29 45.01 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.806 -177.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -105.57 113.81 27.61 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 175.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 3.1 mp -97.74 126.16 50.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.144 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -104.78 143.84 32.57 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 3.9 tt -96.48 129.69 43.79 Favored 'General case' 0 N--CA 1.403 -2.776 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 173.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.691 ' HA ' ' O ' ' A' ' 40' ' ' LYS . 0.5 OUTLIER -130.2 119.83 23.56 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -150.31 103.12 3.13 Favored 'General case' 0 C--N 1.293 -1.879 0 O-C-N 122.304 -0.248 . . . . 0.0 111.246 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.0 t30 59.56 28.71 18.17 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.84 0.856 . . . . 0.0 111.329 171.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.48 -17.03 8.44 Favored Glycine 0 CA--C 1.495 -1.215 0 C-N-CA 119.821 -1.18 . . . . 0.0 111.608 -178.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.691 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 13.3 mmtp -77.63 140.19 39.6 Favored 'General case' 0 CA--C 1.481 -1.705 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 15.1 ptmm? -143.99 112.56 6.53 Favored 'General case' 0 N--CA 1.413 -2.292 0 CA-C-N 114.299 -1.319 . . . . 0.0 108.594 169.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.3 p -149.04 160.46 5.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.772 -174.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.519 ' ND2' ' HG2' ' A' ' 45' ' ' LYS . 15.6 t30 -66.47 109.0 2.58 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.534 HD11 HD11 ' A' ' 77' ' ' ILE . 3.4 tm? -62.73 -25.93 68.44 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.661 0.784 . . . . 0.0 112.713 -173.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.519 ' HG2' ' ND2' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -88.37 24.61 1.87 Allowed 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 122.249 1.024 . . . . 0.0 110.356 178.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 43' ' ' ASN . 52.0 m -122.29 125.94 47.07 Favored 'General case' 0 N--CA 1.4 -2.974 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.145 172.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.46 -23.24 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 47.0 ttp -58.75 -22.02 56.87 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.859 -1.519 . . . . 0.0 110.187 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -84.94 -67.33 1.42 Allowed Glycine 0 N--CA 1.423 -2.211 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 94.4 t -55.09 -40.7 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -175.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 34.5 ttm -77.19 -0.75 26.26 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-O 120.797 0.332 . . . . 0.0 111.537 -175.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 62.8 m -98.89 -19.07 17.56 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 121.692 -0.63 . . . . 0.0 111.748 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.53 ' HB2' ' CG2' ' A' ' 55' ' ' VAL . 4.7 mp -75.13 150.53 38.74 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.5 66.1 3.25 Favored Glycine 0 C--N 1.301 -1.364 0 N-CA-C 107.998 -2.041 . . . . 0.0 107.998 170.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.53 ' CG2' ' HB2' ' A' ' 53' ' ' LEU . 11.1 t -66.98 113.46 3.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 123.996 0.918 . . . . 0.0 110.194 -174.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 10' ' ' ASP . . . -162.22 111.57 0.48 Allowed Glycine 0 N--CA 1.432 -1.587 0 CA-C-O 119.44 -0.644 . . . . 0.0 111.94 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.3 pttp 39.31 -43.9 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.944 0 C-N-CA 129.766 3.226 . . . . 0.0 117.966 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -93.25 7.29 44.93 Favored 'General case' 0 C--N 1.285 -2.212 0 O-C-N 121.336 -0.852 . . . . 0.0 109.399 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.15 89.25 1.15 Allowed 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.173 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 35.5 mt-10 -94.58 93.03 7.35 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 174.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.5 pt -93.69 143.42 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.057 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.538 -174.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 4' ' ' GLN . 25.1 m -106.41 123.24 47.77 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-O 121.273 0.558 . . . . 0.0 109.983 -177.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.3 mp -100.5 129.54 51.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.182 176.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.757 ' CE1' ' HB3' ' A' ' 3' ' ' GLN . 38.0 m-85 -115.55 112.87 22.84 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 123.682 0.614 . . . . 0.0 109.925 174.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -106.29 119.88 40.4 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.516 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 26.1 t70 -131.44 117.06 18.31 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.528 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -173.91 -163.92 28.17 Favored Glycine 0 N--CA 1.425 -2.09 0 C-N-CA 119.524 -1.322 . . . . 0.0 112.736 -174.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.5 m -87.59 -22.32 24.84 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.844 0.831 . . . . 0.0 109.373 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -132.39 35.85 3.63 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.838 -177.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.414 ' OE1' ' HA ' ' A' ' 66' ' ' ASP . 11.3 pt-20 -64.28 -38.0 89.47 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -173.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.31 -30.37 68.42 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.136 0.493 . . . . 0.0 110.658 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -76.06 -39.39 55.56 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 177.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.47 -41.23 98.59 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.441 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.466 HD12 ' HG2' ' A' ' 4' ' ' GLN . 16.6 mm -51.71 -51.33 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.279 0.631 . . . . 0.0 111.235 177.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -65.32 -41.53 93.92 Favored 'General case' 0 N--CA 1.405 -2.716 0 C-N-CA 122.799 0.44 . . . . 0.0 110.46 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.464 ' O ' ' HB3' ' A' ' 79' ' ' ASP . . . -67.15 -38.67 85.91 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.578 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.534 HD11 HD11 ' A' ' 44' ' ' LEU . 5.1 tt -72.25 -35.03 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.025 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.856 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.5 m -66.6 -41.62 88.17 Favored 'General case' 0 C--O 1.253 1.285 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 174.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 76' ' ' ALA . 26.3 t70 -51.22 -55.0 20.31 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 114.199 -1.364 . . . . 0.0 110.975 176.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.409 ' HA ' ' HB3' ' A' ' 83' ' ' LYS . 35.0 m -70.42 -34.14 56.71 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.081 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.9 mp -61.89 -50.35 72.57 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 119.278 0.945 . . . . 0.0 110.949 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.6 p -63.46 -39.22 93.88 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.03 0.443 . . . . 0.0 111.58 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 80' ' ' VAL . 36.8 ttmt -59.25 -43.78 92.41 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 124.227 1.011 . . . . 0.0 109.665 176.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -86.22 5.99 31.65 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 124.473 1.109 . . . . 0.0 112.505 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.88 30.76 70.06 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 115.429 0.932 . . . . 0.0 115.429 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.4 mp -90.56 -34.68 15.42 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 118.436 1.118 . . . . 0.0 109.713 174.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 27.1 p -119.49 150.18 40.66 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 . . . . . 0 N--CA 1.424 -1.749 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.387 . . . . . . . . 0 0 . 1 stop_ save_